Har yaushe wadannan alamun suke?
Dole ne a bi da duk wani abu na ciwo ta wannan hanyar musamman a shekarunku.
kuma tare da zazzabi.
Hakanan kuna buƙatar yin gwajin hawan jini.
Shin kana da zazzabi yanzu?
Shin kana da wannan ciwon a yanzu?
Bugu da ƙari, kuna da matsala wajen numfashi.
kuma za ku iya gaya mani wasu alamun da kuke da shi?
Yaya za a ji game da zazzabinku?
Ina da ƙuƙwalwa kuma.
Ina da bayanan sanyi da kumburi.
Kuma a gaskiya, a yau ina da wasu raunin da ke damuna.
Lokaci ne mafi kyau don tafiya a kan jirgin ruwa.
kuma ta kamu da ciwon hanci.
Ina tsammanin ina da ɗan sukari.
Ina so ku bayyana yadda ake cutar da ƙwayoyin cuta.
Kuma suna da bayanan zazzabi.
da kuma ciwon sukari na baya
Ka san, ina jin kamar kirjina yana fashewa.
Ka san mutane suna yi min ba'a a kowane lokaci.
Kuna da ciwon daji?
Ka ce, "Kana da wani matsa lamba a kirjinka.
kowa a cikin iyali da ke fama da ciwon zuciya, cututtukan zuciya, cututtukan zuciya, high cholesterol, high blood pressure
wasu alamomi ko matsaloli da kake gani a cikin ciwon tsoka?
Ba wani mutum a gidanka da yake da irin wannan rashin lafiya?
Shin kana da irin wannan alamun?
Shin kuna da karancin numfashi?
Shin har yanzu kuna fama da ciwon hanci?
Domin wannan lokacin sanyi ne.
Amma kuma kada mu yi watsi da ciwon hanci da ciwon zuciya.
Amma wata matsala mafi muhimmanci a yanzu ita ce cin abinci.
Amma ina da matsala wajen numfashi.
Amma na san mutane da yawa sun yi fushi da ni.
Amma dole ne mu yi wa kowane irin ciwo na rashin lafiya, biyayya ta fi girma.
Amma kuna numfashi sosai a yanzu, dama?
Saboda wannan ciwon na hanci, na manta da shi gaba daya.
Shin kana jin kamar wani yana shiga kirjinka?
Har yanzu ina jin kamar ina shan numfashi sosai.
Shin suna jin tsoron cewa suna da irin wannan alamun?
Shin kana da wani irin ciwo na dogon lokaci kamar zubar da jini ko wani abu makamancin haka?
Shin kuna da wani ciwo da ya wuce tsawon lokaci, kamar ciwon baya?
Shin kana da wani rashin numfashi da ke fama da wannan ciwon?
Kana da jini?
Shin kuna da rashin numfashi?
Shin kun san alamun da take da shi?
Ka ga labarin?
Akwai ruwa mai yawa a yau.
Koyaya, na ɗauki binciken sukari.
Duk da haka, yana da alamomi iri ɗaya da na data.
Yaya yawan zafin jikinka yake?
Yaya jini yake?
idan kuna da ci gaba da ciwon zazzabi
idan kana da zazzabi mai tsanani ko fiye da haka
idan kuna ganin alamunku ko matsalolinku suna da muhimmanci
Na ji zazzabi jiya.
Kuma akwai wasu bayanai masu yawa game da sukari.
Na yi zazzabi jiya.
Ina da wata rauni a kirji a nan.
Na kuma samu matsala a numfashi.
Zan aika maka da labarin.
Ina da bayanan ciwon hanci a yau.
Ina da kadan daga cikin cututtukan ciwon kai da kuma cututtukan ciwon kai a yau.
A ganina, wannan sanyi ne.
A ganina, wannan wani sanyi ne.
Kamar dai wani mutum ne mai nauyi yana zaune a kan kirji na.
Ya fara ne da ciwon kai da zazzabi a lokaci guda.
Yana cutar da cibiyar kirji.
Wannan matsin lamba ne kamar ciwon ciki.
Yana cikin zuciyata.
Yana tsakiyar zuciyata.
Yana cikin tsakiyar kirji.
Na ji ciwon kirji.
Ina matukar damuwa game da wannan ciwon.
Ina so ku dubi kanku ta hanyar bayyana asalin wannan cuta.
kamar jini ko sukari
Kamar dai a gefen dama na tsakiyar kirji
Yanzu zaka iya ɗaukar zazzabi tare da tachipirina mai zaki.
Yanzu, Mary, kwana nawa ka yi da alamun?
Yanzu kun ce kuna da ciwon hanci.
Wani lokaci ina da bayanan ciwon hanci.
To, kuna da wasu alamun cutarwa a cikin wannan, banda ciwo?
Ko kuma wani yana zaune a kirjinku?
Da kyau, fiye da irin wannan zazzabi da kumburi, ciwon kai da ciwon tsoka.
a gefen dama na tsakiya na kirji
Ka nuna min inda kake jin zafi a cikin labarin.
har sai kun sami zazzabi
Shin kana ganin cewa wani ɓangare na wadannan alamun suna da alaƙa da cewa kana da ciki?
Shin yaranku suna da irin wannan alamar?
Ka gaya mani game da ciwon da kake sha.
A cikin dare, zafin jiki yana ƙaruwa.
Na samu zazzabi a cikin kwanaki biyu da suka gabata.
A yau za a fara samun ciwon zazzabi.
Wannan shi ne Dr. Porter a cikin dakin gaggawa na cibiyar kula da marasa lafiya.
Za ku iya gaya mani ƙarin bayani game da ciwon da kuke ciki?
Na ji zafi a saman jikina a baya.
Na yi fama da ciwon ciki mai tsanani.
A lokacin da na ji wannan ciwon a zuciyata.
To, wane irin ciwo ne kuke da shi a kirjinku?
A wane lokaci ne wannan ciwon ya fara?
A ina ne kuka samu ciwon da ke damun ku?
inda za ku ji wannan ciwon a cikin ƙuƙwalwar kirji
Kuna jin idanunku suna cikin wani abu.
Na sha sukari kuma ina da irin wannan halin.
Ka ce kana da wannan ciwon.
Yaduwar cututtukan cutar coronavirus (COVID-19) a cikin Tarayyar Turai / Yankin Tattalin Arziki na Turai da Burtaniya, daga 1 ga Janairu zuwa 15 ga Maris, 2020
Yawan adadin cututtukan coronavirus (COVID-19) ya nuna irin wannan canjin a cikin Tarayyar Turai / Yankin Tattalin Arzikin Turai da Burtaniya wanda ya tabbatar da hakan, yayin da a matakai daban-daban dangane da ƙasa, cutar COVID-19 ta duniya tana yaduwa cikin sauri a duk ƙasashe.
Bisa ga gogewar da aka samu a Italiya, ƙasashe, asibitoci da sassan gaggawa suna bukatar kara shirye-shiryen su na biye da marasa lafiya da ke fama da COVID-19 da ke bukatar kulawar lafiya, musamman gaggawa.
A ranar 31 ga Disamba, 2020, an samu rahoton wasu mutane da suka kamu da cutar sankara a birnin Wuhan, lardin Hubei, kasar Sin.
Ranar 9 ga Janairu, 2020, Cibiyar Kula da Cututtuka da Rigakafin Cutar ta kasar Sin ta bayyana dalilin sabon coronavirus wanda yanzu ake kira ciwon huhu mai tsanani na alamun cutar coronavirus 2 ((SARS-CoV-2).
Har zuwa yanzu, cutar da ke haifar da kamuwa da cutar SARS-CoV-2 ana kiranta cutar coronavirus (COVID-19).
Akwai hujja har zuwa 80% na mutanen da ke da COVID-19 suna da ƙananan cututtuka, kamar kumburi na numfashi a cikin marasa lafiya ko rashin burburin, kuma galibi suna warkewa.
A kusan kashi 14% na lokuta, COVID-19 yana haifar da ciwo mai tsanani wanda ke buƙatar magani yayin da sauran kashi 6% na lokuta suna magance ciwo mai tsanani wanda ke buƙatar kulawa da gaggawa.
Mutuwar marasa lafiya masu magani na COVID-19 kusan 4%.
A cikin wannan binciken, mun kimanta canje-canje a cikin duk abubuwan da suka faru na COVID-19 a kowace ƙasa ta Tarayyar Turai / Yankin Tattalin Arzikin Turai (EU / EEA) da Burtaniya (UK) idan aka kwatanta da lardin Hubei. China.
Hakanan muna kwatanta adadin shari'o'in COVID-19 na yanzu a cikin ƙasashen EU / Yankin Tattalin Arzikin Turai EU / EEA da Burtaniya UK da Italiya a tsakanin 31 ga Janairu zuwa 15 ga Maris 2020.
Maganganun COVID-19 a cikin ƙasashen Tarayyar Turai / Yankin Tattalin Arzikin Turai EU / EEA da Burtaniya UK
Bayan China, COVID-19 ta bazu zuwa wurare da yawa a yanayin ƙasa. Saurin cutar ta COVID-19 a sauran duniya yanzu yayi kama da na wannan ƙasar.
A ranar 11 ga Maris, 2020, Hukumar Lafiya ta Duniya (WHO) ta amince da COVID-19 a matsayin cuta ta duniya.
A ranar 5 ga watan Maris na shekarar 2020, a cikin taron Eurosurveilance 2020, Spiteri et al. sun ba da rahoton farkon shari'ar COVID-19 a Turai kamar yadda Hukumar Lafiya ta Duniya ta WHO ta bayyana.
A cikin Tarayyar Turai/Yankin Tattalin Arziki na Turai EU/EEA, an bayar da rahoton mutum uku na farko da aka tabbatar da cutar a ranar 24 ga Janairu 2020 daga Wuhan, lardin Hubei, China.
A ranar 15 ga Maris, 2020, an lura da shari'o'in COVID-19 na farko a duk ƙasashe 30 na Tarayyar Turai / Yankin Tattalin Arzikin Turai EU / EEA da Burtaniya (UK), yayin da tsakanin 31 ga Disamba, 2019 da wannan kwanan wata, an ba da rahoton shari'o'i 39,768 da mutuwar 1,727, tare da shari'o'i 17,750 da mutuwar 1,441 a Italiya kadai.
Samun cikakken adadin shari'o'in COVID-19 da kuma yawan abubuwan da suka faru
Cibiyar Tarayya da Kula da Cututtuka ta Turai (ECDC), yawan adadin shari'o'in COVID-19 da aka bayyana a kowace ƙasa a duniya, wanda aka samu daga tushe na hukuma kawai kamar ma'aikatun lafiya na tarayya, shugabannin kiwon lafiya na ƙasa da na yanki da Hukumar Lafiya ta Duniya WHO, ana sanar da su kowace rana da karfe 8:00 na safe.
An yi amfani da wannan bayanin don kimanta canjin COVID-19 a cikin EU/EEA da Burtaniya da kuma kwatanta shi da na Italiya.
A matsayinmu na shugaban rahoto kan shari'o'in COVID-19, mun lissafa kwanaki 14 na rage yawan abubuwan da suka faru na COVID-19, don haka muna lissafin yanayin COVID-19 na halitta a kowace ƙasa ta EU / EEA da Burtaniya, tsakanin 1 ga Janairu zuwa 15 ga Maris 2020.
Mun gabatar da jimlar adadin wadanda aka gano a kowace kasa a ranar 15 ga Maris, 2020 da karfe 8:00 na safe idan aka kwatanta da na Italiya a ranar 31 ga Janairu zuwa 15 ga Maris, 2020.
Canjin COVID-19 a cikin EU/EEA da Burtaniya
Canje-canje daga 14 na yau da kullum na rage yawan lokuta na COVID-19 a cikin ƙasashen EU / EEA da Burtaniya suna faruwa gaba ɗaya a cikin Hubei (China) (zane 1).
A cikin EU / EEA da Burtaniya, yawan adadin shari'o'in COVID-19 ya fara ƙaruwa a kusan 21 ga Fabrairu kuma yanzu ya ƙaru da sauri a kusan 28 ga Fabrairu 2020 (Shayin tallafi).
Wannan ya faru ne saboda yaduwar yawan shari'o'in da aka bayyana a Italiya, amma duk sauran kasashen EU/EEA da Burtaniya suna nuna karuwa a yawan adadin shari'o'in COVID-19 (Shayin da aka taimaka).
Shafin 2 ya nuna jimlar adadin shari'o'in COVID-19, a cikin ƙasashen EU/EEA da Burtaniya idan aka kwatanta da na Italiya daga 31 ga Janairu zuwa 15 ga Maris, 2020
Ya nuna cewa, a ranar 15 ga Maris da karfe 8:00 na safe, wasu ƙasashe 15 na EU / EEA da Burtaniya sun riga sun ba da rahoton jimlar adadin shari'o'in da za a iya kwatanta da na Italiya makonni 2 da suka gabata ko ƙasa da haka.
Sakamakonmu ya nuna cewa adadin shari'o'in COVID-19 da aka gano suna ƙaruwa cikin sauri a cikin EU / EEA da Burtaniya.
Canjin da aka lura a cikin yawan abubuwan da ke faruwa na COVID-19 ya nuna cewa cutar ta yadu a duniya a cikin saurin da za a iya kwatanta da kowace ƙasa.
Wannan ya zo ne saboda ƙasashe suna da bambancin matakan, bambancin amsa ga lafiyar jama'a a cikin ƙasa, da yiwuwar ƙayyade shari'o'i daban-daban a cikin ƙasashe da kuma abubuwan da za a yi la'akari da su don zaɓin marasa lafiya da za a bincika don tabbatar da COVID-19, gami da gwajin daidaitawa.
A farkon watan Maris na shekarar 2020, likitoci a yankunan da cutar ta shafa a Italiya sun bayyana halin da ake ciki inda kashi 10% na marasa lafiya da ke dauke da COVID-19 ke bukatar sashen kula da gaggawa yayin da kafofin yada labarai suka ruwaito cewa asibitoci da kayan aikin kula da yankin sun kai matakin da suka fi dacewa.
Bayanai na rajistar shari'o'in COVID-19 a asibitoci da/ko a sashen kula da gaggawa cewa a halin yanzu ana samun su ne a matakin EU/EEU kawai a kashi 6% da 1% na shari'o'in, bi da bi (ba a bayyana bayanai ba).
Duk da haka, dole ne a tattara shi a cikin tsari don canja bayanan sa ido na yanzu wanda ke mai da hankali kan yawan shari'o'in da aka ruwaito da yawan mutuwar.
Wani binciken da aka gudanar a shekarar 2010-11 ya nuna bambancin da ke tsakanin samun kulawa ta gaggawa da kuma gadajen kulawa ta tsakiya a Turai, daga 29.2 a Jamus zuwa 4.2 a kowace mutane 100,000 a cikin al'ummar Burtuga.
Wannan yana nufin cewa ƙasashe na iya samun kuɗi fiye da ko ƙasa da na Italiya (12.5 a cikin gaggawa da kuma gadaje na gaggawa na 100,000 a kowace mutum a cikin al'umma a shekarar 2010-11)
A cikin matakan tsarawa game da haɗa nauyin kula da lafiya, tare da ƙididdigar kowane ƙasar EU / EEA da Burtaniya don fifita yanayin COVID-19 da aka kwantar a asibiti dangane da > 90% haɗarin wuce haddi na yawan gado na gaggawa, an nuna shi a cikin sabuntawa ta shida na ECDC don kimanta haɗarin gaggawa na COVID-19.
Tun da yawan shari'o'i yana ƙaruwa a wasu yankuna na ƙasashen EU/EEA da na Burtaniya, da kuma asibitoci da cibiyoyin gaggawa waɗanda yawanci ke aiki don daidaitawa da al'umma a cikin yankuna, ya kamata a sa bayanai game da shari'o'i da gadon gaggawa a cikin wuraren da ake samun su a cikin yankin 2 (NUTS-2) matakin.
Kwarewar Italiya da kuma halin yanzu a wasu ƙasashe ya nuna cewa cutar COVID-19 ta duniya tana ci gaba cikin sauri a cikin EU / EEA da Burtaniya.
Kasashe, Asibitoci da sassan gaggawa dole ne su shirya kansu don daidaitawar watsawar SARS-CoV-2 da kuma karuwar yawan marasa lafiya da ke da COVID-19 waɗanda ke buƙatar kulawar likita, musamman kulawar gaggawa, kamar yadda yake faruwa a yankunan da aka shafa a Italiya.
Kamar yadda aka ambata a cikin kimanta haɗarin gaggawa na kwanan nan, hanzari, aiki mai mahimmanci yana da mahimmanci don jinkirta yaduwar SARS-COV-2, ta hanyar motsawa daga hanyar sarrafawa zuwa ragewa, tare da ƙaruwa mai sauri a cikin adadin shari'o'in da bazai iya ba da shawarar da aka yi wa masu tuki da asibitoci a cikin lokaci ba don fahimta, karɓa da daidaita halayen su daidai idan ba a aiwatar da su ba a gaba.
Ƙididdigar haɗari na gaggawa ta ƙara matakan kiwon lafiyar jama'a don rage tasirin cutar ta duniya.
Akwai ƙarancin dama ga ƙasashe da ke da damar haɓaka ƙoƙarin sarrafa su don rage yaduwar SARS-COV-2 da rage matsin lamba akan kiwon lafiya.
Idan wannan ya kasa, tsarin kiwon lafiya na sauran ƙasashen EU/EEA zai fuskanci ƙaruwar yawan marasa lafiya da ke bukatar kulawa ta gaggawa a cikin kwanaki ko makonni masu zuwa.
Cutar cutar Coronavirus 2019 (COVID-19), wanda ya haifar da cutar ta cutar huhu mai tsanani (SARS) coronavirus 2 (SARS-CoV-2), ya kashe mutane sama da 3,000 zuwa yanzu kuma ya shafi sama da 80,000 a China da sauran wurare a duniya, wanda ya haifar da bala'in ɗan adam.
Hakanan, irin wannan kwayar cutar, SARS-CoV, wacce ta haifar da SARS ga dubban mutane a cikin 2003, SARS-CoV-2 na iya wucewa ta hanyar firikwensin kuma ta haifar da alamun bayyanar irin wannan ta hanyar iri ɗaya.
Koyaya, COVID-19 yana da ƙarancin tashin hankali da mutuwa fiye da SARS amma yana da yawa kuma yana shafar manya fiye da matasa da maza fiye da mata.
A cikin martani ga yawan wallafe-wallafen cututtuka masu tasowa, wannan labarin yana ƙoƙarin kawo cikakken ra'ayi game da batun bincike mai sauƙi.
Muna rufe abubuwan da suka shafi cututtukan cututtuka, asalin cutar, nazarin ƙwayoyin cuta, bincike, magani, tsinkaya na dalilin ciwo, da rigakafin ciwo.
Duk da cewa akwai tambayoyi da yawa da ake bukatar amsoshi, muna fatan wannan ra'ayi zai taimaka wajen fahimtar da kuma kawo karshen cutar.
Bikin bazara na 25 ga Janairu, 2020 ya zama abin tunawa da ba a taɓa gani ba kuma an manta da shi ga duk Sinawa waɗanda aka gaya musu cewa suna cikin gidaje a cikin hutu na makonni bayan barkewar sabon cutar.
Kwayar cutar tana kama da cutar coronavirus (CoV) wacce ta haifar da mummunan cututtukan huhu na SARS a cikin 2003; saboda haka, Hukumar Lafiya ta Duniya ta sanya masa suna SARS-CoV-2 a ranar 11 ga Fabrairu, 2020, kuma cutar da ke da alaƙa da ita ta sanya masa suna COVID-19 (Covid-19).
Cutar zazzabin cizon sauro ta fara ne a birnin Wuhan na kasar Sin, kuma ta bazu cikin sauri a duk fadin kasar da kuma wasu wurare kusan 50 a duniya.
Ya zuwa ranar 2 ga Maris, 2020, cutar ta haifar da fiye da 80,000 da aka tabbatar da shari'o'in COVID-19, tare da fiye da 40,000 marasa lafiya sun warke kuma fiye da 3,000 marasa lafiya sun mutu.
Hukumar Lafiya ta Duniya ta yi gargadin cewa COVID-19 "abokin gaba na farko na al'umma" ne kuma yana iya zama mafi iko fiye da ta'addanci.
A cewar PubMed (https://www.ncbi.nlm.nih.gov/pubmed/), a cikin kasa da watanni biyu, an buga takardu sama da 200 game da COVID-19 ciki har da cutar ta kamuwa da cuta, nazarin cutar ta kamuwa da cuta, nazarin asalinta, bincike, da magani tun lokacin da aka fara bayar da rahoton ranar 7 ga Janairu, 2020 wanda ya nuna jerin yadda aka kamu da cutar a cikin marasa lafiya da yawa.
Wannan edita yana ƙoƙarin taƙaita ci gaban bincike a cikin sabon yanki na al'ada wanda ke ci gaba cikin sauƙi.
A duk lokacin da zai yiwu, muna ƙoƙarin kwatanta COVID-19 da SARS da wani cuta da COVID ta haifar, cutar huhu ta Gabas ta Tsakiya (MERS, barkewar 2012).
Zan kuma tattauna abin da muka koya zuwa yanzu dangane da maganin da kuma tsinkaya na dalilin ciwo da kuma sauran batutuwa masu gaggawa.
CoVs an san su da cutar da ba ta kashe mutane ba, kuma suna haifar da kusan kashi 15% na cutar 4.
Duk da haka, a wannan ƙarni, mun sami manyan cututtukan CoVs na mutum sau biyu, kamar SARS-CoV da MERS-CoV, waɗanda suka haifar da annoba a China a 2003 da Saudiyya a 2012, bi da bi, wanda ya bazu cikin sauri zuwa wasu ƙasashe tare da rashin lafiya mai tsanani da mutuwa.
Saboda haka, COVID-19 yanzu shine barkewar COVID na uku a tarihin ɗan adam.
Kamar yadda aka nuna a cikin Figure 1,1, an fara bayar da rahoton rukunin kwayoyin cuta marasa ƙwayoyin cuta a Wuhan a ranar 31 ga Disamba, 2019 ga Hukumar Lafiya ta Kasa ta China.
Bayan kwana bakwai, an saki CoV a jere.
A ranar 15 ga Janairu, 2020, an bayar da rahoton mutuwar farko a Wuhan.
A lokaci guda, cutar sankara ta bazu cikin sauri zuwa garuruwan makwabta, jihohi da tsibirai.
A ranar 20 ga Janairu, an bayar da rahoton cutar ta hanyar kula da lafiya, wanda ke nuna cewa mutum zai iya yin aiki.
A ranar 23 ga watan Janairu, an sanya dokar hana zirga-zirga a birnin Wuhan tare da dakatar da duk jigilar jama'a.
A ranar 24 ga watan Janairu, binciken farko na asibiti ya nuna cewa daga cikin marasa lafiya 41 da aka tabbatar da cutar, 21 ne kawai suka taɓa kasuwar abincin teku ta Wuhan wanda ake tsammanin wuri ne na kamuwa da cutar da albarkatun dabbobi da ba a sani ba.
A ranar 30 ga watan Janairu, Hukumar Lafiya ta Duniya ta ayyana cutar a matsayin gaggawa a duniya.
A lokacin da aka ba da rahoton, cutar ta bazu a kasar Sin da kuma kusan kasashe 50 a duniya.
Yayin da yanayin ke canzawa cikin sauri, girman ƙarshe da kuma mummunan fashewar suna nan.
A ranar 11 ga Fabrairu, 2020, binciken cibiyoyin da aka gudanar akan marasa lafiya 8,866 ciki har da marasa lafiya 4,021 da aka tabbatar da COVID-19 ya nuna sabuntawa mai yawa game da cutar mura kamar haka (https://mp.weixin.qq.com/s/UIBi-HX_rHPXa1qHA2bhdA).
SARS-CoV-2 yana kamuwa da mutane na kowane zamani, amma mafi yawan mutane suna tsakanin shekaru 30 zuwa 65.
Kusan rabin (47.7%) na mutanen da suka kamu da cutar sun fi shekaru 50, kadan ne a karkashin 20, amma 14 ne kawai a karkashin shekaru 10.
SARS-CoV-2 ya faru da maza da yawa (0.31/100,000) fiye da mata (0.27/100,000).
COVID-19 ta yadu zuwa yawancin kungiyoyi a cikin gida da kuma kusa da Hubei.
COVID-19 ya ɗauki matsakaita kwanaki 5 (2-9) kafin a fara gwajin.
Matsakaicin lokacin da ya yi aiki a ciki ya kasance kwanaki 4.8 (3.0-7.2).
Matsakaicin lokacin da ya mutu ya kasance kwanaki 9.5 (4.8-13).
Yawan haihuwa na asali (RO) ya kasance 3.77 (95% Cl: 3.51-4.05), kuma RO mai canzawa ya kasance 2.23-4.82.
Yawan masu kamuwa da cutar ya karu da sauri kafin 23 ga Janairu, 2020, saboda yawan zirga-zirgar motoci a lokacin bikin bazara na kasar Sin.
Mutuwar marasa lafiya tare da tabbatar da shari'o'in ya kasance 1.44% (95% CI: 1.10-1.86%), kuma daidaitaccen adadin mutuwar marasa lafiya ya kasance 3.06% (95% CI: 202-4.59%).
Abubuwa uku da suka fi haɗari ga COVID-19 sune jima'i (matsayi), shekaru (>=60), da kuma tsufa.
CoVs wani nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'
Ana iya raba shi zuwa rukuni huɗu, alal misali, alpha, beta, gamma da delta, wanda alpha da beta suka san faruwa ga ɗan adam.
A cikin ƙwayar cuta mai girma ((S) glycoprotein yana sauraron ƙwayar cuta ta hanyar ƙwayoyin angiotensin-sakewa enzyme 2 (ACE2) da dipeptidyl peptidase 4 (DPP4) don SARS-CoV da MERS-CoV, bi da bi, sannan ƙwayar cuta ta faru.
Ana sakin RNA na kwayar cutar ta hanyar cytoplasm; bayan an haifi kwayar cutar, RNA na kwayar halitta yana tare da membrane.
An bayar da rahoton farkon jerin kwayoyin halitta na SARS-CoV-2 a ranar 10 ga Janairu, 2020.
An gano SARS-CoV-2 a matsayin sabon nau'in beta-CoV wanda ke da fiye da 99.98% na ganowa ta hanyar kwayoyin halitta a cikin gwaje-gwaje 10 masu jere da aka tattara daga wurin da ya fara yaduwa, kasuwar abincin teku ta Huanan a Wuhan.
SARS-CoV-2 ya yi kama da SARS-CoV idan aka kwatanta da MERS-CoV.
Ta hanyar watsa lantarki ta hanyar microscope, an gano alamun SARS-CoV-2 a cikin wani bakin ciki mai laushi a cikin jikin mutum.
An gano ACE2 a cikin mutane a matsayin mai karɓar SARS-CoV-2 da SARS-CoV.
Koyaya, furotin S na SARS-CoV-2 yana sauraron ACE2 a cikin mutane sosai fiye da SARS-CoV, wanda ya fi damuwa da gaskiyar cewa SARS-CoV-2 yana haifar da ƙananan kamuwa da cuta ga marasa lafiya fiye da SARS-CoV.
SARS-CoV-2 na iya samar da ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin.
SARS-CoV-2 orf3b na iya taka rawa wajen kamuwa da cutar kuma ya hana ƙayyadaddun IFNB; duk da haka, babu wani sanannen aiki ko ƙwayoyin cuta a cikin orf8.
A ranar 18 ga Fabrairu, 2020, Zhou, et al., sun ba da rahoton tsarin cryo-EM na cikakken ƙarfin ACE2 a cikin ɗan adam inda 2.9 A ya haɗu da amino acid mai watsawa B0AT1.
Sun gano cewa a cikin wannan kwayar, wadda ta bude kuma ta rufe siginan, mun sanya shi a cikin kwayar a matsayin mai rauni kuma ADCE2-B0AT1 na iya haɗuwa da furotin S guda biyu, wanda ke nuna alamar gano CoV da kumburi.
B0AT1 na iya zama manufa ta magani a cikin gwajin magani don hana kamuwa da cutar SARS-CoV-2.
Ciwon farko da na tsakiya.
An gano cewa SARS-CoV da MERS-CoV sun samo asali ne daga firikwensin kuma an watsa su zuwa ga mutane ta hanyar cats da raƙuma a jere.
Ta hanyar kwatanta tarihin halittu na SARS-CoV-2 da sauran CoVs, an gano cutar maraice a matsayin cutar mai ɗaukar SARS-CoV-2 na asali saboda sabon kwayar cutar ta kasance 96% kamar sauran SARS-CoVs biyu da aka samo a cikin wani kwayar cutar da ake kira maraice-SL-CoVZX45 da kuma firikwensin-SL-CoVZX21.
Koyaya, ba a san ko cutar ta tsakiya ta taimaka wa kwayar cutar ta ƙetare tsarin rayuwa ta mutum ba, kuma hanyar da ta shiga har yanzu ba a bayyana ba.
Ji, et al., sun zargi macizai da kasancewa masu karɓar kwayar cutar ta firikwensin da ke watsawa ga mutane wanda ya haɗa da haɗin kai na ciki na furotin S.
A wani bincike, masu bincike a Gangzhou, China, sun nuna cewa ana amfani da barkono, kayan zaki na madara a cikin maganin gargajiya na kasar Sin - sune mafi girman yiwuwar cutar SARS-CoV-2 ta hanyar tashi a cikin 99% na kwayoyin halitta na CoV da aka gano a cikin kwayoyin halitta da SARS-CoV-2.
Duk da haka, bambancin 1% ya bazu a cikin bayanan biyu na kwayoyin halitta har yanzu bambanci ne mai girma, don haka ana jiran sakamakon haɗin gwiwa na hujjoji masu ƙarfi (Jintuska 33)
Har yanzu ba a san yawancin hanyoyin sinadarai na SARS-CoV-2 ba.
SARS-CoV da MERS-CoV na iya rayuwa a cikin in vitro na awanni 48 a yanayin bushe kuma har zuwa kwanaki 5 a ƙasa da 20C da 40%-50% danshi.
SARS-CoV-2 na iya samun irin wannan tsari.
An bayar da rahoton cewa SARS-CoV-2 yana da saurin hasken rana da zafin jiki na 56C a cikin minti 30, ether, 75% ethanol, mai kashe kumburi wanda ya ƙunshi chlorine, paracetic acid, chloroform, da sauran kwayoyin da ke da ƙwayoyin cuta, amma ba chlorhexidine ba, na iya kawar da cutar yadda ya kamata.
Gabaɗaya, duk ɗan adam yana da kariya ga SARS-CoV-2 kuma saboda haka yana da saukin kamuwa da sabon kwayar cutar.
A halin yanzu, babu wani cikakken binciken da aka bayar game da amsawar rigakafin SARS-CoV-2.
Saboda haka, zamu iya komawa ne kawai ga binciken da aka yi na baya game da sauran CoVs, musamman SARS-CoV da MERS-CoV (Fig. (Fig. 4)).
Gabaɗaya, bayan cutar ta kai wa mai ɗaukar cutar hari, a lokacin da aka kamu da cutar, ana gano tsarin rigakafin jiki na jiki ta hanyar tsarin ganewar asali na jijiyoyi (PRR yo) wanda ya haɗa da na'urori masu auna sigina na C-type na lectin, na'urori masu auna sigina na Toll (TLR), na'urori masu auna sigina na NOD-Like (NLR) da na RIG-l-like (RLR).
Ta hanyoyi daban-daban, cutar tana haifar da cututtukan kumburi, girma a cikin ƙwayoyin jijiyoyin jini, da kuma samar da nau'in I interferons (IFN yo) wanda ke hana yaduwar cutar da kuma saurin macrophage phagocoytosis na maganin rigakafin cutar.
Koyaya, furotin N na SARS-CoV na iya taimakawa kwayar cutar ta tsere daga amsawar rigakafi.
A kwanan nan, amsawar rigakafin jiki ta shiga cikin yaki da kwayar cutar.
T-shiryen jini mai tsabta, ciki har da CD4+ da CD8+ T-kwayoyin suna taka muhimmiyar rawa wajen kare kai.
Kwayoyin CD4+ suna kunna kwayoyin B don samar da ƙwayoyin cuta na musamman na rigakafi, da kuma kwayoyin CD8+ T waɗanda ke kashe ƙwayoyin cuta na kwayar cuta kai tsaye.
Masu taimakawa na T-cell suna samar da ƙwayoyin cytokines don taimakawa wajen kare ƙwayoyin.
Koyaya, CoV na iya hana aikin T cell wanda ke sa T cell ya mutu.
Tsarin kare lafiyar mutum wanda ya hada da masu kare jiki kamar C3a da C5a da anti-inflammatory kuma sune tushen maganin kamuwa da kamuwa da cutar.
Alal misali, maganin rigakafi daga marasa lafiya da suka warke sun daidaita MERS-CoV.
A gefe guda kuma, yin amfani da tsarin rigakafi na jiki a hanyar da ta dace yana haifar da ƙwayoyin cuta da yawa da ke aiki a gida wanda zai iya haifar da mummunan rauni ga zuciya da sauran gabobin jiki, kuma, a mafi munin yanayin, rashin aiki da yawa da mutuwa.
Cutar SARS-CoV-2, wanda aka gano a cikin ƙungiyoyi masu gudana, tana iya kamuwa da cutar ga tsofaffi masu cututtukan farko da mata masu juna biyu.
Yana da kyau a ga mutane da ke da ƙarancin ƙwayar cuta ko kuma waɗanda ba su da ƙarfin rigakafi, suna da damar da za su kamu da cutar idan suka yi wa wasu.
Matsakaicin lokacin kula da yara na SARS-CoV-2 shine kwanaki 1-14, galibi kwanaki 3-7 bisa ga binciken farko na shari'o'i 425 na Wuhan.
Koyaya, binciken da aka yi akan shari'o'i 1,099 ya nuna cewa tsawon lokacin kula da yara ya kasance matsakaita kwanaki 3 tsakanin kwanaki 0 zuwa 24.
Wani ƙarin binciken da aka yi a yanzu, kamar yadda aka bayyana a sama, ya nuna cewa tsawon lokacin kula da yara ya kasance kwanaki 4.8 (3.0-7.2) bisa ga kididdigar shari'o'i 8,866.
Yana da mahimmanci ga masu kula da lafiya su gyara keɓewar wucin gadi mai tasiri a lokacin da ya dace na lokacin kula da yara, wanda zai hana kamuwa da cutar amma ga mutanen da ba su da alamun cutar.
A al'ada, ana buƙatar keɓe masu cutar, ko waɗanda suka kamu da cutar, na tsawon kwanaki 14.
Shin za a ƙara tsawon lokacin keɓewa zuwa kwanaki 24?
Cutar zazzabi yawanci ita ce babbar alama ta farko ta COVID-19, wanda zai iya kasancewa tare da rashin alamomi ko wasu alamomi kamar bushewar ƙashi, rashin numfashi, ciwon tsoka, rashin ƙarfi, ciwon kai, ciwon hanci, yawan ciwon hanci, ciwon ƙafa, kumburi, kumburi, kumburi, da kuma ciwon kumburi.
Wasu marasa lafiya sun sha wahala daga rashin numfashi da rashin iskar oxygen a jikinsu a mako guda bayan fara cutar.
A cikin lokuta masu tsanani, marasa lafiya suna da gaggawa don ci gaba da ciwon zuwa alamun ciwon numfashi mai tsanani, kumburi na kumburi ɗaya, acid a cikin jiki da zubar da jini.
Dole ne a yi bincike na gaggawa a kan marasa lafiya da ke fama da zazzabi da/ko alamun cutar numfashi da kuma zazzabi mai tsanani, ko da ba a yi musu hoton ba game da cututtukan jijiyoyin jini.
Wani binciken kididdiga da aka gudanar a karshen watan Disamba na shekarar 2019 ya nuna cewa alamun ciwon kumburi sun kasance kashi 98% na ciwon sukari, kashi 78% na rashin numfashi, kashi 55% na rashin numfashi, da kashi 3% na ciwon zazzabi; kashi 8% na marasa lafiya sun bukaci a yi musu asibitin numfashi.
An samu irin wannan sakamakon a cikin binciken biyu na yanzu inda ƙungiyar iyali ta haifar da watsa cutar ga mutumin da ba ya nuna alamun cutar.
A matsayin kwatankwacin, binciken kididdiga na shekarar 2012 ya nuna cewa marasa lafiya na MERS-CoV suma suna da zazzabi (98%), bushewar hanji (47%). da rashin numfashi (55%) sune manyan alamun.
Koyaya, kashi 80% na su suna buƙatar duba numfashi, ban da marasa lafiya na COVID-19 da kuma haɗarin mutuwa na MERS na yau da kullun idan aka kwatanta da COVID-19.
Mun ga masu fama da ciwon kumburi (26%) da kuma ciwon daji (21%) kuma muna ganin marasa lafiya da MERS.
A cikin marasa lafiya na SARS, an nuna cewa zazzabi (99%-100%), bushewar ƙuƙwalwa (29%-75%), rashin numfashi (40%-2%), kumburi (20%-25%) da ciwon daji (13%-25%) sune manyan alamomi da tallafin numfashi wanda ya kai kimanin 14%-20% na marasa lafiya.
A ranar 14 ga Fabrairu, mutuwar COVID-19 ta kai kashi 2% a duk faɗin duniya, inda aka tabbatar da shari'o'i 66,576.
A matsayin kwatancen, mutuwar SARS a watan Nuwamba na 2002 ya kai kashi 10% na shari'o'in da aka tabbatar da 8,096.
A cikin MERS, bisa ga kididdigar binciken Yuni 2012, mutuwar ta kai kashi 37% na shari'o'i 2,494 da aka tabbatar.
Wani binciken da aka yi a baya ya nuna cewa R0 na SARS-CoV ya fi 6.47 girma tare da 95% amintacce (CI) maki na 5.71-7.23, yayin da R0 na SRAS-CoV kawai ya kasance daga 2 zuwa 4.
Ana kwatanta SARS-CoV-2 zuwa MERS-CoV-2 da SARA-CoV dangane da alamun su, mutuwar su, da R0 a cikin tebur na Table1.1.
Ƙididdiga masu yawa sun nuna cewa SARS-CoV-2 yana da ƙwarewar yaduwa da yawa idan aka kwatanta da MERS-CoV da SARS-CoV, amma yana da ƙarancin mutuwa fiye da na ƙarshe.
Saboda haka, yana da matukar wahala a sarrafa yaduwar SARS-CoV-2 idan aka kwatanta da wasu kamar MERS-CoV da SARS-CoV.
Ƙungiyoyin da ke gudana a yanzu sukan faru ne a cikin iyali ɗaya ko kuma a wuri ɗaya ko a cikin mota ɗaya kamar jirgin ruwa.
Marasa lafiya da ke da tarihin tafiya ko zama a Wuhan ko wasu wuraren da aka shafa ko kuma waɗanda suka yi hulɗa da masu kamuwa da cuta ko marasa lafiya a cikin makonni biyu na yanzu kafin fara.
Koyaya, an bayar da rahoton cewa mutane na iya kamuwa da cutar ba tare da bayyanar cututtuka ba har tsawon makonni biyu kuma marasa lafiya da aka fitar da su daga asibiti na iya kamuwa da cutar kuma, wanda ke haifar da damuwa game da tsawaita lokacin keɓewa.
A cikin marasa lafiya, yawan jini na jini na jini ya ragu ko kuma ya ragu (musamman na jini) a farkon matakin.
Misali, an samu raguwar adadin jinin fararen <4x109/L ciki har da adadin jini fararen 1x109/L, da kuma karuwa a matakin aminotransferase da verimia na aspartate a cikin marasa lafiya 1,099 na COVID-19.
Ƙarfin ƙwayar hanta da ƙwayar tsoka da kuma myoglobin ya karu a cikin jini na wasu marasa lafiya, kuma sun karu da furotin C mai amsawa da kuma zubar da jini a cikin jini a yawancin marasa lafiya.
A cikin marasa lafiya masu haɗari, matakan D-dimmer, rage yawan fibrin a cikin jini, an ƙara yawan jini, kuma an rage yawan jini mai tsabta a hankali.
An gano rashin aikin daukar hoto na hanci a cikin marasa lafiya da yawa na COVID-19 tare da alamun ƙananan ƙananan ƙwayoyin cuta ko rashin haske na zuciya.
Yawancin lokaci marasa lafiya suna fama da ciwon hanci, mummunan rauni na zuciya, alamun mummunan matsalar numfashi (ARDS).
Lokacin da ARDS ta faru, kumburi ba zai iya sarrafawa ba, tarin ruwa, da kuma ciwon kumburi masu girma suna iya haifar da rikicewar numfashi mai haɗari.
Rashin aiki na jiki na pneumocytes na nau'i na I da nau'i na II yana rage yawan ƙwayar cuta kuma yana ƙara yawan damuwa a yankin, wanda hakan yana rage ƙarfin zuciya na watsawa wanda ke nuna haɗarin mutuwar zuciya.
Saboda haka, mafi munin sakamakon daukar hoto shine
A ranar 18 ga Fabrairu, 2020, wani jerin gwaje-gwaje na COVID-19 sun nuna kawar da ƙwayoyin huhu, samar da hyaline, da kuma haɗuwa da ƙwayoyin jini mai fari, da ƙwayoyin syncytial masu yawa a cikin zuciyar marasa lafiya waɗanda suka mutu daga cutar, gwajin gwaji na yau da kullun don kamuwa da cutar kwayar cuta da ARDs sun kasance daidai da marasa lafiya na SARS da MERS.
Gano RNA na SARS-CoV-2 ta hanyar jerin abubuwan da ke tattare da polymerase reverse-transcriptase (RT-PCR) an yi amfani da shi azaman babban abin da ake buƙata don binciken COVID-19.
Ko ta yaya, saboda tsadar karya, wanda zai iya saurin kamuwa da cutar, an fara amfani da bayanan likita don bincike (wanda ba za a iya amincewa da shi musamman ba tare da RT-PCR) a China a ranar 13 ga Fabrairu, 2020.
Wani abu makamancin haka ya faru a lokacin binciken SARS.
Saboda haka, haɗuwa da tarihin makamancin halitta, abubuwan ban mamaki na kiwon lafiya, gwaje-gwajen dakin gwaje-gwaje da sakamakon wannan hoton sune ainihin abubuwan da ba za a iya kaucewa ba don yin bincike mai amfani.
A ranar 14 ga Fabrairu, 2020, ƙungiyar Feng Zhang ta bayyana wani ƙwayoyin cuta ta amfani da fasahar SHERLOCK bisa CRISPR don gano SARS-CoV-2, ganowa daga samar da SARS-CoV-2 RNA daga 20 x 10- 18mol/L zuwa 200 x 10- 18 mol/L (10-100 kwafin kowane microliter na tambaya) ta amfani da dogon sanda a ƙasa da awa ɗaya ba tare da buƙatar manyan kayan aiki ba.
Da fatan, sabuwar fasaha zata iya inganta ƙwarewa da dacewa ba zato ba tsammani idan aka tabbatar da shi a cikin gwajin likita.
Saboda rashin gogewar sabon CoV, likitoci galibi suna iya ba da kulawa ta asibiti ga marasa lafiya na COVID-19, yayin da suke gwada magunguna daban-daban waɗanda aka riga aka yi amfani da su ko kuma aka ba da shawarar su kafin maganin sauran CoV kamar SARS-CoV da MERS-CoV da cututtukan cututtuka (Covid (Table20.2).
Maganin ya hada da yiwuwar a yanzu a yi maganin maganin cutar, masu hana rigakafin jiki, steroids yo, plasma da kuma marasa lafiya da suka warke, maganin kasar Sin da kuma goyon bayan kwakwalwa.
Ko da plasma a cikin marasa lafiya da suka warke an ba da shawarar yin amfani da shi a matsayin magani.
Kamfanonin magunguna suna gasa don inganta maganin rigakafi da allurar rigakafin cutar.
SARS-CoV-2 yakan faru ne a cikin zuciya a farkon lokaci kuma yana faruwa ne a cikin ƙananan ƙarfi, a cikin sauran gabobin da ke ƙayyade ACE2, ta hanyar ƙwayar ciki da koda.
Ko ta yaya, rashin aiki na numfashi da mutuwar su sune manyan abubuwan da marasa lafiya ke tsoro kuma sune manyan dalilan mutuwa.
Saboda haka, taimakon numfashi yana da haɗari don kawar da alamun da ke ceton rai ciki har da maganin oxygen gaba ɗaya, samar da iskar oxygen mai yawa, ba tare da kayan aiki na numfashi ba, da kuma tare da shigar da kayan aiki na zahiri don numfashi dangane da haɗarin kamuwa da cuta.
Dole ne a yi wa marasa lafiya da ke fama da alamun cutar ta numfashi oxygenation na membrane extracorporeal (ECMO). Wannan shi ne wani sabon tsarin na aikin jijiya na wucin gadi wanda ake amfani da shi wajen magance cututtukan jijiya na zuciya da kuma cututtukan numfashi.
Bugu da kari, kiyaye daidaiton electrolyte, hana da kuma magance cututtukan cututtuka masu girma da cututtukan cututtuka masu aiki, da kuma kare aikin ƙwayoyin cuta masu mahimmanci su ne tushen marasa lafiya na SARS-CoV-2.
An gano cewa hadarin cytokine ya haifar da matsanancin amsawa daga tsarin rigakafi na marasa lafiya na SARS da MERS.
Cytokine storm wani nau'in rikice-rikice ne na ciwo wanda ke haifar da sakin jerin cytokine ciki har da TNFα, IL-1β, IL-2, IL-6, IFNα, IFNβ, IFNγ, da MCP-1.
Wadannan cytokines suna sa kwayoyin rigakafi su bar ni da yawa na radicals wanda shine babban dalilin ARDS da kuma rashin lafiyar kwayoyin halitta.
Rage rigakafin jiki shine tushen maganin hadari na cytokine, musamman ga marasa lafiya marasa ƙarfi.
Ana amfani da corticosteroid da tocilizumb, wanda shine anti-IL6 monoclonal antibody, don magance cytokine mai motsi.
Sauran maganin hana rigakafi na cytokine yana dauke da hana T cell na kai tsaye na maganin rigakafi; hana IFN-y, IL-1, da TNF; JAK; blinatumomab; mai hana cytokine wanda ke nuna 4; da kuma hana HDAC.
Ana amfani da steroids a matsayin maganin rigakafi a cikin maganin SARS don rage yawan rauni.
Koyaya, steroids masu yawa ba su da amfani ga mummunan lalacewar huhu a cikin marasa lafiya na SARS da COVID-19.
A akasin haka, suna iya haifar da wani mummunan sakamako, musamman ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayo.
Hakazalika, an ba da shawarar yin amfani da gajeren lokaci na corticosteroids a cikin ƙananan zuwa matsakaiciyar magani don yin hankali ga marasa lafiya masu fama da COVID-19.
A lokacin rubuce-rubuce, babu wata maganin rigakafin cutar da aka tabbatar da aiki.
Duk da haka, an gano cewa maganin maganin jijiya tare da remdesivir, analog nucleotide, ya sami nasara a cikin marasa lafiya na Amurka da ke da COVID-19.
Remdesivir sabon maganin rigakafin cutar ne wanda Gilead ta haɓaka don maganin cututtukan da Ebola da ƙwayoyin Marlburg suka haifar.
Daga baya, remdesivir ya kuma nuna yiwuwar hana wasu ƙwayoyin cuta na RNA ciki har da MERS da SARS.
Bisa ga wannan, Gilead ta kawo wurin zuwa China don yin gwaje-gwaje da yawa akan mutane da suka kamu da SARS-CoV-2, sakamakon yana da matukar fata.
Bugu da ƙari, ana ba da shawarar baricitinb, interferon-α, lopinavir/ritonavir, da ribavirin a matsayin magani mai yiwuwa ga marasa lafiya da ke fama da alamun rashin lafiyar numfashi mai tsanani.
Za a iya samun ciwon daji, ciwon daji, ciwon zuciya, da kuma mummunan sakamako a lokacin da aka ba da maganin lopinavir/ritonavir.
Dole ne a lura da hulɗar wannan magani da sauran magungunan da aka yi amfani da su a cikin marasa lafiya.
Plasma daga marasa lafiya da suka warke da kuma tsara antibody
Tattara jinin marasa lafiya da suka warke daga cutar da ke yaduwa don magance sauran marasa lafiya da ke fama da cutar ɗaya ko kuma don hana mutane lafiya kamuwa da cutar yana da dogon tarihi.
A gaskiya ma, marasa lafiya da suka warke yawanci suna da matakan antibodies da ke kare su daga kamuwa da cutar jini.
Antibodies sune immunoglobin (Ig) wanda aka samar da shi a cikin jini mai fari B don yaƙar kamuwa da cuta da sauran abubuwa na waje kuma suna gano takamaiman matsa lamba a cikin kamuwa da cuta kuma kai tsaye suna kashe su.
Bisa ga wannan, an tattara plasma daga jinin wani rukuni na marasa lafiya waɗanda suka warke daga COVID-19 kuma an yi wa marasa lafiya 10 da ke fama da rashin lafiya.
A cikin sa'o'i 24, sun kawar da alamun cutar, kuma sun sami raguwar kumburi da ƙarfin kwayar cutar da kuma karuwar oxygen a cikin jini.
Koyaya, tabbaci da ƙayyadaddun bayanai suna da mahimmanci don ba da shawarar hanyar da za a yi amfani da ita sosai kafin a samar da magani na musamman.
Bugu da ƙari, a kan sakamako na magani, dole ne a yi la'akari da wasu matsalolin da ke faruwa a cikin jini.
Alal misali, maganin anti-tarkici na iya haifar da karuwar amsawar tsarin rigakafi kuma ya haifar da alamun sakin cytokine, wanda zai iya haifar da haɗarin cutar kansa.
Ƙarfin ƙwayar cuta a jikin mutum yana da ƙananan ƙarancin ruwa, kuma bukatar plasma tana da yawa don magance marasa lafiya.
Yana da wuya a yi da kuma samar da maganin rigakafi na musamman da sauri don yaƙar cutar ta duniya.
Saboda haka, yana da wuya a cire kwayar cutar B kai tsaye daga marasa lafiya da suka warke kuma a tabbatar da lambar jini ta hanyar shigar da maganin rigakafi mai amfani ko allon anti-bottle mai amfani wanda zai iya magance furotin na asali na ƙwayoyin cuta.
Ta wannan hanyar, zamu iya kimanta samar da anti-sniffing.
An yi amfani da TCM wajen magance cututtuka daban-daban a kasar Sin tsawon dubbai na shekaru.
Koyaya, tasirinsa ya dogara da haɗuwa da yanayin canzawa dangane da binciken cutar bisa ga ra'ayoyin TCM.
Abubuwan da suka fi amfani ba su da kyau ko kuma suna da wuyar ganewa kuma yana da wuya a samar da su kuma tabbatar da su kamar waɗannan abubuwa ko kuma mafi kyawun haɗuwa.
Yanzu, saboda rashin ingantaccen magani na musamman na COVID-19, TCM ya zama babban zaɓi na magani ga marasa lafiya waɗanda ke da ƙananan zuwa matsakaiciyar alamun cutar ko waɗanda suka dawo da matakan tsanani.
Misali, Shu Feng Jie Du capsules da Lian Hua Qing Wen capsules an gano su da tasiri wajen magance COVID-19.
An ga mafi yawan magungunan maganin COVID-19 a larduna da yawa na China waɗanda suka yi amfani da TCM a kashi 87% na marasa lafiyarsu, gami da Gansu (63.7%), Ningxia (50%), da Hunan (50%), yayin da lardin Hubei, wanda ya yi amfani da TCM a kashi 30% na marasa lafiyar COVID-19 kawai, ya sami mafi ƙarancin matakin maganin (13%).
Koyaya, wannan kwatancen ba shi da kyau sosai saboda wasu dalilai kamar yawan marasa lafiya da haɗarin cutar dole ne a ƙara su cikin kimantawa.
A ranar 18 ga Fabrairu, 2020, Boli Zhang da abokan aikinta sun buga wani binciken da ya kwatanta maganin maganin yamma (WM) kawai da cakuda maganin WM da TCM.
Sun ga cewa lokacin da jikin mutum yake bukatar warkewa daga zafin jiki, alamun bayyanar cututtuka, da kuma magani sun fi guntu a cikin WM+TCM fiye da a cikin WM kadai.
Abin mamaki, ƙimar rashin lafiyar mutanen da suka nuna alamun cutar (mai sauƙi zuwa matakin haɗari) ya kasance ƙasa da na WM+TCM kawai (7.4% da 46%) kuma mutuwar ta kasance ƙasa da na WM+TCM kawai (8.8% da cutar 39%).
Koyaya, inganci da aminci na TCM har yanzu suna jiran gwaji mai ƙarfi a hanyoyi da cibiyoyi da yawa.
Hakanan zai zama da kyau a nuna ayyukan na'ura da kuma tabbatar da ingancin kayan aikin TCM na magani ko haɗuwa da su idan ya yiwu.
Marasa lafiya da ake zargi ko waɗanda ke da COVID-19 galibi suna fuskantar babban tsoron cutar da ke yaduwa da mutuwa daga cutar, kuma mutanen da ke keɓewa suna fuskantar rashin ƙarfi, kadaici, da fushi.
Bugu da ƙari, alamun kumburi kamar zazzabi, rashin iskar oxygen a jiki, da kumburi da kuma mummunan sakamako na magani kamar rashin barci da corticosteroids ke haifarwa na iya haifar da damuwa da ciwon hanci.
An bayar da rahoton farkon mutuwar SARS, cututtukan tunanin mutum ciki har da magana ta yau da kullun, damuwa, tsoro, asalin cututtukan tunanin mutum, alamun iyaye, cututtukan da ke haifar da rashin lafiyar da kuma kashe kansa.
Horar da hulɗa da kuma yin abinci, a cikin amsa ga lafiyar jama'a ga barkewar COVID-19, na iya sa mutane su kasance masu damuwa da laifi game da tasirin cutar da ke yaduwa, da kuma sukar danginsu da abokan su.
Saboda haka, dole ne a ba da kulawar lafiya ta rufe fuska ga marasa lafiya na COVID-19, waɗanda ake zargi da su, da waɗanda suka yi hulɗa da su da kuma tsofaffi da ke cikin bukata.
Dole ne a haɗa ayyukan bincike na dakin gwaje-gwaje da ƙirƙirar ƙungiyoyin haɗin gwiwa na lafiyar kwakwalwa, sadarwa mai kyau don lura da cutar ta mutuwa da ingantaccen shirin magani na SARS-CoV-2 na yau da kullun da amfani da kayan aikin lantarki na ƙwarewa da aiwatar da kulawa da kusanci da juna.
Allurar rigakafi mai tasiri ita ce tushen magance sarkar watsawa daga tushen cututtukan dabbobi da mutane masu kamuwa da cuta zuwa cututtukan cututtukan da ke haifar da cutar kuma galibi yana haɓaka maganin cutar ta hanyar sarrafa cututtukan cututtukan da ke haifar da ƙwayoyin cuta.
An yi ƙoƙari don ƙirƙirar allurar rigakafi bisa furotin S don samar da tsayayyen lokaci da matsakaici mai ƙarfi na anti-matsayi da / ko rigakafin SARS-CoV.
An tantance allurar rigakafin cutar a kan nau'in SARS na dabba
Koyaya, ingancin wannan allurar a cikin tsofaffi da kuma sassan haɗari da kuma karewa daga kamuwa da kwayar cutar dabba har yanzu ana tantancewa kafin a fara binciken likita.
Wannan shi ne saboda SARS ta ragu shekaru 17 da suka gabata kuma babu sabbin shari'o'in da aka ruwaito min a yanzu.
A kwatancen, wasu lokuta marasa daidaituwa da kuma wasu nau'ikan cutar MERS suna faruwa a yankin Tsakiya kuma suna yaduwa zuwa wasu jihohi tare da rashin yiwuwar kawar da cutar ta yau da kullun a cikin waɗannan yankuna.
An kirkiro dabarun rigakafi don MERS ta amfani da ƙwayoyin cuta marasa aiki, DNA plasmid yo, na'urorin daukar hoto, nanoparticles, ƙwayoyin cuta masu kama da ƙwayoyin cuta da kuma haɗuwa da ƙananan sassan furotin wanda wasu daga cikinsu aka kimanta su a matsayin sassan dabba.
Samar da allurar rigakafi da maganin cutar SARS-CoV-2 ga mutanen da ba su da isasshen rigakafi na jiki yana da gaggawa da aiki mai wuya don hana jerin gwano.
Ko ta yaya, yana da wuya a shawo kan matsalolin saboda tsawon lokaci (kusan watanni 18) da ake buƙata don ci gaban allurar rigakafi da kuma bambancin CoV.
Kamar yadda sabon cuta, COVID-19 kawai ta fara bayyana a bayyane a cikin cikakken binciken likita na dubban marasa lafiya.
A mafi yawan lokuta, marasa lafiya suna dawowa daga matsalolin rashin lafiya na farko a hankali.
Koyaya, kamar SARS da MERS, COVID-19 kuma cuta ce da ke da alaƙa da ƙaruwar yawan mutane da ƙarin cututtuka da mutuwar marasa lafiya a cikin manyan lokuta.
Saboda haka, gina tsarin tunani game da kula da lafiya game da cututtuka shine tushen da hukumomin kiwon lafiya ke ba da fifiko ga ayyukan su, musamman a wuraren da ke da karancin albarkatu.
Bisa ga binciken kiwon lafiya da aka yi a yanzu, abubuwa masu zuwa na iya shafar ko kuma su danganta da ra'ayin kula da lafiya ga marasa lafiya da ke fama da cutar COVID-19 (Jadawalin 33):
Shekaru: Shekaru shine babban abin da ya haifar da cutar SARS, wanda kuma gaskiya ne ga COVID-19.
COVID-19 galibi yana faruwa ne a cikin shekaru 30 zuwa 65 tare da 47.7% na marasa lafiya sama da shekaru 50 a cikin binciken 8,866 kamar yadda aka ambata a sama.
Marasa lafiya da ke bukatar kulawa ta gaggawa sun fi fuskantar wasu cututtuka da kuma yanayi mai tsanani a baya kuma sun fi waɗanda ba su da su girma (matsakaici shekaru 66 da 51), wanda ke nuna cewa shekaru sune dalilin sakamakon COVID-19 ga marasa lafiya.
Jima'i: SARS-CoV-2 ya fi maza yawa fiye da mata (0./100,000 idan aka kwatanta da 0.27/100,000) kamar yadda aka ambata a sama.
a cikin gaggawa, suna da mafi yawan cututtukan zuciya da kuma bugun zuciya.
Har ila yau, bugun zuciya shine babban dalilin mutuwar marasa lafiya na SARS.
An ce SARS-CoV-2 na iya kuma hana ACE2-posittive cholangiocytes, wanda zai iya haifar da jinkirin zuciya a cikin marasa lafiya na COVID-19.
Dole ne a lura cewa tsufa da ciwo na ci gaba suna da alaƙa da juna kuma suna iya zama masu rarrabewa.
Sakamakon gwaji na musamman: matakin furotin mai amsa C (CRP) a cikin jini yana nuna mummunan ciwon ƙwayoyin halitta ko raunin kuma an ba da shawarar cewa shine dalilin ciwo mai yiwuwa, amsawar magani, kuma ƙarshe warkarwa.
An kuma ba da shawarar alaƙar da ke tsakanin matakin CRP da tsanani da kuma dalilin cutar COVID-19.
Bugu da kari, karuwar lactate dehydrogenase (LDH), aspartate aminotransferase (AST), alanine aminotransferase (ALT), da creatine kinase (CK) na iya taimakawa wajen hango sakamakon.
An bayyana wannan enzyme a cikin wasu kwayoyin halitta, musamman zuciya da hanta, kuma ana sakin su a lokacin lalacewar kwayar.
Saboda haka, alamun gargajiya ne na rashin aikin zuciya ko na hanta.
Babban alamun lafiya: dole ne a yi la'akari da yanayin kirji da lokacin bayyanar alamun lafiya tare da sauran dalilai don hango sakamakon da mummunan yanayin COVID-19.
Amfani da steroids: kamar yadda aka ambata a sama, steroids suna rage rigakafin jiki kuma ana amfani da su a matsayin magani na taimako ga cututtukan cututtuka don rage mummunan rauni.
Tun da ake amfani da magungunan corticosteroid masu nauyi a cikin marasa lafiya na SARS, yawancin waɗanda suka warke sun kamu da cutar osteonecrosis ta hanyar rashin ƙarfi na tsawon rai da ƙarancin ingancin rayuwa.
Saboda haka, idan ya cancanta, ya kamata a yi amfani da steroids a cikin ƙananan adadin da gajeren lokaci ga marasa lafiya na COVID-19.
Littafin kwakwalwa: kamar yadda aka ambata a sama, a lokacin barkewar COVID-19 marasa lafiya da yawa sun sha wahala daga wannan maganganun wuce gona da iri kamar yadda galibi suke cikin dogon lokaci na keɓewa da rashin zama kuma sun ga mutuwar mafi kusa da danginsu da abokan marasa lafiya.
Yana da mahimmanci a ba da shawara ta tunani da tallafi na dogon lokaci don taimakawa marasa lafiya su warke daga wannan magana kuma su koma rayuwa ta al'ada.
A cewar binciken kididdigar zamantakewar jama'a zuwa yanzu, COVID-19 yana da yanayin rashin lafiya daban-daban kamar SARS.
Baya ga yaduwar cutar a cikin ƙananan huhu, SARS-CoV-2 yana yaduwa cikin tasiri a cikin yankin sama na huhu wanda ke haifar da rashin alama ko sauƙi a farkon farkon kamuwa da cuta, kamar sauran CoVs da ke haifar da ƙwayoyin cuta.
Saboda haka, marasa lafiya da ke fama da ciwo a farkon lokaci ko kuma a cikin wani lokaci ba a sani ba na iya samar da ƙwayoyin cuta masu yawa a lokacin ayyukan yau da kullum, wanda ke haifar da ƙalubalen sarrafa ƙwayar cuta.
Koyaya, an gano cewa watsa SARS-CoV yana faruwa ne lokacin da marasa lafiya ke da rashin lafiya sosai, yayin da watsawa galibi baya faruwa a farkon lokaci.
Saboda haka, cutar COVID-19 ta yanzu tana da tsanani sosai kuma yana da wuyar sarrafawa fiye da cutar SARS.
Ana yin gagarumin aiki a kasar Sin a yanzu haka, ciki har da hana birnin Wuhan da garuruwan da ke kusa da shi, da kuma killace kusan dukkanin al'ummomin kasar domin hana yaduwar SARS-CoV-2.
Duk da cewa wannan ya shafi tattalin arziki da sauran sassan kasar, yawan sabbin marasa lafiya na raguwa, wanda ke nuna raguwar kamuwa da cutar.
Mafi yawan tsammanin shine cewa za a ƙare a ƙarshen Maris kuma cewa koma bayan tattalin arziki zai kasance watanni 3-4.
Amma, wasu masana ba su ce haka ba.
Paul Hunter, et al., ya kiyasta cewa COVID-19, wanda ya fi SARS girma, ba zai ƙare ba a shekarar 2020.
Ya kuma nuna cewa SARS-CoV-2 na iya kamuwa da kashi ɗaya bisa uku na al'ummar duniya.
Wani rukuni na Kanada ya ruwaito cewa an gano SARS-CoV-2 a cikin nasal da hanci na marasa lafiya da suka warke daga asibiti makonni 2 da suka gabata, wanda ke nuna cewa sabon kwayar cutar da aka gano na iya zama wani abu mai kama da cutar mura.
Duk da haka, an nuna alamun alƙawarin a Shina saboda raguwar yawan sabbin shari'o'in, wanda ke nuna dabarun da ake amfani da su yanzu.
An yi hasashen cewa cutar Ebola za ta iya haddasa mutum miliyan daya yayin da wasu rabin miliyan za su mutu.
Duk da haka, ta hanyar keɓewa da keɓewa, an kawar da cutar a ƙarshe.
Hakanan yana yiwuwa, kamar SARS-CoV, SARS-CoV-2 zai iya zama mai rauni a cikin kamuwa da cuta kuma a ƙarshe ya mutu ko ya zama ƙananan ƙwayoyin cuta waɗanda zasu iya rayuwa tare da mutane.
An rage yawan adadin masu kamuwa da cutar ta COVID-19 a tsakanin SARS da MERS (Jungiya ta 55).
SARS-CoV-2 ana iya watsa shi ta hanyar ƙwayoyin cuta da ƙwayoyin cuta, kuma mai yiwuwa ta hanyar taɓa abubuwan da cutar ta watsa.
An kuma gano kwayar cutar a cikin hanji, wanda ke ba da sabuwar dama ta shiga cikin hanji zuwa bakin.
Wani binciken da aka yi kwanan nan kan shari'o'i 138 ya nuna cewa kashi 41% na shari'o'in na iya samun ceto daga kamuwa da cutar nosocomial, ciki har da marasa lafiya 17 da suka riga sun kamu da wasu cututtuka da kuma masu kula da lafiya 40.
Saboda haka, dole ne a yi taka tsantsan sosai wajen kare lafiyar mutane, musamman ma masu ba da kiwon lafiya, ma'aikatan jama'a, 'yan uwa, abokai, da kuma waɗanda suka halarci taron da ke da alaƙa da masu jinya ko waɗanda suka kamu da cutar.
Mataki na farko na kariya da za a iya amfani da shi don rage haɗarin kamuwa da cuta shine ta hanyar sanya abin rufe fuska; amfani da abin rufe fuska na tiyata da kuma abin rufe fuska na N95 (serial #1860 yadi) yana taimakawa wajen hana yaduwar ƙwayoyin cuta.
Masarautar da ke rufe baki ta hanyar tiyata tana hana ruwa daga wanda ke da cutar daga tafiya ta iska ko ta taɓa wani wuri inda ba ta wuce ga wani.
Koyaya, N95 (series # 1860 yo) kawai na ƙwayoyin cuta na baka na iya kare karamin ƙwayar cuta kamar 10 zuwa 80 nm a lokacin numfashi, kuma a cikin ƙarfin 5% kawai na ƙwayar cuta na iya watsawa gaba ɗaya; SARS-CoV-2 yayi kama da SARS-CoV a cikin girman kuma duka suna da kusan 85 nm.
Domin abubuwa masu laushi na iya wucewa har ma da masks biyar na rufe baki na tiyata da aka yi wa juna, masu ba da sabis na kiwon lafiya waɗanda ke hulɗa kai tsaye da marasa lafiya dole ne su sa masks na N95 (serial # 1860) amma ba masks na rufe baki na tiyata ba.
Baya ga rufe baki, dole ne masu ba da sabis na kiwon lafiya su sa tufafi masu kariya don rage yawan kamuwa da ƙwayoyin cuta.
Kwayar cutar na iya shiga idanun mutum.
A ranar 22 ga Janairu, 2020, likitan ya kamu da SARS-CoV-2 duk da cewa ya sa murfin N95, yana yiwuwa cutar ta shiga jikinsa ta hanyar idanunsa.
Saboda haka, masu ba da sabis na kiwon lafiya dole ne su sa abin rufe fuska ko kuma abin rufe fuska lokacin da suke aiki tare da marasa lafiya.
A cikin al'umma a wuraren da cutar ta shafa ko kuma za ta iya shafawa, an ba da shawarar sosai cewa kowa ya wanke hannayensa da sabulu mai kashe kwayoyin cuta fiye da dā, ya kasance a gida don ya keɓe kansa da kuma rage hulɗa da mutanen da ke da yiwuwar kamuwa da cutar.
An gano cewa akwai hanyoyi uku na nesa da ya dace da mutane su nisanta kansu daga marasa lafiya.
Wannan aiki hanya ce mai tasiri don rage haɗarin kamuwa da cuta da kuma hana yaduwar cutar.
Kodayake SARS-CoV-2 ya zo a matsayin sabon kwayar cutar ga duniyar ɗan adam, ya yi kama da SARS-CoV kamar yadda aka ruwaito a ranar 7 ga Janairu 2020 kuma ya haifar da babban faɗakarwa a China bisa zurfin ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwal.
Koyaya, har zuwa 19 ga Janairu 2020 darektan Cibiyar Kula da Cututtukan Wuhan bai yi magana da jama'a ba yana cewa sabon kwayar cutar tana da ƙarancin ikon yaduwa da sarrafa haihuwa a tsakanin ɗan adam kuma wannan ba matsala ba ce don hanawa da dakatar da cutar.
Sakon ya kawo damuwa sosai ga jama'a, musamman lokacin da duk ƙasar ke shirin bikin bazara na bazara, kuma an soke wani muhimmin lokaci don dakatar da cutar a cikin ƙaramin yanki a Wuhan.
Hukumomin hana cututtuka na kasar Sin na iya karɓar wannan darasi mai wuya kuma su sami ci gaba mai girma a nan gaba.
Misali, waɗannan hukumomi dole ne su (1) yi hankali sosai yayin yin sanarwar jama'a saboda kowane kalma da aka faɗi a cikin jama'a na iya canza motsin zuciyarsu da ƙudurin su; (2) yawan motsin rai da martani daga bayanan da ba na yau da kullun ba daga cibiyoyin kiwon lafiya yayin jiran sanarwar hukuma daga likitoci da shugabanni; (3) ƙarin ƙuntatawa don kawar da yiwuwar tafiya a cikin fasalin yaduwar cutar fiye da ƙoƙarin tura jama'a; da kuma (4) ƙari, rarraba kayan da aka yi niyya da amfani don ƙara wayar da kan jama'a game da cutar da kuma gwada haɓaka hanyar amsawa ga jama'a.
An fara yaduwar COVID-19 da sabon kwayar cutar SARS-CoV-2 ta haifar a ƙarshen Disamba 2019.
A cikin kasa da watanni biyu, ya bazu a duk kasar Sin da kuma fiye da kasashe 50 a duniya a wannan lokacin.
Tun da cutar ta yi kama da SARS-CoV kuma alamun cutar sun yi kama da COVID-19 da SARS, cutar COVID-19 ta haifar da jin daɗin komawar SARS.
Koyaya, akwai bambance-bambance masu ban mamaki tsakanin COVID-19 da SARS, waɗanda suke tushen dakatar da hawan igiyar ruwa da kula da marasa lafiya.
COVID-19 yana shafar tsofaffi fiye da matasa da maza fiye da mata, kuma yawan haɗari da mutuwar yana da yawa a cikin tsofaffi fiye da yara.
SARS na da yawan mutuwar da ya fi na COVID-19 (10.91% da 1.44%).
Marasa lafiya na COVID-19 suna watsa kwayar cutar ko da ba su da wata alama yayin da marasa lafiya na SARS suka kasance haka lokacin da suka yi rashin lafiya, wanda ke haifar da babbar matsala wajen dakatar da yaduwar COVID-19 fiye da SARS.
Wannan a wani ɓangare yana bayanin dalilin da yasa SARS-CoV-2 ke yaduwa da sauri kuma ya zama mafi girma fiye da SARS-CoV.
Gwajin RNA na yau da kullun na SARS-CoV-2 na iya zama mara ƙarewa a wasu sassan marasa lafiya na COVID-19.
A gefe guda kuma, marasa lafiya da aka warkar za su iya samun cutar ta sake.
Sakamakon ya kara hadarin yaduwar cutar a kwatsam.
Dangane da ci gaban gaggawa na binciken COVID-19, za a warware matsaloli masu yawa, kamar su:
Daga ina SARS-CoV-2 ya fito?
Kodayake an gano kashi 96% na kamanceceniyar hali tsakanin SARS-CoV-2 da kuma SARS-CoV-2 na biyu, har yanzu zamu iya kammala cewa SARS-CoV-2 ya fito ne daga cutar.
Wanne dabba ne matsakaiciyar hanyar da cutar ta yadu daga cutar ta yau da kullum, kamar, a cikin dare, zuwa ga 'yan Adam?
Idan ba mu san amsoshin # 1 da # 2 ba, ba za mu iya yanke watsawa yadda ya kamata ba kuma ɓarna na iya zama mafi muni a kowane lokaci.
Ko da yake bincike a kan tsarin samfurin da kuma sinadarai ya nuna cewa SARS-CoV-2 yana da tasiri akan ACE2, ta yaya kwayar cutar ta shiga cikin iska ta tantanin halitta kuma ta haifar da canje-canje a cikin binciken nan take?
Shin kwayar cutar tana sauraron ACE2 wanda ke bayyana sauran kwayoyin halitta?
Idan babu amsoshin waɗannan tambayoyin, ba za mu iya samun bincike mai sauri da inganci da magani mai tasiri ba.
Har yaushe cutar ta za ta ci gaba?
Ta yaya kwayar cutar ke samun ci gaba ta hanyar kwayoyin halitta yayin watsawa tsakanin mutane?
Shin zai zama annoba ta duniya, raguwa kamar SARS ko kuma mummunan yanayi kamar mura?
Yana da mahimmanci, amma yana iya ɗaukar lokaci don neman amsoshin tambayoyin da ke sama da sauran tambayoyi.
Ko ta yaya, ko yaya kudin da za su kashe, ba mu da wani zaɓi sai dai mu dakatar da cutar ta duniya da wuri-wuri kuma mu dawo da rayuwarmu zuwa al'ada.
Asalin cutar coronavirus da ke kamuwa da dabbobi ga mutane
Canjin kwayoyin halitta da daidaitawa sun haifar da tantancewar cutar coronavirus (CoV) da sauran cututtukan, gami da na mutane, tsawon dubban shekaru.
Kafin 2003, an san cewa CoVs (HCoVs) biyu da ke faruwa a cikin mutane suna haifar da cututtuka masu sauƙi, kamar mura ta yau da kullun.
Fitar da cutar ta hanyar numfashi (SARS) da alamun cutar numfashi ta tsakiyar jini (MERS) sun canza haɗarin don nuna yadda haɗarin numfashi da haɗarin kamuwa da cutar HCoV ke da haɗari.
Fitar da SARS-CoV-2 a tsakiyar China a ƙarshen 2019 ya sake rage damar CoVs kuma ya ba mu mamaki game da ƙarfin watsawa mai yawa amma ya rage yaduwar fiye da ɗan'uwansa SARS-CoV.
kamuwa da cutar korona ta mutum (HCoV) cuta ce da dabbobi ke kamuwa da ita ga mutane don fahimtar asalin kamuwa da cutar ta mutum (HCoVs).
Yawancin HCoVs sun fito ne daga kwayoyin halitta amma ba su da ƙwarewar kamuwa da cutar.
Ana kuma san shi da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut
Gano dabbobi masu baƙo yana da tasiri kai tsaye akan rigakafin cututtukan mutum.
Koyon yadda za a bi da masu karɓar cutar ta CoV a cikin dabbobi na iya kawo muhimmin fahimta game da ci gaban cutar ta CoV a cikin ɗan adam.
A cikin wannan bita, za mu gabatar da cikakken bayani game da ilimin da aka samu game da HCoVs bakwai, tare da nuna tarihin gano su da kuma asalin su da kuma watsa su a cikin halittu.
Abu mai mahimmanci, muna kwatanta da rarrabe tsakanin HCoV da YYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYY
An yi magana game da annobar COVID-19 a wannan yanayin.
Bugu da kari, an kuma bayyana sharuddan da ake bukata don samun nasarar sauya cutar AIDS da kuma yanke shawara na ƙarshe game da kimanta cutar ta cutar.
Coronaviruses (CoVs) na cikin iyalin Coronaviridae, wanda ya ƙunshi ƙungiyoyi masu haɗuwa, masu nuna alama, ƙwayoyin RNA guda ɗaya.
Wadannan ƙwayoyin cuta suna da babban asalin kwayoyin cuta na 26 zuwa 32 kilobases na RNA wanda ake kira "CoV" saboda ƙwayoyin halitta na kwayoyin halitta idan aka duba su a ƙaramin microscope.
A tsarin, CoVs suna da tsarin halittu wanda ba a rarraba shi ba don su kasance cikin ƙungiya ɗaya.
Kimanin kashi biyu bisa uku na kwayoyin halitta na DNA sun ƙunshi manyan kwayoyin guda biyu masu karanta saƙonni (ORF1a da ORF1b), wanda aka fassara zuwa pp1a da pp1b replicase polyprotein.
An sake amfani da polyprotein don samar da furotin 16 marasa tsari, wanda aka tsara a nsp1 ~ 16.
Sauran kwayoyin halitta na kwayoyin halitta sun ƙunshi ORF yo don tsarin furotin, ciki har da spikes (s), envelope (E), membrane (M) da nucleoprotein (N).
An sanya wasu furotin na musamman a cikin jerin inda CoVs suka ɓace a wurare daban-daban.
Dangane da bambancin tsarin furotin, ana rarraba CoVs zuwa rukuni huɗu (alpha-CoV, bet-CoV, gamma-CoV da delta-CoV), wanda rukuni na bet-CoV ya ƙunshi yawancin HCoVs kuma an rarraba su zuwa nau'ikan farko huɗu (A, B, C da D).
Tabbatar da binciken binciken gano zuriya ya nuna cewa kwayar cutar da beraye sune asalin asalin yawancin alpha-CoVs da beta-CoVs, yayin da tsuntsaye sune manyan adana gamma-CoVs da delta-CoVs.
Shekaru dubbai, CoVs sun wuce iyakar nau'in kwayoyin halitta kuma sun bayyana a matsayin ƙwayoyin cuta masu mahimmanci ga ɗan adam.
Ya zuwa yanzu, an san nau'ikan COVID guda bakwai na mutum (HCoV).
Waɗannan sun haɗa da HCoV-229E da HCoV-NL63, alpha-CoV.
Sauran beta-CoV guda biyar sun hada da HCoV-OC43, HCoV-HKU1, coronavirus daga cutar huhu mai tsanani (SARS-CoV), coronavirus daga cutar huhu ta Gabas ta Tsakiya (MERS-CoV) da SARS-CoV-2.
HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63 galibi suna haifar da alamun bayyanar cututtuka, kamar mura na yau da kullun da / ko kumburi.
A madadin haka, SARS-CoV, MERS-CoV da SARS-CoV-2 da aka gano kwanan nan suna da ƙwayoyin cuta sosai, suna haifar da mummunan cututtukan huhu a cikin yawancin marasa lafiya waɗanda ke da babbar dama don ɗaukar alamun tashin hankali na huhu (ARDS) da alamun tasirin huhu.
An samo kwayar cutar HCoV-229E ta farko, B814, daga cikin narkewar hanci na marasa lafiya da ke fama da mura a tsakiyar shekarun 1960.
Tun daga wannan lokacin, an samu ilimi mai yawa ta hanyar zurfin nazarin HCoV-229E da HCoV-OC43, duka biyun suna haifar da alamun hana kai.
A zahiri, an yarda da batun cewa kamuwa da cutar HCoV gabaɗaya ba ta da matsala har zuwa barkewar SARS.
Cutar SARS ta faru a shekara ta 2003 kuma tana daya daga cikin mafi munin a tarihin zamani, tare da kamuwa da mutane sama da 8,000 kuma kusan kashi 10% na mutuwar.
Shekaru goma bayan haka, barkewar cutar ta numfashi a Gabas ta Tsakiya (MERS) ta haifar da ciwon daji na yau da kullun a tsibirin Larabawa da kuma yaduwar cutar a sauran ƙasashe.
HCoV(2019-nCOV) 2019 wanda ba a saba gani ba, wanda aka sake sanya masa suna SARS-CoV-2, shine sanadin cutar ta sabon coronavirus 2019 (COVID-19), wanda ya kashe mutane sama da 3,120 kuma ya shafi mutane sama da 91,000 zuwa 3 ga Maris, 2020.
Bala'in ya yi muni kuma dole ne duniya ta shirya don annobar SARS-CoV-2 mai zuwa.
Dukkanin HCoVs bakwai suna da zuriyar cutar dabba ta hanyar firikwensin, beraye ko dabbobi.
Wasu hujjoji sun goyi bayan juyin halittar HCoVs daga firikwensin, yayin da ƙwayoyin cuta suka daidaita da kyau kuma ba su da kamuwa da cuta amma suna nuna bambancin kwayoyin halitta mai yawa.
Bala'in COVID-19 ya kawo manyan matsaloli ga kasar Sin da kuma duniya a fannin kiwon lafiya, kimiyya, zamantakewa da ɗabi'a.
Binciken asalin cutar HCoVs na dabbobi yana kawo hanyar fahimtar tarihin halitta, ƙarfin motsawa da abubuwan da ke hana tsalle-tsalle.
Wannan kuma na iya jagorantar ko sauƙaƙe ganowa, matsakaici da haɓaka dabbobi masu cutar SARS-CoV-2, tare da mahimman sakamako na hana yaduwar zuwa wasu wurare a nan gaba.
A cikin wannan bita mun gabatar da taƙaitaccen bayani game da zuriyar cutar da ta wuce daga dabba zuwa wani kwayoyin halitta da kuma yadda cutar HCoV ke ci gaba.
Musamman, za mu haskaka kuma mu tattauna game da asalin al'ada na HCoVs. HCoVs galibi ba su da ƙwayoyin cuta a cikin yanayin halittu amma suna zama ƙwayoyin cuta bayan watsawa daga kwayoyin halitta zuwa ciwo na daban.
Muna kuma duba yanayin da HCoV ya samo asali wanda yawanci yakan faru ne lokacin da kamuwa da cutar ya ragu.
An kuma tattauna sakamakon SARS-CoV-2 da ke gudana a wannan taron.
An san dabbobi masu cutar COV tun daga ƙarshen shekarun 1930.
Kafin a gano cutar HCoV-229E B814 ta farko a cikin hanci wanda ya kamu da cutar sanyi, an sanya wasu nau'ikan CoVs a cikin wasu dabbobi da suka kamu da cutar, ciki har da ƙudan zuma, beraye, shanu, aladu, kuliyoyi da karnuka.
A cikin shekarun da suka gabata, an gano nau'ikan HCoV guda bakwai.
Takaitaccen taƙaitaccen tarihin gano HCoV a cikin tsarin da ya dace (Table 1) zai zama mai bayani da kuma bayani.
An fara gano kwayar cutar HCoV-229E a cikin numfashi na marasa lafiya da ke fama da ciwon huhu a shekara ta 1966, kuma an yi amfani da ita a hankali don girma a cikin ƙwayoyin huhu na WI-38.
Marasa lafiya da aka kamu da cutar HCoV-229E sun nuna alamun mura, ciki har da ciwon kai, rashin ciki, rashin gida da rashin cin abinci, tare da zazzabi da kumburi a cikin kashi 10-20% na lokuta.
A ƙarshen 1967, an gano HCoV-OC43 a cikin tsarin kwayar halitta da kuma wucewa ta hanyar jerin abubuwa a cikin kwakwalwar beraye.
Alamun binciken kamuwa da cutar HCoV-OC43 ya zama kamar na HCoV-229E, wanda ba a iya gano shi a cikin wasu ƙwayoyin cuta na numfashi kamar su ƙwayar cutar influenza A da ƙwayar rhino ba.
Dukansu HCoV-229E da HCoV-OC43 sun bazu a duniya, kuma yana da mahimmanci muyi amfani da su sosai a lokacin lokacin yanayin yanayin zafi.
Yawanci, lokacin da ba a nuna waɗannan ƙwayoyin cuta ba bai wuce mako guda ba, sannan kuma akwai kusan makonni biyu na rashin lafiya.
A cewar wani binciken da aka yi a kan mutum, mutane masu lafiya da aka kamu da cutar HCoV-229E suna da zazzabi mai matsakaici.
Sai dai wasu marasa lafiya da ke da ƙananan rigakafin jiki ne suka nuna mummunan kumburi a cikin ƙananan bututun numfashi.
SARS, wanda kuma ake kira "Brunusicides", an fara rubuta shi a matsayin cuta ta duniya wanda HCoV ya haifar a tarihin ɗan adam kuma asalinsa shine SARS-CoV, HCoV na uku an gano.
Ana iya gano farkon cutar SARS a ƙarshen 2002 a lardin Guangdong na China.
A cikin SARS, an samu mutane 8,096 da suka kamu da cutar, kuma sun mutu 774, yayin da ta yadu a ƙasashe da nahiyoyi da yawa.
Sai dai daga cikin manyan masu yaduwa, an kiyasta cewa kowane hali zai iya haifar da ƙarin shari'o'i biyu, a lokacin da ba a nuna alamun cutar ba na kwanaki 4 zuwa 7 da kuma mafi girman ƙarfin cutar a ranar 10 na rashin lafiya.
Marasa lafiya da ke dauke da SARS-CoV suna da ciwon tsoka, ciwon kai, zazzabi, gajiya da kumburi da farko, sannan kuma rashin numfashi, kumburi da matsalolin numfashi a duniya.
Rashin jini, gwaje-gwaje na rashin aikin hanta, da kuma ingantaccen creatine kinase sune matsalolin dakin gwaje-gwaje na SARS.
An kuma lura da yaduwar maganin alveolar, yaduwar ƙwayar cuta da kuma karuwar macrophages a cikin marasa lafiya na SARS.
Kimanin kashi 20-30 na mutanen da ke cikin gida suna bukatar kulawa da sauri da kuma numfashi na inji.
Bugu da ƙari, don rage ƙananan bututun numfashi, ƙwayoyin cuta da yawa ciki har da bututun hanji, zuciya da kuma na zuciya na iya kamuwa da wannan kamuwa da cuta a cikin waɗannan lokuta masu tsanani, galibi tare da sakin cytokine, wanda zai iya zama haɗari ga marasa lafiya masu ƙarancin rigakafi.
An fara ware cutar ne daga gwajin budewa na huhu daga marasa lafiya da ke kusa da su da suka yi tafiya zuwa Hong Kong daga Guangzhou.
Tun daga wannan lokacin, an yi ƙoƙari sosai don samun ci gaba na kimiyya game da HCoV.
An killace HCoV-NL63 a cikin jariri mai watanni 7 daga Netherlands a ƙarshen 2004.
An gano cewa yana da yawa ga yara, tsofaffi da marasa lafiya masu rauni da ke fama da cututtukan numfashi.
Abubuwan da ke faruwa a cikin hanci, kumburi, zazzabi, da kumburi na huhu na yau da kullun ne a cikin cutar da HCoV-NL63.
Wani binciken da aka yi a Netherlands ya bayyana cewa an yi wa yaron da ke da watanni 8 da ke fama da cutar burukici takardar shan magani daga hanci.
Ko da yake an gani a Netherlands, a gaskiya an yada shi a duk duniya.
An kiyasta cewa HCoV-NL63 ya kai kusan kashi 4.7% na cututtukan numfashi na yau da kullun, kuma mafi yawan lokuta ana samun su a farkon bazara, bazara da bazara.
HCoV-NL63 yana hana kumburi na ƙuƙwalwa, wanda kuma ake kira kumburi na ƙuƙwalwa.
A wannan shekarar, an gano HCoV-HKU1 a cikin wani mutum mai shekaru 71 wanda ake bi da cutar sankara da kumburi a cikin bututun numfashi a Hong Kong.
Baya ga kamuwa da cutar sankara a cikin al'umma da kumburi a cikin bututun numfashi, an ce HCoV-HKU1 yana tare da mummunan kumburi.
An gano HCoV-NL63,HCoV-229E da HCoV-OC43, HCoV-HKU1 iri ɗaya a duniya, yana haifar da cututtukan numfashi masu sauƙi.
Dukkanin HCoVs guda huɗu da aka gano a cikin al'umma sun daidaita da ɗan adam wanda gabaɗaya ba shi da ƙarancin girma da haifar da cututtukan annoba masu yawa, duk da cewa akwai wasu lokuta da suka faru saboda dalilai da ba a sani ba amma ba safai ba a cikin nau'ikan HCoV-NK63, wanda yanzu an ruwaito yana haifar da mummunan kamuwa da huhu a cikin China.
Gabaɗaya, lokacin da HCoVs ke buƙatar ƙarfin watsawa mai tasiri kuma su ci gaba da kasancewa a cikin ɗan adam, suna zama masu guba ko ƙarancin ƙwayoyin cuta masu yaduwa.
An fara gano cutar MERS-CoV a cikin 2012 a cikin zuciyar wani mai shekaru 60 wanda aka lura da shi a cikin mummunan burkuitis da koda a Saudiyya.
Duk da yake an tabbatar da yawancin shari'o'in ta hanyar binciken dakin gwaje-gwaje a Gabas ta Tsakiya, an bayar da rahoton wasu shari'o'in da suka fi karuwa a cikin mutane a ƙasashen Turai da Tunisia.
An sake samun wani yaduwar cutar a Koriya ta Kudu a shekarar 2015 inda aka tabbatar da mutum 186 da cutar.
Alamun lafiya na MERS suna kama waɗanda ke da SARS, waɗanda aka gano tare da mummunan ciwon daji mai ci gaba.
Ba kamar MERS ba, an lura da marasa lafiya da yawa da ke da MERS a cikin koda, wanda ya bambanta da MERS da cutar HCoV.
Fiye da kashi 30 cikin dari na marasa lafiya suna da alamun cututtukan hanji, kamar tari da kumburi.
Kamar yadda aka ambata a ranar 14 ga Fabrairu, 2020, an ruwaito cewa fiye da gwaje-gwaje 2500 da aka tabbatar da shari'arsu suna da yawan mutuwar da suka kai kashi 34.4%, wanda ya sa MERS-CoV ya zama ɗayan ƙwayoyin cuta mafi lalacewa da ɗan adam ya sani.
A tsakiyar zuwa ƙarshen Disamba 2019, an gano wasu rukunin marasa lafiya da ke da cutar sankara a cikin ƙididdigar da aka gano cewa sun manta da kamuwa da cutar SARS-CoV-2 a Wuhan, lardin Hubei, China.
Hukumar Lafiya ta Duniya ta sanar da barkewar kamuwa da cutar kumburi ta kasa ta hanyar SARS-CoV-2 a matsayin dokar ta baci ta Kiwon Lafiya ta Jama'a ta Duniya wacce kuma aka kira mu cutar COVID-19.
Tun daga ranar 3 ga Maris, 2020, an tabbatar da shari'o'i 90,053 a duk faɗin duniya, tare da adadin mutuwar 3.4%.
A cewarsa, yawan mutuwar a Hubei, China, ya kai kashi 4.2%, yayin da a wajen ya kai kashi 1.2%.
SARS-CoV-2 yana haifar da mummunan kamuwa da cutar numfashi kamar SARS-CoV da MERS-CoV, wanda aka bayyana a matsayin zazzabi, kumburi da rashin iskar oxygen.
An kuma lura da cutar a wasu marasa lafiya.
Burnout yana ɗaya daga cikin alamun bayyanar cututtuka masu tsanani kuma yana iya wucewa cikin sauri zuwa ciwon numfashi mai tsanani.
Kodayake SARS-CoV da SARS-CoV-2 suna da kamanceceniya da yawa a cikin jerin nucleotide na 82%, suna rarraba su zuwa nau'ikan tsire-tsire daban-daban na tsire-tsire don ƙungiyoyin canji na rayuwa.
SARS-CoV-2 a bayyane yake yana da ƙananan ƙwayoyin cuta amma yana yaduwa fiye da SARS-CoV da MERS-CoV.
An bayar da rahoton cututtuka da ba su nuna alamun kamuwa da cutar SARS-CoV-2 ba kuma suna iya taimakawa wajen saurin yaduwar ta a duniya.
Kwatanta da rarrabe SARS-CoV-2 a tsakanin sauran HCoV shida ya haifar da daidaito da bambance-bambance masu fifiko.
Da farko dai, lokacin da ba a bayyana shi ba da kuma lokacin da ake ciwo yana da mahimmanci.
Saboda haka, SARS-CoV-2 yana bin canjin canji na sauran HCoV shida.
Na biyu, haɗarin bayyanar cututtukan COVID-19 yana tsakanin SARS-CoV da HCoVs huɗu da ke watsawa ta al'umma (misali HCoV-2229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63).
A gefe guda kuma, an lura da shi a lokacin kamuwa da cutar HCoVs ta hanyar zamantakewa, ciki har da gabatar da marasa mahimmanci , masu sauƙi ko ma marasa alamomi.
A gefe guda kuma, ana iya ganin ƙananan ƙananan ƙananan cututtukan COVID-19 kamar yadda ake ganin cututtukan SARS-CoV, duk da cewa adadin bayanai ba su da yawa.
Na uku, watsa SARS-CoV-2 kuma yana nuna alamun ban sha'awa da suka shahara a cikin al'ummomin da ke karɓar HCoVs da SARS-CoV.
A gefe guda kuma, ikon watsa SARS-CoV-2 ya fi na HCoV da kuma na al'umma.
A gefe guda kuma, har yanzu dole ne a tabbatar da cewa ikon watsa SARS-CoV-2 ya ragu bayan ya wuce zuwa ɗan adam kamar yadda ya faru da SARS-CoV da MERS-CoV.
A ƙarshe, ana iya samun wasu irin HCoVs, SARS-CoV-2 daga samfurin tsutsa.
Ko watsa SARS-CoV-2 daga fuka-fuki ta bakin ya taka muhimmiyar rawa kamar yadda SARS-CoV ya yi aƙalla a wasu yanayi, dole ne a tabbatar da shi a cikin nazarin gaba.
Hakanan ya kamata a yi la'akari da cewa SARS-CoV-2 na iya nuna bambancin ɗan lokaci a cikin yanayin da jama'a ke karɓar HCoVs.
Koyaya, alamun SARS-CoV-2 gami da ikon watsawa, ƙwayoyin cuta da yaduwar cutar da ke ci gaba bayan ya watsa ga ɗan adam zai zama sakamakon ƙarshe na barkewar cutar COVID-19.
Dukkanin HCoVs huɗu da aka gano a cikin al'umma waɗanda ke haifar da alamun bayyanar cututtuka sun kasance masu kyau ga mutane.
A gefe guda kuma, yana iya zama gaskiya cewa ɗan adam ya yi aiki da kyau tare da HCoVs arba'in.
A takaice dai, duka biyu na iya zama masu tsira daga cutar HCoV ta zamanin dā.
An kawar da HCoV wanda ke haifar da cutar mai tsanani a cikin mutane da kuma a cikin mutane da aka gano cutar mai tsanani ta HCoV.
Don wannan ya faru, dole ne ya ninka ɗan adam zuwa wani matakin da zai ba shi damar daidaitawa da canje-canje na ci gaba wanda ke magance abubuwan da ke haifar da ciwon daji.
A wannan ma'anar, tsawon lokacin da cutar SARS-CoV-2 ke yaduwa da yawan mutanen da ke kamuwa da cutar, sune manyan damar da za su iya daidaitawa da ɗan adam.
Idan aka daidaita shi da kyau, watsawa ga mutane zai zama da wuya a dakatar da keɓewa ko wasu matakan hana kamuwa da cuta.
A cikin shekaru da yawa, an gano CoVs huɗu a cikin al'umma a cikin yanayin ɗan adam don haifar da mura a cikin mutanen da ke da rigakafin jiki.
Kuma ƙwayoyin cuta ba su buƙatar dabbobi masu adanawa.
Idan aka kwatanta da haka, yawancin cututtukan SARS-CoV da MERS-CoV ba su daidaita da ɗan adam ba kuma ba za a iya dakatar da watsa su zuwa ɗan adam ba.
Suna son karewa da kuma yada cutar da ke kamuwa da dabbobi a cikin gidajensu kuma su nemi hanyoyin da za su iya samun damar cutar da mutane masu rauni, ta hanyar amfani da hanya ɗaya ko biyu da kuma ƙara cutar.
SARS-CoV-2 yana da alamun bayyanar cututtuka iri ɗaya da SARS-CoV/MERS-CoV da HCoVs huɗu da al'umma ta watsa.
Yana da matukar dacewa a watsa shi kamar yadda HCoVs suka samu a cikin al'umma, aƙalla a yanzu.
Duk da haka, yana da ƙarancin kamuwa da cutar fiye da HCoVs da ke cikin al'umma kuma yana da ƙarancin kamuwa da cutar fiye da SARS-CoV ko MERS-CoV.
Har yanzu ana jiran ganin ta daidaita da mutum gaba daya kuma ta yi yawo a cikin mutum ba tare da ajiya ko dabbobi masu ciwo ba.
Kafin mu tattauna asalin dabbobi na HCoV, zai yi kyau muyi magana game da fasalin da halayen canji, yanayi, ajiya, ciwon mai karfafawa da kuma matsakaiciyar HCoV.
Dabba tana aiki a matsayin mai karɓar HCoV idan ta ba da gida ga tsohuwar al'umma da ke da alaƙa da juna ta hanyar raba babban daidaituwa a cikin jerin nucleotide.
An kamu da cutar ta farko a hanya ta yau da kullun kuma ba ta da cutar.
Hakanan, ajiyar masu ɗaukar cutar ta ba da gida ga HCoV na dindindin da na dogon lokaci.
A lokuta biyu, masu kamuwa da cutar sun kamu da cutar ta halitta kuma sune masu kamuwa da cutar HCoV ko kuma kwayar cutar da ta samo asali daga.
A akasin haka, idan HCoV ya kamu da cutar a cikin wani sabon mai ɗaukar ciwo mai matsakaici jim kaɗan kafin a kai shi ga mutum, ba zai iya magance cutar da kyau ba.
Ciwon daji na matsakaici na iya zama tushen cututtukan dabbobi na kamuwa da cutar ta mutum kuma yana iya taka rawa wajen ƙarfafa ciwon daji ta hanyar barin kwayar cutar ta ninka cikin ɗan gajeren lokaci kuma a ƙarshe ta mamaye ɗan adam don ƙarfafa yaduwar kamuwa da cutar ta ɗan adam.
HCoV na iya kamuwa da kamuwa da cuta a cikin jiki idan ba zai iya rayuwa ba tare da ciwon daji na matsakaici ba.
A akasin haka, HCoVs na iya magance cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cuttukan cututtukan cuttukan cututtukan cuttukan cututtukan cututtukan cututtukan cuttukan cututtukan cututtukan cututtuk
A irin wannan yanayin, ciwon ciwon tsakiya zai zama mai riƙe ciwon na halitta.
Bayanai daga binciken cututtukan cuta sun nuna a sake dubawa cewa farkon cutar SARS tana da alaƙa da dabbobi da ake kula da su.
Binciken da aka yi a kan ƙwayoyin cuta ya nuna cewa masu sayar da dabbobi suna da ƙarancin ƙwayoyin rigakafin SARS-CoV igG idan aka kwatanta da na al'umma.
An fara gano cewa cats da aka rufe da daji (Paguma larvata) da karnuka na daji a cikin kasuwannin dabbobi masu rai suna dauke da kwayar cutar SARS-CoV wanda galibi yayi kama da SARS-CoV.
Wannan ya sami goyon baya a fili ta yadda ba a sake yin rahoton SARS ba bayan an kashe dukkan cats masu kiwo a kasuwa.
Koyaya, an bayar da rahoton cewa cats na daji da aka rufe a cikin iska ko gonaki waɗanda ba su haɗu da kasuwannin dabbobi masu rai ba sun ɓace da SARS-CoV, yana ba da shawarar cewa cats na daji da aka rufe na iya zama kawai ciwon mai karfafawa na tsakiya amma ba ajiyar halitta na SARS-CoV ba.
Abin lura, tun da kashi 80% na dabbobi daban-daban a cikin kasuwannin Guangzhou suna da rigakafin jiki na SARS-CoV, ba za a iya kawar da yiwuwar cewa wasu kwayoyin halitta a cikin ƙananan dabbobi na iya zama masu ɗaukar cutar SARS-CoV ba.
Duk waɗannan suna nuna ƙarshen cutar SARS-CoV.
Bincike mai zuwa na cutar da ke tattare da dabbobi masu cutar SARS-CoV ya bayyana CoV mai kusanci, wanda ake kira SARS-related Phinolophus Cov daga HKU3 (SARSr-Rh-BatCoV HKU3), wanda ke cikin takalmin dawakai na China.
Wadannan kwayoyin suna da rigakafin SARS-CoV da kuma jerin kwayoyin halitta na SARSr-Rh-BatCoV HKU3.
Tun da sauran CoVs na firikwensin suna da kashi 88-92% na jerin nucleotide iri ɗaya da SARS-CoV.
Wannan binciken ya karfafa sabon ra'ayi cewa kwayoyin halitta sune ajiyar kwayoyin cutar da ke faruwa a cikin mutane.
An gano wasu nau'ikan SARS masu kama da CoVs (SL-CoVs) a cikin cutar, amma ba wanda sai ɗaya daga cikin WIV1 da aka tsara za a iya gane shi a matsayin kwayar cutar mai rai.
An gano cewa mai karɓar angiotensin 2 (ACE2) a cikin mutum shine mai karɓar SARS-CoV.
An gano cewa WIV1 daga gwajin ƙirar firikwensin yana amfani da firikwensin, cats a cikin daji da ACE2 a cikin ɗan adam azaman mai ɗaukar hoto don shigarwa zuwa kwayar.
Abin sha'awa, masu warkar da cutar SARS sun sami damar kawar da WIV1.
A wani bangare, WIV1 yana gano asalin nau'ikan SARS-CoV da aka gano a cikin cutar, suna raba kashi 95% na jerin nucleotide na haɗin kai.
Duk da cewa akwai kamanceceniya tsakanin waɗannan ƙwayoyin cuta biyu, an yi imani da cewa WIV1 ba shine asalin SARS-CoV ba kuma firikwensin ba shine mafi kusa da cutar mai ɗaukar cutar SARS-CoV ba.
Binciken nazarin asalin kwayoyin halitta ya sanya MERS-CoV cikin rukuni ɗaya na CoV-HKU4 da CoV-HKU5 na jini.
CoV-HKU4 da MERS-CoV suna amfani da maganin cuta iri ɗaya, dipeptidyl peptisase 4 (DPP4), don maganin cutar.
RNA mai dogaro da RNA polymerase na MERS-CoV ya nuna cewa binciken ya kasance kusan iri ɗaya da na beta-CoV na yamma da aka gani a Turai da Afirka.
Har zuwa yanzu, babu wani MERS-CoV mai rai da za a iya samu a cikin daji da yamma.
MES-CoV da kuma CoV-HKU25 da ke da alaƙa da shi a cikin rana suna da kashi 87% na nucleotide guda ɗaya.
Saboda haka, abincin dare ba zai iya zama mafi kusa ba ga cutar MERS-CoV.
A wani bangare kuma, binciken da aka yi a Gabas ta Tsakiya ya nuna cewa an samo raƙuma masu girma guda ɗaya a cikin wani nau'in jiki na musamman na MERS-CoV, raƙuma na Gabas ta Tsakiya suna kama da na ƙasashen Afirka da yawa.
An gano cewa MERS-CoV wanda ke kallon kai tsaye daga kwayar cutar da aka samo daga mutum a cikin binciken da aka yi a kan raƙuma, ban da haka, raƙumi ya nuna cewa yana da kariya daga masu riƙe cutar kamar MERS-CoV.
Ya kamata kuma a lura cewa a cikin alamun bayyanar cututtuka masu sauƙi amma masu yawa na cutar an lura da su a cikin raƙuma a cikin gwajin waɗanda ke da kamuwa da cutar MERS-CoV.
Ya kamata a lura cewa raƙumi mai kamuwa da cutar ba kawai ya saki ƙwayoyin cuta a cikin hanyar numfashi ba, har ma ya saki ƙwayoyin cuta a cikin jijiyoyin jiki, wanda shine babban hanyar da ke fitar da ƙwayoyin cuta a cikin maraice.
Ko ta yaya, har yanzu akwai tambayoyi saboda yawancin shari'o'in MERS da aka tabbatar ba su da tarihin hulɗa da raƙuma kafin bayyanar cututtuka, yana yiwuwa saboda watsawa ta cikin ɗan adam ko kuma hanyoyin watsawa da ba a sani ba da ke tattare da dabbobi da ba a sani ba waɗanda MERS-CoV ya sanya gida.
SARS-CoV-2 yana da daidaituwa ta asali ta 96.2% na nucleotide na CoV RaTG13 wanda aka keɓe daga Rhinolophuw affinis.
Kamar yadda yake a cikin SARS-CoV da MERS-CoV, bambancin SARS-CoV-2 da RaTG13 na iya zama mafi yawan abin da ake tsammani yana haifar da dangantaka tsakanin iyaye.
Wannan ya ce, abincin yamma ba ajiya ne na cutar SARS-CoV-2 ba har sai an gano irin wannan abincin na COVID-2 a nan gaba.
Zai yiwu, cewa dabbobi masu cutar SARS-CoV-2 suna cikin dabbobi masu rai na daji da aka sayi da kuma sayar da su a manyan kantunan sayar da kayayyaki na Huanan SeaFood, wanda aka manta da farkon shari'o'in COVID-19, yana nuna ainihin yanayin watsa dabbobi zuwa ɗan adam.
Yawancin binciken da aka yi a yanzu na binciken kwayoyin cuta sun nuna cewa wasu ƙananan ƙananan kwayoyin cuta masu haɗari da ake kira pangolins (Manis Javanica) na iya zama tushen asalin beta-CoV da kuma SARS-CoV-2.
Sabon kwayar cutar ta cutar ta pangolines ta raba kashi 85-92% na asalin nucleotide tare da SARS-CoV-2
Koyaya, suna da alaƙa da RatG13 kusan 90% na ƙimar ganowa ta atomatik.
Suna rarraba ƙananan ƙananan kwayoyin SARS-CoV-2 zuwa ƙwayoyin cuta a cikin tsarin rarrabuwa, ɗaya tare da ƙwayar cuta mai haɗuwa (RBD) SARS-CoV-2, wanda ke da kashi 97.4% na ganewar amino acid.
Kwatantawar asali na SARS-CoV-2 a cikin RBD da RaTG13 ya bambanta sosai, duk da cewa akwai babban daidaituwa na asali da yawa a cikin jadawalin ƙwayar cuta.
Wani bincike na baya akan cutar pandolins ya kuma nuna cewa an gano wani kwayar cutar da ta yadu daga samfurin zuciya, wanda ya canza zuwa SARS-CoV-2.
Wannan binciken ya samo asali ne daga hanyoyin da aka hada da kuma maganin hannu don samar da jerin kwayoyin cuta na HIV wanda ya ƙunshi kusan kashi 86.3% na jimlar kwayoyin cuta na HIV.
Ba za mu iya kawar da yiwuwar cewa yana cikin masu karɓar SARS-CoV-2 ba.
Koyaya, a halin yanzu babu wata hujja da ta kai tsaye zuwa asalin SARS-CoV-2 na pangolin saboda bambancin SAR-CoV-2 da SARS-CoV-2 na pangolin da ke da alaƙa da beta-CoVs.
Bugu da kari, nisan da ke tsakanin SARS-CoV-2 da RaTG13 ya fi na SARS-CoV-2 da SARS-CoV-2 da kuma bangolin da ke da alaƙa da beta-CoVs gajere.
Hanyar canjin halittu na SARS-CoV-2 a cikin yamma, pangolins, da sauran dabbobi masu shayarwa har yanzu suna tsakiyar tsakiyar su.
A cikin binciken da aka yi na asali na kama da RBD na jini tsakanin SARS-CoV-2 da kwayar cutar, SARS-CoV-2 da ke da alaƙa da beta-CoV da RaTG13 suna da kamanceceniya na asali na jini mai yawa.
Ana tunanin cewa akwai kamanceceniya tsakanin SARS-CoV-2 RBD da ake samu a cikin pangolin da ke da alaƙa da beta-CoV da SARS-CoV-2 wanda ya fito ne daga zaɓin da aka yi a cikin kimantawa iri ɗaya.
Wani kuma ya fi son sake haɗuwa da SARS-CoV-2 zuwa pangolin da ke da alaƙa da beta-CoV da RaTG13 da dabbobi na daji na uku.
A cikin ingantaccen bincike, sake haɗuwa yana yaduwa zuwa beta-CoV.
Har yanzu ƙungiyar bincike ba ta gano asalin cutar da dabbobi ke kamuwa da ita ga mutane ta SARS-CoV-2.
A cikin HCoVs masu yawa, an kuma bincika asalin cututtukan da dabbobi ke kamuwa da su na HCoV-229E, HCoV-OC43, HCoV-NL63 da HCoV-HkU1.
Tabbacin binciken rarrabuwa ya nuna cewa HCoV-NL63 da HCoV-229E duka sun samo asali ne daga CoV a cikin yamma, yayin da asalin ƙwayoyin cuta na HCoV-OC43 da HCoV-HKU1 an samo su a cikin beraye.
An bayar da rahoton cewa wani nau'in CoV mai suna ARCoV.2 (Appalachian Ridge CoV) da aka gani a Arewacin Amurka cewa wani nau'in nau'in nau'i mai launi uku ya nuna kusanci mai yawa tsakanin HCoV-Nl63.
A gefe guda, HCoV-229E ya haifar da wata hanyar da ta dace da wani CoV na yamma, wanda aka sani da Hipposideros/GhanaKwam/19/2008, wanda aka gani a Ghana, inda ake zargin nau'in raƙumi ne mai ciwo mai matsakaici.
A bayyane yake, an taƙaita ilimin yanzu game da asalin dabbobi da aka gano na HCoV da kuma HCoV a cikin Shafi na 1 da kuma Tebur na 2.
Binciken bincike na rarrabuwa ya ba da hujja cewa abubuwan da suka faru na tarihi na watsa HCoV sun kasance.
Lokacin da HcOV-OC43 ya wuce cikin kwayoyin halitta don ya kamu da cutar a cikin mutane wanda aka kawo daga dabbobi masu kashe wuta a kusan 1890, an yi rikodin kamuwa da cutar numfashi ta duniya.
Tarihin watsa HCoV-229E a cikin kwayoyin halitta ya bayyana sarai.
An gano cewa cutar alpha-CoV da kuma cutar ta yi alaƙa sosai da HCoV-229E.
Daga cikinsu akwai alpaca alpha-CoV.
Akwai shaidu da yawa da ke nuna cewa cutar ta iya yaduwa zuwa dan Adam kai tsaye a lokacin maraice.
Da farko dai, mutane ba alpacas ba ne waɗanda suke da kusanci da maraice tare da yanayin da suke rayuwa tare.
A madadin haka, mutane suna da dangantaka ta kusa da alpacas.
Na biyu, HCoV-229E da ke hade da alpha-CoV da yamma yana da bambanci da sauran ƙwayoyin cuta da ba su da cutar a yamma, yayin da alpaca alpha-CoV ke haifar da mutuwar cututtukan numfashi a cikin dabbobi masu kamuwa da cuta.
A ƙarshe, ba a gano alpaca alpha-CoV a cikin dabbobi na daji ba.
Saboda haka, ba za a iya cire yiwuwar alpacas ta sami HCoV-229E da ke da alaƙa da alpha-CoV a cikin ɗan adam ba.
A gaskiya ma, na'urar tacewa ita ce tushen kai tsaye na ƙwayoyin cuta na mutum ciki har da ƙwayar cutar rabies, ƙwayar cutar Ebola, ƙwayar cutar Nipah da ƙwayar cutar Hendra.
Saboda haka ba abin mamaki bane cewa kwayoyin cutar HCoV-229E zasu iya watsawa ga mutane kai tsaye.
Hakazalika, yayin da alpha-CoV da kuma na'urar daukar hoto sune asalin HCoV-229E, alpacas da raƙuma yayin da raƙuman ruwa na iya zama ciwon jigilar kaya mai matsakaici wanda ke watsa kwayar cutar ga mutane, kamar yadda lamarin MERS-CoV yake.
MERS-CoV misali ne mai kyau na watsa kwayoyin halitta daga firikwensin zuwa raƙumi zuwa raƙumi da kuma daga raƙumi zuwa mutum.
An gano asalin canjin MERS-CoV daga firikwensin a farkon gano shi kuma ya kuma ƙarfafa sakamakon bambancin.
Yana da al'ada cewa filtata suna kawo babban yanki na ƙwayoyin cuta masu wadataccen ƙwayar cuta don hulɗa da kwayoyin halitta don yin amfani da kwayoyin halitta da kuma watsa su zuwa kwayoyin halitta.
Tsawan shekaru, ƙungiyoyi masu yawa, haɗin kai na zamantakewa da ƙarfin jirgin sama sune duk yanayin da ya dace don zama mai ɗaukar hoto mai kyau.
A gefe guda kuma, MERS-CoV ya kamu da raƙuma a cikin shekaru da yawa.
Sun yi aiki sosai da wannan raƙuman da suka sauya daga ciwo mai matsakaici zuwa ciwo mai sauƙi na halitta.
MERS-CoV yana haifar da ƙananan cututtuka kuma yana da ƙananan canje-canje a cikin waɗannan dabbobi.
Cutar ta ta mutum a wani lokaci shine hatsari kuma mutum shine cutar ta ƙarshe ta MERS-CoV saboda watsawar ba ta da rai.
A kan matsayin raƙumi a watsa MERS-CoV, matsayin masu ƙasa, idan akwai, a watsa SARS-CoV-2 ya bambanta.
Musamman, beta-CoVs masu tsufa suna da ƙwayoyin cuta mafi yawa a cikin al'ummomi.
Zai iya zama wata cuta mai dauke da cutar beta-CoV da ke da alaƙa da SARS-CoV-2, kamar yadda yake a cikin cats na daji na SARS-CoV.
Akwai yiwuwar watsa SARS-CoV-2 zuwa kwayoyin halittun daji ta hanyar wucewa daga dabbobi zuwa mutane shine a gwada shi ko cire shi yayin gudanar da bincike na gaba.
Da farko dai, sigina na iya zama ajiyar cutar SARS-CoV-2 da ke da alaƙa da cutar wanda galibi ya yi kama da SARS-CoV-2.
Mutane na iya raba abubuwan da ke nuna matsayin ƙasa ta hanyar yankan nama ko gasa kwal.
Na biyu, pangolins na iya zama ɗayan masu haɓaka cutar AIDS wanda aka gano kwanan nan game da cutar SARS-CoV-2.
Kwayar cutar tana kamuwa da mutane ta hanyar shan nama da cin nama.
Yana yiwuwa cewa dabbobi masu shayarwa da yawa ciki har da dabbobi na gida suna da mafi yawan kamuwa da SARS-CoV-2.
An tabbatar da bincike na gaba ɗaya a cikin dabbobi masu gida da na namun daji game da maganin rigakafin cutar.
Na uku, kamar yadda aka ambata a sama, ana zargin sake haɗuwa da daidaitawa da SARS-CoV-2 ya shafi wani nau'in halitta na uku wanda ke da alaƙa da masu cutar da kuma masu ƙasa.
Ana ci gaba da bincike kan asalin dabbobi na SARS-CoV-2.
Baya ga nau'ikan dabbobi masu cutar sankara, manyan abubuwa uku na cutar suna da mahimmanci don sauƙaƙa COVID da kuma ƙetare shinge na kwayoyin halitta.
Na farko, akwai babban adadin canji a cikin RNA.
Idan aka kwatanta da sauran ƙwayoyin RNA guda ɗaya, ana iya gano iyakar canjin CoVs da aka ƙayyade a matsayin "matsakaici" zuwa "babba" tare da matsakaicin iyakar canji na ~10-4 a kowace shekara a wurare 2, dangane da matakin daidaitawar CoV na rashin lafiya na yau da kullun.
CoVs suna da ƙimar karantawa na exoribonuclease, wanda ke kawar da shi saboda yawan canji da rage ƙarfi ko rashin haihuwa.
Abin sha'awa, an san cewa Remdesivir analogue nucleotide yana rage yawan CoV ta hanyar hana exoribonuclease da RNA mai dogaro da RNA polymerase.
Remdesivir yana ɗaya daga cikin magungunan rigakafin SARS-CoV-2 mafi inganci wanda za a gwada shi a cikin gwajin likita.
Koyaya, iyakar canjin COVID ya fi na masu dauke da cutar sau miliyan.
Bugu da ƙari, yawanci yawan canjin girma yana da yawa idan cutar ta CoV ba ta magance cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut
Idan aka kwatanta da SARS-CoV tare da iyakar canji, iyakar canji na SARS-CoV-2 a bayyane yake ƙasa, yana ba da shawarar ƙimar daidaitawar ɗan adam.
Zai yiwu, ya riga ya sha wahala daga wata cuta ta musamman da ke kusa da mutum.
Bugu da kari, SARS-CoV-2 ya shafi MERS-CoV, wanda ya yi aiki sosai tare da raƙuma masu launin fata.
A ra'ayi, ba zai yiwu ba cewa cutar ta shuka ta haifar da allurar rigakafi da ƙwayoyin cuta na SARS-CoV-2 da ba su da tasiri cikin sauri.
Na biyu, RNA mai girma a cikin CoVs yana ba da ƙarin ƙarancin tsari ga tsarin tsarin kwayoyin halitta na canji da haɗuwa, don haka yana haɓaka damar canji a cikin kwayoyin halitta, wanda ke ba da damar bayyanar CoVs na musamman lokacin da yanayin ya dace.
Wannan yana goyan bayan tsarin karatun budewa na musamman da ake samu da kuma aikin gina jiki da aka saka a ƙarshen 3 na kwayoyin halitta.
Na uku, CoVs sau da yawa suna canza tsarin ba tare da sanarwa ba yayin da ake yin kwafin RNA ta hanyar "saukarwa" na musamman.
A cikin cututtukan da ke tattare da cutar, sauye-sauyen cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan
A cikin babban tsayi da kuma ƙananan kwayoyin halitta, RNA zai iya sake haɗuwa don samar da sabon CoV yo.
A cikin hujjojin sake haɗuwa na halitta a cikin nazarin canjin halittu an gano cewa duka HCoV-HKU1 da HCoV-OC43, da kuma CoV na dabba kamar SL-CoV da CoV-HKU9 na firikwensin.
Hadin kai tsakanin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutut
Baya ga waɗannan abubuwa uku na cutar da aka ambata a sama, hulɗar kwayar cuta da jijiyoyin ciwo na iya zama wani muhimmin abu da ke shafar yaduwar kwayoyin halitta.
A nan, ana ɗaukar sake haɗuwa da SARS-CoV a matsayin misali na yau da kullun, wanda kuma ya nuna tabbaci na kyakkyawan zaɓi yayin gudanar da watsa kwayoyin halitta.
Dangane da nazarin kwatancen tsakanin keɓewar mutum da SARS-CoVs na civet, ana tsammanin SARS-CoV yana ba da damar daidaitawa cikin sauri ga cututtukan masu ɗaukar hoto daban-daban, musamman lokacin da yake tare da canjin RBD na furotin S.
Gabaɗaya, RBD na furotin S na CoV yana shiga cikin jijiyoyin sel kuma yana da ƙarfi a cikin maganin antibody akan cutar kansa.
SARS-CoV, RBD a cikin spring yana cikin kashi 318 zuwa 510 na amino acid na S1, wanda ke ƙunshe da ACE2 a cikin ɗan adam kuma kamar yadda yake a saman ƙwayoyin jijiyoyin da ke shiga cikin kwayar.
RBD na SARS-CoV na iya gano masu karɓar ACE2 a cikin dabbobi daban-daban, gami da dabba, civet, beraye da karnuka na daji, yana ba da damar kwayar cutar ta mamaye nau'ikan kwayoyin halitta daban-daban.
A zahiri, an lura cewa amino acid guda 6 ne kawai suka bambanta da rarraba kwayar cutar a cikin mutane kuma a cikin RBD 4 na cats na daji akwai tsarin jijiyoyin kunne don haɗa jijiyoyin ACE2.
SARS-CoV daga cats na daji yana da bambancin K479N da S457T na RBD na kwayoyin halitta, wanda zai iya haɓaka sha'awar yin hulɗa da furotin spike wanda ke tare da ƙwayar cuta ta mutum ACE2.
A wasu kalmomi, canjin amino acid biyu yana da haɗari ga daidaitawar kwayar cutar a cikin ɗan adam.
Yana da kyau a lura cewa SARS-CoV-2 yana da ƙwayar cuta iri ɗaya da SARS-CoV.
30% na bambancin tsakanin SARS-CoV-2 da SARS-CoV na S1 na furotin S ya nuna cewa sha'awar sauraron furotin S ACE2 na mutum na iya canzawa.
A zahiri, binciken cryo-Em ya nuna cewa 10 - zuwa 20 sau da yawa a cikin sha'awar yin wannan a cikin mutane tsakanin ACE2 da furotin S na SARS-CoV.
Zai kuma zama da ban sha'awa a san ko wasu sigina na sama na sel na iya buƙatar watsa SARS-CoV-2.
Abin sha'awa, HCoV-NL63 yana iya samun ACE2 amma tare da sauran cututtukan S.
Akwai wasu masu karɓar HCoV, kamar aminopeptidase N don HCoV-229E, da 9-O-acetylated sialic acid don HCoV-OC43.
Wannan na iya zama dalilin nasarar kamuwa da cutar ta CoV a cikin ɗan adam bayan an sami karuwar kwayoyin halitta daga dabbobi masu cutar.
Baya ga ƙwayoyin ƙwayoyin cuta, sakamakon watsa HCoV zuwa kwayoyin halitta iri ɗaya kuma yana dogara ne akan rashin sauran cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutut
Bambancin waɗannan furotin masu cutar tsakanin mutane da masu adana cutar HCoVs na halitta kamar ƙwararrun, raƙuma mai ɗamara da beraye na iya taimakawa wajen hana yaduwar kwayoyin halitta iri ɗaya.
HCoVs dole ne su canza dalilai na rashin ciwo da kuma rage abubuwan da ke hana ciwo don cin nasara a cikin kwayoyin halitta iri ɗaya.
A wannan yanayin, dole ne a ƙayyade kuma a gano ƙayyadaddun ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin.
Binciken kwayoyin halitta masu yawa da ba su da gurɓataccen abu game da dogaro da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan
Fitowar sabon cutar HCoV: sake komawa inda ta fito.
Bambancin CoV da na yamma yana ba da isasshen damar fitowar sabon HCoV.
A wannan ma'anar, CoVs na cutar tana aiki a matsayin mai ɗaukar kwayoyin HCoVs.
Bugu da kari, canjin ci gaban da ke faruwa cikin sauri da kuma sake haɗuwa da kwayoyin cuta na cutar HCoV suna kawo kimantawar HCoV kuma suna da mahimman matakai biyu a wannan aikin.
Misali, samun ko rasa wani abu mai kama da furotin zai iya inganta daidaiton kwayoyin cutar.
Daga cikin ƙarin furotin na SARS-CoV, ana tsammanin ORF8 yana da mahimmanci a cikin kamuwa da ɗan adam, kamar yadda SARS-CoV ya danganta da ƙwayoyin cuta na kwayar cuta amma an gano cewa suna samar da furotin ORF8 daban-daban.
An gano kawar da fasalin 29-nucleotide na SARS-CoV a cikin ƙungiyoyin da aka keɓe a farkon cutar ta mutum.
Rashin kwayoyin ORF8 a cikin ORF8a da ORF8b ana tunanin cewa shine daidaitawa da canjin girma wanda ke inganta canjin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut
A halin yanzu, SARS-CoV yana da yiwuwar tarihin haɗin kai na alpha da beta-CoV, yayin da ƙananan yankuna da yawa na haɗin kai na RNA sun dogara da RNA polymerase.
Hakanan an ambata wuraren sake haɗuwa da ƙwayar cuta a cikin nsp9, galibi nsp10, da kuma sassan nsp14.
Haka kuma, an lura cewa an lura da cutar ta MERS-CoV a cikin abubuwan da suka faru na sake fasalin kwayar cutar a cikin zuriya daban-daban, wanda ya faru a cikin raƙuma a cikin yankin Saudiyya.
Bayan SARS-CoV da MERS-CoV, an kuma lura da sake haɗuwa da wasu HCoVs, inda HCoVs ke haɗuwa da masu ɗaukar CoVs marasa tsari a cikin wasu dabbobi.
Ya kamata kuma a lura cewa zaɓin ɗan adam na iya haifar da canje-canje marasa ganganci a cikin ƙwayar cuta, galibi waɗanda ke haifar da warkar da ƙwayoyin cuta a ƙarƙashin matsin lamba na zaɓi, kamar tsarin rigakafin ƙwayar cuta.
Misali na sakamako shine rashin tsayi na yau da kullun na nau'ikan ORF4 iri ɗaya na HCoV-229E, wanda ke da rashin ƙwayar nucleotude biyu.
Inda ba a iya ganin cutar ORF4 ba a cikin cutar kwayar cutar da kwayar cutar raƙumi da ke da alaƙa da HCoV-229E, alpaca alpha-CoV yana nuna inda nucleotide ke shiga, wanda ya haifar da haɓakar haɓakar kwayoyin halitta.
A ƙarshe, an kuma kawo sabon kimantawar HCoVs daga masu canza tsarin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cuttukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutut
Babu alamun bayyanar cututtuka ko kuma kawai alamun bayyanar cututtuka masu sauƙi a lokacin da aka kama hoto na CoV, wanda ke nuna daidaituwa tsakanin CoV da kuma cutar.
Ya bayyana cewa masu aikin sun daidaita da cutar sosai a cikin jiki da kuma tsarin aiki.
Alal misali, rashin amsawa ga abubuwan da ke haifar da kumburi a cikin jini yana rage ƙwayoyin cuta da ke haifar da CoV.
Bugu da ƙari, an ƙalubalanci kisan kai na halitta na ayyukan ƙwayoyin cuta na yamma saboda ƙaruwar hana ƙwayoyin cuta na halitta a cikin ƙwayar ƙwayar NKG2/CD94 da ƙarancin ƙayyadaddun ƙimar ƙirar ƙwayoyin cuta na aji na I.
A halin yanzu, babban matakin haɓakar oxygen na kwayoyin halitta (ROS) wanda ya haifar da aikin narkewa na sinadarai a cikin kwayoyin cuta yana matse haɓakar CoV da tasirin sake karantawa na exoribonuclease, wanda ke ba da zaɓi na matsin lamba don haɓaka nau'ikan ƙwayoyin cuta masu yawa lokacin shigar da sabon mai ɗaukar ciwo.
Yawancin kwayoyin cuta da ke haifar da CoV na iya girma a hankali kuma su sake haɗuwa, wanda ke haifar da sabon furotin ko furotin tare da alamun magance ciwo.
Saboda haka, ba abin takaici bane cewa sababbin HCovs guda uku sun bayyana a cikin shekaru ashirin da suka gabata.
CoVs ba su da ƙwayoyin cuta ko kuma ba su haifar da alamun bayyanar cututtuka masu sauƙi ba kamar su maraice da raƙuma.
Suna ninka su sosai ba tare da rage ƙarfin rigakafin jiki ba.
Ga wani asiri game da dalilin da yasa ake ganin mutane da ke fama da cutar ba su da alamun cutar kuma abin da ke haifar da mummunan cututtukan kamuwa da cutar a cikin mutane.
Alamomin da suka fi tsanani galibi suna faruwa ne saboda yawan aiki da tsarin rigakafi da kuma matsalar cytokine yayin da tsarin rigakafi mai tsanani ya fi dacewa da mummunan rauni da kuma rauni na zuciya.
A madadin haka, a cikin masu ciwo da ba su da alamun bayyanar cututtuka, an katse amsar rigakafi ta hanyar tsara CoV.
Irin wannan dabarun da aka yi na kawar da amsawar rigakafi na iya samun sakamako mai amfani a maganin SARS-CoV-2.
Amsar interferon tana da ƙarfi musamman a cikin kyamarar bidiyo.
Saboda haka, shan interferon nau'in I aƙalla a farkon matakin kamuwa da cutar SARS-CoV-2 a cikin ɗan adam yana da amfani.
Bugu da ƙari, NLRP3 mai ƙonewa a cikin ƙwayar cuta yana da lahani.
Saboda wannan dalili, NLRP3 mai hana kumburi tare da MCC950 yana da tasiri a maganin COVID-19.
Fitar da SARS-CoV-2 ya shafi batun da SARS-CoV da MERS-CoV suka samo asali.
Inda aka gano cutar beta-CoV tare da 95% na kama da nucleotide SARS-CoV, akwai kuma CoV mai ganowa wanda ke da kama da 96% na kama da nucleotide SARS-CoV-2.
Duk da yake an gano cewa cats na daji da sauran dabbobi a kasuwa suna adana ƙwayoyin cuta iri ɗaya da SARS-CoV, ba a gano cutar AIDS ta SARS-CoV mafi kusa ba.
An gano beta-CoVs na pangolin da ke da matukar damuwa da SARS-CoV-2, yana nuna cewa pangolins na iya zama ɗayan cututtukan masu ɗaukar hoto na matsakaici ko kuma beta-CoVs na pangolin na iya samar da asalin asalin SARS-CoV-2 na ƙarshe.
Duk da cewa akwai tambayoyi, babu wata hujja cewa SARS-CoV-2 ta kasance ta hanyar mutum da gangan ko ba da gangan ba.
CoVs sun koma haske mai haske saboda barkewar cutar SARS-CoV-2.
Nazarin CoV a cikin firikwensin da sauran dabbobi ya canza ra'ayinmu sosai game da mahimmancin asalin cutar dabba zuwa mutum da yanayin dabba na HCoV zuwa mutum.
Bayanai masu yawa sun nuna cewa SARS-CoV, MERS-CoV da SARS-CoV-2 suna da asalin cutar kuma ana watsa su ga mutane ta hanyar cututtukan da ke cikin tsaka tsaki.
Idan kamuwa da cutar SARS-CoV ta samo asali ne daga hulɗa tsakanin mutane da civets a cikin kasuwa, rufe kasuwanni masu zafi da kashe civets to zai kawo ƙarshen cutar SARS.
Saboda wannan dalili, dole ne a cire pangolin daga kasuwannin ruwa don hana yaduwar cutar dabbobi zuwa mutane, saboda an gano cewa wasu halittu na pangolin beta-CoV suna da alaƙa da SARS-CoV-2.
Koyaya, ko kuma yadda SARS-CoV-2 ke watsawa ga mutane ta hanyar pangolin da sauran masu shayarwa zai zama dole a tabbatar da shi a cikin binciken da za a yi a nan gaba.
A gefe guda kuma, MERS-CoV ya kasance a cikin raƙuma masu ƙuƙwalwa na dogon lokaci.
Kamel yana da muhimmanci a cikin sufuri kuma shine tushen mafi girma na nama, madara, fata da kayan fata na mazauna yankin.
An rarraba shi sosai a Gabas ta Tsakiya da Afirka.
Saboda haka, yana yiwuwa a kashe dukan raƙuma don hana cutar MERS, kamar yadda aka yi da dabbobi na daji a kasar Sin don hana yaduwar SARS-CoV da SARS-CoV-2.
Don hana sake fashewar annobar MERS, dole ne a yi cikakken tsari don yin allurar rigakafin cutar MERS-CoV a cikin raƙuma, tare da sauran matakan hana kamuwa da cuta.
Tun da ba za mu iya kawar da wadannan ƙwayoyin cuta ba, sababbin nau'ikan kwayoyin cuta na iya fitowa don haifar da cututtuka.
Cutar dabbobi da ke yaduwa zuwa mutane suna yawo a cikin iska.
Musamman, ƙwayar cuta ta CoV da ke da yiwuwar cutar dabba da za ta iya wucewa zuwa mutum ta bambanta.
Akwai damar da yawa da cutar ta dabbobi da ke yaduwa da mutane za ta ci gaba kuma ta sake haɗuwa, ta haifar da sabon COVID wanda zai iya yaduwa da kuma / ko kashe mutane a nan gaba.
Dole ne a bar al'adar cin dabbobi a wasu yankuna a China don rage alaƙar da ba ta dace tsakanin mutane da dabbobi.
Ya kamata a shirya da kuma tsara yadda za a magance matsalolin SARS, MERS da COVID-19.
A gaskiya, yawancin ƙwayoyin cuta sun kasance a duniya na dogon lokaci.
Suna zama a cikin albarkatun ƙasa har sai sun sami damar yada su zuwa wani wuri.
Ko da yake masu amfani da bidiyo suna da halaye masu yawa na taimakawa wajen yaduwar ƙwayoyin cuta, yiwuwar ɗan adam ya yi hulɗa da masu amfani da bidiyo da kuma masu amfani da namun daji za a iya rage idan aka koya wa mutane su guji yin hakan.
Kula da dabbobi masu shayarwa a kai a kai ya dace da fahimtar yanayin CoV da cututtukan da ke tattare da su, wanda ke tabbatar da ingancin su wajen hana dabbobi wucewa zuwa mutane da kuma cutar a nan gaba.
A ƙarshe, hanya mafi inganci don hana ƙwayoyin cuta na dabbobi daga mutum shine don mutane su guji yanayin rayuwa na ƙwayoyin cuta na dabbobi daga mutum.
Har yanzu akwai wasu hujjoji game da asalin cutar SARS-CoV-2 da ke yaduwa daga dabbobi zuwa mutane.
Na farko, idan masu cutar suka watsa cutar SARS-CoV-2 ta farko zuwa cutar pandemic, zai zama da ban sha'awa ganin yanayin da ya sa masu cutar da dangi su raba yanayin rayuwa iri ɗaya.
Na biyu, idan fim din yana taka rawa mai yawa a cikin watsawa ga ɗan adam, dole ne a san yadda ɗan adam yake shafar fim din.
Na uku, idan cutar ta uku ta kasance ainihin ciwon daji, yadda ta shiga cikin halittu daban-daban ciki har da ɗan adam, dabba da kuma pangolin dole ne a bayyana.
A ƙarshe, tun da yawancin dabbobi masu shayarwa ciki har da dabbobi masu wanka za su iya ɗaukar SARS-CoV-2, dole ne a yi rigakafi da gwajin kamuwa da cutar.
Ko dai a cikin dabba, pangolin ko wasu dabbobi masu shayarwa, ana sa ran SARS-CoV-2 zai zama asalin kwayar cutar wanda galibi za a gano shi a cikin wani yanayi na rashin lafiya na halitta.
Ci gaba da bincike a wannan wurin zai tabbatar da hanyar canjin SARS-CoV-2 a cikin dabbobi, tare da mahimman sakamako a cikin rigakafi da sarrafa COVID-19 a cikin mutane.
Yanayin sabunta binciken COVID-19 na "al'amarin da ake zargi" da "al'amarin da aka tabbatar" yana da mahimmanci.
A ranar 6 ga Fabrairu, 2020, ƙungiyarmu ta buga ƙa'idodin gaggawa don bincike da magani na sabon kamuwa da cutar coronavirus ta 2019 (2019-nCoV). Wannan ƙa'idar ta haɓaka ƙwarewarmu kuma ta kafa kyakkyawan tunani game da yaƙar wannan cuta da ta bazu a duniya.
Ko ta yaya, cutar coronavirus 2019 (COVID-19) sabuwar cuta ce, hankali da iliminmu suna ƙaruwa a hankali bisa ga sakamakon bincike da kuma bayyanar binciken likita; saboda haka, ana sabunta dabarun bincike da na magani akai-akai.
A cikin wannan wasiƙar, mun amsa wani bayani a cikin dokar kuma mun ba da sabon tsarin bincike na "abubuwan da ake zargi" da "abubuwan da aka tabbatar" dangane da Dokokin Bincike da Kula da COVID-19 (nau'in mako) wanda Hukumar Lafiya ta Jama'a ta kasar Sin ta samar.
A watan Disamba na 2019, sabon coronavirus na 2019 (2019-nCoV) ya haifar da barkewar cutar, wanda yanzu ana kiransa cutar coronavirus ta 2019 (COVID-19) kuma an kira cutar cutar ta coronavirus 2 (SARS-CoV-2).
A ranar 11 ga Maris, 2020, Hukumar Lafiya ta Duniya ta ayyana COVID-19 a matsayin cuta ta duniya.
Don magance kamuwa da cutar SARS-CoV-2, ƙungiyarmu ta ƙirƙiri ƙa'idar gargaɗi na gaggawa kuma ta buga ta kan layi a cikin Nazarin Kiwon Lafiya na Sojoji a ranar 6 ga Fabrairu, 2020.
Ya jawo hankalin mutane sosai har zuwa ranar da aka buga shi.
Ka lura cewa ko da yake COVID-19 sabuwar cuta ce, hankali da iliminmu suna ƙaruwa a hankali bisa sakamakon bincike da ƙwarewar gwajin likita; saboda haka, ana sabunta ƙididdigar bincike da na likita akai-akai.
Matakan bincike da magani na COVID-19 da Hukumar Lafiya ta Jama'a ta Kasa ta China (http://www.nhc.gov.cn/) ta fitar, daga 16 ga Janairu 2020 zuwa 3 ga Maris 2020, sun fitar da duka bakwai da aka sake duba su wanda aka gyara abubuwan da ke ciki.
Yanzu dokarmu ta fito ne daga Zhou etal., sun gabatar da wata shawara mai sauki bisa kwarewar kiwon lafiya.
Ayyukan su sun ba da tabbaci ga dokokin da kuma yin amfani da su wajen yin amfani da wannan cutar a duniya.
Mun lura da muhimman ayyukan su kuma mun nuna godiya.
Koyaya, aikin su kuma yana buƙatar sabuntawa dangane da Sabbin Dokokin Bincike da Kulawa na COVID-19 (Tsarin Gwajin Makonni) da kuma binciken da ake yi yanzu.
A cikin batun gyara na mako (3 ga Maris, 2020), don tabbatar da shari'o'in da ake zargi yana buƙatar haɗuwa da abu ɗaya na tarihin binciken cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan
Tarihin nazarin cututtukan cututtuka masu yaduwa: (1) tarihin tafiya ko zama a birnin Wuhan da yankunan da ke kusa da shi, ko wasu al'ummomin da aka ba da rahoton shari'o'in COVID-19 a ranar 14 ta ƙarshe kafin bayyanar cututtuka; (2) tarihin rufewar cututtuka na kamuwa da cutar SARS_CoV-2 (wanda aka samo daga gwajin nucleic acid); (3) tarihin tuntuɓar marasa lafiya da ke da zazzabi ko alamun numfashi daga birnin Wuhan ko yankunan da ke kusa da shi, ko kuma daga wasu al'ummomin da suka yi fama da COVID-19 a ranar 14 ta ƙarshe kafin bayyanar cututtuka; (4) tarihin tuntuɓar ƙungiyoyin da aka tabbatar da cututtuka (>= 2 lokuta da zazzabi da alamun numfashi a cikin makonni biyu a cikin aji, kamar makaranta, ofis, da sauransu).
Alamar lafiya: (1) zazzabi da/ko alamun numfashi; (2) waɗanda ke da alamun hoto na kamuwa da cutar COVID-19; (3) jimlar adadin fararen kwayar jini da ke nuna cewa ya kasance na al'ada, ya ragu, ko kuma adadin fararen jini da ya ragu a farkon matakin farawa.
Binciken da aka tabbatar ya kamata a kafa shi a kan wani abu da ake zargi da ƙwayoyin cuta ko kuma a kan tabbacin zubar da jini kamar haka: (1) a ainihin lokacin da aka gano PCR na SARS-CoV-2; (2) a cikin dukan kwayar cuta mai jituwa da ke nuna ƙarancin ƙwayar cuta ta coronavirus da kuma wani abu da ba a sani ba; (3) a cikin gwajin jini an gano wani takamaiman IgM antibody da IgG antibody na SARS-CoV-2; ko kuma an gano wani maye gurbin na musamman na IgG antibody na SARS-CoV-2 da ya ɓace, ko kuma an gano wani abu > sau 4 na ci gaban warkarwa fiye da na gaggawa.
Muna iya ganin cewa an ƙara PCR na ainihin lokacin don gwajin nucleic acid a cikin numfashi ko samfurin jini a cikin bugu na biyu (18 Janairu 2020) da na uku (22 Janairu 2020).
An kara da gano cutar a cikin samfurin jini a bugu na huɗu (27 ga Janairu 2020) da na biyar (8 ga Fabrairu 2020), kuma bayan an ƙara tabbatar da zubar da jini a bugu na bakwai.
Wannan canjin ya dogara ne akan ci gaba da aikin masu bincike na neman ingantaccen kayan gano nucleic acid don gwadawa cikin sauri, da kuma samfurin numfashi daga gwajin jini, wanda ya kara samun damar gwaji da yawa, kuma ya goyi bayan isar da takamaiman antibody na sakamakon da aka samu wanda zai zama ingantaccen tsari.
Bugu da ƙari, akwai shaidu da yawa da ke tunatar da mu mu yi hankali da alamun rashin daidaituwa da alamun marasa lafiya.
Saboda haka, dole ne a sabunta taswirar Zhou et al. tun da aka rarraba mutum ba tare da alamun lafiya ba a matsayin "ƙananan haɗari".
Tsarin ba da maki yana buƙatar tabbatar da ƙarin ayyukan likita da karatu.
A ƙarshe, muna fatan samun ƙarin shaidu kai tsaye da kuma gayyatar masu karatu su ba da ra'ayoyinsu.
A cikin binciken "abubuwan da ake zargi" da "abubuwan da aka tabbatar", muna ba da shawarar cewa a bincika kuma a bi sababbin jagororin a ƙasarsu.
Ƙungiyarmu za ta sabunta jagororinmu a kan lokaci don taimakawa.
Bangladesh ta ba da rahoton sabbin mutuwar mutane biyar sakamakon COVID-19, wanda shine mafi girma a kowace rana.
Jiya, Bangladesh ta tabbatar da sabbin mutuwar mutane biyar sakamakon COVID-19 a wannan ranar.
Wannan shi ne adadin mutuwar da aka yi a rana da aka fi yawanta a duniya saboda cutar.
Har zuwa jiya, Cibiyar Nazarin Cututtuka ta Bangladesh, Bincike da Kula da Cututtuka (IEDCR) ta ba da rahoton adadin shari'o'in da aka yi rajista da ya faru ciki har da shari'o'i 114 da ke tsaye da kuma 33 da suka warke a gida.
An samu mutuwar mutane 17 a total.
A wani gajeren rahoto a yanar gizo, darektan IEDCR, DR Meerjady Sabrina Flora, ya ce mutuwar ta shafi maza hudu da mace guda.
A cewar DR Meerjady, mutane biyu sun wuce shekaru 60, biyu suna tsakanin shekaru 51 da 60, ɗayan kuma yana da shekaru 41-50.
Ta kuma ce biyu daga cikin wadanda aka kashe sun fito ne daga birnin Dhaka.
Hukumar Lafiya ta Duniya (WHO) ta ayyana COVID-19 a matsayin cuta ta duniya a tarihi a ranar 11 ga Maris.
Wani jami'in asibiti ya shaidawa hukumar Anadolu, wata jarida ta gida, cewa daya daga cikin wadanda suka mutu shi ne Jalal Saifur Rahman, darektan kwamitin yaki da cin hanci da rashawa na Bengali, wanda aka kula da shi a asibitin Kuwait Maitree.
A ranar Asabar, a cikin sanarwar ta kan layi, ministan sufuri na Bangladesh na Hanyar Hanya da Bridges Obaidul Quader ya ce za a dakatar da zirga-zirgar jama'a fiye da yadda aka tsara, har zuwa Asabar mai zuwa.
An fara dakatar da zirga-zirgar jama'a a ranar 26 ga Maris kuma an shirya ta ta ƙare a ranar Asabar, 4 ga Afrilu.
Ana ba da izinin tafiya don kayayyakin yau da kullun -- kiwon lafiya, mai da abinci -- har yanzu.
Lamarin farko da aka yi rikodin kamuwa da cutar COVID-19 a Bangladesh a ranar 8 ga Maris, mutane biyu da suka dawo daga Italiya da matar ɗaya daga cikinsu.
Tun daga ranar 19 ga watan Maris, duk ukun sun riga sun warke.
A duniya, cutar SARS-CoV-2 ta kai kamuwa da cutar fiye da miliyan daya.
A ranar Alhamis, jimlar adadin masu kamuwa da cutar coronavirus ta SARS-CoV-2 ta wuce miliyan ɗaya a duniya, a cewar bayanan Jami'ar Johns Hopkins.
Akalla mutane dubu 52 ne suka mutu sakamakon cutar COVID-19, cutar da ta haifar da cutar coronavirus.
Lamarin ya faru ne a ranar da Malawi ta tabbatar da kamuwa da cutar coronavirus ta farko kuma Zambia ta sami mutuwar farko da ta shafi coronavirus.
Koriya ta Kudu ta ce, tun ranar Alhamis, tana ɗaya daga cikin ƙasashe kalilan da ta tsira daga kamuwa da cutar coronavirus.
A jiya, Hukumar Lafiya ta Duniya ta ba da rahoton mutane 1,051,635 da aka tabbatar da cutar, ciki har da mutane 79,332 a cikin awanni ashirin da huɗu kafin karfe 10 na safe na ranar 4 ga Afrilu (0800 UTC) na tsakiyar Turai.
A Amurka, an yi rajistar fiye da 244 dubu da suka kamu da cutar coronavirus, wanda ya shafi mutuwar akalla 5,900.
Labaran CBC sun ruwaito, suna ambaton bayanan Jami'ar Johns Hopkins, cewa akwai mutuwar sama da 1,000 a Amurka a ranar Laraba sakamakon kamuwa da cutar coronavirus.
A duniya, kasashe sun sanar da tsauraran matakai don hana cutar ta ci gaba da yaduwa.
A ranar Alhamis, Serei Sobyanin, magajin garin Moscow, ya tsawaita dokar hana fita a babban birnin har zuwa 1 ga Mayu.
A kasa, shugaban kasar Vladimir Putin ya sanar da cewa za a ci gaba da biyan mutanen Rasha kudade ba tare da su tafi aiki ba har zuwa 30 ga Afrilu.
Majalisar dokokin kasar ta Burtaniya ta kada kuri'ar tsawaita dokar ta baci ta kasa na tsawon kwanaki 15, inda aka samu kuri'u 215 a madadin, goma suka yi shiru, kuma daya ya yi adawa.
Saudiyya ta ci gaba da tsawaita dokar hana fita a biranen da aka albarkace da Makka da Madina duk tsawon yini; a baya, dokar hana fita ta kasance daga karfe 3 na yamma zuwa karfe 6 na safe.
Thailand ta shirya yin amfani da dokar hana fita daga karfe 10 na yamma zuwa karfe 4 na safe.
Gwamnan Ohio, Mike DeWine, ya sanar da cewa jihar ta tsawaita dokar hana fita zuwa 1 ga Mayu.
Gidajen sayar da kayayyaki a Ostiraliya suna rage yawan takardar bayan gida a kowane sayayya.
A daren Lahadi da Asabar, jerin shagunan Australiya a Woolworths da Coles sun rage ƙuntatawa kan siyan takardar wanka zuwa fakiti biyu da ɗaya a kowane sayayya a duk shagunan ƙasa, bi da bi.
ALDI ta soke iyakancewar kunshin guda ɗaya a ranar Litinin.
An sanya wannan takunkumin a matsayin sako a wuraren fita da kuma shafin Facebook na jerin.
An ruwaito masu sayayya sun ci gaba da sayayya saboda tsoron COVID-19 idan mutane suka bukaci su yi sulhu.
A ranar Laraba, kamfanin Woolworths ya kuma takaita sayen takardar wanka don gidaje da aka kawo a cikin fakiti daya a kowace bukata.
Wannan canjin ya biyo bayan an dakatar da kayan kwalliya guda hudu a kowane siye da Woolworths da Coles suka yi a ranar 4 da 5 ga Maris bi da bi.
Coles, a cikin sanarwar ta a watan Maris, ta sanar da cewa takunkumin da aka sanya a wurare huɗu "ma'aikata da yawa suna sayen agogo", kuma ta kira bukatar "wanda ba a taɓa yi ba", yayin da ALDI, a cikin wani rubutu a Facebook, ta kira ta abin mamaki.
Sayayya ta karu "ƙaruwa ba zato ba tsammani" a makon da ya gabata, a cewar mai magana da yawun Woolworths.
Hakanan kantin sayar da kayan ado na Canberra ya iyakance adadin da aka yarda da kaya biyu a makon da ya gabata.
Don rage rage yawan kayayyaki, Coles ta bukaci manyan kayan kwalliya daga masu kawo kaya ta hanyar hanzarta isar da kayayyaki, Woolworths ta bukaci karin kayayyaki, yayin da ALDI ta yi shirin gabatar da kayayyakin a ranar Laraba.
Russell Zimmerman, shugaban zartarwa na kungiyar 'yan kasuwa ta Australiya, ya ce 'yan kasuwa suna kara yawan kayayyakin su, amma takunkumin majalisar dokokin kasar kan lokacin jigilar kayayyaki ya kara musu nauyi.
Yana tsammanin farashin samarwa zai karu, rarraba kayan zamantakewa zai yi kokarin biyan bukatar, da sauran masu zaman kansu.
A ranar Talata, Aldi ta sanar da cewa isar da kayayyaki na farko a wasu shagunan ba za su ci gaba ba musamman a ranar Laraba,
A cikin rahoton News.com.au, Dr. Gary Mortimer, masanin sayar da kayayyaki na Jami'ar Fasaha ta Queensland, ya ce za a cika shagunan da kayayyaki kowace dare.
Ya ce takardun wanka abu ne mai nauyi, wanda ke haifar da ƙarancin yawan kayayyaki, kuma, lokacin da aka siyar, ya bar ɗakunan ajiya marasa komai, yana ƙarfafa ƙarancin.
Colos da Woolworths suna da ra'ayin cewa idan suka cika kayan wanka da kayan wanka da kuma maganin kashe kwayoyin cuta [da aka saya] za a rage tsoro, in ji Russell Zimmerman a cewar ABC News.
Masu samar da takardun wanka masu sake amfani da su wadanda ke samar da takardun wanka masu inganci sosai sun ce a ranar Laraba ta gabata za su ƙare.
Kimberly-Clark, wanda ke yin takardar gidan wanka na Kleenex, da Solaris Sheets wanda ke yin Sorbent, sun jaddada cewa suna aiki 24/7 don ci gaba da rarraba kayayyaki, a cewar rahoton News.com.au.
Domain.com, wani shafin yanar gizon dukiyar da ba ta da gida, ya ruwaito cewa wasu masu sayar da gidaje sun ba da takardun wanka kyauta ga mai fara hayar a cikin gwanjon Melbourne, lokacin da aka gudanar da ƙananan gwanjo saboda masu siye sun kasance a hutu na dogon lokaci a ƙarshen mako na ranar ma'aikata ta duniya.
A ranar Alhamis, editionee NT News, ta buga a ranar a Darwin, wanda ya ƙunshi shafuka takwas na rubutu da aka yi niyya don a yanke shi kuma a yi amfani da shi azaman labule na gidan wanka.
Gidan sayar da kayayyaki ya saba da sauya takunkumi, a cewar rahoton ABC Australia na 3 ga Maris kuma ya ce ba su da wani shiri na aiwatar da takunkumin sayayya.
Rusell Zimmerman ya kara da cewa wasu kayayyaki suna kara bukatarsu, ciki har da kayan kwalliya, maganin kashe kwayoyin cuta, kayayyakin bushewa, sabulu na wanke hannu da man shanu.
Hakazalika, a kasashen waje na Ostiraliya, a yammacin Lahadi an sanar da babban shagon yanar gizo na Ocado na Burtaniya cewa ya takaita siyar da takardun wanka na Andress zuwa nau'i biyu na 12.
Hukumar Lafiya ta Duniya ta bayyana COVID-19 a matsayin cuta ta duniya.
A ranar Laraba, Hukumar Lafiya ta Duniya ta sanar da cewa barkewar cutar COVID-19 da coronavirus SARS-CoV-2 ta haifar ita ce cuta ta duniya.
Ko da yake kalmar " cuta ta duniya " tana nufin cuta da ke yaduwa a duniya, amma ba ta da tsanani kamar yadda wasu lokuta suke yi, Hukumar Lafiya ta Duniya ta nuna bukatar gwamnatoci su ɗauki mataki.
Duk ƙasashe har yanzu zasu iya canza yanayin wannan annobar. Wikinews_6:1159 https://en.wikinews.org/wiki/World_Health_Organization_declares_COVID-19_pandemic CC_BY-SA_2.5 en idan ƙasashe suka gano, bincika, bi da su, bi da su da kuma shirya yadda za su amsa mutanensu, in ji Tedros Adhanom Ghebreyesus, babban sakataren Hukumar Lafiya ta Duniya.
Muna matukar damuwa da irin wannan mummunan riba da kuma haɗari da kuma rashin aiki.
A cewar Dr. Tom Frieden, tsohon darektan Cibiyoyin Kula da Cututtuka da Rigakafin Amurka, cutar ta duniya "ba a taɓa gani ba".
Ya ce, a cikin wani bayani da CNN ta wallafa a tsakiyar watan Fabrairu, "ban da mura, babu wani kwayar cutar numfashi da aka bi daga jinkirin bayyanar zuwa ci gaba da yaduwar duniya.
Ghebreyesu ya bayyana irin wannan ra'ayi, yana mai cewa "ba mu taɓa ganin cutar coronavirus ta duniya ba".
Ya ci gaba da cewa, "Ba mu taba ganin cutar ta duniya da za a iya sarrafawa a lokaci guda ba".
A cikin sabon yanayi yayin da cutar ta duniya ke ci gaba da yanke shawara a watan Janairu na Hukumar Lafiya ta Duniya game da sanar da barkewar yanayin kiwon lafiya na gaggawa na jama'a da ke da damuwa a duniya.
Daraktan Cibiyar Kula da Cutar Cutar da Cututtuka ta Amurka, Dakta Anthony Fauci, ya ce, "a cikin ƙananan tushe, zai zama mafi muni".
A ranar Alhamis Associated Press ta ruwaito cewa aƙalla mutane 126,000 ne suka kamu da cutar COVID-19 a duniya, wanda ya haifar da mutuwar sama da 4,600.
Cutar coronavirus ta duniya ta 2019-20 ita ce cutar coronavirus ta duniya ta 2019 (COVID-19), wanda ke haifar da alamun cututtukan numfashi na coronavirus 2 (SARS-CoV-2).
An lura da barkewar cutar a Wuhan, China, a watan Disamba na 2019, wanda aka ayyana a matsayin Halin Kiwon Lafiya na gaggawa tare da Kulawar Duniya a ranar 30 ga Janairu, 2020, kuma an gano shi a matsayin cutar duniya a ranar 11 ga Maris, 2020.
Tun daga ranar 10 ga Afrilu, 2020, an samu kimanin mutane miliyan 1.6 da suka kamu da cutar COVID-9 a kasashe da iyakoki 210, wanda ya haifar da mutuwar kusan 97,000.
Kimanin mutane 364,000 sun warke.
An kiyasta yawan mutuwar a kasar Sin da kashi 4 cikin 100, yayin da a duniya yawan mutuwar ya kai kashi 13.04 cikin 100 a Algeria da kuma 0.08 cikin 100 a New Zealand.
Yawancin alamun sun hada da zazzabi, tari da rashin numfashi.
A cikin yanayi mai tsanani akwai burkuito da alamun rashin numfashi mai tsanani.
Daga lokacin da ake fama da cutar zuwa lokacin da alamun suka fara yana da kusan kwanaki biyar, amma ana iya tunanin cewa yana da kwanaki biyu zuwa kwanaki goma sha huɗu.
Babu allurar rigakafi da aka amince da ita ko magani na musamman na maganin cutar.
Maganin farko shine maganin alamun cutar, matakan rigakafin da aka ba da shawarar sun haɗa da wanke hannu, rufe baki lokacin da mutum ya zubar da jini, nisantar da kansa daga wasu, da kuma lura da mutum da ke da kamuwa da cuta.
Shugabannin duniya sun amsa cewa za su aiwatar da takunkumin tafiye-tafiye, keɓewa, hanawa, sarrafa haɗarin wuraren aiki da rufe wuraren aiki.
Cutar ta duniya ta haifar da mummunar matsalar tattalin arziki da zamantakewa a duniya, jinkirta ko soke ayyukan wasanni, addinai, siyasa da al'adu da kuma yaduwar karancin kayan aiki wanda ya kara lalacewa ta hanyar tsoron sayayya.
An rufe makarantu da jami'o'i a kasa ko a gida a kasashe 193, wanda ya shafi kusan kashi 99.4 cikin dari na yawan daliban duniya.
An yi ta yada labaran da ba daidai ba game da cutar a kan layi, kuma akwai wasu lokuta na ƙiyayya da nuna bambanci ga baƙi a kan Sinawa, wasu daga cikin mutanen da ke ko a'a daga Gabashin Asiya da Kudu maso Gabas, da kuma wasu daga wuraren da akwai cutar.
Saboda rage tafiye-tafiye da rufe manyan masana'antu, akwai raguwa a gurɓataccen iska da kuma sakin carbon.
An ruwaito cewa jami'an kiwon lafiya na Wuhan, Shinaha (babban birnin lardin Hubei) sun samu rahoton wasu cututtukan cutar buruki da ba a san dalilinsa ba a ranar 31 ga Disamba, 2029, an fara bincike a farkon watan Janairu, 2020.
Yawancin lokuta suna da alaƙa da kasuwar Hanyoyin Samun Hanyoyin Samun Hanyoyin Hannu na Huanan saboda haka kwayar tana da asalin cututtukan da dabbobi ke watsawa.
An gano sabon kwayar cutar da ta haifar da annobar da ake kira SARS-CoV-2, wanda ke da alaƙa da cutar coronavirus, coronavirus yaduwa, da SARS-CoV. An gano cewa mutumin da ya fara samun alamun cutar ya kamu da cutar a ranar 1 ga Disamba, 2019, wanda ya bayyana yana da alaƙa da ƙungiyar kasuwa a baya.
A cikin rukunin shari'o'in da aka fara bayar da rahoton su a watan Disamba na 2019, kashi biyu bisa uku na wadanda aka gano suna da alaƙa da kasuwar.
A ranar 13 ga watan Maris na shekarar 2020, wata sanarwa da ba a tabbatar ba ta jaridar South China Morning Post ta bayar da shawarar cewa a cikin shari'ar da aka fara a ranar 17 ga watan Nuwamba na shekarar 2019, wani mutum mai shekaru 55 daga lardin Hubei, shi ne na farko. A ranar 26 ga Fabrairu na shekarar 2020, Hukumar Lafiya ta Duniya ta ruwaito, cewa sabbin shari'o'in da aka ruwaito a kasar Sin sun ragu amma sun karu a tsakanin Italiya, Iran, Koriya ta Kudu, kuma adadin sabbin cututtukan cutar a kasar Sin ya zarce adadin sabbin cututtukan a kasar Sin a karon farko.
Akwai yiwuwar cewa ba a bayyana wasu cututtuka ba, musamman a cikin wadanda ke da alamun bayyanar cututtuka.
A ranar 26 ga Fabrairu, an samu karamin adadin cututtukan a tsakanin matasa, wadanda shekarunsu 19 zuwa kasa suka kai kashi 2.4% na cututtukan a duniya. Shugaban Majalisar Kimiyya ta Burtaniya, Patrick Vallance, ya kiyasta cewa kashi 60% na al'ummar Burtaniya za su kamu da kamuwa da cutar kafin a samu rigakafi mai ƙarfi da tasiri.
Ana nufin yawan mutanen da aka bincika don COVID-19, waɗanda aka bincika su don cutar bisa ga tsarin hukuma.
Har zuwa 23 ga Maris, wata ƙasa da ta bincika fiye da kashi 3 cikin dari na yawan jama'arta a ƙasashe da yawa suna da ƙa'idodi na hukuma don bincika mutanen da ke da alamun cutar, kamar Italiya, Netherlands, Spain, da Switzerland,
Wani binciken da aka buga a ranar 16 ga Maris ya gano cewa a kasar Sin, har zuwa 23 ga Janairu, kusan kashi 86% na kamuwa da COVID-19 ba a gano su ba, kamuwa da cutar da ba a yi rajista ba ita ce tushen kamuwa da cutar 76% na shari'o'in da aka yi rajista.
Wani rahoto na yau da kullum da aka buga a ranar 30 ga Maris ya nuna cewa ƙididdigar yawan kamuwa da cuta a Italiya na iya wuce adadin da aka ruwaito.
Kimanin adadin haihuwa na asali (R0) na COVID-19 a baya ya kasance 1.4 zuwa 2.4.
Wani binciken da Cibiyar Kula da Cututtuka da Rigakafin Cutar Amurka ta wallafa ya kammala cewa zai iya zama 5.7.
Yawancin mutane da ke da COVID-19 suna warkewa.
Ga waɗanda ba su da cutar, lokacin bayyanar cututtuka har zuwa mutuwa yana tsakanin kwanaki 6 zuwa 41, kuma a matsakaicin matsakaici kwanaki 14.
A ranar 10 ga Afrilu, 2020, kimanin mutane 97,000 ne suka mutu sakamakon COVID-19.
A kasar Sin, tun daga ranar 5 ga Fabrairu kusan kashi 80% na mutuwar sun kasance a cikin waɗanda suka haura 60, kuma kashi 75% na su suna da yanayin kiwon lafiya na baya ciki har da cututtukan zuciya da ciwon sukari, an kira jimlar adadin mutuwar COVID-19 na duniya bisa ga tsarin hukuma ga mutanen da aka gano COVID kuma suka mutu.
Yawan mutuwar COVID-19 na ainihi na iya zama mafi girma, ba tare da ƙara waɗanda suka mutu ba tare da bincike ba - alal misali waɗanda suka mutu a gida, waɗanda ke kula da gida, da sauransu.
Wani ɓangare na bayanan da aka samu a Italiya shine yawan mutuwar da aka samu a lokacin annobar ta duniya wanda ya wuce adadin COVID-19 na yau da kullun a cikin lamba 4-5x.
Kakakin cibiyar kula da cututtuka da rigakafin cutar ta Amurka (CDC) ya yarda "Mun san cewa [adadin mutuwar da aka ruwaito] yana da ƙarancin ƙima", a cikin magana da aka tabbatar da rahotanni na yau da kullun game da rage yawan Amurka. Irin wannan rage yawan ƙimar yana faruwa ne a lokacin cututtukan cututtuka, kamar cutar sankarar 2009 N1N1 na naman alade. Mutuwar farko da aka tabbatar ta faru a Wuhan a ranar 9 ga Janairu, 220.
Mutuwar farko a wajen kasar Sin ta faru ne a ranar 1 ga watan Fabrairu a Philippines, kuma mutuwar farko a wajen Asiya ta faru ne a Faransa a ranar 1 ga watan Fabrairu.
A karshen 28 ga watan Fabrairu, a wajen kasar Sin, an yi rajistar mutuwar fiye da ɗari a kowace a Iran, Koriya ta Kudu, da Italiya.
A ƙarshen 13 ga Maris, fiye da ƙasashe huɗu da yankuna sun ba da rahoton mutuwar, a kowace nahiya sai Antarctica. An yi amfani da matakai da yawa don rage mutuwar.
Wannan adadi yana canzawa daga yanki zuwa yanki, yana sauƙaƙa yawan bincike, ingancin kulawar lafiya, zaɓin magani, lokacin zuwa lokacin da annoba ta fara da halaye na zamantakewa kamar shekaru, jinsi da lafiyar jama'a. Yawan mutuwar bisa ga samfurin shari'a yana nuna yawan mutuwar da aka rarraba zuwa yawan shari'o'in da aka bincika a wani lokaci.
Dangane da kididdigar Jami'ar Johns Hopkins, yawan mutuwar mutane a cikin adadin shari'o'i ya kai kashi 6.0% (97,039/1,617,204) zuwa 1 ga Afrilu 2020.
Yawan ya canza idan aka kwatanta.
A kasar Sin, ta kiyasta cewa adadin mutuwar da aka samu a cikin adadin al'amura ya ragu daga 17.3% (wanda alamun suka fara daga 1 zuwa 10 ga Janairu 2020) zuwa 0.7% (wanda alamun basu fara ba bayan 1 ga Fabrairu 2020). Sauran matakan sun haɗa da matakin mutuwa (CFR), wanda ke nuna yawan mutanen da aka bincika da suka mutu saboda cutar, da kuma yawan mutuwar kamuwa da cuta (IFR), wanda ke nuna adadin mutanen da suka kamu da kamuwa da cuta (wanda aka gwada da waɗanda ba a gwada ba) waɗanda suka mutu daga cutar.
Wannan sanarwa ba ta da lokaci kuma tana bin wani tsari na musamman daga kamuwa da cutar zuwa yanke shawara.
Yawancin makarantun sun yi ƙoƙarin lissafin wannan adadin a cikin wasu mutane.
Cibiyar Kula da Lafiya ta Jami'ar Exford ta kiyasta yawan mutuwar kamuwa da cuta a duniya tsakanin kashi 0.1% da 0.39%.
Wannan adadi na sama na adadi na yau da kullun tare da sakamakon binciken farko na COVID-19 wanda ba a rarrabe shi a Jamus ba, da kuma shirya nazarin nazarin tasirin binciken CFR a matsayin mai daidaitawa.
Hukumar Lafiya ta Duniya ta ce za a iya sarrafa cutar a duniya.
Mafi yawan lokutan fashewa ba a sani ba kuma an rarraba su a wuri.
Macieji Boni daga Jami'ar Jihar Penn ya ce, an bar mu ba tare da tabbaci ba, don magance cututtukan annoba a yawancin tsaunuka.
Amma ba za mu iya yin tsinkaya ba game da lokacin da hakan zai faru".
Babban mai ba da shawara kan kiwon lafiya na gwamnatin kasar Sin Zhong Nanshan ya yi jayayya cewa "za a kawo karshen watan Yuni" idan aka shirya dukkan gwamnatoci su bi matakan Hukumar Lafiya ta Duniya don dakatar da yaduwar cutar.
A ranar 17 ga Maris, Adam Kucharski na Makarantar Tsabtace & Kayan Lafiya na London ya ce SARSCoV-2 "zai kasance mai juyawa, a cikin shekara ɗaya ko biyu".
A cewar wani binciken da kwalejin Imperial ta gudanar da shi karkashin jagorancin Neil Fergusin, ana bukatar nisantar jiki da sauran matakai "har sai an yi allurar rigakafi (mai yiwuwa watanni 18 ko sama da haka)".
William Schaffner na Jami'ar Vanderbilt ya ce, "Ina ganin cewa ba shi da yawa cewa cutar coronavirus-sabo za a iya watsawa cikin sauri-a zahiri ta ɓace" kuma "yana yiwuwa a canza ta zuwa cutar yanayi, wanda zai iya dawowa kowace shekara".
Hadarin komawa gida ya danganta da ƙarfin rigakafin jiki da kuma iyakar canjin girma.
Alamomin COVID-19 suna da mahimmanci waɗanda ba su ƙayyade waɗanda suke dauke da su ba kuma bazai nuna alamun ba.
Alamomin biyu da suka fi kowa shine zazzabi (88%) da kuma rashin ƙarfi (68%).
Alamomin da ba su da yawa sun haɗa da gajiya, fitar da numfashi na hacho (hacho), rashin jin ƙanshi, rashin numfashi, ciwon tsoka da gabobin jiki, ciwon kai, ciwon kai, ƙura, tururuwa, jini mai ƙonewa, kumburi ko launin shuɗi. Hukumar Lafiya ta Duniya ta ce mutum ɗaya da ke da alamomi shida zai iya zama mai ciwo mai tsanani da rashin numfashi.
Cibiyoyin Kula da Cututtuka da Rigakafin Cututtuka na Amurka (CDC) sun lissafa alamun gaggawa kamar matsalar numfashi, rashin ciwon hanci na yau da kullun, damuwa, tashin hankali, da fuska ko gashin gashin gashin gashi; ana ba da shawarar kula da lafiyar gaggawa ga wanda ya sami alamun. Ƙananan ci gaban cutar na iya haifar da mummunan buruddan numfashi, alamun cututtukan numfashi mai tsanani, yanayin rashin ƙarfi, haɗarin jini da mutuwa.
Wadanda suka kamu da kamuwa da cuta na iya zama waɗanda ba su nuna alamun cutar ba, waɗanda ba su da alamun likita amma sakamakon binciken ya tabbatar da kamuwa da cutar, saboda haka masu bincike sun ba da shawarar cewa mutumin da ke da kusanci da wanda aka tabbatar da kamuwa da cutar ya kamata a ci gaba da bincika shi sosai don kawar da kamuwa da cuta.
Kasar Sin ta kiyasta adadin mutanen da ba su da alamun cutar a matsayin kashi 44 cikin 100.
Lokacin rashin lafiyar (lokacin da ya rage tsakanin kamuwa da kumburi da fara bayyanar cututtuka) ya kasance daga kwana ɗaya zuwa kwanaki 14; yawanci ya wuce kwanaki biyar, misali ba tare da tabbaci ba, yawan adadin allurar rigakafin mutanen da ke da COVID-19 waɗanda ba su da ƙanshi ya kasance 30% a baya kuma ya ragu zuwa 15%.
Har yanzu akwai wasu bayanai game da yadda cutar ke yaduwa.
Ana ganin cutar tana yaduwa sosai a cikin kusanci da kuma saukad da ƙwayoyin cuta da ke fitowa lokacin da mutum ya yi numfashi, ya yi magana, ko magana; wanda ke kusa da mutum daga mita 1 zuwa 2 (3 zuwa 6 feet).
Wani bincike ya gano cewa ƙwanƙwasa ba tare da an rufe shi ba zai iya haifar da ƙwanƙwasa mai tashi daga mita 4.5 zuwa mita 8.2 (mita 27).
Wasu sun bayar da shawarar cewa za a iya watsa kwayar ta hanyar ƙananan saukad da ke cikin iska na dogon lokaci, wanda zai iya fitowa yayin magana. Saukad da numfashi na iya fitowa ta hanyar numfashi, gami da magana, kodayake cutar ba ta wuce ta iska.
Za a iya samun raunuka a baki da hanci na mutanen da ke kusa da ku ko kuma a numfashi a cikin shekaru.
Hanyar kiwon lafiya kamar su CPR na iya haifar da numfashi mai numfashi wanda zai iya yada shi ta iska.
Hakanan zai iya yaduwa idan mutum ya taɓa wani wuri mai tsabta, ciki har da fata, sannan ya taɓa idanunsa, hanci, ko bakinsa.
Duk da cewa akwai damuwa cewa zai iya yaduwa zuwa kwayar cutar, ana tsammanin haɗarin zai ragu.
Gwamnatin kasar Sin ta musanta yiwuwar yaduwar SARS-CoV-2 ta bakin baki. Kwayar cutar tana yaduwa sosai a cikin kwanaki uku na farko na bayyanar cututtuka, kodayake yaduwar na iya faruwa kafin bayyanar cututtuka da matakan ƙarshe na cutar.
An gano cutar a cikin mutane kwanaki uku kafin bayyanar cututtuka, wanda ke nuna cewa za a iya samun kamuwa da cutar kafin bayyanar cututtuka da yawa.
Rahotanni kaɗan ne kawai na alamun alamun da aka tabbatar a cikin dakin gwaje-gwaje, amma an gano alamun alamun a wasu ƙasashe a lokacin binciken mutane a cikin tsayawa.
Cibiyar Kula da Cututtuka ta Turai (ECDC) ta ce saboda babu tabbacin yadda cutar ke yaduwa, mutum ɗaya yakan kamu da wasu mutane biyu zuwa uku, kuma cutar tana rayuwa na awanni zuwa kwanaki a saman abubuwa.
Musamman, an gano cewa cutar za ta iya ganewa daga jakunkuna (polypropylene) har zuwa kwana uku da 304 bakin karfe, daga itace har zuwa kwana ɗaya, da kuma daga tagulla har zuwa kwana huɗu.
Koyaya, wannan ya bambanta dangane da danshi da zafin jiki.
Babu tabbacin cewa dabbobi za su iya watsa kwayar cutar ga mutane, ko da yake hukumomin Burtaniya sun ba da shawarar cewa mutum ya wanke hannayensa lokacin da ya taɓa dabba, kamar lokacin da ya taɓa wasu wuraren da mutane suka taɓa.
Alamar cutar ta numfashi mai tsanani ta coronavirus 2 (SARS-CoV-2) ita ce kwayar cuta mai ban mamaki, wadda aka fara gano ta a cikin mutane uku da ke da cutar sankarar zuciya dangane da cututtukan cututtukan numfashi masu tsanani da aka gano a Wuhan.
Dukkanin alamun sabon kwayar cutar SARS-CoV-2 suna faruwa ne a cikin coronavirus yo wanda ke da alaƙa da halitta. A waje da jikin mutum, ƙwayar cuta ta mutu ta hanyar sabulu na gida, wanda ke haɗuwa da ƙofar ta mai ƙarfi. SARS-CoV-2 yana da alaƙa da SARS-CoV na asali.
An yi zaton yana da asalin cutar dabbobi da ke gudana ga mutane.
Binciken kwayoyin halitta ya nuna cewa kwayar cutar ta kasance cikin rukunin kwayoyin halitta tare da nau'in Betacoronavirus, na subgenus Sarbecovirus (Cutar B) tare da nau'ikan biyu na firikwensin.
Yawan kwayoyin halitta na sauran samfurori na cutar coronavirus (BatCov RaTG13) ya yi daidai da kashi 96%.
A watan Fabrairun 2020, masu binciken kasar Sin sun gano cewa akwai bambanci guda daya na amino acid a wasu sassan tsarin kwayoyin halitta tsakanin kwayoyin cuta na kwayoyin cuta da na mutane.
A cikin kwatancen genom na yau da kullun an gano kashi 92% na kwayoyin halitta da suka raba cutar coronavirus da SARS-CoV-2, wanda bai isa ya tabbatar da cewa al'ummomi suna da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutut
Ana iya bincika kamuwa da cutar ta hanyar ƙwarewa bisa ga alamun bayyanar cututtuka, ko da yake tabbatarwa ta ƙarshe shine kwafin jerin abubuwan polymerase (rRT-PCR) na bayyanar cututtuka ko CT.
Wani bincike da ya kwatanta PCR da Ct a Wuhan ya nuna cewa CT tana da matukar damuwa fiye da PCR, kodayake tana da ƙarancin ƙarfi, tare da yawancin alamun hoto suna ɓoye wasu cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cuttukan cututtukan cuttukan cututtukan cuttukan cututtukan cuttukan cututtukan cuttukan cuttukan cuttukan cututtukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cututtukan cuttukan cuttukan cuttukan cututtukan cututtukan cuttukan cut
A watan Maris na 2020, Kwalejin Radiology ta Amurka ta ba da shawarar cewa "ba za a yi amfani da CT don gwada gwajin farko na COVID-19 ba".
Hukumar ta WHO ta wallafa wasu hanyoyin bincike na RNA na SARS-CoV-2 wanda aka fara sanar da su a ranar 17 ga Janairu.
Binciken yana amfani da kwafin polymerase-series reaction (rRT-PCR) a ainihin lokacin.
Ana iya yin gwajin ta hanyar numfashi ko kuma ta hanyar samfurin jini.
Ana samun sakamako a cikin 'yan sa'o'i ko kwanaki.
Ana yin wannan bincike ne a kan hanci ko da yake ana iya amfani da shi a cikin hanci. Yawancin dakunan gwaje-gwaje da kamfanoni suna yin gwajin jini, wanda ke gano waɗannan rigakafin.
A ranar 6 ga Afrilu, 2020, babu wanda aka tabbatar da cewa yana da inganci don amfani da shi a cikin duniya.
A Amurka, an amince da gwajin zubar da jini na Cellex don amfani da gaggawa a cikin dakunan gwaje-gwaje masu lasisi kawai.
Abubuwan da ke cikin hotunan hoto na mutum da ke da alamun CT sun haɗa da kwalban ƙasa da ba a gani ba da kuma rashin ruwa tsakanin huhu da kirji.
Kungiyar Masu Fitowa ta Italiya tana tattara bayanan kan layi na duniya game da sakamakon hotunan da aka tabbatar da shari'o'in.
Saboda kamuwa da wasu cututtuka kamar adenovirus, daukar hoto ba tare da tabbacin PCR ba tare da iyakantaccen matakin gano COVID-19.
Wani bincike mai zurfi a kasar Sin ya kwatanta sakamakon CT da CT da PCR kuma ya nuna cewa ko da yake daukar hoto ba na musamman bane ga kamuwa da cuta, yana da sauri kuma yana da mahimmanci, yana ba da shawarar yin la'akari da shi azaman kayan aikin bincike na wuraren zubar da jini.
An kirkiro ilimin wucin gadi bisa tsarin sadarwar jijiyoyi don gano alamun daukar hoto na kwayar cutar a cikin hasken rana da CT.
Hanyoyin hana yaduwar cutar sun haɗa da tsabtace mutum da kyau, wanke hannu, kauce wa taɓa idanu ko bakin hannu ba tare da wanke ba, da kuma numfashi ko motsawa da kuma yin wanka da wanka.
An shawarci wadanda suka kamu da cutar da su a baya su sa abin rufe fuska a wuraren aikin tiyata na jama'a.
Ana kuma ba da shawarar yin nesa da kai don hana watsawa. Jihohi da yawa sun hana ko kuma sun yi gargadin duk ƙaurace-tallace marasa mahimmanci zuwa ko daga ƙasashe da wuraren da kisan ya shafa.
Koyaya, cutar ta kai matakin yaduwar jama'a a yawancin sassan duniya.
Wannan yana nufin cewa cutar ta yadu tsakanin al'ummomi, kuma wani ɓangare na al'umma bai san inda ko yadda ta kamu ba. Ana ba da shawarar cewa masu ba da kulawa na kiwon lafiya da ke kula da wanda ya kamu da cutar su yi amfani da matakan tsaro na zamani, kulawa da taɓawa, da kuma kiyaye tushen. Kula da sadarwa hanya ce mai mahimmanci ga hukumomin kiwon lafiya don gano inda kamuwa da cuta ta fara da kuma hana ci gaba da yaduwa.
Amfani da bayanan wurin zama na wayoyin hannu na gwamnati don wannan dalili ya haifar da damuwa game da sirrin, tare da Amnesty International da fiye da hukumomi 100 da suka wallafa labarai suna kira ga iyakance irin wannan kariya.
An kunna ko kuma an ba da shawarar yin amfani da wani app a wayoyin hannu da yawa, har zuwa 7 ga Afrilu, 2020, fiye da rukuni goma sha biyu na masana suna aiki a kan hanyoyin kare sirrin sirri, kamar amfani da Bluetooth don ganin kusanci ga mai amfani da wasu wayoyin hannu .
Masu amfani za su karɓi saƙo idan sun kusanci wani wanda aka tabbatar da COVID-19. Labarai suna gudana game da yadda za a hana kamuwa da cuta; alal misali, wanke hanci da magana da harshen hannu ba su da tasiri.
Babu allurar rigakafin COVID-19, duk da cewa hukumomi da yawa suna aiki don samar da ɗaya.
Ana bada shawara a wanke hannu don hana yaduwar cutar.
Hukumar kula da lafiyar jiki ta shawarci mutane su wanke hannayensu da sabulu da ruwa aƙalla na tsawon dakika ashirin, musamman bayan sun shiga gidan wanka ko kuma idan hannayensu sun ƙazantu, kafin cin abinci; da kuma bayan sun numfasa wani a cikin safa, ko kuma bayan sun yi wanka.
Wannan ya faru ne saboda a waje da jikin mutum, sabulu na gida yana kashe kwayar, wanda ke kare ta daga cutar.
CDC ta ba da shawarar yin amfani da maganin kashe hannu na giya wanda ke da aƙalla kashi 60% na giya lokacin da sabulu da ruwa ba su da sauƙi.
WHO ta shawarci mutane da su guji taɓa idanu, hanci, ko baki da hannayensu marasa wanka.
Ana iya kashe farfajiya ta hanyar maganin maganin kashe-kashe (a cikin minti daya a matsayin mai kashe-kashe na farfajiya na ƙarfe mara lalata), wanda ya ƙunshi 62-71% ethanol, 50-100% isoproponal, 0.1% sodium hypochlorite, 0.5% hydrogen peroxide, da 0.2-7.5% povidone-iodine.
Sauran magunguna, kamar benzalkonium chloride da chrohexidine gluconate, ba su da tasiri sosai.
CDC ta ba da shawarar cewa idan ana zargin ko an tabbatar da wani hali na COVID-19 a wuraren kula da lafiya kamar ofishi ko wurin kula da rana, duk wuraren da aka yi amfani da su kamar ofisoshin, dakunan wanka, wuraren jama'a, na'urorin lantarki kamar kwamfutar hannu, allon taɓawa, kwamfutar hannu, masu sarrafa taro, da na'urorin ATM da marasa lafiya ke amfani da su, su kashe.
Hukumomin lafiya sun ba da shawarar cewa mutane su rufe bakinsu da hancinsu ta hanyar yin tawaye ko motsawa a kusurwoyin gashin kansu ko kuma su saka shara a kowane kwandon da sauri.
Ana ba da shawarar yin amfani da abin rufe fuska na tiyata don waɗanda suke yin hakan, saboda saka abin rufe fuska na iya iyakance motsi da nisan da maki ke tafiya da suke buƙata yayin magana, motsawa, ko kumburi.
Hukumar lafiya ta duniya (WHO) ta fitar da shawarwari kan lokacin da kuma yadda za a yi amfani da abin rufe fuska.
A cewar Stephen Griffin, masanin ilimin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut
Hukumar ta WHO ta ba da shawarar yin amfani da abin rufe fuska ga mutanen da ke da lafiya idan suna cikin haɗari, kamar waɗanda ke kula da wani mai cutar COVID-19, duk da cewa sun kuma yarda cewa yin amfani da abin rufe fuska na iya taimaka wa mutane su guji taɓa fuskokinsu.
Kasashe da dama sun fara ƙarfafa amfani da abin rufe fuska ga membobin al'umma.
A Amurka, CDC ta ba da shawarar yin amfani da abin rufe fuska mara lafiya na tufafi. China ta ba da shawarar musamman amfani da matakan kiwon lafiya da za a iya yarwa da su ga membobin kiwon lafiyar jama'a, musamman lokacin da suke kusa da wasu mutane (1 mita (3 inci) ko ƙasa da haka.
Hong Kong ta ba da shawarar saka abin rufe fuska na tiyata lokacin amfani da sufuri na jama'a ko a wuraren jama'a.
Hukumomin lafiya na Thailand suna karfafa mutane su sanya abin rufe fuska a gida kuma su wanke su kowace rana.
Jamhuriyoyin Czech da Slovakia sun dakatar da fita a cikin jama'a ba tare da rufe fuska ko rufe hanci da baki ba.
A ranar 16 ga watan Maris, Vietnam ta bukaci kowa ya sa abin rufe fuska lokacin da ya shiga shafukan sada zumunta don kare kansa da na wasu.
Gwamnatin Austria ta ba da izini ga duk wanda ya shiga shagon kaya ya sa abin rufe fuska.
Isra'ila ta nemi dukkan mazauna yankin su sa abin rufe fuska a lokacin da suke cikin al'umma.
Taiwan, wadda ta samar da masks miliyan goma a rana tun daga Maris, ta bukaci fasinjojin jiragen kasa da bas na birane su sa masks na fuska daga ranar 1 ga Afrilu.
Panama ta sanya sanya sanya fuska a kan mutane a waje, yayin da ta kuma bada shawarar samar da fuska a gida wanda aka gyara don amfani da waɗanda ba za su iya siyan fuska ba.
An kuma yi amfani da abin rufe fuska a Japan, Koriya ta Kudu, Malaysia, da Singapore.
Tsayawa a baya (wanda kuma ake kira nesa da nesa) yana cikin ayyukan hana kamuwa da cuta wanda ke nufin rage yaduwar cutar ta hanyar rage kusanci tsakanin mutane.
Hanyoyi sun haɗa da cin abinci, hana zirga-zirga, da rufe makarantu, wuraren aiki, filayen wasa, wuraren wasan kwaikwayo, ko wuraren cin kasuwa.
Mutane na iya aiwatar da tsarin keɓewa ta zamantakewa ta kasancewa a gida, ƙuntata ƙaura, nisantar wuraren jama'a, amfani da gaisuwa mara kyau, da kuma nisantar da kai daga wasu.
Yawancin jihohi yanzu suna ba da doka ko kuma bayar da shawarar nisantar zamantakewa a yankunan da cutar ta shafa.
Matsakaicin adadin taron da hukumomin gwamnati da cibiyoyin kiwon lafiya na Amurka suka ba da shawarar an rage shi daga mutane 2500 (ba tare da yaduwar COVID-19 da aka sani a yankin ba) zuwa mutane 50, kuma a ƙarshe mutane 10.
A ranar 22 ga Maris, 2020, Jamus ta dakatar da taron jama'a na mutane fiye da biyu. Manya da waɗanda ke da ƙananan yanayin kiwon lafiya kamar ciwon sukari, cututtukan zuciya, cututtukan numfashi, hawan jini da ƙananan tsarin rigakafi suna fuskantar haɗarin ciwo mai tsanani da lahani kuma CDC ta ba da shawarar su kasance a gida gwargwadon iko a wuraren zamantakewar da ta shafa. A ƙarshen Maris, 2020, WHO da sauran hukumomin kiwon lafiya sun fara canza amfani da kalmar "nesa ta zamantakewa" zuwa "nesa ta zamantakewa", don bayyana cewa manufar sanya ta a bayyane ta hanyar kasancewa a cikin wuraren hulɗa da jama'a, ba kai tsaye ba ko kuma nesa.
Amfani da kalmar "tsayawa daga zamantakewar jama'a" ya haifar da sakamakon cewa mutane suna shiga cikin cikakken rarrabuwa ta zamantakewa, maimakon a gargaɗe su su yi hulɗa da wasu ta hanyar da ta dace. Wasu hukumomi sun ba da shawarwari na kiwon lafiya na jima'i don amfani a lokacin annobar duniya.
Wadannan sun haɗa da shawarwari cewa ka yi jima'i da mutumin da kake zaune tare da shi kawai, wanda ba shi da cutar ko alamun cutar.
An ba da shawarar yin keɓewa a gida ga mutanen da aka gano COVID-19 da waɗanda suke zaton sun kamu da shi.
Hukumomin kiwon lafiya sun fitar da takamaiman jagororin keɓewa. Jihohi da yawa sun halatta ko kuma sun ba da shawarar keɓewa ga duk al'ummomin da ke cikin wuraren da cutar ta shafa.
An ba da shawarwari mafi ƙarfi game da keɓewa ga ƙungiyoyin haɗari.
Wadanda suka haɗu da wani wanda ke da COVID-19 kuma waɗanda suka yi tafiya kwanan nan zuwa wata ƙasa ko yanki tare da yaduwar yaduwar cutar an shawarce su da su keɓe kansu na kwanaki 14 daga lokacin da suka haɗu da shi.
Dabarun hana yaduwar cutar su ne dakatar da yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar.
Ana dakatar da cutar a farkon matakan yaduwar cutar kuma suna son ganowa da keɓe waɗanda suka kamu da ita kuma kamar yadda suke so su gabatar da wasu matakan hana kamuwa da cuta da allurar rigakafi don hana cutar yadawa ga sauran al'umma.
Idan ba za a iya dakatar da yaduwar cutar ba, sai a yi ƙoƙari a rage shi, a ɗauki matakai don rage yaduwar da kuma rage tasirinsa a kan tsarin kiwon lafiya da zamantakewa.
Ana iya haɗa matakan dakatar da ragewa a lokaci guda.
Rage cutar yana buƙatar matakai masu yawa don dawo da cutar ta duniya ta hanyar rage yawan haihuwa zuwa ƙasa da 1. sashin kula da cututtukan kumburi na mutuwa yana ƙoƙarin rage haɓakar saphramen, wanda aka sani da faɗaɗa juyin juya halin saphramen.
Wannan zai rage haɗarin ɓacewar sabis na kiwon lafiya kuma zai ba ku ƙarin lokaci don yin allurar rigakafi da magunguna.
Hanyoyin da ake yi na kula da kashe-kashe sun haɗa da matakan kariya ta mutum, kamar tsabtace jiki, saka abin rufe fuska, da kuma keɓewa; matakan da ba su da iyaka ga nesa kamar rufe makarantu da dakatar da manyan taro; shiga cikin al'umma da ake kira karɓar da kuma yin kuka game da irin wannan tsoma baki; da kuma matakan muhalli kamar tsaftace farfajiyar. An ɗauki ayyuka masu ƙarfi da yawa na hana kashe-kashe a China lokacin da tashin hankali ya bayyana, kamar keɓewa a cikin birane da kuma gabatar da tsauraran matakan hana zirga-zirga.
Sauran ƙasashe ma sun aiwatar da matakai da dama don hana yaduwar cutar.
Koriya ta Kudu ta kaddamar da bincike mai zurfi da keɓewa na gida, kuma ta ba da gargadi game da motsi na mutanen da aka shafa.
Singapore ta ba da tallafi na kuɗi ga mutanen da suka shiga keɓewa kuma ta ba da manyan tarar waɗanda ba su yi hakan ba.
Taiwan ta kara samar da masks na fuska kuma ta dakatar da kara farashin kayan aikin kiwon lafiya. Tsarin Burtaniya da Amurka ya nuna cewa rage (ƙanƙasa amma ba dakatar da yaduwar cutar sankara ba) da kuma matsa lamba (ƙaruwa da ci gaban cutar sankara) suna da ƙalubale da yawa.
Mafi kyawun hanyoyin ragewa na iya rage yawan buƙatun kiwon lafiya na matsakaicin kashi 2/3 na wannan mutuwar, amma har yanzu sakamakon ɗaruruwan dubban mutuwar da kuma kawar da tsarin kiwon lafiya.
Za a iya barin matsa lamba amma yana buƙatar ci gaba har sai an sami rigakafin cutar a cikin ɗan adam (ko kuma har sai an sami rigakafin, idan wannan ya hana shi), in ba haka ba watsawar za ta ninka sau biyu da sauri lokacin da aka sauƙaƙe matakan.
Matsayi na dogon lokaci na matsa lamba kan cutar ta duniya yana haifar da farashi na zamantakewa da tattalin arziki.
Babu takamaiman maganin rigakafin cutar da aka amince da shi don COVID-19, amma ana ci gaba da ƙoƙari, ciki har da gwajin magunguna masu dorewa.
Shan magungunan farko da ake samu, shan ruwan 'ya'yan itace, da kuma hutawa na iya taimakawa wajen kawar da alamun.
Dangane da tsanani, ana iya buƙatar maganin oxygen, cire ruwa daga jijiyoyin jini, da kuma taimakon numfashi.
Yin amfani da kwayoyin steroid na iya lalata sakamakon.
Ana bincika yawancin abubuwan haɗin da aka riga aka amince da su don magance wasu cututtukan ƙwayar cuta don amfani da su don maganin COVID-19.
Hukumar ta WHO ta kuma ce wasu "magungunan gargajiya da na gida" na iya rage alamun cutar ta SARS-CoV-2.
WHO ta bayyana karuwa da daidaitawa da bukatun kula da lafiya ga marasa lafiya na COVID-19 a matsayin matakin mayar da martani na asali.
ECDC da ofishin WHO na Turai sun fitar da umarni ga asibitoci da sabis na kiwon lafiya na asali don canja wurin albarkatu a matakai da yawa, gami da mai da hankali kan ayyukan dakin gwaje-gwaje don gwajin COVID-19, dakatar da hanyoyin zaɓi a duk lokacin da zai yiwu, rarraba da keɓe marasa lafiya na COVID-19, da ikon kula da gaggawa ta hanyar horar da ma'aikata da haɓaka yawan masu ba da numfashi da gadaje da ake dasu.
Akwai wasu da'awar game da inda cutar ta farko (wanda ake kira cutar ta Ibrananci) ta fito.
An fara gano sabon cutar coronavirus a watan Disamba na 2019 a Wuhan, Hubei, China.
A cikin wata daya, adadin masu kamuwa da cutar coronavirus a Hubai ya karu a hankali.
An danganta wadannan da kasuwar sayar da kayayyakin teku ta Huanan, wadda kuma ke sayar da dabbobi masu rai, amma ra'ayin daya shine cewa cutar ta fito ne daga daya daga cikin wadannan nau'ikan dabbobi; ko kuma, a wata ma'ana, tana da asalin cutar dabbobi da ke yaduwa zuwa ga mutane. An gano wani rukuni na abin da ake kira burucin a ranar 26 ga Disamba kuma an yi wa likita Zhang Jixian magani a asibitin lardin Hubei, wanda ya sanar da Wuhan Jianghan CDC a ranar 27 ga Disamba.
A ranar 30 ga watan Disamba, ƙungiyar likitoci a Babban Asibitin Wuhan sun yi gargadin abokan aikin su game da "coronavirus daga SARS".
Wasu lauyoyi takwas, ciki har da Li Wenliang, sun yi gargadin 'yan sanda game da yada labaran karya, kuma a wasu abubuwa, Ai Fen, jami'an ta sun yi ta tsawata mata saboda kara jin tsoro.
Hukumar Lafiya ta birnin Wuhan ta fitar da sanarwar jama'a a ranar 31 ga watan Maris, a cewar Hukumar Lafiya ta Duniya.
An bayar da rahoton isasshen adadin cutar ta buruki a wurin jami'an kiwon lafiya na Wuhan wanda ya fara bincike a farkon watan Janairu. A farkon fasalin barkewar cutar, adadin cututtukan ya karu da kusan bakwai a kowace rana.
A farkon da tsakiyar watan Janairun 2020 cutar ta bazu zuwa wasu yankunan kasar Sin, wanda ya faru ne a lokacin taron Sabuwar Shekarar kasar Sin yayin da Wuhan ta kasance cibiyar sufuri da kuma babbar hanyar jirgin kasa.
A ranar 20 ga watan Janairu, kasar Sin ta ba da rahoton kusan sabbin mutane 140 a rana guda, ciki har da mutum biyu a Beijing da kuma mutum daya a Shenzhen.
Bayanai na hukuma sun nuna cewa mutane 6,174 sun riga sun nuna alamun cutar a ƙarshen 20 ga Janairu, 2020, kuma a ranar 26 ga Maris, Amurka ta riga ta gaba da China da Italiya tare da mafi yawan adadin da aka tabbatar a duniya.Zuwa ranar 9 ga Afrilu, 202o, an ba da rahoton fiye da miliyan 1.61 na cututtuka a duniya; sama da mutane 97,000 sun mutu kuma sama da 364 sun warke.
An gano akalla hali guda a kusan kasashe da yankuna 200.
Saboda annobar ta duniya a Turai, ƙasashe da yawa na yankin Schengen sun hana 'yancin motsa jiki kuma sun kafa ƙuntatawa a kan iyakoki.
Sakamakon haka ya hada da matakan hanawa kamar keɓewa (wanda ake kira umarnin zama a gida, umarnin zama a gida, ko rufewa gaba ɗaya) da kuma hanawa,Daga ranar 2 ga Afrilu, kusan mutane miliyan 300, ko kusan kashi 90% na yawan jama'a suna cikin wani nau'in hanawa a Amurka,Mutane sama da miliyan 50 suna cikin hanawa a cikin Philippines, kusan mutane miliyan 59 a Afirka ta Kudu, da mutane biliyan 130 a cikin hanawa a Indiya.
A ranar 26 ga watan Maris, mutane biliyan 1.7 a duniya suna cikin wani nau'i na hanawa, wanda ya karu zuwa mutane biliyan 2.6 bayan kwana biyu - kashi ɗaya bisa uku na yawan duniya.
An samu mutum na farko da aka tabbatar da cutar COVID-19 a Wuhan tun daga ranar 1 ga Disamba, 2019; rahoto mara tabbata ya nuna cewa mutum na farko ya kamu da cutar ne a ranar 17 ga Nuwamba.
Likita Zhang Jixian ta ga wani rukuni na cututtukan burkuito wanda ba a san dalilinsa ba a ranar 26 ga Disamba, inda asibitinta ya sanar da Wuhan Jianghan CDC a ranar 27 ga Disamba.
Binciken cutar AIDS na farko a cikin samfurin marasa lafiya a ranar 27 ga Disamba, 2019 ya nuna samun SARS daga cutar coronavirus.
Hukumar kiwon lafiya ta birnin Wuhan ta fitar da sanarwar likita a ranar 31 ga watan Disamba.
Hukumar Lafiya ta Duniya ta sanar da shi a wannan rana.
Bayan da aka samu wannan sakon, likitocin Wuhan sun gargadi 'yan sanda da su "yi yada labaran karya" game da annobar.
Hukumar Lafiya ta kasar Sin ta ce a baya-bayan nan babu "bayani mai kyau" na cewa mutum yana kamuwa da cutar.
A karshen watan Janairu, gwamnatin kasar Sin ta kaddamar da wani yunkuri na sauyi wanda daga bisani babban sakataren jam'iyyar kwaminis ta kasar Sin Xi Jinping ya bayyana "yaƙi da mutane" don dakatar da yaduwar cutar.
An bayyana shi a matsayin "babban killace a tarihin bil'adama", an sanar da haramcin ranar 23 ga Janairu wanda ya hana masu yawon bude ido shiga da fita daga Wuhan, wanda aka fadada zuwa jimlar biranen Hubei 15, wanda ya shafi jimlar mutane kusan miliyan 57.
An haramta amfani da motocin sirri a babban birnin.
An soke wasu wuraren da ake bikin Sabuwar Shekara ta kasar Sin (25 ga Janairu).
Shugabannin sun kuma sanar da gina asibitin wucin gadi, Asibitin Houshenshan, wanda aka kammala cikin kwanaki 10.
An gina wani asibiti a baya, asibitin Leishenshan, don kula da sababbin marasa lafiya.
Baya ga sabon asibitin da aka gina, kasar Sin ta sauya wasu wurare 14 a Wuhan zuwa asibitoci na wucin gadi, kamar cibiyoyin taro da filayen wasa. A ranar 26 ga Janairu, gwamnati ta gabatar da ƙarin matakai don dakile yaduwar COVID-19, ciki har da samar da shaidar lafiya ga matafiya da tsawaita hutun bikin bazara.
An rufe makarantu da makarantu a duk faɗin ƙasar.
Hukumomin Hong Kong da Macau sun gabatar da wasu matakai, musamman ga makarantu da jami'o'i.
An kafa matakan aiki a wajen aiki a wasu yankuna da ke kusa da kasar Sin.
An kafa takunkumin tafiye-tafiye a cikin gida da waje na Hubei.
An sauya zirga-zirgar jama'a, an rufe gidajen wasan kwaikwayo na wucin gadi a duk ƙasar Sin.
An sanya dokar hana zirga-zirgar jama'a a manyan biranen kasar, kuma an kiyasta cewa kusan mutane miliyan 760 (fiye da rabin yawan jama'a) sun yi wasu nau'ikan takunkumi. Bayan barkewar cutar ta shiga matakin duniya a tsakiyar watan Maris, shugabannin kasar Sin sun dauki tsauraran matakai don hana "fitarwa" daga wasu ƙasashe.
Misali, Beijing ta sanya dokar killace-kike na kwanaki 14 ga duk matafiya na duniya da ke shiga babban birnin kasar. A ranar 23 ga Maris, babban yankin China ne kawai ya gabatar da wani lamari guda biyar a cikin kwanaki biyar da suka gabata, a cikin irin wannan yanayin ta hanyar matafiya zuwa Guanzzhou daga Istanbul.
A ranar 24 ga watan Maris na shekarar 2020, Shugaban kasar Sin Li Keqiang ya ce an kame yaduwar cututtukan a cikin gida kuma an kame yaduwar a cikin kasar Sin.
A daidai ranar da aka sassauta takunkumin tafiye-tafiye a Hubei, banda Wuhan, watanni biyu bayan da aka sanya dokar kulle gaba daya. Ma'aikatar Harkokin Wajen China ta ba da sanarwar a ranar 26 ga Maris, 2020 cewa za a dakatar da masu shiga biza da masu riƙe da takardun zama daga ranar 28 ga Maris zuwa gaba, ba tare da wani bayani na musamman game da lokacin da dokar za ta ƙare ba.
Wadanda suke son shiga kasar Sin dole ne su nemi takardar izinin shiga a ofisoshin jakadancin kasar Sin ko kuma a ofisoshin jakadancin kasar.
Gwamnatin kasar Sin ta karfafa harkokin kasuwanci da masana'antu su sake budewa daga ranar 30 ga watan Maris, kuma ta ba da tallafin ga kamfanoni. Majalisar jihar ta sanar da ranar makoki ta kasa da za ta fara da minti uku da yamma a karfe 10:00 na ranar 4 ga Afrilu, wanda ya dace da bikin Qinming, duk da cewa gwamnatin tarayya ta nemi iyalai su nuna girmamawa ta yanar gizo yayin kiyaye zaman lafiya don kauce wa barkewar COVID-19 da kuma sabuntawa.
An tabbatar da cewa COVID-19 ta bazu a Koriya ta Kudu ta hanyar fitowa daga China.
Hukumar lafiya ta kasa ta ruwaito karuwar yawan wadanda aka tabbatar da cutar a ranar 20 ga Fabrairu, wanda yafi zuwa da taron da aka yi a Daegu a sabon cocin Shincheonji na Yesu.
Masu bauta wa Shincheonji da ke ziyartar Daegu daga Wuhan an yi zargin su ne tushen cutar.
A ranar 22 ga watan Fabrairu, 9,336 na mabiyan cocin, 1,261 ko kusan 13% sun ba da rahoton alamun cutar. A Koriya ta Kudu kun sanar da mafi girman faɗakarwa a ranar 23 ga Fabrairu, 2020.
A ranar 28 ga Fabrairu, an samu karin mutane 2,000 da suka kamu da cutar a Koriya, wanda ya karu zuwa 3,150 a ranar 29 ga Fabrairu.
An killace dukkan cibiyoyin sojin Koriya ta Kudu bayan an tabbatar da cewa an gano wasu sojoji uku da cutar.
An kuma shafi jadawalin jiragen sama kuma saboda haka an canza su. Koriya ta Kudu ta gabatar da abin da ake ganin shine mafi girma da kuma mafi kyawun shirin da aka tsara a duniya wanda ke bincika yawan mutanen da ke dauke da cutar, keɓe duk wanda ya kamu da cutar da kuma bin sawun waɗanda suka kamu da ita.
Hanyoyin bincike sun haɗa da bayar da rahoton alamun cutar da ake zargi da dole ga mutane daga ko'ina cikin duniya ta hanyar aikace-aikacen waya, zuwa gwajin cutar tare da sakamakon a rana mai zuwa, da haɓaka ƙarfin bincike don iya bincika mutane 20,000 a rana.
An lura cewa shirin Koriya ta Kudu ya kara daurin rigakafin fashewa duk da cewa an yi wa'adin killacewa a duk manyan biranen kasar.
Yawancin 'yan Koriya sun sanya hannu kan karar da ke nuna cewa karbar Moon daga mulki ya nuna cewa gwamnati ta yi amfani da shi wajen yin faduwar, ko kuma ta yaba da martani.
A ranar 23 ga watan Maris, an bayar da rahoton cewa Koriya ta Kudu tana da mafi ƙarancin adadin shari'o'i a kowace rana na tsawon makonni huɗu.
A ranar 29 ga Maris, an bayar da rahoton cewa daga ranar 1 ga Afrilu, za a yi wa duk matafiya da suka zo daga ƙasashen waje keɓewa na makonni biyu.
A cewar kafofin yada labarai a ranar 1 ga Afrilu, Koriya ta Kudu ta karɓi buƙatun jinkirta binciken cutar daga ƙasashe 121 daban-daban.
Iran ta ce an fara samun kamuwa da cutar SARS-CoV-2 a ranar 19 ga Fabrairu a Qom, yayin da, a cewar Ma'aikatar Lafiya da Ilimin Lafiya, mutane biyu suka mutu a wannan ranar.
Gwamnati ta sanar da matakan gaggawa ciki har da soke kide kide da sauran abubuwan al'adu, wasanni, da sallar Juma'a, da rufe jami'o'i, makarantun sakandare, da makarantu.
Iran ta ba da dala tiriliyan biyar don yaki da cutar.
Shugaban kasar Hassan Rouhani ya ce a ranar 26 ga Fabrairu 2020 babu wani shiri game da wuraren keɓewa da cutar ta shafa, za a keɓe mutane ne kawai.
An sanar da shirin hana zirga-zirgar manyan birane a watan Maris, duk da cewa an yi gagarumin tayar da motoci tsakanin manyan biranen kafin sabuwar shekarar Farisa ta Nuurus.
Har zuwa ranar 16 ga Maris, 2020, wuraren da aka yi wa alfarma a kasar Sin har yanzu suna buɗewa ga masu zanga-zangar, kuma Iran ta zama cibiyar yaduwar cutar bayan China a watan Fabrairu.
Rahotanni na matsakaici na ɓoye iyakar kisa a cikin Iran, fiye da ƙasashe goma sun bi ta zuwa Iran a ƙarshen 28 ga Fabrairu, wanda ke nuna cewa iyakar fashewar ta kasance mafi muni fiye da shari'o'in 388 da gwamnatin Iran ta bayar da rahoton a wannan ranar.
An rufe majalisar dokokin Iran, inda aka ce an kashe 'yan majalisa 23 daga cikin 290 a ranar 3 ga Maris.
A ranar 12 ga watan Maris, Hukumar kare hakkin bil adama ta bukaci shugabannin kurkuku na Iran da su saki masu kare hakkin bil adama da aka tsare da su saboda bambancin ra'ayi ba tare da wata sharudda ba, da kuma a saki duk fursunonin da suka cancanci.
Ta ce akwai babban haɗarin yaduwar cutar a cibiyoyin da aka rufe kamar kurkuku, inda ba a samun isasshen kulawar lafiya.
A ranar 5 ga watan Maris, gwamnatin Iran ta ba da rahoton mutuwar mutane 100 a rana guda, wanda shine mafi yawan mutane da aka yi rajista a kasar tun lokacin da aka fara kisan kai.
Akalla shugabannin majalisar dokoki 12 ko tsoffin 'yan siyasar Iran da shugabannin gwamnati sun mutu sakamakon cutar a karshen ranar 17 ga Maris.
A karshen ranar 23 ga watan Maris, Iran ta sami kamuwa da cutar 50 a kowace awa da mutuwar mutum daya a kowane minti goma sakamakon cutar korona.
A cewar jami'an Hukumar Lafiya ta Duniya, an bayar da rahoton cewa akwai yiwuwar samun karin shari'o'i biyar a cikin Iran fiye da yadda aka samu.
An kuma yi tunanin cewa takunkumin da Amurka ta sanya wa Iran zai iya shafar ikon tattalin arzikin kasar na amsawa ga barkewar cutar.
Babban wakilin kare hakkin dan Adam na Majalisar Dinkin Duniya ya bukaci sassauta takunkumin tattalin arziki ga kasashen da cutar ta shafa sosai, ciki har da Iran.
An tabbatar da cewa cutar ta bazu a Italiya a ranar 31 ga Janairu, lokacin da aka gano wasu 'yan yawon bude ido biyu na kasar Sin da cutar SARS-CoV-2 a cikin Rome.
Al'amuran sun fara karuwa cikin sauri, wanda ya sa gwamnatin Iran ta dakatar da dukkan jiragen sama zuwa da zuwa China kuma ta ayyana dokar ta baci.
An gano wasu shari'o'i da suka shafi COVID-19 a ƙarshe, tare da fara da shari'o'i 16 da aka tabbatar a cikin Lombardy a ranar 21 ga Fabrairu. A ranar 22 ga Fabrairu, Majalisar Ministoci ta ba da sanarwar sabon tsarin mulki don dakatar da kashe-kashe, wanda ya haɗa da keɓe mutane sama da 50,000 daga garuruwa 11 na arewacin Italiya.
Shugaban kasa Giuseppe Conte ya ce, "Ba za a samu wuraren da cutar ta barke ba, ba za a samu shiga da fita ba.
An ba da umarnin dakatar da ayyukan aiki da taron wasanni a waɗannan wuraren. " A watan Maris, gwamnatin Italiya ta ba da umarnin rufe dukkan makarantu da ƙungiyoyi a duk faɗin ƙasar kuma Italiya ta kai 100.
Dukkanin taron wasanni, gami da wasannin ƙwallon ƙafa na Serie A, dole ne a gudanar da su a cikin wuraren da aka rufe, amma a ranar 9 ga Maris, an dakatar da duk wasanni gaba ɗaya aƙalla wata ɗaya.
A ranar 11 ga watan Maris, Firayim Minista Conte ya ba da umarnin dakatar da kusan dukkanin ayyukan kasuwanci sai dai manyan kantuna da kantunan magani. A ranar 6 ga Maris, Kwalejin Talla, Ragewa, Sake Rayuwa da Kula da Nan take (SIAARTI) ta buga shawarwarin kiwon lafiya tare da ambaton wasu ladabi da za a iya aiwatar da su.
A ranar 19 ga watan Maris, Italiya ta zarce kasar Sin a matsayin kasa da ta fi yawan mutuwar da ke tattare da cutar korona a duniya lokacin da ta ba da rahoton mutuwar 3,405 da cutar ta haifar a duniya.
A ranar 22 ga watan Maris, an bayar da rahoton cewa Rasha ta tura jiragen soja tara zuwa Italiya a matsayin kayan aikin kiwon lafiya.
A ranar 5 ga Afrilu, an tabbatar da shari'o'i 128,98, mutuwar 15,887, da kuma warkewa 21,815 a Italiya, yawancin waɗannan lokuta sun faru ne a lardin Lombardy.
Rahoton da CNN ta fitar ya nuna cewa haɗuwa da yawan tsofaffi a cikin al'ummar Italiya da rashin iyawar gano mutanen da ke dauke da cutar na iya haifar da babban adadin mutuwar.
Amsar cutar a Burtaniya ta fara zama mafi sassauƙa a cikin ƙasashen da aka shafa, kuma har zuwa 18 ga Maris 2020, gwamnatin Burtaniya ba ta gabatar da wani nau'in keɓewar zamantakewar jama'a ko wani nau'in matakan keɓewa ba.
A sakamakon haka, an soki gwamnati saboda rashin daukar mataki da kuma yawan yadda take amsa damuwar jama'a. A ranar 16 ga Maris, Firayim Minista Boris Johnson ya yi sanarwa yana gargadi mutane da yin tafiye-tafiye marasa mahimmanci da kuma irin wannan hulɗar zamantakewa, yana ba da shawarar cewa mutane su yi aiki a gidajensu idan ya yiwu kuma su guji wuraren kamar mashaya, otal-otal, da gidajen wasan kwaikwayo.
A ranar 20 ga watan Maris, gwamnati ta sanar da rufe dukkan wuraren taruwa na hutu kamar sanduna da wuraren motsa jiki da wuri-wuri, kuma ta yi alkawarin biyan kusan kashi 80% na albashi na ma'aikata har zuwa £2,500 a kowane wata don hana rashin aikin yi a lokacin rikicin. A ranar 23 ga Maris, Raisul Wasaraha ya sanar da tsauraran matakan nisantar jama'a, hana taruwa fiye da mutane biyu da kuma satar baƙi da gidaje da aka ɗauka da mahimmanci.
Ba kamar matakan da suka gabata ba, 'yan sanda sun aiwatar da wannan takunkumin ta hanyar tsaurara da kuma soke taron.
An ba da umarnin rufe yawancin kasuwancin, ban da kasuwancin da aka ɗauka "babban" ne, ciki har da manyan shaguna, kantunan magani, bankuna, shagunan kayan gini, cibiyoyin batrauokla, da kuma gidajen kashe mutane.
A ranar 20 ga watan Janairu, an tabbatar da mutum na farko da aka sani da cutar COVID-19 a arewa maso yammacin Pacific a jihar Washington, wani mutum da ya dawo daga Wuhan a ranar 15 ga Janairu.
An kafa kungiyar yaki da cutar Corona a fadar White House a ranar 29 ga watan Janairu.
A ranar 31 ga watan Janairu, gwamnatin Trump ta ayyana dokar ta baci ta kiwon lafiya ta jama'a, kuma ta sanya takunkumi kan shiga matafiya daga China.
A ranar 28 ga Janairu, 2020, Cibiyar Kula da Cututtuka - cibiyar farko ta kiwon lafiyar jama'a ta gwamnatin Amurka - ta sanar da cewa ta kirkiro kayan bincike na kansu.
Amma a yin hakan, binciken gwamnatin Amurka ya zama farkon rashin ƙarfi, wanda ke ɓoye ainihin girman ɓarnar lokaci.
Binciken ya sami kayan bincike marasa inganci da gwamnatin tarayya ta samar a tsakiyar Fabrairu, rashin amincewar gwamnatin tarayya da kayan bincike na ba-gwamnati a makarantun kimiyya, kamfanoni da asibitoci) har zuwa ƙarshen Fabrairu, da kuma iyakancewar hanyar da mutane ke cancanci yin bincike har zuwa farkon Maris. (bayan haka ana buƙatar shawarwari na likita).
A ranar 27 ga Fabrairu, jaridar The Washington Post ta ruwaito cewa an gudanar da bincike kadan fiye da 4,000 a Amurka.
A ƙarshen Maris 13, Atlantic ta ba da rahoton cewa ba a gudanar da bincike sama da 14,00 ba.
A ranar 22 ga watan Maris, Associated Press ta ruwaito: "Mutane da yawa da ke da alamun cutar da umarnin likita sun jira awanni da kwanaki don bincika". Bayan mutuwar farko da aka ruwaito a Amurka a cikin jihar Washington a ranar 29 ga Fabrairu, Gwamna Jay Inslee ya ba da sanarwar gaggawa, wani mataki da daga baya wasu jihohi suka bi.
Makarantun yankin Seattle sun soke aji a ranar 3 ga Maris, kuma a tsakiyar watan Maris an rufe makarantun kasar. A ranar 6 ga Maris, 2020, ƙungiyar kwararru na cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cuttukan cututtukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttuk
A daidai ranar da Shugaba Trump ya rattaba hannu kan Dokar Shirya da Amsa Mai Inganci, wanda ya ba da dala biliyan 8.3 nan da nan don saka hannun jari ga hukumomin tarayya don amsa kisan kai.
Kamfanoni sun sanya takunkumin tafiye-tafiye ga ma'aikatansu, soke taron, da kuma karfafa ma'aikata su yi aiki daga gida.
An soke wasanni da kuma lokacin wasanni. A ranar 11 ga Maris, Trump ya sanar da takunkumin tafiye-tafiye a yawancin Turai, banda Burtaniya, na kwanaki 30, wanda zai fara aiki daga ranar 13 ga Maris.3
Kashegari, ya faɗaɗa takunkumin da ya ƙara zuwa Burtaniya da Ireland.
A ranar 3 ga Maris, ya ayyana dokar ta baci ta kasa, wanda ya sanya kudaden tarayya a cikin hanyar da za a iya magance bala'in.
Tun daga ranar 15 ga Maris, masana'antu da yawa sun rufe ko rage lokutan aiki a duk faɗin Amurka don ƙoƙarin rage yaduwar cutar.
A ranar 17 ga Maris, an tabbatar da kamuwa da cutar a duk jihohi 50 da gundumar Columbia. A ranar 23 ga Maris, an bayar da rahoton cewa an gano mutane 10,700 da suka kamu da cutar coronavirus a birnin New York, wanda ya fi yawan adadin mutanen da suka kamu da cutar a Koriya ta Kudu.
A ranar 25 ga watan Maris, likitan ya ce ana ganin cewa nisantar zamantakewar ta yi aiki, saboda yawan adadin masu kamuwa da cutar ya ragu daga kwanaki 2.0 zuwa kwanaki 4.7.
Ya zuwa ranar 28 ga Maris, an sami mutane 32,308 da aka tabbatar da cutar a birnin New York, kuma mutane 672 sun mutu saboda cutar. A ranar 26 ga Maris, an ruwaito cewa a Amurka an gano karin mutane da suka kamu da cutar coronavirus fiye da kowace ƙasa a duniya, ciki har da China da Italiya. A ranar 8 ga Afrilu, an tabbatar da mutane 400,335 a Amurka, kuma mutane 12,841 sun mutu.
Kamar yadda kafofin yada labarai suka ruwaito a ranar 30 ga watan Maris, Shugaban Amurka Trump ya yanke shawarar tsawaita shawarar nisantar zamantakewa har zuwa 30 ga Afrilu.
A wannan rana, USNS Comfort, wani asibiti mai asibiti mai kusan gado 1000, ya rufe a New York.
A ranar 3 ga watan Afrilu, Amurka ta yi rikodin mutuwar mutane 884 sakamakon cutar coronavirus a cikin awanni 24.
A jihar New York, adadin mutane sun wuce 100,000 a ranar 3 ga Afrilu. An soki Fadar White House saboda rage haɗari da kuma sarrafa saƙonni ta hanyar ba da umarnin hukumomin lafiya da masana kimiyya su haɗa labarai da wallafe-wallafen da suka shafi cutar a ofishin mataimakin shugaban Amurka Mike Pence.
Ana nuna rashin amincewa da gwamnatin Trump game da annobar a tsakanin masu raba gardama.
Wasu shugabannin Amurka da masu sharhi sun soki amincewar Amurka da muhimmancin da ta ba da ga kayayyakin kiwon lafiya masu mahimmanci, ciki har da kayayyakin kiwon lafiya na asali, da aka shigo da su daga China.
An yi amfani da tsarin tafiye-tafiye na iska don yin hoto da hango ko hasashen yanayin yaduwar kuma an buga shi a cikin Journal of Travel Medicine a tsakiyar Janairu 202o.
A cewar bayanan 2018 na kungiyar jiragen sama ta kasa da kasa, Bangkok, Hong Kong, Tokyo, da Taipei sun sami mafi yawan masu tashi daga Wuhan.
Dubai, Sydney, da Melbourne kuma an ruwaito cewa sune wuraren da aka fi ziyarta daga Wuhan zuwa Wuhan.
An ruwaito cewa Bali ita ce mafi ƙarancin shirye-shirye daga cikin manyan biranen 20 da masu yawon buɗe ido ke tafiya zuwa, yayin da aka gano manyan biranen Ostiraliya a matsayin mafi shirye-shirye. Ostiraliya ta saki Shirin Amsa na gaggawa ga sabon kwayar cutar Corona (COVID-19) a ranar 7 ga Fabrairu.
An ce har yanzu ba a san komai game da COVID-19 ba, kuma Ostiraliya za ta mai da hankali kan kula da iyakoki da sadarwa don amsa cutar ta duniya.
A ranar 21 ga Maris, an sanar da matakan kare dan Adam daga abubuwa masu haɗari a Ostiraliya.
Tare da ingantaccen keɓewa na jigilar jama'a a Wuhan da Hubei, ƙasashe da yawa sun shirya ƙaurawar jama'arsu da ayyukan sufuri daga wurin, da farko ta hanyar amfani da jiragen haya na ƙasar, tare da ba mu izinin zama na yau da kullun daga shugabannin China.
Kanada, Amurka, Japan, Indiya, Sri Lanka, Australia, Faransa, Argentina, Jatmalka, da Thailand sun kasance daga cikin na farko da suka yi dariya game da ambaliyar gidaje ga mazauninsu.
Pakistan ta ce ba za ta fitar da wani daga kasar Sin ba.
A ranar 7 ga watan Fabrairu, Brazil ta yi ambaliyar ruwa da mutane 34 na Brazil ko 'yan uwa ban da hudu na Poland, Sin, da Indiya.
An dawo da 'yan asalin Poland, China, da Indiya zuwa Poland, lokacin da jirgin saman Brazil ya tsaya a tsakiyar kafin ya ci gaba da tafiya zuwa Brazil.
An killace wani ɗan ƙasar Brazil da ya tafi Wuhan a wani sansanin soja kusa da Brasília.
A wannan ranar, an kwashe masu tono 215 daga Kanada (176 tare da jirgin sama na farko, da mutane 39 tare da jirgin sama na biyu da gwamnatin Amurka ta haya) daga Wuhan kuma an kai su CFB Trenton don keɓewa na makonni biyu.
A ranar 11 ga Fabrairu, wani jirgin sama kamar na Kanada 185 daga Wuhan ya sauka a kan jirgin CFB Trenton.
Hukumomin Ostiraliya sun yiwa 'yan kasar 277 albarka a ranar 3 da 4 ga Fabrairu a Cibiyar Kurkuku ta Tsibirin Kirsimeti, wanda aka sanya a matsayin wuri na keɓewa, inda suka zauna na kwanaki 14.
Jirgin saman da ya tashi daga New Zealand ya isa Auckland a ranar 5 ga Fabrairu, kuma an killace fasinjojinsa (ciki har da waɗanda suka fito daga Ostiraliya da Pacific) a wani tashar sojin ruwa a Whanaparoa, arewacin Auckland.
A ranar 15 ga Fabrairu, Amurka ta sanar da cewa za ta tura jami'an Amurka zuwa jirgin ruwa mai suna Diamond Princess.
A ranar 21 ga Fabrairu, jirgin sama mai dauke da fasinjoji 129 na Kanada daga Diamond Princess ya sauka a Trenton, Ontario.
A farkon watan Maris, gwamnatin Indiya ta fara fitar da 'yan kasar ta daga Iran. A ranar 14 ga Maris, jirgin saman South African Airways na gwamnatin Afirka ta Kudu ya dawo da 'yan kasar 112 daga Afirka ta Kudu.
An gudanar da bincike na asibiti kafin a kai hari, kuma an bar Afirka ta Kudu 4 da suka nuna alamun cutar coronavirus don rage haɗarin.
Sai dai mutanen Afirka ta Kudu da suka bace ne aka mayar da su kasar.
Sakamakon binciken ya bayyana cewa duk mutanen Afirka ta Kudu, gami da ma'aikatan jirgin sama, matukan jirgi, ma'aikatan otal, 'yan sanda da sojoji da ke da hannu a ayyukan jin kai, an kiyaye su duka a cikin killacewa na kwanaki 14 a Ranch Resort.
A ranar 20 ga watan Maris, Amurka ta fara janye sojojinta daga Iraki saboda tashin hankali.
A ranar 5 ga watan Fabrairu, ma'aikatar harkokin wajen kasar Sin ta ce kasashe 21 (ciki har da Belarus, Pakistan, Trinidad da Tobago, Masar, da Iran) sun aika da taimako ga kasar Sin.
Wasu daliban kasar Sin daga jami'o'in Amurka sun taru don taimakawa wajen tura sassan da cutar ta addabi kasar Sin, tare da wata kungiya mai haɗawa a babban yankin Chicago da aka ruwaito ta gudanar da aikawa da masks N95 50,000 zuwa asibitin yankin Hubei a ranar 30 ga Janairu. Ta hanyar taimakon kai tsaye na Cibiyar Taimako ga Jama'a, wanda ke aiki tare da FEDEX, an aika da masks na fuska 200,000 tare da wasu kayan kariya na mutum, gami da gashin hannu da gashin ciki, tare da jigilar gaggawa zuwa asibitin Wuhan Union a ranar 30 ga Janairu.
A ranar 5 ga Fabrairu, Bill da Melinda Gates sun sanar da kyautar sadaka na dala miliyan 100 daga WHO don tallafawa gwajin allurar rigakafi da ƙoƙarin magani yayin kare "mutanen da ke cikin haɗari a Afirka da Asiya".
Kamfanin Interaksyon ya ruwaito cewa gwamnatin kasar Sin ta ba da masks 200,000 ga Filipinos a ranar 6 ga Fabrairu, bayan da masanin fasaha Richard Gordon ya ba da masks miliyan 3.16 ga Wuhan.
A ranar 9 ga watan Fabrairu, Kamfanin Red Sea na Singapore ya sanar da cewa zai aika da tallafin dala miliyan 2.26 zuwa kasar Sin.
Japan ta ba da masks miliyan daya a Wuhan, Turkiyya ta ba da kayan aikin likita, Rasha ta aika da kayan aikin kiwon lafiya sama da tan 13 zuwa Wuhan, Malaysia ta ba da kyautar kayan aikin kiwon lafiya miliyan 18 ga China, Jamus ta ba da kayan kiwon lafiya daban-daban ga marasa lafiya 10,000 na Hazmat, kuma Amurka ta ba da tan 17.8 na kayan kiwon lafiya ga China kuma ta yi alkawarin ƙarin dala miliyan 100 don tallafawa ƙasashen da cutar ta shafa. Bayan da ya bayyana cewa China ta sami ƙaruwa, ƙasar ta aika da taimako ga ƙasashe daban-daban da cutar ta shafa a duniya.
A tsakiyar Marisob, China, Cuba da Rasha sun aika da kayan aikin likita da masana don taimakawa Italiya wajen magance mummunan cutar coronavirus.
Jack Ma ya aika da kayan bincike miliyan 1.1, abin rufe fuska miliyan 6, da kuma kayan kariya 60,000 zuwa Addis Ababa, Habasha don rarraba wa Kungiyar Afirka.
Daga nan ya aika da kayan bincike 5,000, masks 100,000 da kuma masu ba da numfashi 5 zuwa Panama.
Shin ya kuma ba da kayan aikin kiwon lafiya ga Kanada. Netherlands, Spain, Turkiyya, Georgia, da Jamhuriyar Czech sun bayyana damuwarsu game da masks da kayan aikin bincike da China ta yi.
Misali, Spain ta cire kayan gwajin coronavirus 58,000 na kasar Sin da ke da daidaito na kashi 30%, a lokaci guda kuma, Netherlands ta dawo da masks na fuska 600,000 na kasar Sin wadanda ba su da kyau.
Belgium ta dawo da masks 100,000 da ba za a iya amfani da su ba, wanda ake zaton sun fito ne daga China, amma a zahiri daga Colombia.
A bangaren Latin Amurka da Afirka, an yi maraba da taimakon da kasar Sin ke bayarwa. A ranar 2 ga Afrilu, Bankin Duniya ya fara ba da tallafi mai sauri ga kasashe masu tasowa.
Hukumar ta WHO ta yaba da kokarin da hukumomin kasar Sin ke yi na sarrafa da kuma hana ambaliyar.
Hukumar ta WHO ta ce ta yi adawa da barkewar cutar SARS tsakanin 2002-2004, inda aka zargi hukumomin kasar Sin da ɓoye jinkirin hanawa da kuma hanawa, da kuma annobar yanzu yayin da gwamnatin tsakiya "ta samar da sabon tsari don hana tashin hankali a hutun Sabuwar Shekarar Lunar".
A ranar 23 ga watan Janairu, a cikin martani ga shawarar da hukumomin tsakiya suka yanke game da dokar hana zirga-zirgar Wuhan, wakilin WHO Gauden Galea ya lura cewa ba "shawarwarin WHO ba ne", shi ma "babban mahimmin abin da ke tattare da ƙaddamar da rigakafin a wuraren da ya fi yawa" kuma ya kira shi "ba a tabbatar da tarihin lafiyar jama'a". A ranar 30 ga Janairu, yayin da wakilin WHO ya tabbatar da cewa yana ci gaba da ƙaruwa ga bil'adama a cikin kasar Sin da kuma ƙaruwar yawan shari'o'in a wasu ƙasashe, WHO ta sanar da cewa an yi gaggawa a cikin gaggawa a cikin allurar rigakafin Lafiya ta Jama'a (PHEIC), har zuwa na shida na PHEIC da aka yi a cikin jerin sunayen a shekarar 2009.
Babban daraktan WHO Tedros Adhanom ya ce PHEIC tana da "hadarin yaduwar duniya, musamman a ƙasashen da ke da ƙananan da matsakaitan kuɗi waɗanda ba su da ingantaccen tsarin kiwon lafiya.
A cikin martani ga matakan hana zirga-zirga, Tedros ya ce "babu wani dalili da zai sa ba a yi aiki da kyau tare da zirga-zirga da kasuwancin duniya ba" kuma "WHO ba ta ba da shawarar hana zirga-zirga da kasuwanci".
A ranar 5 ga Fabrairu, WHO ta nemi taimakon dala miliyan 675 daga al'ummar duniya don tallafawa shirye-shiryen dabarun ƙasashe masu ƙananan kuɗi, yana nuna gaggawa don tallafawa waɗannan ƙasashe "ba su da tsarin gano mutane da suka kamu da cutar, koda kuwa ta bayyana".
Tedros ya kara da cewa a cikin labarin "mun fi karfi ne kawai a matsayin mu na rashin dangantaka" kuma ya yi kira ga al'ummar duniya da su "yi zuba jari a yau ko kuma su biya fiye da haka gobe". A ranar 11 ga Fabrairu, WHO ta kira cutar COVID-1 a taron manema labarai.
A wannan ranar, Tedros ya ce Sakatare Janar na Majalisar Dinkin Duniya Antonio Guterres ya amince ya ba da "hakki ga tsarin aikin Majalisar Dinkin Duniya".
An tura kungiyar kula da bala'in Majalisar Dinkin Duniya saboda sakamakon, ta ba da izinin haɗin kai a cikin ayyukan da Majalisar Dinkin Duniya ke yi, wanda WHO ta ce zai ba ta damar "daidaita hankali kan aikin lafiya yayin da sauran hukumomi za su iya ba da ƙwarewa don magance tasirin zamantakewa, tattalin arziki da ci gaban cutar".
A ranar 14 ga Fabrairu, an kafa Ƙungiyar Aiki ta WHO da ke jagorantar Sin don tabbatar da cewa masana na duniya da na WHO a China suna taimakawa wajen gudanar da ayyukan gida da kimanta "ciwo da yaduwar cutar" ta hanyar gudanar da tarurruka da tarurruka tare da mahimman abubuwan da ke tattare da cutar a matakin ƙasa da kuma yin ziyara a wurin don kimanta "samar da ayyukan amsawa a matakin yanki da na gwamnati, gami da birane da yankunan karkara". A ranar 25 ga Fabrairu, WHO ta ba da sanarwar cewa "ta yi abubuwa da yawa don kasancewa a kan gaba wajen magance yiwuwar cutar coronavirus a duniya", duk da cewa a wani lokaci ana bukatar "tabbata ta duniya".
A sakamakon ci gaba da kisan kai a Iran, WHO ta aika da Ƙungiyar Aiki ta Ƙungiya don tantance halin da ake ciki. A ranar 28 ga Fabrairu, jami'an WHO sun ce ana haɓaka kimantawar haɗarin coronavirus a duniya daga "babba" zuwa "mafi girma", tare da mafi girman matakin gargadi da kimanta haɗari.
Mike Ryan, darektan gudanarwa na shirin kiwon lafiya na gaggawa na WHO, ya yi gargadin a cikin wata kasida cewa "Wannan tabbaci ne na gaskiya ga kowane gwamnati a duniya: Toosa,
Wannan kwayar cutar na iya kasancewa a hanya kuma kuna buƙatar kasancewa a shirye", in ji shi, yana mai cewa matakan da suka dace na iya taimakawa duniya ta guje wa "mafi munin".
Ryan ya kara da cewa bayanan yanzu ba su tabbatar da cewa hukumomin kiwon lafiya na jama'a za su ayyana cutar a duniya ba, yana mai cewa irin wannan sanarwar tana nufin "mun yarda da cewa kowane ɗan adam a duniya yana kamuwa da cutar.
A ranar 11 ga watan Maris, WHO ta ayyana cutar coronavirus a matsayin cuta ta duniya.
Babban daraktan WHO ya ce WHO "ta damu sosai game da mummunan matakin yaduwar cutar da tashin hankali, da kuma mummunan matakin rashin aikin yi". WHO ta fuskanci mummunan zargi game da abin da ke da alama bai isa ya magance cutar ta duniya ba, ciki har da jinkirin sanar da dokar ta baci ta kiwon lafiya ta jama'a da kuma gane cutar a matsayin cutar ta duniya.
A cikin zargi an haɗa da takardar neman izinin shugaban hukumar WHO Tedros Adhanom ya yi murabus, wanda mutane 733,000 suka sanya hannu a ranar 6 ga Afrilu.
A ranar 26 ga Maris, 2020, wani binciken da masana kare hakkin bil'adama na Majalisar Dinkin Duniya suka yi ya sake tabbatar da girmama hakkin kowa a lokacin annobar COVID-19.
Kungiyar masana ta ce kowa yana da hakkin ya yi aikin ceto rai kuma gwamnati ce ke da alhakin hakan.
Wasu kungiyoyi sun jaddada cewa rashin samun kudin shiga ko inshorar lafiya ba zai taba zama hujja ba ga nuna bambanci ga wani rukuni.
Masana sun jaddada cewa kowa yana da hakkin samun lafiya, ciki har da nakasassu, daga ƙananan kungiyoyi, manya, 'yan gudun hijira, marasa gida, waɗanda ke rayuwa a cikin yanayi mai wuya, waɗanda ke kurkuku, da kuma 'yan gudun hijira da sauran kungiyoyin da ba a bayyana su ba waɗanda ke bukatar tallafin gwamnati.
Hukumomin gwamnati na duniya sun yi rahoton tasirin tattalin arziki da zamantakewar annobar COVID-19.
Kungiyar hadin gwiwar tattalin arziki da ci gaba ta kaddamar da wani dandamali wanda zai samar da cikakken bayani a kan yadda kasashen duniya ke amsawa, da kuma ra'ayoyi da shawarwari.
Daga hanyoyin karfafa tsarin kiwon lafiya da tattalin arzikin duniya zuwa tattauna tasirin hanawa da takunkumin balaguro, cibiyar zamani, ciki har da Cibiyar Kula da Dokokin Kasa, tana nufin taimaka wa ƙasashe su koya da sauƙaƙe haɗin gwiwar duniya game da ƙalubalen coronavirus.
Gwamnatin kasar Sin ta yi Allah wadai da Amurka, Ministan ministocin Birtaniya Michael Gove, da kuma dan shugaban kasar Brazil Jair Bolsonaro, kan yadda suka magance annobar da ta bullo a lardin Hubei na kasar Sin.
An kara yawan hukumomin jam'iyyar kwaminis ta kasar Sin a matakin larduna kan yadda suka bi da kokarin killace jama'a a kasar Sin ta tsakiya, a matsayin alamar rashin gamsuwa da yadda siyasa ke mayar da martani ga rashin nutsuwa a wadannan yankuna.
Masu sharhi sun yi imanin cewa wannan matakin zai kare babban sakataren jam'iyyar kwaminis ta kasar Sin Xi Jinping daga tserewa daga cutar coronavirus.
Wasu jami'an kasar Sin, misali Zhao Lijian sun musanta yarda da farko cewa cutar coronavirus ta fara ne a Wuhan, suna la'akari da ra'ayoyin makirci game da COVID-19 ko ta fito ne daga Amurka ko Italiya.
Gwamnatin Amurka Donald Trump ta bayyana coronavirus a matsayin "virus na kasar Sin" ko "virus na Wuhan" inda ta ce binciken da kasar Sin ta yi ya haifar da cutar da ta zama annoba ta duniya", wanda masu sukar ta yi la'akari da ita a matsayin launin ƙiyayya da kuma nuna wa mutane yadda gwamnatinsa ta gaza wajen sarrafa cutar".
Jaridar Daily Beast ta gano wani rahoto na gwamnatin Amurka da ke nuna magudi a harkokin sadarwa da ke da asalinsa a Majalisar Tsaro ta Kasa, tare da dabarun da ke cewa "Dukkanin game da China ne.
An gaya mana mu yi kokarin samun wadannan sakonni ta duk hanyar da za mu iya, ciki har da taron manema labarai da kuma hotunan talabijin. "Shafukan labarai kamar Politico, Siyasa ta waje, da Bloomberg sun ce kokarin da kasar Sin ke yi na tura tallafi ga kasashen da cutar ta shafa na daga cikin matsin lamba ga duniya.
Shugaban siyasar kasashen waje na EU Josep Borrell ya yi gargadin cewa akwai "rashin daidaituwa a cikin siyasa ta ƙasa wanda ya haɗa da rikice-rikice da ake shafar ta ta hanyar lalata da 'rashin daidaituwa na siyasa'.
Borrell ya kuma ce "China tana tura sakon da karfi, banda Amurka, cewa ita abokiyar da za a iya amincewa da ita".
Kasar Sin ta kuma bukaci Amurka ta cire tallafi daga Syria da Venezuela da Iran, ta tura tallafi ga kasashen biyu na baya.
An dakatar da horon Jack Ma na sanya masks 100,000 a Cuba a ranar 3 ga Afrilu ta Amurka.
An kuma zargi hukumomin Amurka da karkatar da tallafin da ake ba wa wasu kasashe a kasarsu.
An bayar da rahoton cewa akwai matsala game da rufe fuska tsakanin wasu ƙasashe, kamar Jamus, Austria, da Switzerland; da Jamhuriyar Czech da Italiya.
Bugu da kari, Turkiyya ta kama daruruwan injunan numfashi da aka tura zuwa Spain.
A farkon watan Maris, gwamnatin Italiya ta yi Allah wadai da rashin kulawar da kungiyar Tarayyar Turai ke yi wa Italiya game da cutar coronavirus.
Jakadan Italiya a EU, Maurizio Massari, ya ce "China ce kawai ta amsa da bambanci.
Wannan ba alama ce mai kyau ba ga daidaiton Turai".
A ranar 22 ga watan Maris, bayan kiran waya da Firayim Ministan Italiya Giuseppe Conte, Shugaban Rasha Vladimir Putin ya shirya tura sojojin Rasha likitocin soji, motocin kashe-kashe na musamman, da sauran kayan aikin kiwon lafiya zuwa Italiya.
Jaridar Italiya Stampa ta nakalto "mafi kyawun tushen siyasa" wanda ba a san shi ba cewa kashi 80 cikin dari na tallafin Rasha "ba shi da amfani ko kuma ba shi da amfani ga Italiya".
Majiyar ta zargi Rasha da kafa "dandalin siyasa da diflomasiyya" don tallafawa bincike.
Shugaban Lombardy, Attilio Fontana, da Ministan Harkokin Wajen Italiya Luigi Di Maio sun janye rahoton kafofin watsa labarai kuma sun nuna godiyarsu.
Rasha ta kuma tura jirgin sama mai dauke da kaya zuwa Amurka don kai taimakon kiwon lafiya.
Kakakin Kremlin Dmitry Peskov ya ce "a lokacin da ake ba da tallafi ga abokan Amurka, [Putin] ya ɗauka cewa lokacin da masana'antun kayan aikin kiwon lafiya da sauran kayan aikin Amurka suka sami iko, za su iya ba da lada idan ya cancanta".
Za a gudanar da shirin shirin NATO na soja na "Defense 2020" a Jamus, Poland, da kasashen Baltic, wanda shi ne babban taron NATO tun bayan karshen yakin sanyi, a wani karamin matakin.
Sakatare Janar na Hukumar Sanya Makaman Nukiliya Kate Hudsan ta soki shirin kare dakarun kasar na shekarar 2020: "Abubuwan da ke damun lafiyar jama'a a yanzu, suna barazana ga rayukan ba kawai sojojin Amurka da kasashen Turai da dama ba, har ma da mazauna kasashen da suke aiki". Gwamnatin Iran ta sha wahala sosai daga cutar, tare da kusan 'yan majalisa goma sha biyu da kuma wasu 'yan siyasa goma sha biyar da ke da alhakin siyasa a yanzu ko a baya.
Shugaban Iran Hassan Rouhani ya rubuta wata wasika ta musamman ga shugabannin duniya yana neman taimako a ranar 14 ga Maris, 2020, yana mai cewa kasarsa ta gaji da fama da rashin amincewa da kasuwannin duniya sakamakon rashin tallafin da Amurka ta yi wa Iran. Fitar da annobar ta haifar da kira ga Amurka ta aiwatar da hanyoyin da suka fi sauran ƙasashe adalci, gami da kula da lafiya ta duniya, kula da yara na duniya, hutun iyali mai albashi, da kuma babban matakin kudaden kiwon lafiyar jama'a.
Masu nazarin siyasa sun yi hasashen cewa hakan zai shafi yiwuwar sake zaben Donald Trump a zaben shugaban kasa na 2020. Dangantakar diflomasiyya tsakanin Japan da Koriya ta Kudu ta kara tabarbarewa sakamakon annobar duniya.
Koriya ta Kudu ta yi suka kan "saurin yin keɓewa" bayan da Japan ta sanar da cewa za a yi wa duk wanda ya zo daga Koriya ta Kudu keɓewa na makonni biyu a wuraren da gwamnati ta shirya.
A Koriya ta Kudu, al'umma sun riga sun raba game da yadda Shugaba Moon Jae-in ya amsa bala'in.
Yawancin 'yan Koriya sun sanya hannu kan takardar neman cewa za a tsige Moon saboda abin da suka ce game da rashin adalci na gwamnati a cikin barkewar cutar, ko kuma don yaba da martani. Cutar ta duniya ta ba wa ƙasashe damar aiwatar da dokar ta baci don amsawa.
Wasu manazarta sun nuna damuwa cewa hakan zai ba gwamnatoci damar karfafa ikon su.
A Hungary, majalisa ta kada kuri'a don ba da izinin mai lalata, Viktor Orban, ya gabatar da doka ba tare da nuna bambanci ba, ya dakatar da majalisa da kuma zaɓen kuma ya hukunta waɗanda aka ɗauka suna yada bayanan karya game da cutar da yadda gwamnati ke magance annobar.
An zargi yaduwar cutar korona da karancin wadata a yanayi da dama, wanda ya haifar da karuwar amfani da kayan aiki don yaki da zalunci, sayayya saboda tsoro, da matsalar masana'antu da ayyukan samarwa.
Hukumar Abinci da Magunguna ta Amurka ta ba da gargadi game da raguwar magunguna da kayan aikin kiwon lafiya saboda karuwar bukatar masu amfani da kuma rashin wadatar masu samar da kayayyaki.
Wasu wuraren da aka samu sun kuma yi shaidar sayen kayayyaki da ke haifar da raguwar shagunan sayar da kayayyaki kamar abinci, takardun wanka, da ruwan roba, wanda ya haifar da raguwar wadata.
An yi gargadin masana'antar fasaha musamman game da jinkirin shigo da kayayyakin lantarki.
A cewar babban darektan Hukumar Lafiya ta Duniya Tedros Adhanom, bukatar kayan kariya ta mutum ta ninka har zuwa sau 100.
Wannan ya haifar da karuwar farashin sau ashirin a kan farashin yau da kullun wanda kuma ya haifar da jinkirin samar da kiwon lafiya na makonni huɗu zuwa shida.
Wannan ya haifar da raguwar kayan kariya na mutum a duniya, yayin da Hukumar Lafiya ta Duniya ta ba da gargadi cewa wannan zai iya kawo hadari ga ma'aikatan kiwon lafiya.
A Ostiraliya, cutar ta haifar da sabuwar dama yayin da shagunan wakilai ke sayar da kayayyakin Ostiraliya zuwa China.
Wannan aikin ya haifar da rage yawan madarar jarirai a wasu manyan shagunan da gwamnatin Ostiraliya ta dakatar daga baya. Kasokowa a cikin yanayin COVID-19 a Arewacin Italiya da lardin Wuhan, da kuma babban buƙatar kayan abinci, duka wuraren sun tsira daga mummunan karancin abinci.
Matakan da kasar Sin da Italiya suka dauka wajen yaki da talla da cinikin kayayyakin hadari sun yi nasara, suna kauce wa matsanancin karancin abinci da ake tsammani a Turai da kuma Arewacin Amurka.
Arewacin Italiya da ke da yawan aikin gona ba a ganin ta da wani babban kashe kansa, amma farashin zai iya ƙaruwa a cikin masana'antu.
An samu tarukan abinci marasa abinci na wucin gadi, har ma a Wuhan, inda gwamnatin kasar Sin ta saki kayan alade a hukumance don tabbatar da wadatar jama'a.
A Italiya akwai irin wannan doka game da buƙatar samar da abinci don adanawa da kuma biyan buƙatu a cikin gaggawa.
An ji rauni a tattalin arzikin duniya a kasar Sin: a cewar wani rahoto na kafofin watsa labarai a ranar 16 ga Maris, tattalin arzikin kasar Sin ya sha wahala sosai a farkon watanni biyu na shekarar 2020 saboda matakan da gwamnati ta dauka don dakile yaduwar cutar, sayen kayayyaki ya ragu da kashi 20.5%.
Tun da kasar Sin ta zama babbar cibiyar tattalin arziki da samarwa, an ga cewa barkewar cutar ta haifar da mummunan tsoro da kuma rushe tattalin arzikin duniya.
Agathe Demaris na Financial Analysts ta yi hasashen cewa kasuwanni za su tashi har sai an bayyana bayyanar sakamako mai amfani.
A tsakiyar watan Janairun 2020, wasu masu ba da shawara sun kiyasta farfadowar tattalin arziki daga cutar sankara cewa ci gaban duniya zai wuce na 2002-2004 na cutar SARS.
Wani kimantawa da wani masanin jami'ar Washington ta St. Louis ya bayar ya ba da dala biliyan 300+ don tasiri a sarkar samar da kayayyaki a duniya wanda zai iya wuce shekaru biyu.
Kungiyar kasashen da ke fitar da man fetur ta OPEC ta "ruɗe" bayan da farashin mai ya ragu sosai sakamakon karancin bukatar da kasar Sin ke da ita.
Kasuwannin kayayyakin alamar sun ragu a ranar 24 ga Fabrairu saboda karuwar yawan shari'o'in COVID-19 a wajen babban yankin China.
A ranar 27 ga watan Fabrairu, damuwa da ke tasowa game da yaduwar cutar korona, alamun jari na kayayyaki kamar NASDAQ-100, S&P 500 index, da kuma Dow Jones Industrial Average sun ba da rahoton raguwa mafi ƙasƙanci tun daga 2008, yayin da Dow ya ragu da maki 1,191, wanda shine raguwa mafi girma a rana ɗaya tun lokacin rikicin tattalin arziki na 2007-08.
Dukkanin alamun alamun da aka samu na hannun jari sun ƙare a wannan makon da raguwa sama da 10%.
Har zuwa 28 ga Fabrairu, kamfanin kimantawa na SCope Ratings GmbH ya tabbatar da cewa kimantawar kai tsaye game da haɗarin saka hannun jari a China, amma ya kasance a cikin mummunan hangen nesa.
A cikin sake faɗuwar kayayyaki bisa tsoron cutar corona, babban raguwa ya kasance a ranar 16 ga Maris.
Mutane da yawa suna ganin yiwuwar koma bayan tattalin arziki.
Mai bayar da tallafi Mohamed El-Erian ya yaba da matakin gaggawa da babban bankin da na jihar suka dauka.
Babban bankin ya yi sauri wajen magance matsalar tattalin arziki da ta auku a shekarar 2008.
Yawon shakatawa shine mafi munin abin da ya shafi shi saboda takunkumin tafiye-tafiye, rufe wuraren jama'a ciki har da wuraren jan hankalin matafiya, da kuma gargadi na gwamnati game da tafiya zuwa ko'ina cikin duniya.
A sakamakon haka, kamfanonin jiragen sama da dama sun soke jiragen su saboda raguwar bukatar da ke tsakanin kamfanonin jiragen sama na British Airways, China Eastern Airlines, da Qantas, yayin da kamfanin jirgin sama na yankin na Ingila Flybe ya yi ta faduwa.
Tasirinsa a kan kamfanin jirgin ruwa ya kasance mai girma.
An kuma rufe wasu tashoshin jiragen kasa da jiragen ruwa.
Cutar ta koma ta kwanta a Chunyun, babban lokaci da ya shafi hutun sabuwar shekara ta kasar Sin.
Gwamnatin ƙasa da na ƙasa sun soke taron da yawa da suka shafi taron jama'a, kamar bikin Sabuwar Sand na shekara-shekara, tare da kamfanoni masu zaman kansu rufe shagunan su da wuraren yawon buɗe ido kamar Hong Kong Disneyland da Shanghai Disneyland.
Yawancin abubuwan da suka faru na Sabuwar Shekara ta Lunar da abubuwan jan hankali na yawon bude ido an rufe su don hana taron jama'a, ciki har da birnin Forbbiden na Beijing da wuraren ibada na al'adu a cikin haikalin.
A cikin jihohi 24 daga cikin 31 na kasar Sin, kananan hukumomi da yankuna, shugabannin sun tsawaita hutun Sabuwar Shekara zuwa 10 ga Fabrairu, suna ba da umarnin cewa yawancin wuraren aiki kada su sake buɗewa har zuwa wannan ranar.
Waɗannan yankuna sun wakilci kashi 80% na samar da kayayyakin cikin gida na ƙasar da 90% na fitarwa.
Hong Kong ta kara yawan yadda ta amsa cutar ta ta hanyar sanar da dokar ta baci, rufe makarantu har zuwa watan Maris da soke bukukuwan Sabuwar Shekara.
Ziyarar yan kasuwa zuwa Turai da Latin Amurka ta ragu da kashi 40%.
Kasuwancinmu na Arewacin Amurka da Gabas ta Tsakiya sun ga raguwar 50-60%.
Wannan kuma ya haifar da raguwar kashi 33-43% a cikin farashin shagunan a watan Maris idan aka kwatanta da Fabrairu.
An kara wa masu cin kasuwa a duk fadin duniya wasu matakai, kamar inganta tsaftacewa, shigar da ma'aunin zafin jiki don duba yanayin zafin jiki na masu siye, da soke taron taron. A cewar kimar kwamitin tattalin arzikin Majalisar Dinkin Duniya a Latin Amurka, annobar ta haifar da koma bayan tattalin arziki wanda ya sa tsakanin mutane miliyan 14 zuwa 22 ke fama da talauci a Latin Amurka idan aka kwatanta da yanayin da za su kasance ba tare da annobar ta duniya ba.
A tsakiyar watan Janairu da Fabrairu, yayin da cutar ta kamuwa da cutar a Wuhan, kusan ma'adinai miliyan 5 a China sun rasa ayyukansu.
Kusan ma'aikata 300 na kasar Sin da suka yi gudun hijira daga karkara sun makale a gidajensu a yankunan cikin gida ko kuma a lardin Hubei. A tsakiyar watan Maris na shekarar 2020, sama da Amurkawa miliyan 10 sun rasa ayyukansu kuma sun nemi taimakon gwamnati.
Cutar korona na iya haifar da rashin aikin yi ga mutane miliyan 47 a Amurka da kuma rashin aikin yi na iya kaiwa kashi 32%, a cewar kimantawar Federal Reserve Bank na St. Louis. Tallace-tallacen Indiya ya sanya dubun miliyoyin ma'aikatan da suka yi hijira (waɗanda ake biyan su albashi na yau da kullun) marasa aiki.Binciken da Cibiyar Angus Reid ta gudanar ya gano cewa kashi 44% na iyalai na Kanada sun fuskanci wasu nau'ikan rashin aikin yi.Kimanin ma'aikata 900,000 sun rasa ayyukansu a Spain tun tsakiyar watan Maris 2020.
A rabin watan Maris, ma'aikata miliyan 4 na Faransa sun nemi tallafin rashin aikin yi na wucin gadi kuma ma'aikata 1 na Burtaniya sun nemi aikin tallafin shekaru. Kimanin rabin miliyan na ma'aikata a Jamus sun aika wa ma'aikatansu shirin aiki na ɗan gajeren lokaci da gwamnati ta kafa da ake kira Kurzarbeit.
Faransa da Ingila sun amince da tsarin biyan kuɗin aiki na ɗan gajeren lokaci a Jamus.
Gidan baje kolin fasaha da al'adun gargajiya ya sha wahala sosai daga cutar ta duniya, yana shafar ayyukan ƙungiyoyi da kuma na mutum-mutumin-ma'aikata da masu aikin kai tsaye a duk faɗin duniya.
Kungiyoyin fasaha da al'adu na hannu sun yi ƙoƙari su tallafa wa manufofin su (galibi ta hanyar zamantakewar al'umma) don samar da damar samun gado na bush, kiyaye lafiyar ma'aikatanta da al'umma, da tallafawa masu fasaha a inda ya dace.
A ƙarshen Maris 2020, duk duniya a cikin yanayi daban-daban, gidajen tarihi, dakunan karatu, wuraren bukukuwa, da kuma wuraren liyafa sun rufe nunin su, abubuwan da suka faru da bukukuwa da aka soke ko jinkirta su.
A sakamakon haka, an yi ƙoƙari sosai don samar da madadin sabis ta hanyar dandamali na dijital. Abubuwan da ke saurin magance matsalar cutar yanzu shine soke ayyukan addini, manyan abubuwan wasanni , da sauran abubuwan al'adu, kamar bukukuwa na kiɗa da wasan kwaikwayo, tarurrukan fasaha, da nunin salon.
Kamfanin fim din ma ya fuskanci matsala, kuma Vatican ta sanar da soke bikin Juma'ar Albarka a Roma, wanda ya faru a makon da ya gabata a lokacin tuba na Lent.
Yawancin shugabannin gidajen cin abinci sun ba da shawarar cewa tsofaffin Kiristoci su kasance a gida yayin halartar bikin ibada a ranar Lahadi; Ikklisiya tsirara za su iya samun sabis a kan layi, kan layi ko a talabijin yayin da wasu ke ba da sabis a cikin mota.
Yayin da shugaban Roman Catholic Church na Roma ya rufe gidajen ibada da haikalinsa kuma ya kwance wuraren da ake kira na Kirista a St.Peter's Square, jama'ar sauran addinai sun soke ayyukan da suka hana taron jama'a a majami'u, masallatai, haikalin Yahudawa, haikalin coci da wuraren ibada na gurdwara.
Ma'aikatar Lafiya ta Iran ta sanar da soke sallar Juma'a a wuraren da ambaliyar ta shafa da wuraren da aka yi wa albarka da aka rufe a baya, yayin da Saudiyya ta haramta shigar da al'ummar kasashen waje da kuma na kasarsa a wuraren da aka yi wa albarka da ke Makka da Madina.
Wannan annobar ta haifar da babbar matsalar wasanni tun lokacin yakin duniya na biyu.
An soke ko kuma jinkirta manyan wasanni, ciki har da Euro 2020, kakar 2019-20 ta NBA, da kakar 2019-20 ta NHL. ciki har da 2019-20 EUFA Champions League, 2019-20 Premier League, UEFA Euro
Cutar zazzabin ta rushe shirin gasar Olympics ta bazara ta 2020, wanda a baya aka shirya a fara a karshen watan Yuli; Hukumar Gasar Cin Kofin Duniya ta bayyana cewa a ranar 24 ga Maris za a gudanar da taron "bayan shekarar 2020 amma ba bayan lokacin rani na shekarar 2021 ba". An rufe caca da sauran dandamali na duniya a duk alamar kuma an dage ko kuma an rufe gasar karta ta duniya.
Wannan ya haifar da yawan masu caca na yau da kullun da ke juyawa zuwa kan layi, wanda yawancin shafukan yanar gizon caca suka ba da rahoton cewa kudaden shiga sun karu sosai ta hanyar sababbin shiga. Hakanan ɓangaren nishaɗi ya shafar, wanda ƙungiyoyi daban-daban suka dakatar ko kuma sun dakatar da wasan kwaikwayon magoya bayan su.
Manyan gidajen wasan kwaikwayo kamar Broadway sun dakatar da duk wasan kwaikwayon.
Wasu masu fasaha suna neman hanyar da za su iya fitar da kayayyakin su zuwa intanet wanda shine wata hanyar da za a iya nuna wani abu kai tsaye, kamar watsa shirye-shiryen kai tsaye ko yin "sarrafa" na zane-zane ta yanar gizo, rarraba da kuma buga abin da suka samar.
A cikin layi, an yada shirye-shiryen coronavirus da yawa akan Intanet waɗanda ke ba da dariya game da abin da ba a tabbatar da shi ba.
Tun lokacin da annobar COVID-19 ta fara, ƙiyayya, nuna bambanci da nuna bambanci sun tashi a tsakanin jama'ar Jayni da na Gabashin Asiya, da kuma mutanen Turai, Amurka da sauran ƙasashe.
An ga abubuwan tsoro, shakku, da yaƙi a ƙasashe da yawa, ciki har da Turai, Yammacin Asiya, Arewacin Amurka da yankin Asiya Basifig.
Rahotanni da aka fitar a watan Fabrairu (wanda a lokacin ya fi dacewa da Jayne) sun nuna cewa akwai wasu abubuwa masu ban mamaki da kuma cewa kungiyoyi daban-daban a duniya sun yi tawaye da Jayne da ke yin abin da suke da'awar sun cancanci.
A wasu ƙasashen Afirka an ga ƙiyayya ga Jayne.
Mutane da yawa da ke zaune a Wuhan da Hubei sun ce an nuna musu wariya game da asalin su.
Akwai goyon baya ga Jayne, a kan layi da kuma layi, da kuma a wuraren da cutar ta mamaye.
Bayan da aka samu sabbin kasashen da suka samu cutar, mutanen Italiya, kasar Turai ta farko da ta fara samun cutar COVID-19 mai tsanani, ana zargin cewa ana kallon su a matsayin tushen shakku da nesa. 'Yan asalin Malaysia, New Zealand, Singapore, da Koriya ta Kudu sun sanya hannu kan yakin neman su hana 'yan kasar Sin shigo da su kasar don haka su hana yaduwar cutar.
Japan, hashtag #ChineseDontComeToJapan yana gudana a shafin Twitter.
Jama'ar Jayni da sauran 'yan Asiya a Birtaniya da Amurka sun kuma yi ikirarin cewa an samu karuwar nuna bambanci da kuma cin zarafin da ake yi musu.
An soki shugaban Amurka Donald Trump saboda kiran coronavirus "Cutar Jayne", kalma da wasu ke ganin ta nuna wariya da kuma nuna wariya ga Jayne.
Masu zanga-zangar a Ukraine sun kai hari kan bas din kamar na Ukrainians da na kasashen waje da aka kawo daga Wuhan zuwa Novi Sanzhary.
An ce an yi wa daliban da ke Arewacin Indiya, wanda ke kan tudun Jayna, da kuma daliban da ke manyan biranen Indiya gargaɗi game da annobar coronavirus.
Shugaban jam'iyyar Bharatiya Janata a jihar West Bengal Dilip Ghosh ya ce Jains sun lalata rayuwar da ba ta dace ba kuma "saboda haka Allah yana ɗaukar fansa".
Daga bisani, ofishin jakadancin Jayni a Kolkata ya soki wannan furucin, wanda ya kira shi "kuskure". Jayna, ƙiyayya da nuna bambanci a kan mutanen da ba 'yan Jayna ba ne, wanda ya haifar da yawon shakatawa, kuma an kira baƙi "ƙuruwar shara" kuma dole ne a "ruɓe su".
Jaridu na masu sayen sassan sun cire wasu ko duk labaran coronavirus.
Wasu masana kimiyya sun yada wani rahoto na kimiyya wanda ke da alaƙa da samun damar budewa.
Wasu masana kimiyya sun zaɓi raba sakamakon gaggawa na binciken da aka buga a baya wanda shine bioRxiv.
Cutar da ta taso - Cutar da ta taso a cikin ƙwayar cuta, yawanci a cikin ƙwayar cuta ko kuma a cikin hanyar watsawa.
Yunƙurin duniya da ciwo - Takaitaccen bayani game da yunƙurin duniya da kuma ciwon ciwo
Jerin kamuwa da cutar mura da cututtuka - Jerin adadin mutanen da suka mutu saboda kamuwa da cutar
Cutar dabbobi da cututtukan suonotic - haɗarin kiwon lafiya da ke tattare da cinikin dabbobi
Gwajin cutar coronavirus ta numfashi ta 2019 (COVID-19) da kuma alaƙar da ke tsakanin cutar SARS-CoV-2 ciki har da yadda ake gano mutum da kuma gano kasancewar maganin rigakafi wanda ke amsa kamuwa da cuta.
Samun kwayar cutar ta hanyar samfurin RT-PCR, wanda ke biye da RNA na coronavirus.
Lab din na musamman ne kuma an tsara shi don gano RNA na SARS-CoV-2 na kwayar cutar.
Ana amfani da shi don gano kamuwa da cuta na yanzu ko na yanzu.
Ana iya amfani da gano maganin rigakafi (serogly) a cikin dakin gwaje-gwaje da kuma sa ido kan jama'a.
Gwajin antibody yana nuna yawan mutanen da ke fama da ciwo, ciki har da waɗanda ba a bayyana alamun su ba ko waɗanda ke da alamun.
Ana iya gano adadin cutar da ta dace da kuma matakin da jama'a ke hulɗa da ita ta hanyar wannan dakin gwaje-gwaje.
Saboda ƙuntatawa a cikin dakin gwaje-gwaje, tun daga watan Mayu na 2020 babu wata ƙasa da ke da ingantaccen bayani game da hana cutar daga jama'arta.
A ranar 23 ga watan Maris, babu wata kasa da ta yi gwajin ga kashi 3 cikin dari na yawan jama'arta, kuma akwai bambanci mai yawa tsakanin yawan gwaje-gwajen da kasashe suka yi.
Wannan bambancin zai iya bayyana a cikin karuwar yawan mutuwar, wanda zai iya zama cewa adadin da aka yi hasashen zai karu sosai a wasu ƙasashe.
Ta amfani da amsa mai ɗaurewa ta polymerase mai rubutu (rRT-PCR) a cikin dakin gwaje-gwaje don yin samfurin numfashi daga siffofi daban-daban, gami da samfurin ƙura ko samfurin ruwa.
A yawancin lokaci, ana samun sakamako na tsawon sa'o'i da yawa zuwa kwanaki 2.
Ana yin gwajin RT-PCR ne da samfurin abinci wanda za a iya ɗauka a farkon makon ciwo.
Lokacin da cutar ta yi amfani da shi, ta fito daga cikin hanji yayin da ta ninka a cikin huhu.
A cikin gwajin da aka yi a kan mutane masu cutar a mako na biyu, ana iya amfani da wasu samfurori da aka cire daga iska ta hanyar shan katitaran ko kuma abubuwan da suke numfashi (ruwa).
Daya daga cikin gwaje-gwajen PCR na farko da Charite ta gudanar a Berlin a watan Janairun 2020 ta amfani da amsawar jerin jerin polymerase mai rikodin da aka sake maimaitawa (rRT-PCP), wanda aka yi amfani da shi daga lebe 250,000 sannan aka rarraba shi ga Hukumar Lafiya ta Duniya (WHO).
Birtaniya ta kuma yi wani gwaji a ranar 23 ga Janairu 2020. Kamfanin Kogenebiotech na Koriya ta Kudu ya yi wani asibiti, na baki na lura da SARS-CoV-2 wanda ya dogara da PCR (PowerCheck Coronavirus) a ranar 28 ga Janairu 2020.
An yi nazari akan irin "E" da kwayoyin cutar korona ke raba, da kuma irin RdRp na SARS-CoV-2. Jayna, BGI Group na daga cikin kamfanoni na farko da suka sami amincewar amsa gaggawa daga Hukumar Kula da Lafiya ta Kasa ta Jayna don bin SARS-CoV-2 ta baka bisa PCR. A Amurka, Hukumar Kula da Cututtuka da Rigakafin (CDC) ta rarraba gwaje-gwajen kiwon lafiya zuwa Labaran Coronavirus RT-PCR Lab Labari Sannan 2019 Cibiyar Amsar Duniya (2019-nCoV) da kuma a lokacin da ta Bayyana.
Daya daga cikin dakunan gwaje-gwaje masu taimako na kwafin lebe na farko ya samar da sakamakon da bai cika ba, sannan ba daidai ba, kuma dakin gwaje-gwaje na harshen harshen kasa da kasa na CDC a Atlanta; ya kawo a matsakaici kasa da samfurori 100 a rana don bincika sosai a cikin Fabrairu 2020.
An gano cewa ba za a iya amincewa da gwajin ta amfani da bangarori biyu ba har zuwa 28 ga Fabrairu 2020, har sai an ba da izinin ci gaba da gwajin ta hanyar gwaje-gwaje na jihar da na muhalli.
Hukumar Abinci da Magunguna ta amince da wannan dakin gwaje-gwaje ta amfani da ikon gaggawa. A Amurka, masana'antun kasuwanci sun fara aikin a farkon Maris 2020.
Daga ranar 5 ga Maris, 2020, LabCorp ta ba da sanarwar cewa za a yi gwaje-gwaje na COVID-19 a duk faɗin ƙasar bisa RT-PCR.
An fara neman irin wannan gwajin COVID-19 a duk fadin kasar a ranar 9 ga Maris, 2020.
Babu adadin da aka ƙayyade; an ɗauki samfurin kuma dole ne a sarrafa shi bisa ga bukatun CDC.
A Rasha, an kirkiro dakin gwaje-gwaje na COVID-19 kuma Cibiyar Nazarin Kwayar cutar da Biotechnologu ta VECTOR ta kirkiro shi.
A ranar 11 ga Fabrairu, 2020, an yi rajistar lab ɗin a cikin Hukumar Kula da Kula da Lafiya ta Tarayya. A ranar 12 ga Maris, 2020, Cibiyar Kula da Lafiya ta Mayo ta ba da rahoton cewa ta yi gwajin gano kamuwa da COVID-19. A ranar 13 ga Maris, 2020, Roche Diagnostic ta amince da FDA don yin lab na lgau na awanni 3.5 a cikin babban adadin, don haka injin guda ɗaya yana yin kimanin gwaje-gwaje 4,128 a cikin awanni 24.
A ranar 19 ga Maris, 2020, FDA ta ba da izinin gaggawa (EUA) daga Abbott Laboratories don yin gwaji don tsarin m2000 na Abbott; FDA ta riga ta ba da izini iri ɗaya ga Halogic, LabCorp, da Thermo Fisher Scientific.
A ranar 21 ga Maris, 2020, Cepheid ya kuma sami EUA daga FDA don yin wani gwaji na minti 45.
FDA ta amince da dakin gwaje-gwaje don amfani da isothermal nucleic don haka fasahar ta kara girma maimakon PCR.
Tun da ba a buƙatar zagaye mai yawa na zafin jiki ba, wannan hanyar za ta iya ba da sakamakon da aka samu a cikin minti kaɗan wanda ya rasa a arewacin 13.
A halin yanzu akwai kimanin 18,000 na'urori a Amurka kuma Abbott tana aiki don samar da kimanin 50,000 na kwayoyin a kowace rana. Waɗannan gwaje-gwajen za su yi amfani da maganin rigakafi kawai wanda ke da alaƙa da furotin nucleocapsid (N-proton) na sabon coronavirus wanda za a yi a Taiwan, tare da tsammanin za a sami sakamako a cikin mintuna 15 zuwa 20 kamar yadda yawancin gwaje-gwaje na mura suke yi.
A watan Maris na shekarar 2020 an duba bayanan da aka samu na "samuwar jijiyoyin kirji a cikin dakin gwaje-gwaje masu tsada a baya, inda sakamakon CT [samuwar kwamfuta] zai iya nuna alamun cutar".
Tsarin CT na yau da kullun ya ƙunshi madubi na bangarorin da ke da haɗin kai, tsarin da kuma tsari.
Rashin haihuwa, hauka da rikici lokacin da ciwon ya ci gaba.
Wani bincike na kwatanta PCR da CT da aka yi a Wuhan inda cutar ta fito a wannan lokacin ya nuna cewa CT ta fi sanin PCR, kodayake ba ta da kyau, saboda yawancin siffofin hoto suna haɗuwa kamar kumburi da ciwon huhu.
Tun daga watan Maris na 2020, Kwalejin Kula da Ayyukan Sojoji ta Amurka ta ba da shawarar cewa "ba za a yi amfani da CT a cikin dakin gwaje-gwaje ko dakin gwaje-gwaje na farko na COVID-19 ba". A watan Maris na 2020, CDC ta ba da shawarar cewa dakin gwaje-gwaje na farko ya zama PCR.
Wani ɓangare na amsawar rigakafin jiki ga kamuwa da cuta shine samar da maganin rigakafi wanda ya ƙunshi IgM da IgG.
Ana iya amfani da shi don gano kamuwa da cuta a cikin mutum daga kwanaki 7 ko kuma lokacin da ciwo ya fara, don haka don kare kansa, sannan kuma don yin bincike a cikin jama'a. Ana iya yin gwajin a cikin dakin gwaje-gwaje na tsakiya (CLT) ko kuma ta hanyar ganowa a cikin dakin gwaje-gwaje na kulawa (PoCT).
Za a iya haɗa tsarin shigar da abubuwa da yawa a cikin dakunan gwaje-gwaje na kiwon lafiya da yawa amma samunsa ya dogara da yawan samar da kowane tsarin.
Ana amfani da CLT a kan samfurin jini guda ɗaya na kamuwa da cuta, ko da yake ana iya amfani da samfurin mai wuya don bin diddigin amsa.
Ana samun PoCT a cikin jini ta hanyar zubar da jini.
Ba kamar PCR ba, ba a buƙatar ɗaukar matakan a wuri guda. A ranar 26 ga Maris, 2020, FDA ta nada kamfanoni 29 waɗanda ke sanar da hukumar yadda ake buƙata don haka za su iya rarraba dakunan gwaje-gwaje na rigakafi.
Tun daga ranar 7 ga Afrilu, 2020, kawai gwaje-gwaje ne kawai aka amince da su ta hanyar FDA don dokar hana amfani da gaggawa. A ƙarshen Maris 2020 Euroimmum Medical Laboratory da Epitope Laboratory sun amince da Turai don lab ɗin leɓunansu, wanda za a iya bi da shi tare da IgG da IgA antibacterial antibodies a cikin samfurin jini.
A cikin sa'o'i da yawa, ana iya yin samfurori ɗari da yawa a cikin dakin gwaje-gwaje, wanda ya fi saurin PCR na yau da kullun na RNA.
Ana lura da maganin rigakafi a cikin kwanaki 14 bayan kamuwa da cutar ta farko. A farkon watan Afrilu, Ingila ta samar da maganin hana rigakafi wanda aka sayar da shi kuma ana amfani dashi sosai.
A Hong Kong, an kafa shirin da ake zargi da kasancewa a gida, "sashen gaggawa zai ba da samfurin samfurin marasa lafiya", suna busa ƙwanƙwasa, suna aika da sakamakon bayan ɗan lokaci. NHS ta Ingila ta ba da sanarwar gwajin gwajin gwajin gwaji na masu zargin gida wanda ke kawar da haɗarin kamuwa da wasu marasa lafiya idan aka kai su asibiti ko kuma an kashe ambulanci masu kamuwa da cutar idan ba a yi amfani da su ba.
Cibiyoyin da ke amfani da sufuri suna taimaka wa mutanen Koriya ta Kudu su shiga cikin dakin gwaje-gwaje na gaggawa, wanda ba shi da yawa fiye da sauran ƙasashe. A Jamus, Kungiyar Kula da Lafiya ta Likitoci ta Duniya ta ce a ranar 2 ga Maris, za su iya yin kimanin dakunan gwaje-gwaje 12,000 a rana don yin motar asibiti kuma an bincika 10,700 a makon da ya gabata.
Asusun inshorar lafiya ne zai biya kuɗin lokacin da likitan ya ba da umarnin a cikin dakin gwaje-gwaje.
A cewar shugaban hukumar Robert Koch, Jamus na da damar yin dakunan gwaje-gwaje 160,000 a mako.
Daga ranar 19 ga Maris, za a ba da gwajin tare da motar motsa jiki a wasu manyan birane.
Daga 26 ga Maris 2020 ba a san yawan gwaje-gwajen da aka yi a Jamus ba, saboda an bayyana wanda kawai za a samu.
Bayanai na farko na dakin gwaje-gwaje da aka tattara a wannan makon 12/2020 an bincika samfurori 483,295 a cikin wannan makon 12/2020 da kuma samfurori 33,491 (6.9%) na dakin gwaje-gwaje da aka samu na SARS-CoV-2. a Isra'ila, masu bincike na Technion da asibitin Rambam sun yi kuma sun gwada hanyar yin gwaji tare da samfurori masu dacewa na marasa lafiya 64, sannan suka haɗa samfurori kawai don ƙarin bincike idan an sami sakamako. Wuhan 2000 mita na gwajin gaggawa da ake kira "Huo-Yan" (Asar: XXXX, ko "Asariki na yau da kullun" a Turanci) za a iya buɗe samfurori sama da 10,000 a ranar 5 ga Fabrairu, 2020 BGI.
A cikin ginin da Wanda ya kafa BGI Wang Jian ya lura da shi da kuma daukar tsari na kwanaki 5, an gano cewa fiye da kashi 47% na kudin da ake kashewa na kawar da keɓewa zai ninka idan waɗannan gwaje-gwajen ba su dace ba.
An shigo da dakin gwaje-gwaje na Wuhan nan take daga dakin gwaje-gwajen Huo-Yan a Shenzhen, Tainjin a Beijing, da Shanghai, da kuma a cikin birane 12 na Jayna.
A ranar 4 ga Maris, 2020 jimlar damar yau da kullun ta kasance 50,000 labs a rana. An saki budewa, ƙirar ƙirar ƙira da aka yi ta hanyar Origami Assays wanda zai iya bincika samfurori 1122 na marasa lafiya na COVID19 ta amfani da masu haɗin gwiwa 93. Ana iya sarrafa waɗannan ƙirar daidaitawa a cikin ƙananan labs ba tare da buƙatar hannuwan robot ba.
A watan Maris, ƙarancin da kuma rashin isasshen adadin sinadarai sun zama abin damuwa ga ƙasashen duniya a cikin dakunan gwaje-gwaje da yawa a cikin EU da Ingila da Amurka.
Wannan ya sa wasu marubuta su lura da tsarin shirya samfurin sannan su hada da yin taro na samfurin 98 C (208 C) na tsawon minti 5 don haka su cire RNA daga cikin kwayoyin halitta na ƙarin dakin gwaje-gwaje. A ranar 31 ga Maris, Amurka ta sanar da cewa za ta samar da ƙarin dakin gwaje-gwaje na Coronavirus ga al'ummarta fiye da kowace ƙasa, sannan ta bi matakan gwajin don isa ga yawancin jama'a.
Wannan ya kasance haɗuwa da ƙarfin motar ta hanyar haɗuwa da sayen ƙananan dakunan gwaje-gwaje na Group 42 da BGI (wanda ke cikin dakunan gwaje-gwajen gaggawa na "Huo-Yan" a China).
An gina shi cikin kwanaki 14, kuma dakin gwaje-gwaje na iya yin gwajin RT-PCR dubu goma a rana kuma shine na farko a duniya a wannan matakin da ke aiki a waje da Jayna.
An hada dakunan gwaje-gwaje daban-daban don yin niyya ga sassan cutar coronavirus daban-daban kuma an yi bayanan a kasar Sin, Faransa, Jamus, Hong Kong, Japan da Amurka.
Hukumar Lafiya ta Duniya ta dauki hadin gwiwar Jermal don aika da magungunan zuwa ƙasashen da ke da ƙananan kuɗaɗe waɗanda ba su da albarkatu da za su yi amfani da su.
An fitar da abun cikinta a Jamus a ranar 17 ga Janairu, 2020; tsarin da Cibiyar Kula da Cututtuka da Rigakafin ta Amurka ta kafa bai fito ba har zuwa ranar 28 ga Janairu, wanda hakan ya jinkirta samun lab a Amurka. Jena da Amurka sun fuskanci matsala game da amincin lab lab a farkon wannan zazzabi, kuma waɗannan ƙasashe da Ostiraliya ba su da isasshen lab a cikin aikace-aikacen da masana likitanci suka ba da shawarar.
A sakamakon haka, masana sun ce samun damar yin amfani da lab a Koriya ta Kudu ya taimaka wajen rage yaduwar cutar coronavirus.
Gwamnatin Koriya ta Kudu ta gina ikon dakin gwaje-gwaje, wanda galibi masu zaman kansu ne, tsawon shekaru.
A ranar 16 ga watan Maris, Hukumar Lafiya ta Duniya ta yi kira da a hada shirye-shiryen dakunan gwaje-gwaje don ganin yadda za a rage yaduwar annobar COVID-19. Babban bukatar dakunan gwaje-gwaje saboda haka yaduwar cutar ta haifar da sanya daruruwan dubban dakunan gwaje-gwaje a cikin dakunan gwaje-gwaje masu zaman kansu a Amurka, kuma kayan samfurin da sinadarai sun ragu.
A watan Maris na shekarar 2020, Jane ta bayyana matsalar amincewa da labaranta.
A Amurka, lab lab lab na CDC ya kasance "mai banƙyama"; kuma gwamnati ta kawar da abin da ke hana su daga dakunan gwaje-gwaje na musamman. A Spain ta sayi lab lab daga kamfanin Shenzhen Bioesy Biotechnology Co Ltd. wanda aka gano cewa sakamakon ba daidai ba ne.
Kamfanin ya bayyana cewa sakamakon da bai dace ba ya fito ne daga samfurin da ba a ɗauka ba ko kuma daga amfani da bakin da ba daidai ba.
Ministan kasar ta Sweden ya ce za su janye daga labaran sakamakon da ya yi, kuma za su maye gurbin labaran da suka yi a Shenzhen Bioeasy. 80% na labaran da Jayna ta sayi daga Jayna daga Jayna sun samar da sakamakon da bai dace ba.
Ministan kasar Matovic ya ce za a zubar da wadannan a Danube. Ministan lafiya na Turkiyya ya ce magungunan dakin gwaje-gwaje da suka saya daga Jayna "sun yi kuskure sosai" saboda haka "ba su yi amfani da su ba".
Lab, wanda ke bin keɓewar mutane da waɗanda aka gano a cikin bayanan mutane masu dauke da SARS-CoV-2 sun kusanci, wanda ya haifar da ganowa.
Masu bincike da ke aiki a garin Vo na Italiya, inda aka fara ganin mutuwar COVID-19 a Italiya, sun gudanar da zagaye na biyu na gwaji na mutum 3,400 a cikin al'umma, wanda a lokacin ya ɗauki kwanaki goma.
Kuma ba a sami wata alama a cikin harshen mutum ba, kuma an ware dukan waɗanda aka samu a cikinsa.
Idan an cire iyakancewar da ke cikin gida, wannan zai kawar da ciwo gaba ɗaya.
Bayan an yi gargadin cewa a cire wuraren da za a yi tafiya, a hana wuraren da za a yi tafiya, a sanya dakunan gwaje-gwaje da keɓewa, an lura cewa annobar cutar coronavirus ta 2020 a Singapore ta ragu sosai fiye da sauran ƙasashe masu tasowa, amma ba tare da yin tsayayya da rufe gidajen abinci da shagunan ba.
An dakatar da taron da yawa, kuma Singapore ta fara gaya wa mutane su zauna a gidajensu a ranar 28 ga Maris, amma an sake buɗe makarantu bayan hutun ranar 23 ga Maris.
Wasu ƙasashe da yawa suna sarrafa jerin abubuwan da suka yi na yin ƙoƙari don shiga wuraren da mutane suka ɗauka, ƙuntatawar tafiya zuwa wurin da ya fara, dakunan gwaje-gwaje da keɓewa amma umarnin zama a gida ba su da ƙarfi kamar Ayslan da Koriya ta Kudu.
A kididdigar binciken an nuna cewa kasashen sun yi gwaje-gwaje da yawa, saboda haka yawan mutanen da suka mutu a cikin manya sun fi yawan wadanda suka mutu, wanda zai iya haifar da su iya ganowa da kyau lokacin da alamun cutar ba su da yawa ko kuma babu alamun cutar.
WHO ta ba da shawarar cewa ƙasashe da ba su da damar yin amfani da dakunan gwaje-gwaje na ƙasa da ƙwarewarsu ta COVID-19 su aika da samfurin farko daga cikin manyan goma da ba su da COVID-19 a ɗayan dakunan gwaje-gwaje 16 na WHO don tabbatar da dakunan gwaje-gwaje.
Daga cikin dakunan gwaje-gwaje 16, 7 daga cikinsu suna cikin Asiya, 5 a Turai, 2 a Afirka, 1 a Arewacin Amurka da 1 a Ostiraliya.
A cikin teburin da ke gaba, an cire sashin "An gano % na dakin gwaje-gwaje" daga dokar dakin gwaje-gwaje ta ƙasar.
Ka bincika kawai a cikin kasar da aka yi wa asibiti, kuma ka ga cewa kashi daya cikin dari na yawan mutanen da aka yi wa asibiti a cikin kasar, ko suna da alamun cutar ko a'a, sai dai idan sun yi kama da juna.
Wanke hannu (ko wanke hannu), wanda kuma ake kira wanke hannu, doka ce da mutum yake tsabtace hannayensa don tsabtace yashi, man shafawa, kwari, da sauran ƙazanta.
Wanke hannu (ko kuma wanke hannu), wanda aka fi sani da wanke hannu, doka ce da mutum yake tsabtace hannayensa don tsabtace ƙasa, kitse, kwari, ko wasu abubuwa marasa amfani.
Wanke hannuwanka da sabulu a kai a kai a waɗannan "lokatai masu wuya" na rana yana hana yaduwar cututtuka masu yawa, kamar tari da kuma ciwon daji, wanda ke motsa ƙwayoyin cuta.
Mutane kuma za su iya kamuwa da cututtukan numfashi kamar mura ko allura, misali, idan ba su wanke hannayensu ba kuma suka taɓa idanunsu, hanci ko bakinsu (misali, ruwa).
Sau biyar a rana yana da muhimmanci a wanke hannuwanka da sabulu: kafin da bayan wankewa, bayan wanke bayan yaro ko kuma sauya masa ɗamara, kafin ka ciyar da abinci, kafin abinci da kuma kafin ka shirya abinci ko kuma ka riƙe nama mai raw, kifi, ko kaji.
Idan ba ku da sabulu da ruwa, za ku iya wanke hannuwanku da toka. Hukumar Lafiya ta Duniya ta ba da shawarar wanke hannu:
Kafin, a lokacin da kuma bayan shirya abinci.
Kafin da bayan kula da mai ciwo.
Bayan an canja wurin wanka ko wanke shi da wanka na ɗan ƙaramin yaro.
Bayan ka shafa hanci, ka yi ta tsokoki ko kuma ka yi ta tsokoki.
Bayan ka taɓa dabba, ka ciyar da dabba, ko kuma ka zubar da dabba.
Tsabtace hannu na kiwon lafiya yana nufin ayyukan tsabtace jiki da ke tattare da tsarin kiwon lafiya.
Yin wanka kafin a ba da magani ko kuma kula da lafiyar jiki yana hana ko rage yaduwar cututtuka.
Babban manufar wanke hannu shine tsabtace hannu daga kamuwa da cuta (kwayoyin cuta, ƙwayoyin cuta, ko wasu kwari da ke haifar da ciwo) da kuma sunadarai da ke haifar da cutar ko cutar.
Wannan yana da mahimmanci musamman ga masu aikin abinci ko ma'aikatan kiwon lafiya, amma kuma yana da mahimmanci ga jama'a gaba ɗaya.
Wanke hannu yana da fa'idodi masu yawa na kiwon lafiya, ciki har da rage yaduwar mura, coronavirus, da sauran cututtuka; yana kawar da kumburi da ke haifar da kumburi; kumburi da cututtukan numfashi;
kuma yana rage yawan mutuwar yara a gida.
Wani bincike da aka gudanar a shekarar 2013 ya nuna cewa ci gaba da yin wanka na hannu zai iya haifar da ci gaba a lokacin girma na yaro a lokacin yana ƙasa da shekaru biyar.
A ƙasashe masu tasowa, yawan mutuwar yara da ke tattare da matsalolin numfashi da cututtukan kumburi za a iya ragewa ta hanyar sauya halaye, kamar wanke hannu da sabulu.
Wannan mataki mai sauƙi zai iya rage yawan mutuwar daga waɗannan cututtuka har zuwa 50%.
Taron wayar da kan jama'a game da wanke hannu zai iya rage yawan ruwan sha zuwa kashi uku cikin uku, wanda ya yi daidai da samar da ruwa mai tsabta ga yankunan da ke da ƙananan kuɗi.
Rage yawan ciwon kumburi da kashi 48% yana da alaƙa da wanke hannu da sabulu. Wanke hannu da sabulu na iya zama mafi mahimmanci da mafi arha hanyar magance kumburi da kumburi mai tsanani na numfashi (ARI), wanda shine abu na kai tsaye a gida, makaranta, da kuma al'umma gaba ɗaya.
Ciwon huhu, wanda yake da matukar tsanani, shine babban dalilin mutuwar yara a karkashin shekaru biyar, wanda ke kashe kimanin yara miliyan 1.8 a kowace shekara.
Ciwon sukari da ciwon huhu suna kashe kusan yara miliyan 3.5 a kowace shekara.
A cewar UNICEF, wanke hannu da sabulu kafin cin abinci da kuma bayan an yi amfani da sabulu a al'ada na iya ceton rayuka fiye da kowane rigakafi ko magani, kuma yana kawar da rabin ciwon kumburi da rabin mutuwar cututtukan numfashi a kowane watanni uku.
A cikin gidajen wanka ana samun sauƙin amfani da su tare da wasu ayyukan tsabtace jiki, kamar su ruwa, tsabtace jiki, da kuma tsabtace jiki (WASH).
Yin wanka da hannu yana kare mutum daga cututtukan fata da ke wucewa ta hanyar taɓawa.
Ƙananan sakamako mai illa na wanke hannuwan yau da kullum shi ne cewa wanke hannuwan yau da kullum na iya haifar da bushewar fata.
Wani bincike a Denmark a shekarar 2012 ya gano cewa wanke hannu da yawa na iya haifar da ciwon fata, ko kuma cututtukan fata kamar eczema ko ciwon fata da kumburi, wanda galibi ma'aikatan kiwon lafiya suka sani.
Yin wanke hannuwan sau da yawa yana nuna alamun rashin ji na mutum (OCD).
Akwai sau biyar a rana da ake bukatar wanke hannu da sabulu don rage ciwon da ke shiga bakin mutum: bayan ka yi amfani da yatsanka (farfajiyar hannu, ƙuƙwalwar hannu), bayan ka wanke bayan yaro (canja wurin ɗamara), kafin ka ciyar da yaro, kafin ka ci abinci da kuma kafin/bayan ka shirya abinci ko kuma ka yi aiki da nama, kifi, ko kaza.
Wani lokaci kuma, ya kamata a yi amfani da wanke hannu a hanyar da ta dace don hana yaduwar ciwo, ciki har da kafin da bayan maganin ciwo ko rauni; bayan an zubar da ƙashi, ƙashi, ko kuma bayan an wanke ƙura: bayan an taɓa ƙwanƙolin dabba ko kuma an yi aiki da dabba; da kuma bayan an taɓa sharar gida.
A ƙasashe da yawa, mutane kalilan ne suke wanke hannuwansu da sabulu.
Wani bincike ya nuna cewa a cikin ƙasashe 54 a shekarar 2015 an gano cewa a matsakaita, kashi 38.7% na iyalai suna wanke hannu da sabulu. Wani binciken da aka gudanar a shekarar 2014 ya nuna cewa Saudiyya tana da kashi mafi girma na kashi 97; Amurka a kusa da matsakaici da kashi 77; da China tare da mafi ƙasƙanci kashi 23%. Akwai hanyoyi da yawa na sauyawa na dabi'a don haɓaka ɗaukar al'adar wanke hannu a lokacin makaranta. Rashin hannu na rukuni na yara a makaranta shine lokaci na musamman na rana ga ƙasashe masu tasowa don taimakawa wajen motsa hannu ga yara.
"Tsarin Kula da Lafiya a cikin girgije" da Ma'aikatar Ilimi ta Philippines ke aiwatarwa misali ne na aikin da za a yi don inganta lafiyar yara da ilimi.
Tare da biyan kuɗi sau biyu a shekara, ban da sabulu, wanke hakora da kuma wankewa, shine asalin shirin na ƙasa.
An yi amfani da shi sosai a Indonesia.
Ana amfani da sabulu ko ruwa don kawar da kwari a fata.
Babban mataki na sabulu da kayan ado shine rage matsalolin da ke tattare da maganin, da kuma inganta ingancin su.
Ruwa kawai bai isa ya wanke fata ba saboda kitse da furotin, wanda ɓangare ne na yashi na halitta, ba su narkewa cikin ruwa.
Duk da haka, tsabtace ruwa yana taimakawa wajen samun ruwa mai kyau.
Sabulu mai ƙarfi, saboda ana iya sake amfani da shi, na iya riƙe ƙwayoyin cuta da suka rage daga amfani na farko.
Kadan daga cikin binciken da aka yi kan yadda kwayoyin safa suka kamu da cutar ya nuna cewa yana da wuya kwayoyin su bi ruwa.
CDC ta bada shawarar "don sabulu mai ruwa wanda ba ya isa hannun kuma don haka ya fi kyau a fitar da shi daga cikin akwati".
Ana tallata sabulu mai kashe kwayoyin cuta sosai don haka jama'ar kiwon lafiya suna da amfani su sani.
Har zuwa yau, babu wata hujja da ta nuna cewa amfani da maganin kashe kwari ko maganin kashe kwayoyin cuta da aka ba da shawarar don maganin antibody ba ya ɗaukar shi da kyau.
Duk da haka, sabulu mai kashe kwayoyin halitta yana dauke da wani abu mai kashe kwayoyin halitta kamar triclosan, wanda a sakamakon haka yana dauke da wani abu mai hana kwari.
Saboda haka, ko da an zaɓi nau'in maganin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin.
Baya ga tashi a saman da kuma kare fata, sabbin nau'ikan na iya ƙunsar acid (acetic acid, ascorbic acid, lactic acid) kamar na'urar sarrafa pH, benzoic acid mai aiki da ƙarin kayan sanyaya fata (aloe vera, bitamin, menthol, kayan tsire-tsire). Wani kwatancen da Jami'ar Oregon ta gudanar Sashen Kiwon Lafiya ta Jama'a ya nuna cewa sabulu mai tsabta yana aiki kamar sabulu na kwastomomi na sabulu na ƙwayoyin cuta masu ƙwayoyin cuta waɗanda ke ƙunshe da triclosan kafin da kuma cire kwayoyin cuta a hannu.
Ruwan zafi da za a iya ɗauka a hannu ba ruwan zafi ne da zai kashe ƙwayoyin cuta ba.
Ƙarfin kwayoyin cuta yana ƙaruwa idan yanayin jiki ya kai (37°C).
Amma, ruwan sabulu mai sanyaya yana da tasiri fiye da ruwan sabulu mai tsabta a cikin wanke mai na halitta wanda ke riƙe yashi da ƙwayoyin cuta.
Sabanin abin da mutane suke tunani, binciken kimiyya ya nuna cewa amfani da ruwa mai dumi ba shi da tasiri a rage kwari a hannu.
Mai tsabtace hannu ko mai kashe kwari yana nufin mai tsabtace hannu kuma ba a amfani da ruwa.
A ƙarshen 1990s da farkon karni na 21, kayan tsabtace ruwa marasa amfani da giya (wanda kuma ake kira kayan tsabtace ruwa mai amfani da giya, masu kashe kwari da aka shafa, ko kuma kayan tsabtace hannu) sun zama sananne.
Mafi yawa daga cikinsu sune isopropyl giya ko waɗanda aka yi da ethanol sannan kuma tare da waɗanda aka yi amfani da su a cikin Carbomer (sand polymer acrylic) sannan kuma a yi shi a cikin gel, ko kuma humectant kamar glycerin a cikin ruwa, ko kumfa don haka a sauƙaƙe amfani da shi kuma rage tasirin kayan aikin giya.
Idan aka ƙara hydrogen peroxide mai tsabta, zai ƙara aikin kashe kwari. Mai tsabtace hannu wanda ke dauke da akalla 60 zuwa 95% na barasa ya isa ya kashe kwari.
Tsaftace hannu yana kashe kwayoyin cuta, ƙwayoyin cuta masu magani (MRSA da VRE), cutar kumburi, da wasu ƙwayoyin cuta (ciki har da HIV, herpes, RVS, rhinovirus, vaccinai, mura, da kuma cutar sankara) da kuma ƙwayoyin cuta.
Abincin da ke dauke da shayarwa mai tsabtace hannu wanda ya ƙunshi kashi 70% na giya yana kashe kashi 99.97% (3.5 rage ƙwayoyin cuta, kuma 35 rage ƙwayoyin cuta) a hannayen mutum bayan dakika 30 da shansa da kuma kashi 99.99% zuwa 99.999% (4 zuwa 5 rage ƙwayoyin cuta) a hannayen mutum bayan minti 1 da shansa. Abincin mai tsabtace hannu yana da kyau wajen magance kwayoyin cuta kuma baya taimakawa ƙwayoyin cuta sosai.
Ana amfani da kayan wanke hannu da giya don hana cutar Norovirus (ko Norwalk), wanda shine mafi yawan masu haifar da gestroentertis. Dole ne a yi amfani da kayan wanke hannu da giya mai kyau yayin da suke da danshi ko kuma a haɗa hannuwan biyu.
A lokacin rani, a farkon da baya na hannayen hannu, a tsakanin da kuma a ƙarshen yatsun hannu, ana shafa su a matsakaici na tsawon dakika 30 har sai ruwa, kumfa ko kwanon rufi sun bushe.
Dole ne a wanke yatsunsu, tare da shafa su a kan yatsunsu. Cibiyar Kula da Cututtuka ta Amurka ta bada shawarar wanke hannayensu a kan su da hannuwan mai tsabta, musamman idan hannayensu suna da tsananin tsananin tsananin.
Yawancin amfani da waɗannan abubuwa ya dogara da sauƙin amfani da su da kuma yadda suke kashe kwari; duk da haka, ba za su zama maye gurbin tsabtace hannu na yau da kullun ba sai dai tare da sabulu da ruwa.
Yin amfani da kayan tsabtace hannu na giya a kai a kai na iya haifar da fata mai bushewa tare da fata mai danshi da/ko emollients.
Za a iya rage tasirin shan giya ta hanyar cire glycerin da/ko wasu abubuwa masu sanyaya jiki da aka ƙara a cikin maganin.
A cikin gwajin likita, kayan tsabtace hannu masu ƙanshi waɗanda ke dauke da emollients suna haifar da ƙananan cututtukan fata da bushewa fiye da sabulu ko sabulu mai kashe kwari.
Sau da yawa na sami rashin tausayi na taba, ciwon urticaria ko kuma rashin jin daɗi na shan giya ko abin da ke tattare da shan giya da hannu.
A wannan yanayin, ƙananan ƙarancin cutar dematitis na iya zama mafi ƙarancin ƙarancin sa idan aka kwatanta da safa da ruwa.
Duk da tasirin su, ba su wanke hannuwansu da ruwa ba, kawai suna kashe ƙwayoyin cuta.
Wannan shine dalilin da ya sa tsabtace hannu ba ta da amfani kamar sabulu da ruwa don hana yaduwar kwari, saboda kwari zasu kasance a hannayen.
Mai tsabtace hannu mara ƙuƙwalwa ya dogara da abin da aka yi da kuma siffar, kuma ya kasance mai amfani sosai a lokacin da ake amfani da ƙuƙwalwar ƙuƙwalwar ƙuƙwalwar ƙuƙwalwar ƙuƙwalwar ƙuƙwalwar ƙuƙwalwar ƙuƙwalwar ƙu.
Kwanan nan, an lura da waɗanda suka fito da amfani da chloride benzalkonium a cikin kwanciyar hankali da kuma daidaita aikin kashe kwari bayan shan giya, sabanin abin da aka lura da shi a lokacin da aka yi amfani da shi akai-akai, saboda yana iya daidaita fata.
Mutane da yawa a cikin al'ummomin da ke da ƙananan kuɗi ba su iya yin amfani da sabulu ba kuma suna amfani da shi a matsayin madadin don bukukuwa ko bukukuwa.
A baya ko ƙasa suna da ruwa da kansu, amma ba su da amfani fiye da sabulu.
Wani abin damuwa shi ne cewa ƙasa ko ƙura suna da kwari wanda hakan zai kara yaduwar cutar inda zai rage.
Kamar sabulu, sabulu kuma yana da tsabtace jiki, saboda idan ya yi aiki tare da ruwa, yana haifar da cakuda alkaline.
WHO ta ba da shawarar cewa ƙwayoyin cuta ko ƙwayoyin cuta na iya maye gurbin sabulu idan babu sabulu.
Ayyukan wanke hannu na musamman da Cibiyar hana cututtuka da kula da cututtuka ta Amurka ta ba da shawarar don hana yaduwar cututtuka sun haɗa da matakai masu zuwa:
Ka wanke hannunka da ruwa mai dumi ko ruwa mai gudana.
Ana ba da shawarar ruwa mai gudana saboda ruwan da ke tsaye zai iya gurɓata, kuma zafin ruwan ba zai haifar da bambanci ba.
Ƙarƙashin hannu idan an shafa shi da sabulu, wanda ya ƙunshi baya, yatsun hannu, da ƙashin ƙafa.
Sabulu yana cire ƙwayoyin cuta daga fata, kuma bincike ya nuna cewa mutane suna wanke hannayensu da kyau idan suna amfani da sabulu fiye da idan suna amfani da ruwa kawai.
Kuna yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin sa.
Saurin shafawa yana haifar da saurin shafawa, wanda ke taimakawa wajen kawar da kwayar cutar a fata, kuma ƙara sautin yana haifar da tarin ƙwayoyin cuta a fata.
Ruwa mai gudãna.
Idan ka haɗa da waɗanda suke tsaye, zaka iya motsa hannayenka baya.
Drying da tawul ko kuma bushewa da iska.
Hannun da ke da danshi ko kuma da yawa suna iya zama masu ƙazantawa. Mafi yawan wuraren da ake yin tsalle su ne yatsunsu, ƙafar hannu, tsakanin yatsunsu, da kuma ƙarƙashin ƙafar hannu.
Ƙananan ƙwayoyin cuta da ƙwayoyin fenti na iya ɓoyewa a ƙarƙashin kwari.
Ana bada shawara a yi amfani da ruwa a cikin ruwa don kada a bushe hannuwan; fata mai bushewa na iya haifar da lalacewar fata wanda hakan zai kara haɗarin kamuwa da kumburi.
Za a iya yin abubuwa masu rahusa daban-daban don sauƙaƙe wanke hannu idan babu ruwa daga bututu da/ko sabulu, kamar, zubar da ruwa daga cikin ruwa ko wuraren da ke da rami mai kyau da/ko amfani da ruwa idan kana cikin ƙasashen da ke tasowa.A cikin yanayin rashin ruwa (kamar a makarantu ko yankunan ruwa a ƙasashen da ke tasowa), akwai hanyar adana ruwa, kamar "ƙananan ruwa a cikin wuri mai kyau" da sauran zaɓuɓɓuka masu rahusa.
Karamin filastik mai tsabta shine fasaha mai sauƙi wanda za'a iya amfani da filastik mai tsabta daga igiya, sannan a gyara shi don haka za'a iya amfani da ruwa kaɗan don wanke hannu da sabulu.
Yin bushewar hannu da kyau muhimmin ɓangare ne na tsarin tsabtace, amma ana jayayya game da ingancin bushewa na hannu a wuraren da jama'a ke raba su.
Yawancin karatu sun nuna cewa tawul ɗin yana da tsabta fiye da na'urar bushewa da aka yi amfani da ita a kan yatsunsu.
A shekara ta 2008, Jami'ar Westminster, London ta gudanar da wani bincike, wanda masana'antar tawul ɗin takarda ta tallafawa ta hanyar taron taron tarurruka na Turai, don kwatanta matakan tsabtace da tawul ɗin takarda, masu bushewa na iska da na masu bushewa na iska na zamani ke bayarwa.
Bayan wanke hannu da kuma bushewa a iska mai dumi, adadin kwayoyin da aka samu a cikin yatsunsu ya karu da kashi 194% da kuma alamu 254%.
Drying a cikin iska ta jirgin sama ya kara yawan kwayoyin yatsunsu da kashi 42% da kuma ƙwayoyin cuta da kashi 15%.
Bayan wanke da kuma bushe hannu da kayan wankewa, ƙwayoyin cuta suna raguwa a yatsunsu da kashi 76% da kuma alamun su zuwa 77%. Masana kimiyya sun kuma yi gwaje-gwaje don gano ko akwai haɗuwa da sauran wuraren wanke hannu da kuma yanayin wankewa wanda hakan ya haifar da tsarin bushewa.
Mai sanyaya iska na jirgin sama, wanda a lokacin yana fitar da iska da ke gudana da saurin mita 180 a dakika (650km a kowace awa; 400mph), ya sami damar fesa kwari a hannu kuma ya gurbata wurin da mazauna wurin da ake amfani da shi da kuma wurin wanka wanda ya kai mita 2 a hade.
Yin amfani da iska mai dumi a cikin mai bushewa yana iya yada kwari a cikin mita 0.25 zuwa mai bushewa.
Ba a lura da wani yaduwar kwari a cikin allunan ba. A shekara ta 2005, binciken da TUV Produkt da Umwelt suka yi, ya kimanta nau'ikan bushewar hannu daban-daban.
An lura da canje-canje masu zuwa a cikin adadin kwayoyin bayan an bushe hannu:
Akwai kamfanoni da yawa da ke samar da kayan bushewa, kuma an gwada kayan bushewa da bushewar takarda.
Yin wanke hannu ta hanyar wanke hannu tare da wanke hannu shine wata hanya ta yin amfani da shi yayin tafiya idan babu sabulu da ruwa.
Aikin tsabtace hannu mai giya wanda ya ƙunshi giya ya kai kashi 60 cikin ɗari.
An sanya farin ciki na kiwon lafiya a matsayin wajibi bayan da likitan Hungary Ignaz Semmelweis (1846) ya ga amfanin shi a cikin hana cututtukan asibiti.
Akwai na'urori na lantarki waɗanda ke tunatar da ma'aikatan asibiti su wanke hannayensu idan sun manta.
Wani binciken ya gano cewa yawan kamuwa da cuta ya ragu ta amfani da su.
Yin wanka a hannu na tsawon minti 15 a cikin likita, ta amfani da sabulu da ruwa ko gel mai yawa don wanke da kuma shafa kowane ɓangaren hannu.
Dole ne a motsa hannayen hannu a cikin wani wuri.
Idan akwai datti a ƙarƙashin ƙura, za a iya amfani da goga don cire shi.
Tun da yake ana samun kamuwa da cuta a cikin ruwa a hannayen hannu, yana da muhimmanci a yi wa hannayen hannu haskaka sosai kuma a bushe su da tawul mai tsabta.
Bayan an bushe, ana iya amfani da takardar ruwa don rufe ruwa (kuma a buɗe ƙofar fita idan ya cancanta).
Ka guji cire hannayenka daga wannan wurin.
Dalilin wanke hannu a cikin tsarin kiwon lafiya shine cire kwari da kuma guje wa watsawa.
Jaridar New England Health ta rubuta cewa rashin jin daɗi ba a yarda da shi a cikin wuraren kiwon lafiya, wanda yawancin likitoci da masu ba da taimako na kiwon lafiya suka manta da wanke hannayensu a kai a kai kafin su taɓa marasa lafiya, don haka suna watsa kwari.
Wani bincike ya nuna cewa wanke hannu da wasu hanyoyin da suka dace suna rage yawan jini da ke shiga cikin fitsari zuwa kashi 66. Hukumar Lafiya ta Duniya ta ba da sanarwar cewa a takarda an rubuta matakin wanke hannu da kuma wanke hannu a fannin kiwon lafiya.
Za a iya samun jagorar tsabtace hannu na hukumar a shafin yanar gizonmu don yin tsokaci a kan jama'a.
Whitby et al. sun yi wannan zargi.
Ana iya auna kayan aikin da ake siyarwa kuma a tabbatar da tsabtace hannu idan ya zama dole a nuna cewa sun cika ka'idoji.
Hukumar Lafiya ta Duniya ta ba da "Lokaci Biyar" na wanke hannu:
bayan an taɓa jini/ruwa a jiki
kafin ka yi aikin da zai iya gurɓata ka, kuma
Bayan kula da marasa lafiya. Hakanan, maganin kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe kashe.
Ana iya buƙatar irin wannan aikin kashewa kafin a yi aiki ko kuma a wurin da ake kashewa sosai. Dole ne a shafa shi a cikin kayan shafawa, idan ya cancanta, a shafa bututun da ba a taɓa shi ba, a wanke chlorheidine ko iodine, a yi wanka da tawul mai tsabta don bushe hannuwan bayan wanka, da kuma tsabtace goga da sauran kayan da aka tsabtace da kuma tsabtace su a ƙarƙashin suturar.
Dole ne a cire duk kayan kwalliya.
Wannan tsari yana buƙatar wanke hannuwanku da hannayenku daga farko zuwa ƙafar hannu, yawanci na minti 2-6.
Ba a buƙatar dogon lokacin motsa jiki (minti 10) ba.
A lokacin da ake yin ruwa, dole ne a hana ruwa daga hannayenka kafin ya koma hannunka.
Bayan an gama wanke hannuwan, dole ne a wanke hannuwan da kayan aiki masu tsabta kuma a rufe su a lokacin aikin.
Don rage yaduwar kamuwa da cuta, yana da kyau a wanke hannuwanku ko kuma a yi amfani da maganin kashe cuta kafin da bayan yin hidima ga mai ciwo.
Don hana kamuwa da cutar staphylococcal a asibiti, an gano cewa mafi yawan amfanin wanke hannu daga wankewa na farko ya kasance kashi 20%, kuma an sami karamin amfani idan wankewa ta yau da kullun ya wuce kashi 35%.
Wanke da sabulu na yau da kullun yana da sau uku na kawar da cututtukan cuta daga abinci fiye da wankewa da sabulu mai kashe kwayoyin cuta. Idan aka kwatanta da wanke hannu da sabulu mai kashe kwayoyin cuta na wucin gadi da wanke hannu da sabulu mai kashe kwayoyin cuta na wucin gadi har zuwa sakan 30 kowannensu an lura cewa wanke hannu da wankewa yana rage yawan kwayoyin cuta da kashi 26% fiye da wankewa da sabulu mai kashe kwayoyin cuta.
Amma sabulu da ruwa suna da tasiri sosai a kan shan giya don rage cutar H1N1 da cutar mura ta A da kuma rage yawan hannu a cikin Clostridium. Ayyukan tsabtace hannu a cikin tsarin kiwon lafiya na iya haɗa da koyar da ma'aikatan wanke hannu, ƙara samun ruwan giya don wanke hannu, da rubutu da tunatarwa ga ma'aikata.
Ana buƙatar ƙarin bincike don sanin yadda waɗannan suka fi dacewa da tsarin kula da lafiya daban-daban.
A ƙasashe masu tasowa, wanke hannu da sabulu ya zama mafi arha, abu mai mahimmanci don samun lafiya mai kyau, har ma da abinci mai gina jiki.
Amma, saboda rashin ruwa, sabulu da kuma wuraren shakatawa a gidajen mutane, makarantu da wuraren aiki yana da wuya a ware daga halin farin ciki na duniya.
Alal misali, a yankunan Afirka da yawa akwai ƙananan bututun nishaɗi na masu zaman kansu ko ƙananan wuraren shakatawa na jama'a, duk da cewa zaɓin mafi arha shine gina wuraren shakatawa.
Amma rashin farin ciki shine dabi'ar da aka gada daga rashin sabulu da ruwa.
Tallafawa da kuma inganta farin ciki ta amfani da sabulu na iya shafar yanke shawara na doka, yana iya haifar da wayar da kan jama'a game da fa'idodin farin ciki kuma yana iya haifar da canjin halaye na dogon lokaci a cikin al'umma.
Don cimma wannan, ana buƙatar kulawa da kimantawa.
Wani kimantawa da aka yi a cikin bincike 70 ya gano cewa tsarin zamantakewar al'umma yana da tasiri wajen kara farin ciki a cikin LMICs, yayin da kamfen ɗin tabbatar da zamantakewar al'umma ba shi da tasiri. Misali ɗaya na wayar da kan jama'a game da farin ciki a makarantu shine "Tsarin Taurari Uku" na UNICEF wanda ke ƙarfafa makarantu su ɗauki matakai masu sauƙi, matakai marasa tsada don tabbatar da cewa ɗalibai suna farin ciki da sabulu, da sauran bukatun tsafta.
Idan aka kai matakin mafi ƙarancin, makarantar za ta cire manyan taurari uku.
Ƙirƙirar wuraren nishaɗi na iya zama ɓangare na kamfen na wayar da kan jama'a game da farin ciki don rage rashin lafiya da mutuwar yaro.
Ranar farin ciki ta duniya misali ne na wayar da kan jama'a game da sauya halaye. Saboda barkewar cutar coronavirus 2019-20, UNICEF tana gudanar da kamfen don magance farin ciki.
An yi bincike da yawa kan yadda ake samun farin ciki a ƙasashen da ke tasowa a cikin DALYs.
Koyaya, ɗayan shawarar da aka bayar game da inganta wanke hannu sabulu yana da ƙima sosai fiye da sauran ayyukan wanke ruwa da tsabtace jiki.
Muhimmancin jin daɗin rashin lafiyar mutum  musamman a cikin yanayin rauni kamar mahaifiyar da ta haihu yanzu ko kuma sojojin da suka ji rauni a asibitoci  an fara gane su a tsakiyar karni na 19 kuma shugabannin biyu na tsabtace hannu sun gane su: Ignaz Semmelweis, likitan Hungary da ke aiki a Vienna, Austria da Florence Nightingale, a Turanci "mahaifin mai ba da taimako na zamani".
A lokacin mutane da yawa sun yi imani cewa kumburi yana haifar da ƙanshi da ake kira miasma.
A cikin shekarun 1980, kamuwa da cuta da kuma kula da lafiyar da ke da alaƙa da kamuwa da cuta ya sa Cibiyar Kula da Cututtuka da Rigakafin Amurka ta fara wayar da kan jama'a game da tsabtace hannu wanda shine babban hanyar hana yaduwar kamuwa da cuta.
Cutar zazzabin alade a shekarar 2009 da annobar COVID-19 a shekarar 2020 sun kara wayar da kan mutane a kasashe da dama game da muhimmancin yin farin ciki da sabulu don haka kauce wa cututtuka.
Alal misali, an sanya takardu game da "dabara mai kyau na farin ciki" a cikin wuraren farin ciki a cikin wuraren shakatawa na jama'a da kuma wuraren shakatawa na gine-ginen ofisoshi da filayen jirgin sama a Jamus.
Kalmar "yi aiki tare" ta zo ne daga rashin yarda da wani abu ko kuma raba shi.
Ya fito ne daga ayar Matta inda Pontius Pilate ya wanke hannunsa daga hukuncin kisa na Yesu Almasihu, amma ya zama kalmar da aka fi amfani da ita a wasu al'ummomin Ingila.
Shakespeare Macbeth, Lady Macbeth ta fara wanke hannayenta a cikin ƙoƙari don tsabtace ƙazantar tunanin, wakiltar lamirinta mai laifi game da laifuffukan da ta aikata kuma ta jagoranci mijinta ya yi.
An kuma gano cewa mutane, bayan sun tuna ko sun aikata wani abu mai tsanani na lamiri, sukan wanke hannuwansu sau da yawa fiye da dā, kuma suna ƙoƙarin yin la'akari da kayan nishaɗi fiye da dā.
Bugu da ƙari, waɗanda aka ba da izinin wanke hannuwansu bayan an yi la'akari da su ba su da wataƙila su shiga wasu ayyukan "tsabtace" na musamman, kamar su yin zaɓi.
Addinai suna bayyana aikin halayya da tsabta ta hanyar misali. Alamar farin ciki, ta amfani da ruwa mara sabulu don farin ciki ya haɗa da farin ciki a cikin addinai da yawa, ciki har da Baha'i, Hinduism, tevilah da netilah yadayim na Judaidm, Lavabo na Krista da Wudu na Musulunci. Addinai kuma suna rubuta farin ciki, musamman wasu ayyukan da ake yi.
Addinin Hindu, Yahudanci, da Musulunci sun bukaci yin farin ciki lokacin da suka fita daga cikin mulkin mallaka.
Kuma, Hindu, Buddha, Sikh, Yahudawa da Musulunci sun ba da umarnin farin ciki da abinci.
Gudanar da haɗarin COVID-19 a wurin aiki shine shirye-shiryen da za a aiwatar da aminci a wurin aiki da kuma tsarin kiwon lafiya don sarrafa lalacewa don hana cutar coronavirus 2019 (COVID-19).
Hanyar da ta dace ta sarrafa haɗarin wurin aiki ta dogara ne akan wurin aiki da wurin aiki, ta dogara da kimanta haɗarin daga inda mutum zai iya isa, yadda yawan cututtukan zamantakewar ke ciki, da kuma yanayin haɗarin da ke cikin ma'aikatan da ke da haɗari ga kamuwa da COVID-19.
A cewar Hukumar Lafiya da Tsaro ta Aiki ta Amurka (OSHA), idan akwai karamin haɗarin shiga cikin aikin zai rage yawan aiki tsakanin jama'a da abokan aiki, wanda ke buƙatar matakan asali don hana yaduwar kamuwa da cuta, gami da wanke hannu, ƙarfafa ma'aikata su kasance a gida idan suna rashin lafiya, suna da cututtukan numfashi, da kuma yin tsaftacewa da kashe kwayoyin cuta a wuraren aiki.
Hadarin aiki na ɗan lokaci ya haɗa da mutanen da ake buƙatar hulɗa da ko kusanci da mutanen da ba a san su ba ko waɗanda ake zargin suna da cutar COVID-19, amma suna iya kawar da kamuwa da cutar ta zamantakewa yayin tafiya zuwa ƙasashen waje.
Waɗannan sun haɗa da ma'aikata da suka isa ga jama'a kamar makarantu, wuraren aiki masu yawan jama'a, da kuma shagunan da ke da yawan jama'a.
Tsaron haɗari a cikin wannan rukuni, da kuma matakan rigakafin kamuwa da cuta na asali, gami da injunan numfashi waɗanda ke amfani da iska mai tsabtace iska mai inganci, karewa daga ayyukan wasu, da kuma samun kayan kariya na mutum wanda zai kasance a wurin mutum idan ya kai ga wanda ke da COVID-19.
OSHA tana lura da kulawar lafiya da ma'aikatan tsofaffi waɗanda ba a san su ba ko kuma waɗanda ake zaton suna da COVID-19 ana ɗaukar su a matsayin masu haɗari, wanda ke ƙara haɗarin idan ma'aikaci ya sami tsarin gama gari, ko tattara ko aiki da samfurori, wanda aka sani ko ake zaton mutum yana da COVID-19.
Kula da lalacewar da ke tattare da ma'aikatan, ciki har da kula da farsa a cikin dakin tsabtace iska don matsin lamba mai ƙyama, da kuma kayan kariya na mutum na aikin.
Cutar COVID-19 na iya yin tasiri mai tsanani a wurin aiki.
Ma'aikaci na iya kasancewa a wurin aiki saboda rashin lafiya, ko kuma yana bukatar kula da wani, ko kuma yana tsoron cewa zai iya zuwa.
Za a iya canza tsarin kasuwanci, wato, abin da ake bukata, da kuma yadda ake samun wannan kaya (kamar sayen kaya a lokacin da ba daidai ba ko kuma kawo gida tare ko ta hanyar mota).
A ƙarshe, ana iya samun ɓarna a cikin kayayyaki daga wuraren da COVID-19 ke da tasiri sosai. Ana iya amfani da shirin shirye-shirye da amsawa ga cututtukan kamuwa da cuta don jagorantar matakan kariya don jagorantarmu.
Shirye-shiryen amsawa ga haɗarin da ke tattare da wurare daban-daban na aiki da aiki, ciki har da wuraren aiki, haɗarin gida da na zamantakewa, da kuma haɗarin aiki na mutum kamar tsufa ko matsalolin kiwon lafiya na dogon lokaci.
Sun kuma bayyana yadda ake magance wadannan barazanar, da kuma shirin da za a yi don tserewa idan akwai irin wannan yanayi.
Shirye-shiryen shirye-shiryen da za a yi don magance cututtukan cututtuka na iya canza ko canza shawarwari.
Amsar da ta dace ga yaduwar cutar ta ƙunshi rage yawan aiki, kare mutanen da ke cikin haɗarin samun mummunan sakamako na kiwon lafiya, gudanar da kasuwanci, da rage mummunan yanayi a cikin sauran kamfanoni.
Matsayin da ya shafi yanayin da kasuwancin ke ciki yana shafar yadda ake amsawa.
A cikin tsarin aiki, ana amfani da tsaro da lafiya a wurin aiki don ingantaccen sarrafa haɗarin rukuni.
Inda ba za a iya iyakance tasirin COVID-19 ba, hanya mafi inganci don sarrafawa ita ce ta hanyar sarrafawa, bin diddigin gudanarwa, kuma a ƙarshe kayan tsaro na sirri.
Yin iko ya ƙunshi rufe ma'aikata daga haɗarin lalacewar aiki ba tare da amincewa da halayen ma'aikata ba, kuma zai iya zama mafi ƙarancin hanyar warware matsalar.
Gudanarwa na gudanarwa shine canji a tsarin aiki ko tsarin mulki wanda ke buƙatar ma'aikaci ko wanda ake aiki da shi ya yi aiki.
Ana ganin cewa kayan kariya ta mutum (PPE) ba su da tasiri sosai fiye da yin amfani da su da kuma aiwatar da su, amma suna iya hana wasu cututtuka.
Dole ne a zaɓi kowane nau'in PPE bisa ga haɗarin ma'aikata, don samun damar shiga da kuma dacewa (misali numfashi), don rufe shi a kai a kai, bincika shi, gyara shi, canza shi, kuma a cire shi, tsaftace shi, adana shi ko jefa shi yadda ya kamata don hana kamuwa da cuta.
A cewar Hukumar Lafiya da Tsaro a Aikin Amurka (OSHA), ayyukan da ba su da haɗari suna da haɗari ga ƙananan mutane da abokan aiki.
Abubuwan da ake ba da shawara na farko na rigakafin ciwo a duk wuraren aiki sun haɗa da wanke hannuwansu a kai a kai, ƙarfafa ma'aikata su kasance a gida idan suna rashin lafiya, suna da cututtukan numfashi wanda ya haɗa da riƙe bakinsu da hancinsu idan sun numfashi, ba da kayan wanke da salatin shara, shirya su don aiki a wani wuri ko shirya lokacin aiki idan ya cancanta, ƙarfafa ma'aikata su yi amfani da kayan aiki tare, da kuma tsabtace da kashe ƙwayoyin cuta a wuraren aiki.
A nan da nan a cire mutum daga wurin kuma a ajiye shi a wurin aiki zai iya haifar da kamuwa da cuta wanda zai zama muhimmin mataki wajen kare ma'aikata, abokan ciniki, baƙi da sauran mutane a wurin aiki.
Cibiyar hana cututtuka da kula da cututtuka ta Amurka (CDC) ta ba da shawarar cewa ma'aikatan da ke da alamun ciwon numfashi na tsanani su zauna a gida har sai cutar ta ɓace, alamun cutar, da sauran alamun sun ɓace aƙalla awanni 24 ba tare da amfani da magungunan ragewa ko maye gurbin cutar ba, kuma su sami ƙa'idar izinin ciwo mai sassauƙa, wanda ke ba ma'aikata damar kasancewa a gida don kula da wani memba na iyali mai rashin lafiya, kuma ma'aikatan su san waɗannan ƙa'idodin.
A cewar OSHA, ayyukan da ke da ƙananan haɗari sun haɗa da waɗanda mutane ke haɗuwa da su a kai a kai ko kuma waɗanda ke hulɗa da mutane da ba a san su ba ko kuma waɗanda ake zargin suna da cutar COVID-19, amma suna iya kamuwa da cutar SARS-CoV-2 a matsayin cuta mai yaduwa a yankin kasuwanci, saboda mutum ya yi tafiya zuwa wani wuri a cikin wuraren da ake zargin COVID-19 ya yada.
Daga cikin su akwai ma'aikata da suka je wuraren jama'a kamar makarantu, wuraren aiki masu kyau, da wuraren da mutane ke da yawa a cikin shaguna. Yin aiki a cikin rukunin masu haɗari ya haɗa da yin iska mai tsabta mai inganci, ƙara yawan iska mai tsabta, yin abubuwa kamar roba mai tsabta da kuma rufewa da kuma rufe windows a cikin motar mutum yayin da yake cikin haɗari. Don ƙarfafa hukumomi da rukunin haɗari su kasance a gida, ana iya tilasta ma'aikatan da ke fama da rashin lafiya su kasance a cikin gida, su canza tufafi da ke rufe su a cikin gida, su kasance a cikin yanayin da ya dace da aiki, su kasance a cikin yanayi mai kyau da kuma a cikin yanayi mai kyau, su kasance a cikin yanayin da ya dace da aiki, ko kuma su kasance a cikin yanayin da ya dace da yanayin da ake ciki. Wannan zai iya ba da bayanai ga ma'aikata, ko kuma a cikin yanayin COVID-19, don ba da tabbacin cewa ana iya amfani da kayan aiki na gaggawa, ko kuma a cikin yanayin da ake bukata don kiyaye lafiyar jiki, don ba da izinin yin amfani da kayan aiki na gaggawa, don ba da izinin aiki, don ba da izinin yin amfani da kayan aiki na gaggawa, don ba da izinin aiki, don ba da izinin aiki, don ba da izinin aiki, don ba da izinin aiki, don ba da izinin aiki, don ba da izinin aiki, don ba da izinin aiki, don ba da izinin aiki, don ba da izinin aiki, don ba da izinin aiki, don ba da izinin aiki, don ba da izinin aiki, don ba da izinin aiki, don ba da izinin aiki, don ba da izinin aiki, don ba da izinin da izinin shiga cikin yanayin COVID-19.
Ma'aikatan wannan rukunin haɗari ba sa yawan amfani da numfashi.
Idan mutum ya yi rashin lafiya a cikin jirgin sama, hanyar da ta dace ta sarrafa ma'aikata da sauran fasinjoji ta ƙunshi cire mutum daga cikin mutane kuma a yi masa horo da ƙafa 6, sanya mutum ɗaya a kan mai ciwo mai tsanani, da sanya abin rufe fuska ga mai ciwo ko kuma a nemi mai ciwo ya rufe bakinsa da hanci kuma ya cire shi daga cikin allurar idan ya numfashi ko ya yi numfashi.
Ma'aikatan jirgin sama suna saka kwalban lafiya wanda za a yi amfani da shi ne kawai lokacin da suke kula da wani mai haƙuri ko kuma suna shan ruwa ko kuma a wuraren da cutar za ta iya zama, da kuma ƙarin kayan kariya idan mai haƙuri yana da kumburi, yana ci gaba da ci, ko kuma yana da wahalar numfashi.
Dole ne a saka kwalba da sauran abubuwa masu amfani da su a cikin jakar shara ta sinadarai, kuma a tsabtace wuraren da aka taɓa su kuma a kashe su. Don jiragen ruwa na kasuwanci, gami da jiragen ruwa masu yawon shakatawa da sauran jiragen ruwa masu fasinjoji, abubuwan da za a iya hana haɗari sun haɗa da jinkirta tafiya na mai haƙuri, rufe wurin da mutum yake, da kuma ba da taimako na likita ga mutumin nan da nan idan mutum ya sami kumburi ko wasu cututtuka a cikin yanayin.
A cikin al'ada, dole ne a lura da lafiyar mutumin da ke cikin ɗakin ajiya. A makarantu da cibiyoyin kula da yara, CDC ta ba da shawarar rufewa na ɗan lokaci don tsaftacewa ko kashe kwayoyin idan wani mai kamuwa da cuta ya zo makaranta ba tare da la'akari da ko ya kai ga al'umma ba.
A lokacin da ake fama da kamuwa da cuta ta tsakiya ko kuma mai tsanani, ana amfani da dokar ware mutane kamar dakatar da tafiye-tafiye na ilimi, tarurruka, da kuma sauran hanyoyin da za a taru da mutane kamar zuwa makaranta ko a cikin darussan fasaha ko abinci a gidan abinci, ƙara nesa tsakanin tebur, daidaita lokacin zuwa da lokacin fita, iyakar ziyarar da ba ta dace ba, da kuma amfani da ofishin kiwon lafiya na musamman a wani wuri don yara da ke da alamun sanyi.
Idan akwai kamuwa da cuta a cikin al'ummar yankin, ban da kuɗin keɓewa, ana ɗaukar matakin rufe makarantu. 'Yan sanda da ke yin aikin yau da kullun, CDC ta ɗauki haɗarin lafiyarsu kaɗan.
Ana ba da shawarar cewa jami'an 'yan sanda da ke tuntuɓar mutanen da aka tabbatar ko ake zargin suna da COVID-19 su bi umarnin da masu aikin gaggawa na gaggawa suka bi, gami da kayan kariya na mutum.
Idan sun haɗu a lokacin da mutum yake da su, ma'aikaci ya kamata ya tsabtace da kuma kashe ƙwayoyin cuta daga belin aikinsa da kayan aikinsa kafin ya sake amfani da su ta hanyar yin amfani da fesa tsabtace gida ko kuma wanka, kuma ya bi tsarin aikin aiki na al'ada na zubar da ƙazanta da kuma zubar da PPE da aka yi amfani da shi, ciki har da wanke tufafi masu ƙazanta.
Hukumar ta OSHA ta ce wasu cututtuka na kiwon lafiya da mutuwar ma'aikata suna da haɗari ko kuma suna da haɗari sosai.
Ayyukan da ke da haɗari mai yawa sun haɗa da samar da kiwon lafiya, tallafi, dakunan gwaje-gwaje, da ma'aikatan sufuri na kiwon lafiya waɗanda ya gano ko kuma ake zargin suna da COVID-19.
Wannan zai zama mafi haɗari idan ma'aikata suna aiki, ko kuma suna aiki don ɗaukar samfurori, waɗanda ake zargi ko sanannu na marasa lafiya na COVID-19.
Tsarin aiki na yau da kullum ya ƙunshi siffofi, siffofi, bronchoscopes, wasu hanyoyin haƙori da kuma dakin gwaje-gwaje, ko kuma daukar samfurin.
Ayyukan da ke da haɗari ga mutuwa sun haɗa da ma'aikatan da ke aiki a cikin dakin wanka don mutanen da aka sani ko ake zargi da COVID-19 a lokacin mutuwarsu; waɗannan suna da haɗari sosai idan suna yin tiyata a jikin jiki. Ƙarin aikin fasaha na ƙungiyar haɗari ya haɗa da ɗakin da aka tsare marasa lafiya da aka sani suna da COVID-19, gami da aikin gama gari da aka yi a lokacin.
Za a iya yin wasu matsi na musamman na musamman a cikin tsarin kiwon lafiya da kuma wuraren binne mutane.
Dole ne a tabbatar da samfurin a cikin matakin Biosafety na 3.
Hukumar Lafiya ta Duniya (WHO) ta ba da shawarar cewa a ajiye marasa lafiya a wani wuri na musamman don tsaro dangane da zargin COVID-19. Hakanan a cikin wani PPE, OSHA ta ba da shawarar cewa numfashi na mutanen da ke aiki ya kasance a cikin nisan ƙafa 6 daga marasa lafiya da aka sani, ko ake zargi da su, ko kuma waɗanda suka ɗauki SARS-CoV-2, da kuma waɗanda ke yin magani na gaba ɗaya.
A Amurka, NIOSH ta amince da N95 don amfani da fuska mai tace numfashi ko n a cikin shirin kulawa da numfashi wanda ya haɗa da gwajin idan an haɗa shi, gwaji, da kuma dakin gwaje-gwaje na likita.
Sauran nau'ikan numfashi na iya ba da tsaro mai yawa da kuma inganta kwanciyar hankali ga ma'aikata. WHO ba ta ba da shawarar rufe fuska gaba ɗaya ba, saboda COVID-19 cuta ce ta numfashi wacce ba ta watsa ruwa a jiki.
Hukumar ta WHO ta ba da shawarar kawai a saka abin rufe fuska a wuraren aikin tiyata na ma'aikatan da ke shiga dakin gwaje-gwaje.
Ga mutanen da ke daukar samfurin numfashi, kula da, ko shan marasa lafiya na COVID-19 ba tare da magani na yau da kullun ba, WHO ta ba da shawarar su sa masks na tiyata, golf, ko kuma su rufe fuska, su sa riguna da golf.
Idan ana yin maganin da zai iya haifar da kamuwa da cuta, ana maye gurbin abin rufe fuska na tiyata da abin rufe fuska na N95 ko FFP2.
Saboda samun PPE ba shi da yawa, WHO ta ba da shawarar rage buƙatar PPE na ji da gani, daidaitawa kamar taga mai tsabta, wanda zai ba da damar duk waɗanda ke da hannu a cikin kulawa kai tsaye don shiga ɗakin da marasa lafiya na COVID-19 ke ciki, amfani da PPE na dole ne kawai don ayyuka na musamman, ci gaba da amfani da wannan abin rufe fuska ba tare da cirewa ba yayin da ake kula da marasa lafiya da yawa masu ciwo, bincika da kuma gwada tallace-tallace na PPE, da kuma wayar da kan masu amfani da fuskokin marasa lafiya.
A ranar 4 ga Maris, 2020, na sanar da gaggawa a California wanda ya haifar da hadarin COVID-19;
AKA: Dukan ma'aikatan Wikimedia
Hanyar da za a yi: [Covid-19] Bayyana nauyi da kuma shiri don rayuwa a nan gaba
RANAR DA KARANTA: 14 ga Maris, 2020, 00:24 UTC
LISAN: CC0: Babu lambar da aka ambata
Mun sami kanmu cikin mawuyacin hali a wannan watan.
Rikicin COVID-19 ya tabbatar da cewa akwai haɗin kai tsakanin bil'adama a duniya da kuma alhakin juna.
Ba mu da ikon dakatar da yaduwar cutar, amma mun san hanyar da za mu iya dogara da ita wajen amsawa ga karbar aiki, aiki da kuma gina al'umma ta duniya wanda ke da tasiri ga wannan hukumar.
Wannan yana nuna kokarin da muke yi da kuma sha'awar da muka samu a cikin dukkan ma'aikatanmu ta hanyar imel, tattaunawa da tattaunawa wanda ke tabbatar da cewa mun yi farin cikin aiki tare da ban mamaki.
Ba mu da abin alfahari da cewa muna aiki tare.
A makon da ya gabata, wani ya yi godiya ga aikinmu.
Sun tunatar da ni yadda yake da amfani a duniya a yau don samun damar Wikipedia, da kuma yadda alama mai karfi ta kasance tushen mahimman bayanai a kan layi don haka kowa zai iya samun damar.
Aikinka zai sa ya yiwu, idan shafin yanar gizon yana aiki ko kuma idan an biya ma'aikatanmu albashi ko kuma an ba su tsaro na al'umma.
Duniya tana bukatar bayanan da Wikipedia ke bayarwa, yanzu a kowane lokaci.
A yanzu ba wai kawai abin da muke yi ba, amma yadda muke yi, yana da tasiri sosai a duniya.
Tun da wannan aiki yana da mahimmanci kuma matsayin ku, za mu yi babban gyare-gyare a yadda muke aiki tare, daga wannan makon.
Don daidaita ayyukanmu da jadawalinmu.
Kamar yadda Robyn ta fada, kungiyar C ta taru a daren jiya don tattauna tsarin da jadawalin kwanaki da watanni masu zuwa.
A wannan tattaunawar, mun duba abin da muke ganin shine amsa mai kyau ga abin da muke fuskanta da kuma yadda za mu ci gaba da gudanar da aikin a wannan lokacin.
Muna son mu cire labarai daga labaranmu kuma mu tallafawa aikinmu na dogon lokaci.
Idan kana bukatar samun kudin shiga, abu ne na al'ada.
Dukan ma'aikatanmu, masu ba da gudummawa, da kuma ma'aikatan da aka yi wa kwangila:
Za mu yi aiki na sa'o'i 4 a rana, ko 20 a mako har sai an samu wani sanarwa.
Ba za mu ba da izinin hutu ba - idan za ku iya yin aiki a cikin sa'o'i na yau da kullum, wanda zai iya zama aiki.
Amma, a duniya ba za a iya hango ko wane lokaci ba a wannan lokacin, kuma idan kana bukatar ka kula da wani iyali, sayen abinci, ko zuwa likita, amincinka ne na farko.
Ba za mu yi tafiya a lokacinku ba.
Idan kana rashin lafiya, kada ka yi aiki.
Kuma na kasance a cikin harshen Larabci, amma ba na cewa.
Babu buƙatar yin amfani da hutu na rashin lafiya ko PTO - kawai gaya wa mai gudanarwa kuma taimaka wa ƙungiyar ku tsara jadawalin su don haka su sami lokaci don yin ayyuka masu mahimmanci.
(Idan an ba ka shawara game da COVID-19, ka gaya wa Bryan cewa T&C Ops na iya taimaka maka wajen tallafawa yanayin da kake ciki don gudanar da shi).
Za a biya cikakken albashi na sa'o'i.
Mun riga mun ce, kuma mun yi alkawarin cewa za mu bi wanda muke da shi a cikin kwangilarmu da kuma lokutan da ma'aikatanmu suke aiki.
Kowa zai sami albashi na sa'o'i na al'ada da ya yi aiki a ƙarƙashin yanayi na al'ada.
Wannan ya hada da idan kana rashin lafiya kuma ba za ka iya aiki ba.
Idan kana son yin aiki, za mu taimake ka.
Mutane da yawa suna amfani da aikin a cikin hanyar rage hayaniya a duniya.
Yana ba da lada mai ban mamaki, musamman a irin wannan lokacin.
Na sake maimaita, wannan shine kula da kanka.
Abin da muke bukata shi ne ka tuntubi manajanka, don mu san abin da za mu iya tsammani kuma mu daidaita aikin.
Ana ganin wasu ayyuka wajibi ne.
Akwai wasu abubuwa da dole ne mu ci gaba da rike su.
SRE, HR Ops, Amincewa da Tsaro, da kuma Tattalin Arzikin Ƙungiya (da sauran abubuwan da suka shafi) ayyuka ne na musamman da ke bukatar ƙarin tallafi.
Za mu fara aiwatar da tsarin a duk sassan don mu iya cimma burin wannan lokacin kuma mu mai da hankali kan tallafawa ayyukanmu na asali.
Akwai abubuwa da yawa da za mu iya yi da su, za mu mai da hankali ne kawai ga ayyukan girgije.
A yanzu, rage yawan adadin zai kawo rashin amfani.
Ba mu da shirin "shiga aiki sau biyu" bayan ya warke daga ciwon.
Ba za a iya ba ka damar yin aiki na tsawon lokaci ba don ka iya kammala aikin a lokacin da ba haka ba ne.
Mun yarda cewa yanayin ya canza, kuma za mu yi manufa a cikin lokaci da kuma lokaci.
Menene ya faru da APP (Tsarin Shekara)?
Don daidaita sabon aikin ibada da aikin rana a cikin sa'o'in da ake tsammani, muna shirin daidaita lokacin bayarwa a cikin Shirin Shekara na 2020-2021.
Muna so mu ba da shawarar tsawaita shirin 2019-2020 don haka za a ba da lokaci ga kasafin kuɗi don ba da damar ma'aikata su ba da fifiko ga ayyukan da suka dace, kula da kansu, da kula da iyali yayin karɓar mutanen da ke bukatar ko suke son yin aiki na ɗan lokaci a farkon makonni masu zuwa.
Ƙara wannan lokacin zai rage nauyin aiki a cikin wannan tsarin lokaci da kuma matsa lamba ga dukan ma'aikata.
Za mu sanar da kwamiti shirinmu a mako mai zuwa kuma za mu sabunta hukumomi da kungiyoyi zuwa mataki na gaba da zaran mun tabbatar da hakan.
Na gode da ƙungiyar APP don jagorantar wannan.
Yanayin ofishin, wurin da za a yi aiki da kuma tsabtace.
A makon da ya gabata, mun gano cewa wani ma'aikacin SF na iya kamuwa da cutar COVID-19.
Amma, da kuma ta'aziyya, mun dauki rukuni na kashe kwayoyin cutar a duk ofishin San Francisco.
Amfani da maganin kashe kwayoyin cuta don asibitoci don kashe kwayoyin cuta a wuraren da ake haɗuwa, da kuma wuraren karɓar mutane da kuma hawa a hawa.
Ginin yana da tsarin kula da gida wanda zai iya ba da taimako ga masu haya.
Muna da tabbacin cewa ofishin zai kasance a shirye don mu lokacin da muke so mu dawo.
Ofishinmu na DC yana cikin WeWork, wanda ya raba mana tsarin COVID-19 da duk ma'aikatan DC.
A makon da ya gabata, an tura ofishinmu na DC zuwa aiki daga gida gaba ɗaya bisa ga umarnin da suka raba tare da San Francisco.
Kamar yadda wasu daga cikin ma'aikatanmu na NYC suka sani, mun kuma tattauna yadda za mu yi hayar wani wuri a Brooklyn.
Wannan tattaunawar tana gudana amma ta koma baya.
Wasu ma'aikatanmu suna aiki a wani wuri a karon farko.
Ma'aikatanmu na dogon lokaci suna aiki daga gida sun san cewa za mu iya daidaita wannan, kuma muna so mu ba ku wasu shawarwari:
Za ku iya yin taro na sa'o'i ɗaya ko biyu a kalla.
Idan kana bukatar wani dandali mai tsawo, za ka iya yin amfani da shi don yin amfani da shi na 'yan kwanaki.
Don taron da aka bayyana a fili, dole ne ka kafa jadawalin, kuma ka aika da rahoton da za a karanta a gaban mai gani.
Kuna yin bidiyo kai tsaye, kuma kuna amfani da kayan aiki kamar Google Docs da Zoom don sauƙaƙe da haɗa su.
Kuna jagorantar sauƙaƙe kowane taro, wani yana tattaunawa da ku game da duk tambayoyin sannan kuma yana kula da jerin masu magana, wanda zai taimaka wajen karɓar bayanan (ko haɗa bayanan da aka ɗauka).
Za ku aika imel zuwa sashen goyon bayan fasaha idan kuna buƙatar yin aiki daidai.
Ka yi amfani da rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin rabin
Za ku shiga cikin tattaunawar #remoties a kan tashar Slack na abokan aiki game da rarraba aiki
Ƙungiyar Aiki ta Ma'aikatar Aiki ta duba jagororin yanar gizo don ƙara tallafi ga rarraba aiki na asali.
A makon da ya gabata mun nemi al'umma su nemi dakatar da ayyukan tallafi na Wikimedia, kamar gyara, har sai WHO ta sanar da cewa an kammala ziyarar.
Mun gaya mata cewa mun fahimci cewa an soke takardarmu da kuma wasu takunkumi da za a iya sanyawa a kan ta don a biya kuɗin da ta amince da su don aikin kuma cewa babu wanda ya cancanci a yi masa hukunci ko a yi masa gyara.
A mako mai zuwa za mu bi ƙarin jagororin Wikimedia da sauran wuraren da kuma taron jama'a na zafin jiki.
Tsarin al'ummomin duniya na iya zama mai ban tsoro ga rikice-rikice amma mun yi imani da bayyanawa da ikon mayar da hankali ga al'ummomin su, Wikimedia da sauransu.
A cikin wannan tsari, CRT tana aiki don ƙirƙirar shafin Meta-Wiki don samar da shafukan zamantakewa don bin diddigin tasiri da kuma bin diddigin hulɗarmu.
Kula da duk wani abu da ya shafi COVID-19
Za mu aika gayyata zuwa taron ma'aikata na musamman a ranar Alhamis mai zuwa, 14:00 UTC/07:00 PT.
Za mu yi amfani da wannan lokacin don samar da ƙarin bayani, amsa tambayoyi da kuma ba da ƙarin lokaci don haɗuwa da wasu.
Domin mu ma muna tare da shi, za mu kuma yi masa biyayya ta kowace hanya.
A halin yanzu, ana ci gaba da samun bayanai daga wannan imel ɗin, da sauran bayanan da suka shafi COVID-19, zuwa ofishin Wiki.
CRT za ta yi aiki wajen shigar da wannan shafin da duk bayanan a wuri guda.
Muna kuma aiki don ci gaba da tuntuɓar ma'aikata a cikin ƙasashe a lokacin da wannan ya yi tasiri sosai.
Idan kana da wasu tambayoyi game da balaguro, abubuwan da suka faru, watsa shirye-shiryen kai tsaye na aikin da ke wurin dattawa, ko kuma wasu abubuwan da kake bukata, kada ka yi jinkirin sanar da su kuma ka yi aiki tare da CRT.
Muna nan don taimaka muku da kuma aiki tare da ku a duk lokacin da kuke buƙata.
Idan kana da wata matsala mai mahimmanci ko kuma mai mahimmanci, don Allah aika da imel zuwa Bryan Judan - Daraktan Ayyukan Duniya na Ma'aikatar Ma'aikata.
Babu wani canji da ya kamata a ɗauka a matsayin nauyi ga aikinmu da kuma ayyukanmu.
Amma, yana nufin ganewa a wannan lokacin, kuma ayyuka da wajibai za su iya daidaita su kamar yadda suka saba.
Akwai matakai da muke ganin suna da muhimmanci don tallafawa al'ummarmu domin mu ci gaba da aiki, don mu taimaka wa al'ummarmu su samu tallafi da suke bukata, da kuma don duniya ta dogara da su.
Ayyukanmu na yau da kullum za su kasance a wurin lokacin da lokaci ya yi.
A wannan lokacin, lokaci ya yi da za mu goyi bayan juna kuma mu yi shirin yin ayyuka masu muhimmanci a makonni da watanni masu zuwa.
Muna bukatar ku duka ku yi hakan, kuma muna so ku kula da kanku da iyalanku domin mu iya taimaka muku a duk lokacin da ake bukata.
Yanzu, don Allah -- ku wanke hannuwanku kuma kada ku taɓa fuskarku!
Katherine, CRT (Amanda K, Amy V, Bryan J, Doreen D, Gregory V, Jaime V, Joel L, Lynette L, Ryan M, da Tony S), da sauran a cikin rukuni na jagoranci (Grant I, Heather W, Jaime V, Janeen U, Lisa S, Robyn A, Ryan M, da Toby N).
Kwayar cutar SARS-CoV-2 da COVID-19 ke haifarwa (cuta ta coronavirus 2019), cuta ce mai yaduwa ta numfashi wacce aka fara gano a watan Disamba na 2019, a Wigan, Hubei, Jayna.
ACE2 yana hana aikin da ke tattare da enzyme mai canza angiotensin (ACE) ta hanyar rage adadin angiotensin-II da haɓaka Ang (1-7) wanda ke haifar da magani mai kyau wanda ke niyya ga ciwon zuciya. ACE2 kuma shine hanyar shiga wasu ƙwayoyin cutar coronavirus.
Kwafin enzyme wanda ba na mutum ba ne aka fi sani da hACE2.
Angiostensin-reversible enzyme 2 shine sinadarin da ke cikin metalloenzyme a cikin endothelial surface da sauran sel.
Protein ACE2 yana dauke da N-terminal na peptidase M2 na yankin da kuma C-terminal wanda ke dauke da yankin amino acid.
ACE2 shine kawai nau'in furotin I, wanda ke da wani yanki mai aiki na enzymatic wanda ke kaiwa saman ƙwayoyin huhu da sauran ƙwayoyin.
Ƙarin ƙwayoyin halitta na ACE2 suna ƙunshe da ƙwayoyin halitta waɗanda ke ɗaukar enzyme mai suna sheddase, wanda ke samar da furotin mai narkewa wanda ke shiga cikin jijiyoyin jini kuma yana lalata abubuwan da aka samar a cikin fitsari.
ACE2 yana cikin ƙwayoyin halitta: ACE2 yana kai hari ga ƙwayoyin halitta na yau da kullum a cikin huhu na alveolar cell type II, enterocytes a cikin ƙananan hanji, ƙwayoyin jijiya da endothelial da ƙwayoyin tsoka na ƙwayoyin halitta.
Hakanan ana samun ACE2mRNA mai ƙididdiga a cikin ƙwaƙwalwar ƙwaƙwalwa, striatum, hypothalamus, da kuma ƙwayoyin kwakwalwa.
Aikin farko na ACE2 shine daidaita ACE.
Kwayoyin ACE suna rarraba angiotensin I a cikin ƙwayar angiotensin II.
ACE2 yana karɓar carboxyl-terminal acid phenylalanine angiotensin II (Asp-Arg-Val-Tyrlle-His-Pro-Phe) da hydrolyses kuma yana sanya su cikin vasodalitor angiotensin (1-7), (H-Asp-Arg-Val-Tyrlle-His-Pro-OH).
ACE2 yana karɓar wasu nau'ikan peptides ciki har da [des-arg9] - bradykinin, apelin, neurotensin, dynorphin A da ghrelin.
Hakanan ACE2 yana sarrafa tsarin amino acid mai tsaka tsaki wanda aka samo daga SLC6A19 wanda aka bayyana a cikin cutar Hartnup.
A cikin furotin na motsi na ƙwayar cuta, ACE2 shine babban hanyar shiga kwayar cutar coronavirus, ciki har da HCoV-NL63; SARS-CoV (kwayar cutar da ke haifar da SARS); SARS-CoV-2 (kwayar cutar da ke haifar da COVID-19).
Musamman, haɗuwa da haɓakar S1 botorians na SARS-CoV da SARS-CoV2 a cikin yankin enzymatic na ACE2 a saman sel daga endocytosis da watsa kwayar cutar da kuma enzyme na yaduwa a cikin endosomes a cikin sel.
Duk wannan tsarin yana buƙatar haɓaka ƙwayoyin cuta na S na TMPRSS2, wanda aka cire daga hanci wanda a halin yanzu ana bincika shi a matsayin furotin na halitta. Wannan na iya haifar da zato cewa zai iya rage matakan ACE2, a cikin tantanin halitta, wanda zai iya taimakawa wajen magance ciwo.
Amma, al'ummomin sana'a da yawa da kungiyoyin da suka kafa dokoki sun ba da shawarar ci gaba da yawan shan ACE da ARB.
Wani bincike na yau da kullum da kuma kimantawa na ƙarfe da aka fitar a ranar 11 ga Yuli, 2012, ya gano cewa "amfani da numfashi na ACE yana da alaƙa da raguwa mai girma na 34% na haɗarin ciwon huhu fiye da yadda aka sarrafa shi".
Haka kuma, "hadarin ciwon huhu na iya ragewa ga marasa lafiya da ke shan maganin numfashi na ACE wanda hakan ke haifar da haɗarin ciwo, musamman ga mutanen da ke fama da ciwon hanci da zuciya.
Yin amfani da maganin numfashi na ACE wanda ke da alaƙa da cututtukan huhu na mutuwa yana rage, kodayake maganin numfashi ba shi da tasiri sosai idan aka kwatanta da haɗarin cututtukan huhu gaba ɗaya".
Haɗuwa zuwa mutum na ACE2 (rhACE2) wanda shine babban magani na sabon magani na mummunan rauni na huhu, da kuma ci gaba a cikin haemodynamics na ƙwayoyin cuta da oxygen mai yawa a cikin alade tare da alamun ciwon numfashi mai tsanani tare da lipopolysaccharide.
Rayuwar rabi na rhACE2 ba tare da mutum ba ya kai sa'o'i 10 kuma bisa ga aikin, an ƙara minti 30 zuwa tsawon sa'o'i 24.
Yawancin karatu sun nuna cewa rhACE2 magani ne mai amfani ga mutanen da ba za su iya shan maganin numfashi mai suna renin-angiotesin (RAS) ba ko kuma cutar da ke tattare da angiotensin II ta ƙaru. An kimanta amfani da rhACE2 a cikin gwaji na asibiti don magance cututtukan numfashi masu tsanani.
SARS-like coronavirus WIV1 (Bat SL_CoV-WIV1), wanda kuma ake kira SARS-like coronavirus WIV1, cuta ce mai tsanani ta numfashi ta coronavirus (SARSr-CoV) wanda aka samo daga wani mai tsabtace jini (Rhinolophus sinicus).
Gwamnatoci daban-daban sun samar da su ko kuma sun ba da shawarar su, kuma jami'an gwamnati suna tallafawa muhalli da wasu wurare.
An kirkiro wasu tsarin kula da app.
Akwai damuwa game da sirrin sirri, musamman a cikin tsarin bin diddigin wurin da mai amfani ya kasance.
A wani yanayi, ana iya amfani da mai kunnawa na Bluetooth don yin rikodin lokacin da aka yi amfani da wata wayar hannu.
A ranar 10 ga Afrilu, 2020, Google da Apple sun sanar da cewa za su haɗa hanyar ƙarfafa aikace-aikacen Blue Note kai tsaye daga tsarin Android da iOS masu biyayya.
Gwamnatin Jaina, tare da Alipay, ta kirkiro wani app wanda zai ba 'yan kasar damar duba ko wani ya kusanci wani mai dauke da COVID-19.
Ana amfani da shi a cikin birane sama da 200 na kasar Sin. A Singapore, ana amfani da app mai suna TraceTogether.
Kungiyar IT ta cikin gida ta kirkiro wannan app ɗin, ta saki shi a bude kuma ta tura shi ga gwamnati. A Arewacin Macedonia ta kirkiro "StopKorona!", wani app na Bulutuut wanda ke sa ido kan masu fama da ciwo kuma yana ba da amsa mai sauri ga hukumomin kiwon lafiya.
Ma'aikatar Sadarwa da Fasaha da Ma'aikatar Lafiya ne suka kirkiro wannan app.
A ranar 14 ga Afrilu, 2020, app ɗin yana jiran amincewa daga Google Play Store da Apple App Store.
A ranar 12 ga watan Afrilu, gwamnati ta ce an samu kyakkyawan wuri ta hanyar manhajar sa ido kan mutane masu cutar, wanda za a fara amfani da ita a cikin mako guda.
Ostiraliya da New Zealand suna tunanin aiwatar da aikace-aikacen Singapore na TraceTogether da tsarin BlueTrace. Rasha tana aiwatar da aikace-aikacen muhalli don mai haɗawa da COVID-19 a cikin mazaunin Moscow, wanda aka tsara don tabbatar da cewa ba za a bar gida ba.
Ross Anderson, farfesa a fannin injiniya na ambibi na Jami'ar Cambridge, ya samar da jerin matsalolin da za su iya faruwa tare da tsarin da aka yi amfani da shi, ciki har da yin ƙarya game da wanda ke yin hakan da kuma ko rashin amfani zai yi muni idan amfani da app ɗin ya iyakance ga ƙananan mutane.
Dangane da damuwar cewa cutar ta zama karya ne ko kuma cutar coronavirus, Apple ta sanya iyakancewar cewa hukumomi na iya ƙara aikace-aikacen coronavirus zuwa App Store, wanda kawai ya iyakance ga " jami'ai " ko manyan hukumomi.
Google da Amazon sun yi irin wannan ƙuntatawa.
Masu gudanar da harkokin sirri sun nuna damuwa game da matsalar da ke tattare da bin diddigin jama'a ta amfani da aikace-aikacen coronavirus, musamman idan an yi bin diddigin mutane a gine-gine don magance annobar coronavirus da aka rarraba lokacin da haɗarin ya wuce.
Amnesty International da fiye da kungiyoyi 100 sun fitar da wata sanarwa suna kira ga a takaita irin wannan sa ido.
Hukumar ta gabatar da ka'idoji guda takwas ga ayyukan gwamnati:
Za a ce "aiki na doka, wajibi ne kuma wajibi ne".
cire sa ido da kuma saka idanu ya kasance magana mai haske;
amfani da bayanai za a iyakance shi ne kawai ga dalilai na COVID-19;
Ana iya kiyaye tsaro da sirrin bayanai don tabbatar da cewa an tabbatar da hakan ne.
Ana iya hana nuna bambanci da nuna bambanci ta hanyar saka idanu na dijital;
Dokar ta tanadar da duk wani bayani da aka raba da wani;
dole ne a yi kariya daga zalunci da kuma hakkin 'yan ƙasa su amsa zalunci;
Don samun tasiri ga duk "masu sha'awar" abin da suke buƙata, gami da ƙwararrun likitocin kiwon lafiya na jama'a da ƙungiyoyin da ke fama da cutar.
Shirin da Google / Apple suka ba da shawarar ya kasance don magance matsalolin sa ido na yau da kullun ta hanyar kawar da tsarin kula da na'urorin su ta hanyar tsarin su ba tare da buƙatar ba.
Wasu ƙasashe suna amfani da cibiyoyin sadarwar gida don saka idanu kan aikace-aikacen, wanda ya kawar da buƙatar saukar da aikace-aikacen da ikon saka idanu.
A Isra'ila, an amince da tsarin sa ido kan cibiyar sadarwa.
Maganin cibiyar sadarwa a wurare iri ɗaya yana da matsalar ɓoyewa a nan gaba.
Duk da haka, duk tsarin da ke da cibiyar sadarwa na cibiyar sadarwa suna buƙatar samun bayanai daga wurin mutum; an ƙirƙiri tsarin da yawa na sirri wanda ke amfani da cibiyar sadarwa ta cibiyar sadarwa don haɗa su (duba sashin ƙasa).
A Koriya ta Kudu, ana bin diddigin tsarin da ba shi da aikace-aikace.
Maimakon amfani da app na musamman, tsarin yana tattara bayanan sa ido daga wurare daban-daban, ciki har da bayanan sa ido daga na'urar hannu da bayanan sayayya daga katin, kuma yana ƙara saƙonnin rubutu zuwa ga masu kamuwa da cuta.
Hakanan, ta hanyar amfani da bayanan gargadi na sirri, gwamnati kuma tana sanya bayanan shafin a bayyane ga kowa, wani lokacin ana ba da izini saboda yana da wahala a canza dokar sirrin bayanai bayan cutar ta MERS ta mamaye ƙasar.
Ana iya samun wannan bayanin a ko'ina a cikin adadin aikace-aikacen da kuma shafukan yanar gizo. A cikin ƙasashe da Jamus ta haɗa da shi, tana duba tsarin ɓoye sirrinta da kuma wanda kowa zai iya shiga.
A ranar 6 ga Afrilu, 2020, ba a ba da cikakkun bayanai ba.
Kula da sirrin sirri yana da babban abun ciki, wanda aka inganta ta hanyar nazarin bayanai mai yawa wanda ya gudana har zuwa 2013. A ranar 7 ga Afrilu, 2020, ƙungiyar ƙwararrun masana sun yi aiki a kan mafita mai sirrin sirri, kamar amfani da BLE don gano wuraren da wayoyin wasu ke ciki.
Duk da haka, PEPP-PT yana haɗa ƙoƙari a cikin tsari guda ɗaya da kuma na gama gari, ba kawai a cikin tsari ɗaya ba. Tsarin wuri ɗaya ya haɗa da Tsarin Kula da Yankin Sirri da Aka Kare (DP-PPT/DP-3T), Lambar Sadarwa ta Kamel (TCN, fka Lambar Sadarwa, CEN), Tsarin Sirri mai mahimmanci da Tsarin Kula da Sadarwar Wayar hannu (PACT) da sauransu.
A cikin waɗannan tsarin, gano bayanan sirri ba ya wuce na'urar, kuma duk abubuwan da ke faruwa a kan na'urar.
Ƙungiyar Sirri ta MIT Media Lab ta kirkiro SafePaths, dandamali wanda ke amfani da fasahar tsaro na sirri yayin tattara bayanai na wuri ko kuma tattara bayanai don bin diddigin yaduwar COVID-19.
Bisa ga binciken da aka samu daga takardun fararen "Apps Gone Rogue: Safmarka's Privacy Protection" za su fitar da wani irin wannan aikin a cikin dandalin SafeTrace na Enigma MPC, wani kamfanin fasaha wanda aka fara yi a MIT Media Lab.
SafeTrace yana amfani da fasahar wayar hannu wanda ke ba masu amfani damar raba bayanan sirri na shafin da bayanan kiwon lafiya tare da sauran masu amfani da jami'ai, ba tare da keta sirrin bayanai ba.
Ranar 5 ga Afrilu, 2020, TCN ta Duniya ta kafa ta hanyar kungiyoyin hadin gwiwa wanda ke da tsari da tsarin da suka hada da juna, da nufin rage tsangwama, da sauƙaƙe haɗin kai na duniya na saka idanu da kuma aikace-aikacen gargadi, hanya mai mahimmanci don cimma aiwatar da shi a ko'ina.
A ranar 9 ga Afrilu, 2020, gwamnatin Singapore ta sanar da cewa ta bude tsarin BlueTrace ta amfani da aikace-aikacen gwamnati na hukuma.
A ranar 10 ga Afrilu, 2020, Google da Apple, manyan kamfanonin sarrafa wayar hannu na Android da iOS, sun ba da sanarwar shirin kula da haɗin kai, wanda aka ce yana kare sirrin, wanda ya ƙunshi haɗuwa da fasahar Cloud Low Power da ɓarkewar sirrin.
Sun kuma bincika abubuwan da ke cikin fasahar da tsarin ke amfani da su.
A cewar Apple da Google, an tsara tsarin ne a cikin sassa uku:
sashen kayan aiki wanda zai ba gwamnati damar ƙirƙirar aikace-aikacen sa ido kan cutar coronavirus wanda ke kiyaye sirrin sirri
don haɗa ayyukan iOS da Android tare da shirin Google da Apple don amsawa da ci gaba da matsalolin saka idanu ta hanyar rarraba tsarin farko da sabunta tsarin obeetin, sannan cire shi lokacin da haɗarin ya ɓace daidai.
Ana ci gaba da bincike kan samar da maganin COVID-19 don yin allurar rigakafi ko magani don kawar da cutar coronavirus (COVID-19) ta 2019-20.
Wannan shine layin binciken kimiyya wanda a halin yanzu ake amfani dashi don ƙirƙirar magani mai lafiya da inganci ga COVID-19.
Wasu bincike sun yi game da yanayin da ya shafi yin allurar rigakafi da kuma yin amfani da kwayoyin jini don cutar COVID-19. SARS-CoV-2 yana da maganin sunadarai guda 66, kowannensu yana da wuraren da aka haɗa da ligand mai yawa.
Ƙididdigar waɗannan wuraren haɗin gwiwa suna ba da kyakkyawan tsinkaya game da samar da ingantaccen furotin wanda ke kashe cutar COVID-19.
Daga cikin manyan kwayoyin da ke niyya ga SARS-CoV-2 akwai papain-kamar protease, RNA mai dogaro da RNA polymersare, helicase, S protein, da ADP ribophosphatase.
Hussein A, et al sun yi nazarin wasu kwayoyin da aka yi amfani da su kuma suka kimanta tasirin su a kan kwayoyin da aka amince da su don hanzarta abun da ke cikin maganin SARS-CoV-2 a cikin binciken gwaji na farko don samar da tsarin binciken gwaji.
Chloroquine magani ne na yaki da zazzabin cizon sauro wanda aka yi amfani da shi a wasu maganin rigakafi kai tsaye.
A ranar 18 ga Maris, WHO ta sanar da cewa chloroquine da abubuwan da ke da alaƙa da shi hydroxychloroquine za su kasance cikin magunguna huɗu da ke cikin ɓangaren binciken gwajin likita na Majalisar Dinkin Duniya.
Shugaban jihar New York Andrew Cuomo ya sanar da cewa gwajin jihar New York na chloroquine da hydroxychloroquine zai fara ne a ranar 24 ga Maris. A ranar 28 ga Maris, FDA ta amince da amfani da sulfate na hydroxychloroquie da phosphate na chloroquine a cikin takardar izinin Amfani da Gaggawa (EUA).
FDA ba ta amince da maganin ba don gwajin likita kuma an amince da shi a ƙarƙashin EUA kawai a matsayin gwajin gwaji don amfani da gaggawa ga marasa lafiya da aka kwantar a asibiti amma ba a adana shi don gwajin gwaji na asibiti ba.
CDC ta ce "amfani, yawan, ko tsawon hydroxychloroquine a cikin rigakafi ko magani na kamuwa da cutar SARS-CoV-2" ba a sani ba tukuna.
Likitoci sun ce za su yi amfani da wannan magani ne a lokacin da akwai "wani zaɓi" na magani.
Wata ƙungiyar masu binciken Turkiyya ta gudanar da karamin bincike a Istanbul ta amfani da chloroquine da zinc, bitamin A, bitamin C da bitamin D.
Akwai manyan bincike a Jami'ar Duke da Jami'ar Oxford.
Makarantar Lafiya ta NYU Langone tana gudanar da gwajin aminci da inganci na amfani da hydroxychloroquine.
A gwajin asibiti da aka yi a Wuhan da Shenzhen a kasar Sin an ce an gano cewa favipiravir "yana da tasiri sosai".
An rasa marasa lafiya 35 a Shenzhen a cikin sashin kwanaki 4, yayin da tsawon lokacin ciwo ya kasance kwanaki 11 ga marasa lafiya 45 da ba a ba su magani ba.
A wani binciken da aka yi a kan marasa lafiya 240 da ke fama da cututtukan huhu, rabin sun karɓi favipiravir kuma rabin sun karɓi umifenovir.
Hukumar Magunguna ta Italiya ta shaida wa jama'a cewa akwai shaidu da ke nuna cewa har yanzu ana gwada maganin kuma har yanzu yana kan gaba.
A ranar 2 ga watan Afrilu, Jamus ta sanar da cewa za ta sayi magungunan Jafananci daga kantin sayar da kayayyakin ta, wanda za ta yi amfani da su don sojojin su kawo magungunan zuwa asibitocin jami'o'i, amma za a yi amfani da magungunan don magance marasa lafiya na COVID-19.
A cikin jaridar South Chine Morning Post, Shinzo Abe ya amsa gwamnatin Trump game da sayen magunguna. Magungunan na iya zama ba su da amfani ga cutar da ta fara yaduwa.
Yana iya zama ba shi da lafiya ga mata masu ciki ko waɗanda suke ƙoƙarin ɗaukar ciki.
Wani binciken da aka yi akan lopinavir/ritonavir (Kaletra), haɗuwa da maganin kwayar cutar lopinavir da ritonavir, "ba a sami amfani ba".
An tsara maganin ne don mutanen da ke da cutar HIV don canza haɗuwa da protease.
Wata ƙungiyar masu bincike daga Jami'ar Colorado na ƙoƙarin canza magunguna don nemo masu kwayar halitta waɗanda ke haɗuwa da protease na SARS-CoV-2. Akwai zargi daga ƙungiyar kimiyya game da daidaita albarkatun don sake amfani da abin da aka yi musamman don cutar HIV / AIDS.
Hukumar ta WHO ta kara da lopinavir/ritonavir a cikin gwajin Ƙungiyar Duniya.
Remdesivir ya ƙirƙira kuma ya haɓaka Gilead Sciences don magance cutar Ebola da cutar Marburg. Gilead Sciences daga baya ta haɓaka Remdesivir wanda ke da aikin maganin rigakafi na vitro na filayo, pneumonia, paramyxo, da corona-virus.
Wata matsala ita ce, maganin da aka yi don hana maye gurbin zai iya haifar da ciwo da kuma ciwon sukari.
Wasu nazarin da aka yi akan remdesivir sun nuna cewa yana da babban ƙarancin ƙarfin rigakafin ƙwayar cuta. Akwai gwaje-gwaje na asibiti da yawa a cikin gudana, ciki har da biyu da ake gudanarwa a asibitocin Jami'ar Cleveland; ɗaya a cikin marasa ciwo mai sauƙi da kuma waɗanda ke da ciwo mai tsanani.
Akwai gwajin gwaji na shan bitamin C a cikin mutanen da aka kwantar da su asibiti da waɗanda ke fama da cututtukan COVID-19; biyu da aka sarrafa da placebo (Jana, Kanada) da ɗaya da ba a sarrafa ba (Italiya).
Jihar New York ta fara gwajin maganin azithromycin a ranar 24 ga Maris, 2020.
Cibiyar Lafiya da Magunguna ta Duniya ta kasar Japan (NCGM) na shirin yin gwajin asibiti na Teijin Alvesco (ciclesonide), magani mai shan taba na corticosteroid, don kula da marasa lafiya kafin su kamu da cutar coronavirus.
Wannan wani tsari ne na maye gurbin angiotensin zuwa enzyme 2, gwajin Phase II yana kan marasa lafiya 200 daga mutanen da ke fama da ciwo mai tsanani, kuma an sanya su a asibitoci a Denmark, Jamus, da Austria don gano tasirin magani.
Masu bincike daga Cibiyar Zuciya ta Montreal a Kanada a halin yanzu suna nazarin rawar da colchicine zai iya takawa wajen rage tashin hankali da cututtukan bugun jini a cikin marasa lafiya da ke fama da cutar COVID-19.
A cikin binciken, wanda aka bayar don COLCORONA, an yi amfani da manya 6000 na shekaru 40 da sama da COVID-19 waɗanda ke da cututtukan cututtukan cututtukan da ke buƙatar shiga asibiti.
Mata masu ciki ko mata masu shayarwa ko waɗanda ba su yi haihuwa ba ba sun cancanci yin amfani da takardar hana haihuwa.
An gwada wasu magungunan rigakafi a Italiya.
Ana amfani da ƙananan kwayoyin heparin a cikin maganin marasa lafiya, wanda ya sa Hukumar Magunguna ta Italiya ta fitar da umarnin yadda za a yi amfani da su.
Wani binciken da aka yi a cibiyoyin da yawa na marasa lafiya 300 da ke halartar amfani da enoxaparin sodium a matsayin maganin rigakafi da magani wanda aka sanar a Italiya a ranar 14 ga Afrilu.
Tunda SARS-CoV-2 kwayar cuta ce, masana kimiyya da yawa suna mai da hankali kan sake amfani da maganin cutar da aka amince da shi a baya wanda aka yi tun kafin barkewar cutar MERS, SARS da cutar West Nile.
Ribavirin: Ana ba da shawarar ribavirin don magance COVID-19 bisa ga umarnin kwafin 7 na JINA.
Umifenovir: an ba da shawarar cewa a yi amfani da umifenovir don magance COVID-19 bisa ga umarnin kwafin 7 na JINA.
An gano cewa wasu magungunan rigakafi za a iya sake amfani da su wajen magance COVID-19.
Tocilizumab (mai karɓar maganin IL-6): An yarda da ita.
Hakanan gwajin a Italiya da Jina.
Har yanzu ba a bayyana yanayin da zai iya faruwa a lokacin daukar ciki ba, ciki har da ciwon sukari, ciwon zuciya, hypercoagulability ko tashin hankali wanda ke haifar da ƙarin haɗari ga masu juna biyu kamar yadda aka tsara don marasa juna biyu.
Ko da yake babu allurar rigakafi da ta kammala gwajin, akwai wasu gwaje-gwaje da ake yi don yin allurar.
A karshen watan Fabrairun 2020, Hukumar Lafiya ta Duniya (WHO) ta ce ba ta tsammanin samun allurar rigakafin SARS-CoV-2, cutar mai tsanani, a cikin watanni 18 masu zuwa.
An zabi alluran rigakafi biyar zuwa Faje I na binciken tsaro na Afrilu.
An gano COVID-19 a watan Disamba na 2019.
Wani babban motsi a duniya a shekarar 2020, wanda ya haifar da samun kudade da kuma gudanar da bincike da yawa na gwamnati kan samun rigakafi.
Yawancin hukumomi suna amfani da kwari don yin allurar rigakafin SARS-CoV-2.
Kamar yadda aka ruwaito a watan Afrilu, cibiyar CEPI ta yi aiki tare don yin allurar rigakafi kuma ta haka ne ta ci gaba da sauri, samarwa, samar da nauyi, da samun damar duniya.
A watan Afrilu, Masana kimiyya na CEPI sun ce ana gudanar da bincike kan dandamali 10 na fasaha don bayar da rigakafin COVID-19 mai tasiri a farkon 2020.
Babban cibiyoyin suna da niyyar yin binciken tsaro na Fasali na I wanda ya haɗa da:
nucleic acid (DNA da RNA) (An tsara kuma an samar da allurar rigakafi ta fuska na I: Moderna, mRNA-1273)
tsarin kwayar cutar (Tashin kai da kuma fitar da allurar rigakafi na farko: CanSino Biologics, adenovirus na nau'in 5 factor)
A cewar masana kimiyya na CEPI a watan Afrilu, an samu sunadarai 115 na allurar rigakafi daga masu samar da allurar rigakafi na farko, kuma an tabbatar da su a cikin ayyukan 78 na ci gaba (79, a cewar Cibiyar Milken), 37 wasu sun ce, amma an adana bayanai kadan (wanda aka ce an tsara ko tsara).
Mataki na I-II na gwajin lafiya da rigakafin rigakafi na gwaji, yawanci da aka samu ba tare da kyakkyawan sakamako ba, a cikin maganin placebo, a wurare da yawa, yayin da aka gano wani abu mai kyau, kuma ya ɓace.
Gwaje-gwaje na III yawanci suna da yawan masu halarta, ciki har da ƙungiyar sarrafawa, da kuma ƙwarewar gwaji na maganin rigakafin ciwo, tare da mummunan tasirin amfani da iyaka.
Daga alluran rigakafi 79 da ake gudanarwa (wanda aka tabbatar a farkon watan Afrilu na 2020), har yanzu ba a tantance 74 ba (har yanzu ana gudanar da binciken "kafin gwaji").
Har zuwa 24 ga Janairu, 2020, Jami'ar Queensland ta Ostiraliya ta sanar da binciken allurar rigakafin kwayoyin da za ta canza yanayin furotin na cutar don yin aiki na kariya.
A ranar 24 ga Janairu, 2020 a Kanada, Cibiyar allurar rigakafi ta duniya (VIDO-InterVac) ta Jami'ar Saskatcheman ta ba da sanarwar fara aikin allurar, wanda za a fara gwaji ba tare da mutum ba a 2021.
Cibiyar Kula da Cututtuka da Rigakafin Cutar ta sanar da ayyukan samar da allurar rigakafin a ranar 26 ga Janairu, 2020, a Jami'ar Hong Kong a ranar 28 ga Janairu.
A ranar 29 ga Janairu, 2020, Kamfanin Janssen Pharmaceutical Company, wanda Hanneke Schuitemaker ke jagoranta, ya sanar da cewa sun fara samar da allurar rigakafi.
Janssen suna samar da allurar rigakafin baki ta biotechnology, Vaxart.
A ranar 18 ga Maris, 2020, Emergent BioSolutions ta sanar da cewa za ta samar da allurar Vaxart tare.
A ranar 8 ga Fabrairu, 2020, dakin gwaje-gwaje na OncoGen a Romania ya fitar da rahoto cewa ya kirkiro irin wannan rigakafin da za a yi amfani da shi a maganin cutar kansa ta neoantigen.
A ranar 25 ga watan Maris, shugaban binciken cibiyar ya sanar da cewa sun kammala samar da allurar rigakafi kuma daga nan ne za su fara gwaji.
A ranar 27 ga Fabrairu, 2020, kamfanin haɗin gwiwar Generex, NuGenerex Ummo-Ancology, ya ba da sanarwar ƙaddamar da aikin allurar rigakafi na li-Key peptide na allurar COVID-19.
Suna son samar da allurar rigakafi ta musamman wanda za a iya gwada ta ba tare da takardar shaida ba cikin kwanaki 90.
A ranar 5 ga Maris, 2020, Jami'ar Washington ta St. Louis ta sanar da aikin samar da allurar rigakafi.
A ranar 5 ga Maris, 2020, Ma'aikatar Bincike ta Sojojin Amurka da Ma'aikatar Bayarwa ta Fort Detrick da Ma'aikatar Bincike ta Sojojin Walter Reed ta Silver Springs, duka a yammacin Maryland, sun sanar da cewa suna aiki kan allurar rigakafi.
Har zuwa 10 ga Maris, 2020, Emergent Biosolution ta sanar da cewa tana aiki tare da Novavax Inc.
samar da allurar rigakafi da kuma samar da ita.
Haka kuma mutane sun sanar da cewa za su shirya gwajin likita na farko da na I na gwajin lafiya a karshen Yuli 2020.
A ranar 12 ga Maris, 2020, Ministan Lafiya na Indiya ya sanar da cewa za su yi aiki tare da mutane 11 a cikin asibitin, suna hanzarta yin aikin don ɗaukar aƙalla shekara ɗaya da rabi zuwa shekaru biyu don yin allurar rigakafi.
A ranar 12 ga Maris, 2020, Medicago, wani kamfanin kere kere mai zaman kansa da ke birnin Quebec, Quebec, ya ce yana shirin yin wani abu mai kama da coronavirus wanda wani ɓangare na kudadensa na Kanada na Nazarin Kiwon Lafiya ke biya.
Zaɓin allurar rigakafi a cikin dakin gwaje-gwaje, gwajin da ba tare da mutum ba wanda aka shirya a watan Yuli ko Agusta 2020.
A farkon makon nan, jaridar The Guardian ta wallafa cewa shugaban Amurka Donald Trump ya ba CureVac "kudi mai yawa don su kimanta rigakafin Covid-19 da kansu", duk da ƙin yarda da gwamnatin Jamus.
A ranar 17 ga Maris, 2020, kamfanin magunguna na Amurka Pfizer ya sanar da cewa yana aiki tare da kamfanin BioNTech na Jamus don yin aiki tare akan mRNA-taron.
An zabi allurar mRNA da BNT162, wanda a halin yanzu ana gwada ta kafin a gwada ta a asibiti kuma ana sa ran fara gwajin asibiti a watan Afrilu 2020.
A Italiya a ranar 17 ga Maris, 2020, kamfanin ta'addancin na'urar kiwon lafiya na Italiya, Takis Biotech, ya bayyana cewa za su sami sakamakon gwajin asibiti kafin watan Afrilu na 2020, kuma za a fara gwajin allurar da suka zaɓa ba tare da an fara ba a lokacin kaka.
A Faransa a ranar 19 ga Maris, 2020, Cibiyar Hadin Kan Shirin Tsinkaye (CEPI) ta sanar da cewa za a ba da dala miliyan 4.9 na kudaden shiga na COVID-19 don nazarin allurar rigakafin da ta yi aiki tare da Istitut Pasteur, Themis Bioscience (Fuyeena, Astariya), Jami'ar Pittsburgh, wanda hakan ya sa adadin kudaden shiga na CEPI na allurar rigakafin COVID-19 ya kai dala miliyan 29.
CEPI ta kuma ba da tallafin yin allurar rigakafin COVID-19 ga Moderna, Curevac, Inovio, Novavax, Jami'ar Hong Kong, Jami'ar Oxford, da Jami'ar Queensland.
A ranar 20 ga Maris, 2020, jami'an kiwon lafiya na Rasha sun sanar da cewa masana kimiyya sun fara gwajin wasu alluran rigakafi da aka zaɓa a kan dabbobi daban-daban.
Masu binciken Kwalejin Imperial ta London sun sanar da cewa a ranar 20 ga Maris, 2020 za su yi allurar RNA ta COVID-19 ta atomatik.
Sun yi allurar rigakafin ne a cikin kwanaki 14 bayan sun san cewa Jayna ta yi tafiya.
A karshen watan Maris, gwamnatin Kanada ta sanar da cewa za ta saka dala miliyan 275 a cikin ayyukan bincike 96 don yaki da COVID-19, gami da wasu alluran rigakafin da kamfanoni da jami'o'in Kanada ke gudanarwa, kamar shirye-shiryen Medicago da Jami'ar Saskatchewan.
Har zuwa wannan lokacin, gwamnatin Kanada ta ba da sanarwar dala miliyan 192 na C don allurar rigakafin COVID-19, da kuma shirin samar da "takarar allurar rigakafi" na ƙasa don wasu sabbin alluran rigakafi don amfani da su a lokacin da cutar ta coronavirus ta sake farawa.
A ranar 2 ga Afrilu, 2020, masu binciken Jami'ar Pittsburg Sashen Magunguna sun yi sharhi game da gwajin PittCoVacc, allurar COVID-19 da ake gwadawa a cikin beraye, wanda ya ce "MNA tana samar da allurar SARS-CoV-2 S1 kuma ta haka ne antibody antigen na musamman ya amsa [fashin] wanda ke farawa a cikin makonni 2 bayan haɗuwa".
A Kanada a ranar 16 ga Afrilu, 2020, a cikin maganin Waterloo, Ma'aikatar Magunguna ta sanar da cewa ta kirkiro allurar rigakafin DNA wanda za a iya cirewa daga hanci.
Ta amfani da kwayoyin cuta, ana amfani da DNA don maye gurbin kwayoyin cuta marasa kwayoyin halitta zuwa kwayar cutar mara lahani, wanda zai iya samar da tsarin rigakafin jiki don cire maganin rigakafi ga kwayar cutar SARS-CoV-2.
A watan Maris na 2020, gwamnatin Amurka, masana'antu, da jami'o'i uku sun haɗa albarkatu don samun damar kwamfutar IB ta musamman, wanda ke adana bayanansa a cikin albarkatun Hewlett Packard Enterprise, Amazon, Microsoft, da Google.
Wasu siffofi suna da aiki iri ɗaya, wanda ake kira aiki mara iyaka.
Wannan yana nufin cewa yana da amfani fiye da rigakafin ciwo.
Ana buƙatar ƙarin gwajin sa'a a Austria don sarrafa shiga ma'aikatan kiwon lafiya 4,170.
Yana yiwuwa cewa allurar rigakafin ba ta da lafiya ko kuma ba ta da amfani.
Nazarin farko na yin kimantaccen ingancin allurar rigakafi ta amfani da COVID-19 na musamman a cikin dabbobi, kamar su beraye da aka yi wa ACE2, sauran gwaje-gwajen dabbobi, da sauransu, ya nuna cewa amincin matakin 3 na matakan da aka yi amfani da su wajen aiki da kwayar cutar mai rai, da haɗin gwiwar duniya don tabbatar da matakan tsarin tsaro.
An gwada allurar rigakafin SARS da MERS a cikin nau'ikan da ba a ba su ba.
Har zuwa shekarar 2020, babu wani magani ko allurar rigakafi da za su kare mu daga SARS wanda aka tabbatar da cewa ba shi da haɗari kuma yana da amfani ga mutane.
A cewar rahoton binciken da aka fitar a shekarar 2005 da 2006, ganowa da kuma samar da allurar rigakafi da magungunan da za su magance SARS babban fifiko ne ga gwamnatoci da hukumomin kiwon lafiya a duniya.
Lokacin da cutar ta MERS ta fara, an ga cewa binciken da ake yi game da SARS zai iya samar da ingantaccen tsari don yin allurar rigakafi da maganin kamuwa da cutar MERS-CoV.
A watan Maris na 2020, akwai (DNA) rigakafin MERS wanda ya kammala mataki na farko na gwajin ba tare da mutum ba, da kuma wasu uku masu gudana, duk rigakafin cutar ne, adenoviral na cutar biyu (ChAdOx1-MERS, BVRS-GamVac), da kuma MVA-MERS-S guda ɗaya.
An kafa wani shafi a shafukan sada zumunta na sanar da cewa an riga an yi allurar rigakafin cutar COVID-19.
Kamfanoni sun wallafa a shafukan sada zumunta daban-daban game da farkon jerin cututtukan cutar Hide sida da kuma allurar rigakafin wasu cututtukan coronavirus kamar SARS coronavirus.
B' Coronavirus rukuni ne na ƙwayoyin cuta da ke da alaƙa da juna wanda ke haifar da su daga dabbobi masu rarrafe da tsuntsaye.
Alamomin da aka fi sani da su sun haɗa da kumburi, kumburi, da kuma numfashi.
Sauran alamun sun haɗa da gajiya, ciwon tsoka, kumburi, ƙwanƙwasawar hanci, ƙanshi mai ƙanshi, da ciwon ciki.
Idan aka sha shi, tsawon lokacin da ake nuna alamun cutar zai kasance daga kwanaki biyar zuwa goma sha huɗu.
Ko da yake yawanci yana haifar da ƙananan ciwo, akwai yiwuwar cutar cututtukan huhu da kuma ƙwayoyin cuta da yawa da suka daina aiki.
A ranar 17 ga Afrilu, 2020, an samu karin shari'o'i miliyan 2.24 a kasashe da yankuna 210 da suka yi sanadiyar mutuwar mutane sama da 153,000.
Fiye da mutane 568,000 ne suka warke. Kwayar cutar tana watsawa ga mutane a karo na farko lokacin da suka kusanci juna, har ma da saɓo daga jikin mai tashi idan ya yi numfashi, ya motsa ko ya yi magana.
Ko da yake waɗannan cututtukan suna haifar da numfashi, yawanci suna faruwa ne a ƙasa ko wuraren da ake taɓawa inda za a iya rarraba ta daga nesa.
Mutane da yawa suna iya ɗaukar shi idan sun taɓa wani wuri a saman shi kuma sun taɓa idanunsu, hanci, ko bakinsu.
Kwayar cutar tana iya kasancewa a cikin mutum har zuwa sa'o'i 72.
Ana samun yaduwar cutar a cikin kwanaki uku na farko bayan bayyanar cututtuka, kodayake yana yiwuwa a yi amfani da su kafin bayyanar cututtuka. Hanyar da aka fi sani don ganowa ita ce rubuta amsa polymerase response (rRT-PCR) a cikin samfurin ƙwayar cuta.
Ana ba da shawarar yin amfani da abin rufe fuska ga waɗanda ake zargi da kamuwa da cutar da kuma masu kula da su.
Shawarwarin amfani da abin rufe fuska ga jama'a sun bambanta, kuma wasu hukumomi sun yi gargadin amfani da su, wasu sun ba da shawarar amfani da su, wasu kuma sun sanya su wajibi.
A halin yanzu, babu takamaiman allurar rigakafi ko takamaiman magunguna don magance cutar COVID-19.
An bayar da rahoton cewa cutar ta daɗe tana yaduwa a yawancin ƙasashe shida da WHO ke aiki.
Wadannan cututtuka sune cututtukan cuta ko kuma suna haifar da alamun sanyi kamar haushi, gajiya, da numfashi.
Alamomin da ke faruwa sun haɗa da matsalar numfashi, ciwon hanci ko matsa lamba, rashin ƙarfi, ƙafafun da suka yi wuya, da fuska ko kafafu da suka zama shuɗi; ana ba da shawarar a nemi magani nan da nan idan akwai waɗannan alamun.
A cikin rashin abinci mai yawa, ana iya ganin alamun numfashi na sama kamar ƙuƙwalwa, ƙuƙwalwa ko ƙuƙwalwa.
An lura da alamun ciki kamar ciwon ciki, ciwon ciki, da kuma kumburi a cikin adadi daban-daban.
A wasu lokuta, an lura da Jayna da farko da ciwon hanci da bugun zuciya mai tsanani.
A wasu wurare, ciwon zai iya zama ciwon huhu, rashin aikin kwayoyin halitta, da mutuwa.
Wannan shi ne lokacin da ba a nuna alamun cutar ba.
Lokaci ba tare da alamun COVID-19 ba ne sau da yawa gajere kuma yana iya zama kwanaki biyar zuwa shida, wanda a mafi yawan lokuta zai iya zama kwanaki biyu zuwa 14.
Kashi 97.5% na mutanen da ke da alamun cutar suna da kwanaki 11.5 na kamuwa da cutar. Rahotanni sun nuna cewa ba duk waɗanda ke da alamun cutar ba ne ke da alamun cutar.
Ba a san ko menene tasirin waɗannan alamun a cikin yaduwar cutar ba tukuna; amma, shaidun farko sun ce suna taimakawa wajen yaduwar ciwo.
Ba a san yawan mutanen da ke da alamun cutar ba a halin yanzu kuma ana gudanar da bincike, Cibiyar Kula da Cututtuka ta Koriya (KCDC) ta ce kashi 20% na dukkan cututtukan da aka tabbatar suna da alamun cutar yayin da suke asibiti.
Hukumar Lafiya ta Kasa ta Jannah ta fara hada alamun cutar a kowace rana daga 1 ga Afrilu; kuma mutane 166 da ke fama da kamuwa da cutar a wannan rana, 130 (78%) sun sami alamun cutar a lokacin binciken.
Wasu ƙwayoyin cuta da ƙwayoyin cuta na iya kamuwa da ƙwayoyin cuta da yawa.
Wannan babban adadin ƙwayoyin yana samar da maki da yawa fiye da yadda ake samu a yau.
Wani bincike da aka yi a Singapore ya gano cewa idan an saka ƙuƙwalwa a bakinsa ba tare da an saka ƙuƙwalwar ba, ƙuƙwalwar ƙuƙwalwar ƙuƙwalwar ƙuƙwalwar ƙuƙwalwar ƙuƙwalwar ƙuƙwalwar ƙuƙwalwar ƙuƙwalwar ƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙuƙ
Kodayake cutar ba ta da ƙwayar cuta a cikin iska, Cibiyar Kimiyya ta ƙasa ta ce za a iya watsa bioserosol kuma an gano RNA daga ƙwayar cuta a cikin masu tara iska a cikin ɗakunan ajiya na waje.
Wasu tsarin kiwon lafiya kamar cututtukan numfashi da cututtukan zuciya (CPR) na iya haifar da cire numfashi daga mutum wanda zai iya haifar da iska ta numfashi.
Ko da yake suna da damuwa game da yaduwar cutar ta tsokoki, ana ganin wannan haɗarin ba shi da yawa. Kwayar cutar tana iya yaduwa ga mutanen da ke da alamun; kodayake yana yiwuwa a yada ta ga mutanen da ba su da alamun, wannan haɗarin yana da ƙarancin gaske.
Cibiyar Kula da Cututtuka ta Tarayyar Turai (ECDC) ta ce ko da yake ba a bayyana yadda cutar ta fi sauƙin kamuwa da ita ba, yawanci mutum biyu zuwa uku ne ke kamuwa da cutar.
A musamman, kwayar cutar na iya rayuwa a kan katunan a rana ɗaya, kuma na iya rayuwa a kan filastik (polypropylene) da ƙarfe (AISI, 304) na kwana uku na tsawon sa'o'i huɗu a 99% na copper.
Wannan, duk da haka, ya bambanta kuma ya dogara da yanayin zafi da zafin jiki.
Sabulu da tayu suna da tasiri idan aka yi amfani da su yadda ya kamata; sabulu yana lalata kitse mai ƙwayoyin cuta wanda ke kare jiki daga cutar, kuma yana cire fata da wuraren da take.
Wani bayani kuma, kamar benzalkonium chloride da chlorhexidine gluconate (jermis dile), wanda ba shi da tasiri sosai. A wani binciken da aka gudanar a Hong Kong, an dauki samfurin kumfa tare da magani na kwanaki biyu bayan da aka kwantar da shi asibiti.
A cikin marasa lafiya biyar zuwa shida, an gano cewa samfurin farko yana da ƙwayar cutar da yawa, kuma a cikin marasa lafiya na shida an gano cewa yana da ƙwayar cutar da yawa fiye da na biyu a rana ta binciken.
Cutar huhu mai tsanani ta coronavirus 2 (SARS-CoV-2) cuta ce ta huhu mai tsanani ta coronavirus, mutane uku na farko da aka kwantar da su a asibiti suna da cututtukan huhu masu haɗari na cuta mai tsanani a Wuhan.
Dukkanin nau'ikan SARS-CoV-2 na kwayar cutar da ke da alaƙa da coronavirus a cikin rayuwa ta halitta.
A jikin mutum ba tare da mutum ba, ana kashe kwayar cutar ta sabulu na gida, wanda ke fashewa a cikin murfin kariya. SARS-CoV-2 yana da alaƙa da SARS-CoV.
Fushi shine mafi yawan kwayoyin da COVID-19 ke shafar saboda kwayar cutar tana iya shiga cikin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayo.
Kwayar cutar tana amfani da glycoprotein mai girma da ake kira peplomer don ɗaure ACE2 zuwa dukkan kwayoyin da ke karɓa.
Raunin zuciya mai tsanani yana faruwa a kashi 12% na mutanen da aka kwantar da su a asibitin Wuhan, Jayna, kuma yana da mafi yawan cututtukan zuciya.
Ana samun ciwon zuciya mai yawa, wanda ke haifar da tashin hankali da kuma lalata tsarin rigakafi a lokacin, amma mummunan rauni na zuciya na iya kasancewa tare da mai karɓar zuciya ACE2.
Ana ganin mai karɓar ACE2 a zuciya kuma yana hana zuciya aiki.
An samu karuwar cutar ta thrombosis (31%) da kuma cutar ta venous thromboembolis (25%) a cikin marasa lafiya na ICU da ke fama da cutar COVID-19 kuma ana iya danganta shi da rashin lafiyar su. A cikin gwajin da aka yi a kan mutanen da suka mutu daga COVID-19, an gano cewa cutar ta lalata alveolar (DAD), kuma a cikin lymphocyte akwai ƙonewar mai tacewa a huhu.
Kodayake SARS-COV-2 yana da yanayin ACE2 na ƙwayar epithelial a cikin numfashi, marasa lafiya da ke da COVID-19 mai tsanani suna da alamun tsarin tashin wuta.
Musamman, an lura cewa cutar ta GM-CSF-tushen-T tana da alaƙa da zuwan harshen IL-6 zuwa shigar da ciwon huhu a cikin marasa lafiya na COVID-19.
An kuma gano ƙonewar lymphocytic a cikin dakin gwaje-gwaje na jiki.
Hukumar ta WHO ta fitar da wasu dakunan gwaje-gwaje da aka yi don magance ciwo.
Tsarin aikin gwaji na yau da kullum shine sauya rubutun polymerase a cikin amsa (rRT-PCR).
Ana yin gwajin ne kawai da samfurin ƙura da aka ɗauka da goga mai ƙura; amma ana iya amfani da samfurin ƙura ko ƙura.
Yawanci ana samun sakamako a cikin 'yan sa'o'i zuwa kwanaki biyu.
Ana iya amfani da jini, amma zai bukaci a ɗauki samfurin jini biyu a cikin makonni biyu kuma sakamakon zai zama ɗan ɗan lokaci.
Masana kimiyya sun ware kwayar cutar coronavirus kuma suna buƙatar wani nau'i don haka dakunan gwaje-gwaje na duniya zasu iya yin amsa ta atomatik (PCR) na dakin gwaje-gwaje don gano kamuwa da cutar.
A ranar 4 ga Afrilu, 2020, an yi wani samfurin rigakafi (wanda ke gano kamuwa da cuta mai aiki da kuma idan mutum ya riga ya ɗauka) amma har yanzu ba a yi amfani da shi sosai ba.
Gwajin Jayne na dakin gwaje-gwaje ya nuna cewa yana da daidaito tsakanin kashi 60 zuwa 70%.
Hukumar kula da lafiya ta Amurka ta amince da dakin gwaje-gwaje na farko don amfani a ƙarshen watan Maris 21, 2020. Jagorancin dakin gwaje-gwaje sun buƙaci asibitin Zhongnan na Jami'ar Wihan don hanyar ganowa da aka ba da shawarar dangane da tsarin gwajin asibiti na haɗarin kamuwa da cuta.
Yawancin ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan
Ƙarfin subpleural, ƙarancin ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar cu.
Akwai bayanai kadan game da cutar COVID-19.
Babban ciwon da aka gano a cikin shaidan jiki shine:
Mascroscopy: pleurisy, pericarditis, haɗuwa da huhu da kuma kumburi
An gano nau'ikan cutar guda hudu masu tsanani:
cututtukan huhu: cututtukan huhu, cututtukan cututtukan huhu, cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukta.
ciwon huhu mai tsanani: an hana cutar ta alveolar (DAD) ta shiga cikin alveolar.
ADD yana haifar da ciwon huhu mai tsanani (ARDS) da kuma hypoxemia.
cututtukan huhu na zafi: abin da suke yi shi ne cire shinge na alveolar da kuma hanji na snake.
Jinin: rarraba tsoka (DIC); amsa ta leukerythroblastic
Matakai don rage kamuwa da cuta sun haɗa da kasancewa a cikin gida, guje wa wuraren taruwa, wanke hannuwanka da sabulu da ruwa da yawa da kuma shafawa aƙalla na dakika 20, kula da tsabta ta numfashi da kuma guje wa taɓa idanu, hanci, ko baki ba tare da jin dadi ba.
CDC ta ba da shawarar cire hanci da hanci a lokacin da ake numfashi ko kuma a lokacin da ake zubar da jini kuma ta ba da shawarar yin amfani da hanci na ciki idan ba a yi asibiti ba.
Abin farin ciki na ainihi bayan an yi masa rauni ko kuma an yi masa rauni.
CDC ta ba da shawarar yin amfani da tufafi masu tsabta da ke rufe fuska a wuraren waje lokacin fita, don rage yawan haɗuwa da mutane. An tsara nesa don rage haɗuwa da mutane ta hanyar haɗuwa da yawa a wuraren makaranta da aiki, ƙuntatawa na tafiya da kuma dakatar da taron jama'a.
Abubuwan da ke nuna cewa mutane suna da nisa tsakanin juna sun haɗa da mita 1.8.
Babu magani da aka gano don hana COVID-19. Ba a tsammanin allurar rigakafi za ta fito ba har zuwa farkon 2021, wani muhimmin ɓangare na sarrafa COVID-19 shine rage haɓakar yaduwar, wanda ake kira "rage yawan tafiya".
CDC ta ba da shawarar yin amfani da sabulu da ruwa na akalla sakan 20, musamman idan yatsunsu sun fita ko kuma hannayensu sun yi sanyi, kafin a dafa abinci da kuma bayan an zubar da kayan, a yi musu abinci ko kuma a zubar da su.
Hakanan ana ba da shawarar yin amfani da kayan tsabtace hannu tare da akalla kashi 60% na giya, amma kawai idan babu sabulu da ruwa. A wuraren da ba a sayar da kayan tsabtace hannu, WHO ta ba da umarnin yin hakan.
A wannan tsari, aikin antimicrobial ya samo asali ne daga ethanol ko isopropanol.
Ana amfani da hydrogen peroxide don kawar da ƙwayoyin cuta a cikin giya; "ba abu ne mai aiki ba".
Ana ƙara glycerol zuwa humicant.
Ana kula da mutane a ƙarƙashin kulawa, wanda ya haɗa da maganin ruwa, taimakon oxygen, da kuma taimakon sauran ƙwayoyin da cutar ta shafa.
Hukumar ta CDC ta ba da shawarar cewa mutanen da ake zargi da cutar su sa abin rufe fuska.
Ana amfani da maganin extracororeal (ECMO) wajen magance matsalolin numfashi, amma har yanzu ana lura da amfaninta.
Ana cewa tsaftace mutum da kuma salon rayuwa mai kyau da abinci mai gina jiki suna haɓaka rigakafi.
Maganin tallafi na iya taimakawa mutane da ke da alamun rashin lafiya a lokacin cutar. WHO da Hukumar Lafiya ta Kasa ta Jeniza sun nemi shawarwari kan yadda za a kare masu asibiti da ke fama da COVID-19.
Likitocin hanji da huhu sun hada da maganin da aka ba da shawarar Amurka a tsakanin hukumomi daban-daban kuma sun sanya shi kyauta, IBCC.
A watan Afrilu 2020, babu takamaiman magani don COVID-19.
Domin alamun cutar, wasu masana kiwon lafiya sun bada shawara cewa a fara amfani da acetaminophen a kan ibubaraphine.
Dole ne a yi hankali don rage haɗarin kamuwa da cutar, musamman a tsarin kiwon lafiya lokacin yin magani wanda zai iya haifar da iska mai numfashi, kamar intubation ko numfashi a hannayen.
Masu aikin kula da lafiya da ke kula da mutanen da ke fama da COVID-19, CDC ta ba da shawarar cewa a saka mutane a cikin dakin keɓewar marasa lafiya (AIIR) fiye da yadda ake so, don kula da mutane da kuma kula da iska. CDC ta ce a yi amfani da umarnin don amfani da kayan kariya na mutum (PPE) yayin ziyarar.
Abubuwan da aka ba da shawarar su ne: PPE mai ɗaukar fuska, mai ɗaukar numfashi ko abin rufe fuska, mai kula da idanu, da kuma ƙwanƙolin hannu.
An amince da abin rufe fuska na N95 don wannan aikin amma FDA ta samar da shi don amfani da abin rufe fuska don Amincewa don Amfani da Gaggawa (EUA).
An tsara shi don hana cututtukan iska kamar haihuwa amma yana da amfani ga kowane mai rai amma ba a ba da tabbacin amfani da kowane nau'i ba.
Idan ba a sami abin rufe fuska ba, CDC ta ba da shawarar rufe fuska, ko, idan babu wani abu, yin abin rufe fuska a gida.
Yawancin lokaci COVID-19 ba ta da wuya ko kuma ba ta canza yanayin ba, amma a wasu lokuta ba haka ba ne.
Nau'in tallafin numfashi na COVID-19 yana da alaƙa da rashin numfashi wanda ake nazari sosai a cikin asibitoci, wanda ke nuna cewa ana iya kauce wa shigar da bututun numfashi tare da ƙwanƙwasa hanci ko matakan iska biyu.
Idan waɗannan abubuwa biyu suna da amfani ga masu rashin lafiya ba a sani ba.
Wasu likitoci sun fi son kasancewa a gida a cikin hanyar numfashi idan akwai saboda wannan hanyar tana rage yawan numfashi fiye da a cikin hanci.
Kasashe da yawa masu tasowa ba su da isasshen gadajen asibiti don yawan jama'arsu, wanda iyakancewar ikon tsarin kiwon lafiya zai iya magance idan ba zato ba tsammani yawan mutanen da ke da COVID-19 masu tsanani suka karu kuma suna buƙatar asibiti.
Wani binciken da aka yi a Jayna ya gano cewa kashi 5% na mutanen da ke cikin babban kulawar, kashi 2.3% suna bukatar na'urar taimakon numfashi, kuma kashi 1.4% sun mutu.
A Jayna, a matsakaita kashi 30% na mutanen da aka kwantar da su asibiti don COVID-19 an tura su zuwa ICU.
Tsarin numfashi ya zama mai wahala yayin da cutar numfashi ta kara (ARDS) yayin da COVID-19 ke ƙaruwa kuma shan oxygen yana da wuya.
Ana buƙatar na'urar numfashi mai iya sarrafa yanayin matsin lamba da kuma babban PEEP don cimma matsakaicin isar da iskar oxygen don rage haɗarin numfashi da ke tattare da lalacewar huhu da preumothorax.
Ba a da na'urorin numfashi na baya a cikin PEEP na sama.
Wani bincike ya nuna cewa za a fara maganin a watan Janairun 2020, kuma za a gwada magungunan cutar a asibiti.
Remdesivir yana da alama shine mafi amfani.
Duk da cewa sabbin magunguna na iya amfani da su har zuwa shekarar 2021, an gwada wasu daga cikin wadannan magunguna kuma an riga an amince da su don amfani da su a wasu abubuwa ko kuma suna da inganci.
Ana iya gwada magungunan cutar a kan mutane masu fama da ciwo mai tsanani.
Hukumar ta WHO ta ce mutane masu aiki iri daya za su shiga cikin gwajin inganci da amincin magani na gaba. Hukumar ta FDA ta ba da izinin wucin gadi na plasma convalescent wanda shine magani na gwaji lokacin da yanayin mutum ya yi tsanani ko kuma yana buƙatar magani na gaggawa.
Har yanzu ba a gudanar da wani gwaji na asibiti ba wanda zai nuna yadda hankali yake da tasiri a kan ciwo.
A watan Fabrairun 2020, Jayna ta kirkiro wani app don aiki da cutar ta kamuwa da cuta.
Ana buƙatar masu amfani su shigar da suna da lambar shaidar.
Aikace-aikacen yana iya bin diddigin 'yan adam' ta amfani da bayanan sa ido da haɗarin watsawa.
Kowane mai amfani zai iya duba yanayin wasu masu amfani uku.
Idan aka gano wata barazana, app din ba kawai yana ba da shawarar yin haɗin kai ba, yana kuma sanar da hukumomin yankin. Yana gyara bayanai da yawa ciki har da wayar hannu, gano fuska, bin diddigin wayar hannu da kuma fasahar da ake amfani da ita don bin diddigin masu kamuwa da cutar da kuma mutanen da ke kusa da su a Koriya ta Kudu, Taiwan da Singapore.
A watan Maris na shekarar 2020, gwamnatin Isra'ila ta ba da izinin hukumar ta kula da hankali ta duba wayar salula ta mutum da ake zargin yana dauke da cutar coronavirus.
An dauki matakan da za su tabbatar da keɓewa da kuma kare mutanen da ke kusa da mutanen da ke da kamuwa da cuta.
A watan Maris na shekarar 2020, kamfanin dillancin labarai na Deutsche Telekom ya raba bayanai game da inda wayar tarho ta hukumar tarayya ta Jamus, Cibiyar Robert Koch take, domin a yi bincike da kuma hana yaduwar cutar.
Rasha ta kirkiro fasahar gano fuska don bin diddigin mutanen da suka keta dokar keɓewa.
Shugaban hukumar kiwon lafiya ta Italiya Giulio Gallera ya shaida wa kamfanin wayar tarho cewa "kashi 40% na mutane suna tafiya yadda suke so".
Kungiyar Jamus ta gudanar da nazarin kwamfuta na tsawon sa'o'i 48 a cikin kwanaki biyu na hutu tare da halartar mutane sama da 42.000.
Shugaban Estonia, Kersti Kaljulaid, ya yi kira ga kasashen duniya su magance yaduwar cutar coronavirus.
Mutane na iya yin magana a lokacin keɓewa, ƙuntatawa na tafiya, illa ga lafiyar magani ko kuma suna tsoron ɗaukar shi.
BBC ta nakalto Rory O'Connor ya ce, "Ƙara yawan ware mutane, kadaici, labarai, hayaniya da rufe tattalin arziki iska ce mai lahani ga lafiyar hankali da lafiyar mutane".
Zai iya rage cutar ta rashin bayyanar cututtuka ko kuma rashin bayyanar cututtuka, wanda ya yi daidai da sauran cututtukan numfashi kamar mura.
A cikin ƙananan cututtuka ana warkar da su na tsawon makonni biyu, yayin da a cikin waɗanda suke da tsanani ko tsanani, ana iya ɗaukar har zuwa makonni shida don warkewa.
Mata masu juna biyu na iya samun haɗarin kamuwa da COVID-19 kamar yadda aka gano daga bayanan da aka samu game da irin waɗannan ƙwayoyin cuta, kamar SARS da MERS, amma bayanan COVID-19 har yanzu kaɗan ne. Ga wasu mutane, COVID-19 na iya shafar abin da ke haifar da cututtukan huhu.
A cikin matsanancin hali, COVID-19 na iya zama cutar numfashi mai tsanani (ARDS) wanda ke haifar da ciwon numfashi, ciwon jini a cikin ƙwayoyin cuta ko kuma a cikin ƙwayoyin da suka tsaya.
Matsalolin da ke tattare da COVID-19 na jini, cututtukan jini da cututtukan zuciya, koda, da hanta.
Ana ganin cewa cututtukan jini na yau da kullum suna ƙara tsawon lokacin gwajin jini yayin da suke da damar yin gwajin, kuma an ce suna da kashi 6% na mutanen da aka kwantar da su a asibitin COVID-19, yayin da a cikin wannan rukuni ana ganin aikin koda na yau da kullun a kashi 4%.
A matsakaici, kashi 20-30% na mutanen da aka gano suna da ƙwayoyin cuta na hanta (transaminases).
Rahoton ya ce, lokacin da alamun suka fara zuwa mutuwar kwanaki goma ne, biyar a asibiti.
Amma, lokacin da aka kai marasa lafiya zuwa ICU ya kasance kwana bakwai daga lokacin da aka kwantar da su zuwa lokacin mutuwar su.
A cikin binciken da aka yi a cikin mutane na farko, lokacin da aka samu alamun rashin lafiya zuwa mutuwa ya kai kwanaki 14, wanda a matsakaicin lokaci ya kai kwanaki 41.
A wani binciken da Hukumar Lafiya ta Kasa (NHC) ta Jayna ta gudanar, maza suna da adadin mutuwar 2.8% yayin da mata ke da kashi 1.7%.
Gwajin Histopathological na samfurin huhu wanda aka bincika tasirin alveolar na fubromyxiod da aka cire daga huhu.
An canza canjin cutar kuma an gano dalilin ciwo.
An lura da hotunan huhu na ciwon huhu mai tsanani (ARDS).
Hukumar Lafiya ta Kasa ta Jayna ta bayar da rahoton cewa kashi 11.8% na mutuwar da aka samu sakamakon cutar zuciya sun haifar da karuwar yawan kwayoyin cutar troponin ko kuma rashin aikin zuciya.
A cewar bayanan Maris a Amurka, kashi 89% na mutanen da aka kwantar a asibiti suna da cututtukan farko.
Tsarin ya bambanta saboda yanayin da yanayin da ke kewaye da shi, amma kuma saboda yanayin da ya dace.
An yi ƙoƙari don rage yawan ƙananan cututtuka da ke haifar da mutuwa.
Amma, saboda mutuwar ta haifar da lokacin da aka ɗauka a cikin lokaci, adadin mutuwar da aka rage a wannan lokacin ya yi daidai da adadin mutuwar.
Masu shan sigari suna da damar kamuwa da cutar COVID-19 sau 1.4 kuma a matsakaita sau 2.4 suna da damar samun kulawa mai kyau ko mutuwa fiye da waɗanda ba sa shan sigari. An nuna damuwa game da ciwon na dogon lokaci.
Hukumar asibitin Hong Kong ta gano cewa an samu raguwar kashi 20 zuwa 30% na ƙarfin huhu na mutanen da suka warke daga cutar, kuma an yi hotunan huhu da aka gani cewa an sami lalacewar kwayar.
Wannan kuma zai iya haifar da sakamako mai illa.
Har zuwa Maris 2020, ba a san ko wani ciwo da kuma rigakafin jiki na dogon lokaci da ya warke daga ciwo ya haifar da kamuwa da cuta ba.
Ba za a iya yin komai ba, bisa ga wasu halaye na coronavirus, amma an biye da shari'o'in da suka warke daga COVID-19 ta hanyar binciken da aka samu game da coronavirus wanda aka bayar daga baya.
Ana ganin cewa waɗannan lokuta suna ƙara cutar koda zuwa wani abu kuma hakan zai iya haifar da ciwon baya.
Ana ganin cewa kwayar cutar ta samo asali ne daga dabbobi, kuma ta kamu da cuta.
Ba a san asalinsa ba, amma a watan Disamba na shekarar 2019 cutar ta kasance tana yaduwa sosai.
A wani binciken da aka gudanar kan mutane 41 da aka fara tabbatar da cutar COVID-19, wanda aka buga a watan Janairun 2020, The Lancet, an bayyana cewa ranar farko da alamun suka fara ba 1 ga Disamba 2019 ba ce.
Rahoton WHO ya bayyana cewa alamun sun fara ne a ranar 8 ga Disamba, 2019.
An yi wasu magungunan da suka dace da mutuwa.
Wadannan kididdigar sun bambanta a wurare da lokatai kuma suna iya shafar girman dakin gwaje-gwaje, tsarin kula da lafiya, zaɓuɓɓukan magani, tsawon lokacin da ya fara da kuma tsarin magani kamar shekaru, jinsi da lafiyar jama'a.
A ƙarshen 2019, WHO ta sanya cutar ICD-10 a cikin ƙa'idar mutuwar U07.1 ta hanyar tashi yayin da gwajin gwajin ya tabbatar da cutar SARS-CoV-2 mai kamuwa da cuta da U07.2 na mutuwar asibiti ko gwajin gwajin cutar COVID-19 mai kamuwa da cuta wanda aka tabbatar da cutar SARS-CoV-2 mai kamuwa da cuta.
Bisa ga kididdigar Jami'ar Hopkins, adadin mutuwar daga cutar kwayar cutar ya kai kashi 6.9% (153,822/2,240,191) a ranar 17 ga Afrilu 2020.
Yawan zai iya bambanta daga wuri zuwa wuri. Sauran matakai sun haɗa da yawan mutuwar (CFR), wanda ke nuna yawan mutanen da suka mutu saboda ciwon, da kuma yawan adadin ciwon (IFR), wanda ke nuna yawan mutanen da suka mutu (na bincike ko ba a bincika ba) saboda ciwon.
A cikin wannan ƙididdigar, ba za a iya samun lokaci ba don bin wani samfurin na waɗanda suka warke daga ciwo.
Ko da yake ba kowa ba ne ke da maganin rigakafi, kasancewar maganin zai iya ba da bayani game da yawan mutanen da suka kamu da cutar.
A cikin mafi yawan yankunan Italiya, Castiglione d'Adda, ƙauyen ƙauye guda 4,600, 80 (1.7%) sun mutu.
A Galgelt, cutar ta bazu a lokacin bikin Carnival, kuma ta bazu ga ƙananan mutane, wanda ya haifar da ƙananan mutuwar, kuma ba a bayyana duk mutuwar COVID-19 a matsayin sakamakon cutar ba.
Hakanan, tsarin kiwon lafiya na Jamus bai yi tasiri ba.
A cikin Needarlan, kusan kashi 3 cikin dari sun karɓi maganin rigakafi, kamar yadda aka ba da rahoton wanda ya ba da jini.
An tabbatar da cewa 69 (0.004% na yawan jama'a) sun mutu daga COVID-19.
A sakamakon ciwo da kuma yawan mutuwa, akwai bambanci sosai tsakanin maza da mata.
Yawanci mutane ne ke mutuwa a ƙasar Janai da Italiya.
Wannan haɗarin ya fi girma ga maza a cikin shekaru 50, kuma bambanci tsakanin maza da mata ya kai 90.
A cikin Jayna, an ba da rahoton mutuwar kashi 2.8 cikin dari a cikin maza da kashi 1.7 cikin dari a cikin mata.
Dalilin da ya sa mutane suke da bambancin jinsi ba a sani ba, amma irin mutane da halayensu na iya zama sanadiyar hakan.
Jima'i bisa ga bambancin rigakafin jiki, rashin shan taba a cikin mata da kuma rashin rashin jin daɗin tashin hankali a cikin ƙananan yara fiye da mata sun ba da gudummawa ga yawan mutuwar maza.
A Turai, kashi 57% na mutanen da suka kamu da cutar sun kasance maza kuma kashi 72% na waɗanda suka mutu daga COVID-19 sun kasance maza.
A watan Afrilu na shekarar 2020, gwamnatin Amurka ba ta saka idanu kan bayanan mutuwar jinsi daga COVID-19.
Wani bincike ya nuna cewa cututtukan cutar Ebola, HIV, mura da SARS suna aiki daban-daban tsakanin maza da mata.
Yawancin ma'aikatan kiwon lafiya, musamman ma ma'aikatan kiwon lafiya, mata ne, kuma suna da damar kamuwa da cutar.
Hukumar Lafiya ta Duniya ta bayyana a ranar 11 ga Fabrairu, 2020 cewa sunan hukuma na cutar shine "COVID-19".
Shugaban WHO Tedros Adhanom Ghebreyesus ya ce CO na nufin corona, VI na nufin virus, D na nufin cuta kuma 19 na nufin cutar a karon farko da aka lura da cutar: 31 ga Disamba, 2019.
An zabi sunan ne don kauce wa bayyana yanayin da ke cikin katin cutar (kamar Jayna), nau'in dabba ko rukuni na mutane, gas daidai da shawarwarin duniya game da manufar suna don kawar da nuna bambanci. Kwayar cutar COVID-19 tana da sunan cutar coronavirus mai tsanani ta cutar numfashi 2 (SARS-CoV-2).
WHO tana amfani da "kwararriyar cutar COVID-19" da "kwararriyar cutar COVID-19" a lokacin da take samar da rahotanni.
Ana kiran cutar da kuma cutar "coronavirus".
A lokacin da cutar ta farko ta barke a Wuhan, Jinai, an san cutar da cutar da "coronavirus" da "Wuhan coronavirus".
A watan Janairun 2020, WHO ta ba da shawarar cewa 2019-nCov da 2019 nCoV na ciwon huhu na ciwon huhu su zama na wucin gadi na cutar da cutar daidai da umarnin 2015 don kada a yi amfani da wuri a matsayin cutar da cutar.
An kirkiro sunayen hukuma na COVID-19 da SARS-CoV-2 a ranar 11 ga Fabrairu, 2020.
Saboda ƙuntatawa a cikin tallace-tallace, wasu masana'antun dijital sun buga kayayyakin kiwon lafiya kamar jakar samfurin fata da kayan aikin numfashi.
Misali, lokacin da asibitin Italiya ya nemi tsarin injin numfashi da sauri, kuma ba su da kayan aikin da ake buƙata a lokacin, wani kamfani na muhalli ya ƙirƙira kuma ya buga nau'ikan 100 a dare ɗaya.
Bayan barkewar cutar COVID-19 ta farko, an yi ta yin ta ta ta hanyar ɓoye abubuwa da yawa, tare da bayanan da ba daidai ba da kuma bayanan da ba daidai ba game da asalinsa, tsawonsa, rigakafi, magani da sauran fannonin cutar kuma saboda haka ana buƙatar su cikin sauri akan layi.
Ba tare da mutum ba, za mu iya yin aiki fiye da sauran dabbobi.
Ba a gano cewa cutar ta fito ne daga alade, da naman alade, da kaza.
Babu magani ko allurar rigakafi da aka amince da su.
Ana gudanar da bincike na duniya kan allurar rigakafi da magungunan COVID-19 ta hukumomi da gwamnatoci, ƙungiyar ilimi da sassan bincike.
A watan Maris, Hukumar Lafiya ta Duniya ta ƙaddamar da "Gwaji na DARACIYA" don kimanta tasirin maganin maganin ƙwayoyin cuta waɗanda aka ce a lokacin za su iya kawar da cutar.
Wataƙila rigakafi, amma hukumomi daban-daban suna aiki a kan samun rigakafi.
An yi amfani da ayyukan SARS-CoV na farko a matsayin SARS-CoV da SARS-CoV-2 guda biyu don amfani da mai karɓar ACE2 wanda ke shiga cikin sel ɗin da ba mutum ba.
Akwai matakai uku na allurar rigakafi da ake bincike.
Na farko, masu bincike suna da burin samar da allurar rigakafi ga cutar gaba daya.
Ana amfani da wannan nau'in kwayar cutar, wadda ba ta aiki ko kuma ta mutu, don inganta tsarin rigakafin jiki na mutum ba tare da sabon kamuwa da cutar COVID-19 ba.
Mataki na biyu, yin allurar rigakafi, shine gano rashin lafiyar tsarin rigakafi na wasu ƙwayoyin cuta.
Game da SARS-CoV-2, irin wannan binciken ya mai da hankali ne kan karuwar furotin S wanda ke taimakawa ƙwayoyin cuta masu karɓar enzyme ACE2.
Hanyar ta uku ta allurar rigakafi ta hanyar nukiliya (DNA ko RNA, fasaha ta samar da allurar rigakafi).
Za a gwada lafiyar da ingancin allurar rigakafin da aka yi a kan farashin wani abu. A ranar 16 ga Maris, 2020, an fara gwajin farko na rigakafin tare da mutane huɗu da suka yarda da kansu a Seattle.
Allurar rigakafi tana dauke da kwafin kwayar cutar da ba ta da lahani. Ana kara yawan maganin rigakafi wanda ke nuna cewa akwai wata matsala wajen yin allurar SARS-COV-2, amma akwai rikici.
Akwai gwaji na asibiti sama da 300 da ke aiki har zuwa Afrilu 2020.
An yi nazari da kuma amincewa da gwaje-gwaje da dama a kan malati, ciki har da nazarin hydroxychloroquine ko chloroquine.
Sake amfani da magungunan cutar shine binciken Jayneys, wanda ya wuce ta hanyar gwajin remdesivir na kashi tara na III a cikin wasu ƙasashe a ƙarshen Afrilu, kamar yadda rahoton ya bayyana.
An yi nazari sosai kan samar da allurar rigakafin COVID-19 a cikin asibiti da kuma magungunan da aka yi, Afrilu 2020. An yi la'akari da wasu magungunan cutar da suka gabata don magance COVID-19, ciki har da remdesivir, chloroquine da hyroxychloroquine, lopinavir/ritonavir da lopinavir/ritonavir tare da interferon beta.
Ana lura da raguwar cutar ta remdesivir, har zuwa Maris 2020.
An lura da kyakkyawan lafiyar marasa lafiya lokacin amfani da remdesivir cikin jinƙai.
An gudanar da gwajin sashi na III a cibiyar kiwon lafiya a Amurka, Jena, da Italiya. Chloroquine, wanda aka yi amfani da shi a dā a maganin rigakafi, an gudanar da bincike a Jena a watan Fabrairun 2020, wanda sakamakon farko ya fito.
Amma, akwai bukatar masu bincike su duba.
Hukumar Lafiya ta Koriya da Jina sun bada shawarar yin amfani da chloroquine.
Amma, Cibiyar Kwayar cutar Wuhan, duk da cewa ta bada shawarar iyakar gram daya a kowace rana, ta ce yawan adadin ya ninka haɗarin cutar sau biyu.
A ranar 28 ga Maris, 2020, FDA ta ba da izinin amfani da hydroxychloroquine da chloroquine a cikin gaggawa wanda likitan da ke kula da mutane da COVID-19 ya amince da shi. Kwafin 7 na jagorar Jayna ya ƙunshi interferon, ribavirin ko umifenovir don amfani da COVID-19.
Bayanai na farko sun nuna cewa ana amfani da ribavirin a cikin hanci don SARS-CoV-2 a cikin vitro.
Nitrozoxanide an yi niyyar amfani da shi a nan gaba a cikin nazarin vivo bayan an gano ƙananan matsin numfashi na SARS-CoV-2. Nazarin da aka yi akan furotin mai haɓaka na farko na protease na watsawar ƙwayar cuta serane 2 (TMPRSS2) ya zama dole don shigar da SARS-CoV-2 a cikin hulɗar masu karɓar ACE2.
Binciken da aka yi akan chloroquine da hydroxchloroquine tare da ko ba tare da azithromycin ba ya iyakance ƙuntatawa a cikin al'umma ta kiwon lafiya don gano wannan magani ba tare da yin binciken ba. Oseltamivir ba ya iyakance shan SARS-CoV-2 a cikin vitro kuma ba a san rawar da yake takawa a cikin maganin COVID-19.
Cyroquin hadari na iya zama matsala mai tsanani a ƙarshen COVID-19.
Akwai hujja cewa hydroxychloroquine na iya samun tasirin anti-cytokine. Tocilizumab kuma yana cikin magani a cikin umarnin Hukumar Lafiya ta Kasa ta Jayna bayan kammala binciken.
Idan ba a yi amfani da hanyar 2 ba a matsayin wata hanyar da aka yi amfani da ita a cikin Italiya bayan an gano cewa ta kasance mai kyau ga mutanen da ke fama da ciwo mai tsanani.
Hada ferritin serum da kwayoyin jini don gano cytokine na hadari, yana nufin wani abu da aka yi don yaki da cutar, wanda aka ɗauka yana haifar da mutuwar wasu mutane.
FDA ta amince da mai karɓar interleukin-6 mai karɓar maganin, bisa ga sakamakon binciken likita na abin da ke haifar da isotonin cytokine wanda ke haifar da kumburi, CAR T cell mai lura, a shekara ta 2017.
Har yanzu, babu wata hujja ta hana rigakafin cutar ta CRS.
Ana gudanar da bincike kan samar da maganin rigakafi mai tsafta da kuma karko a tsarin rigakafin mutanen da ke murmurewa daga COVID-19 ga mutanen da ke cikin bukata ta hanyar rigakafin da ba rigakafi ba.
An biya wannan kuɗin don maganin SARS wanda ya haɗa da sakamakon da bai cika ba.
Ana iya watsa kwayar cutar a cikin hanyar da ake so ta maganin maganin hana bacci zuwa SARS-CoV-2.
Amma wasu hanyoyi, kamar maganin rigakafi wanda ya dogara da cytotoxicity a cikin sel da / ko phagocytosis, suna yiwuwa.
Ana yin wasu nau'ikan maganin anti-jump, misali, ta amfani da maganin anti-jump monoclonal.
Abubuwan da ke cikin ƙwayar cuta, wanda ya ƙunshi wani ɓangare na jini daga cikin marasa lafiya wanda ya ƙunshi wani maganin rigakafi na ƙwayoyin cuta, zai iya haɓaka haɓakar sauri.
Cutar coronavirus, wata cuta mai matukar kusanci
Li Wenlian, likita a babban asibitin Wuhan, wanda daga bisani ya kamu da COVID-19 kuma ya mutu bayan ya ba da rahoton barkewar cutar.
Li Wenlian, likita a babban asibitin Wuhan, wanda daga bisani ya kamu da COVID-19 kuma ya mutu bayan ya ba da rahoton barkewar cutar.
